<?xml version="1.0" encoding="UTF-8"?>
<pmxi_records><node>
		<id><![CDATA[7162]]></id>
		<title><![CDATA[一醫生一iPad 巡房快夾準]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;">一醫生一iPad 巡房快夾準</span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">電視劇中的醫生總是記憶力特強，能一口氣向病床上的病人講解醫療報告，但現實是醫生巡房時要先查看病房中俗稱「台頭機」的電腦，瀏覽醫療紀錄、抽血或化驗報告等，再到床邊向病人講解。若遇到複雜的報告，醫生更要穿梭病床與電腦之間查看，打斷會診。公立醫院引入「一醫生一iPad」計劃，醫生巡房時毋須再被「台頭機」困身。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><iframe allow="encrypted-media" allowfullscreen="" frameborder="0" gesture="media" height="480" scrolling="no" src="http://tv.on.cc/hk/index.html?i=ONS180107-14661-22-M&amp;d=1515340518" width="680"></iframe></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">除了掛在身上的聽診器，平板電腦將成為醫生巡房時的必備工具。將軍澳醫院外科副顧問醫生李文傑稱，每間病房有四至五部「台頭機」，供醫生巡房時瀏覽臨床管理資訊系統（CMS），包括病人用藥情況、病歷紀錄、X光或抽血報告等。一來電腦數目不夠，二來醫生難以看一次便全部記住報告內容，總要反覆來回查看電腦數次，甚至要拿紙筆抄寫，「病人見醫生無啦啦走開，會好不解，亦覺得唔尊重，容易產生誤會。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h3><strong><span style="font-size:20px;"><span style="color:#000000;">可直接更改服藥指令</span></span></strong></h3>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">將軍澳醫院前年四月起最先推行「一醫生一iPad」計劃，每名醫生人手執一部平板電腦，巡房時只要到病床邊用平板電腦瀏覽CMS，便可即時向病人講解臨床情況，亦可直接在系統內更改服藥指令等，毋須再依賴「台頭機」。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">李文傑分享經驗，指出不少「斷肋骨」病人最想知道自己究竟斷了多少條肋骨，「以往多數係醫生喺台頭機睇完用口講解畀病人知，依家可用iPad開畀病人睇張3D嘅X光片，病人掌握多啲，同醫生互動都好咗。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(14).jpg" style="width: 300px; height: 400px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">李文傑（左）指只要用平板電腦，便可向病人講解臨床情況。圖中為醫管局資訊科技及醫療訊息主管張毅翔。（吳艷玲攝）</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2(8).jpg" style="width: 600px; height: 400px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">醫生過去十分依賴病房「台頭機」瀏覽病人醫療紀錄。（資料圖片）</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <h3><strong><span style="font-size:20px;">影傷口免反覆揭紗布</span></strong></h3>  <p>&nbsp;</p>  <p><span style="font-size:16px;">此外，平板電腦的拍攝功能亦帶來好處。以外科病人為例，李表示不少醫生巡房時須揭開病人傷口紗布查看狀況，傷口經常暴露易有感染風險，之後醫生又須改用數碼相機拍攝傷口狀況，再列印出來夾於排板內，供不同巡房醫生檢閱，做法費時失事，現時醫生只要用平板電腦拍攝傷口照片，即可直接上傳到CMS，下一名醫生便可清楚見到傷口變化，毋須反覆揭開病人紗布。</span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;">「一醫生一iPad」計劃去年擴展至十五間急症醫院，不少前線專科醫生已經使用，醫管局目前約購置了五百部平板電腦供更多人使用。</span></p>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:14px;">文章來自: ON.CC</span></p>  <p><span style="font-size:14px;"><a href="http://orientaldaily.on.cc/cnt/news/20180108/00176_100.html" target="_blank"><span style="color:#0000FF;">http://orientaldaily.on.cc/cnt/news/20180108/00176_100.html</span></a></span></p>  <p style="text-align: center;">&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180110]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%80%e9%86%ab%e7%94%9f%e4%b8%80ipad-%e5%b7%a1%e6%88%bf%e5%bf%ab%e5%a4%be%e6%ba%96/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%80%e9%86%ab%e7%94%9f%e4%b8%80ipad-%e5%b7%a1%e6%88%bf%e5%bf%ab%e5%a4%be%e6%ba%96]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[129]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180110]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7163]]></id>
		<title><![CDATA[牛津研究：中年處男 患前列腺癌機會少47%]]></title>
		<content><![CDATA[<p class="ArticleIntro" style="padding: 0px; margin: 0px 0px 15px; font-size: 15px; letter-spacing: 1.2px; line-height: 1.5em; color: rgb(51, 51, 51); font-family: PMingLiu, mingliu, 細明體_HKSCS-ExtB, &quot;Ming(for ISO10646)ExtB&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);">英國牛津大學一項研究發現，如果中年男子仍是處男，患前列腺癌機會比性生活活躍的男士少47%。</p>  <p style="padding: 0px; margin: 0px 0px 15px; font-size: 15px; letter-spacing: 1.2px; line-height: 1.5em; color: rgb(51, 51, 51); font-family: PMingLiu, mingliu, 細明體_HKSCS-ExtB, &quot;Ming(for ISO10646)ExtB&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);"><span style="color: rgb(51, 51, 51); font-family: PMingLiu, mingliu, 細明體_HKSCS-ExtB, &quot;Ming(for ISO10646)ExtB&quot;, Arial, Helvetica, sans-serif; font-size: 15px; letter-spacing: 1.2px; background-color: rgb(255, 255, 255);">研究人員調查了22萬名年齡介乎40至69歲的男子，發現中年處男相對性生活活躍的男士，患前列腺癌機會少47%。前列腺癌是英國男士「頭號敵人」，平均每8名男士便有1人患病。</span></p>  <p style="padding: 0px; margin: 0px 0px 15px; font-size: 15px; letter-spacing: 1.2px; line-height: 1.5em; color: rgb(51, 51, 51); font-family: PMingLiu, mingliu, 細明體_HKSCS-ExtB, &quot;Ming(for ISO10646)ExtB&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);"><span style="color: rgb(51, 51, 51); font-family: PMingLiu, mingliu, 細明體_HKSCS-ExtB, &quot;Ming(for ISO10646)ExtB&quot;, Arial, Helvetica, sans-serif; font-size: 15px; letter-spacing: 1.2px; background-color: rgb(255, 255, 255);">負責研究的蒂姆基（Tim Key）教授表示，「（患者）透過性行為感染，增加患前列腺癌風險，這個可能性存在。」蒂姆教授指另一個可能性與低水平睪丸酮水平有關，因為睪丸酮水平低便能避免患前列腺患癌，「因為（睪丸酮）是性荷爾蒙，這或許可以解為何這些男士對性興趣不大。」</span></p>  <p style="padding: 0px; margin: 0px 0px 15px; font-size: 15px; letter-spacing: 1.2px; line-height: 1.5em; color: rgb(51, 51, 51); font-family: PMingLiu, mingliu, 細明體_HKSCS-ExtB, &quot;Ming(for ISO10646)ExtB&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/pcancer.jpg" style="width: 521px; height: 340px;" /></p>  <p style="padding: 0px; margin: 0px 0px 15px; font-size: 15px; letter-spacing: 1.2px; line-height: 1.5em; color: rgb(51, 51, 51); font-family: PMingLiu, mingliu, 細明體_HKSCS-ExtB, &quot;Ming(for ISO10646)ExtB&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);"><span style="font-size:16px;"><strong>Stay virgin to avoid cancer: Study reveals middle-aged virgins have less risk of getting prostate cancer</strong></span></p>  <h2 class="subline" itemprop="alternateName" style="margin: 10px 0px 15px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 22px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17); position: relative;">The study revealed that men who had never experienced sexual intercourse were 47 percent less likely to develop the disease.</h2>  <p>&nbsp;</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">A new study has revealed that the chances of middle-aged virgins getting prostate cancer is much less as compared to men who are sexually active.</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">Scientists, compiled data from 220,000 men aged between 40 and 69 for the study and found that virgins have half the risk of getting prostate cancer when compared to sexually active men.</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">The study revealed that men who had never experienced sexual intercourse were 47 percent less likely to develop the disease.</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">According to the research carried out by Oxford University, the likelihood jumps up to almost one in 16 for virgins.</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">It is to be noted that prostate cancer is one of the most common cancers among men in the UK. One in eight is being diagnosed with the deadly disease in their lifetime, with reportedly 43,000 cases in the UK, each year.</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">Professor Tim Key told The Sun: &quot;Infections passed during sex, raising prostate cancer risk, could be a possibility.&quot;</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">Professor Key added: &quot;Low testosterone levels are also a possible explanation. We know it is a protective factor against prostate cancer. And as it is a sex hormone, it may explain why these men are less interested in sex.&quot;</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">He explained saying that reduced levels of testosterone in virgins may have contributed to the lower levels of diagnosis.</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">However, Prof Key also admitted: &quot;It is a huge study but there were only about 20 cases of men who had never had sex.&quot;</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);">The study also showed that being fat also appears to slash the risk by a quarter. Referring to the lower risk of the disease for obese men, Prof Key said: &quot;It may be that it is simply harder to pick up cancer in these men.</p>  <p style="margin: 0px 0px 25px; padding: 0px; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 17px; line-height: 24px; font-family: Lato, Helvetica, Arial, sans-serif; color: rgb(17, 17, 17);"><a href="http://www.ibtimes.co.in/stay-virgin-avoid-cancer-study-reveals-middle-aged-virgins-have-less-risk-getting-prostate-cancer-755304" target="_blank">http://www.ibtimes.co.in/stay-virgin-avoid-cancer-study-reveals-middle-aged-virgins-have-less-risk-getting-prostate-cancer-755304</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180112]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%89%9b%e6%b4%a5%e7%a0%94%e7%a9%b6%ef%bc%9a%e4%b8%ad%e5%b9%b4%e8%99%95%e7%94%b7-%e6%82%a3%e5%89%8d%e5%88%97%e8%85%ba%e7%99%8c%e6%a9%9f%e6%9c%83%e5%b0%9147/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>統計分析]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%89%9b%e6%b4%a5%e7%a0%94%e7%a9%b6%ef%bc%9a%e4%b8%ad%e5%b9%b4%e8%99%95%e7%94%b7-%e6%82%a3%e5%89%8d%e5%88%97%e8%85%ba%e7%99%8c%e6%a9%9f%e6%9c%83%e5%b0%9147]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[130]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180112]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7164]]></id>
		<title><![CDATA[深圳揭抗癌藥造假：與醫生「合作」推薦假藥給病患　每盒賺上萬元]]></title>
		<content><![CDATA[<p><strong><span style="color:#000000;"><span style="font-size:26px;">深圳揭抗癌藥造假：與醫生「合作」推薦假藥給病患 每盒賺上萬元</span></span></strong></p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:14px;">撰文： 劉莎莎</span></span></p>  <div class="date"><span style="color:#696969;"><span style="font-size:14px;">發佈日期：2018-01-13 11:22</span></span></div>  <div class="date"><span style="color:#696969;"><span style="font-size:14px;">最後更新日期：2018-01-13 13:30</span></span></div>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><strong><span style="color:#000000;"><span style="font-size:26px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/e4a02cb4d815a3a2407f69cfed16a842.jpg" style="width: 640px; height: 360px;" /></span></span></strong></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <ul> 	<li> 	<h2><span style="font-size:16px;">深圳市中級法院近日審結一宗假抗癌藥案件，8名被告被指在一年半時間內，通過醫生「搭橋牽線」，向全國30多個省市銷售數十種所謂抗癌藥物，總金額超千萬元（人民幣．下同）。</span></h2> 	</li> 	<li>&nbsp;</li> 	<li class="article_summary_pt"> 	<h2><span style="font-size:16px;">經權威機構鑑定，這些抗癌藥部分是假藥，有的屬於未經批准，有的根本不含有效成分，還會耽誤病情。</span></h2> 	</li> </ul>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2(9).jpg" style="width: 640px; height: 427px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">深圳揭抗癌藥造假：與醫生「合作」推薦假藥給病患，每盒賺上萬元。（網絡圖片）</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">案情指，2016年3月，深圳警方接到舉報後，查獲大量未銷售的假藥，抓獲8名涉案人員。據辦案人員介紹，該犯罪集團主要負責人紀維維分別在香港和內地註冊公司，然後從新加坡及印度等地購賣馬法蘭、格列衞、易瑞沙等30多種抗癌藥物，再轉售到內地。由於內地市場需求大，他們除從海外買藥銷售外，甚至自製假藥，盜用知名抗癌藥品牌出售。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">從2014年9月到案發，涉案人員在沒有營業許可證的情況下銷售真假藥物，售價一般是進貨價的兩倍以上，一盒抗癌藥價格從幾百元到幾萬元不等，最高一盒可獲利上萬元。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">涉案人員通過派人到全國各大醫院，與腫瘤及血液病科室的醫生「合作」，讓醫生將有關藥物推薦給患者及其家屬，然後再通過網絡銷售快遞寄送，醫生可以從中提取售價約10%的回扣。據悉，這些藥物大部分被賣到北京、上海、湖南等地。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">當局接報後化驗假藥，發現這些藥物不但沒有有效成分，還貽誤病情。有受害者反映，服用後出現頭暈、嘔吐、四肢乏力等不良反應。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:14px;">（經濟參考報）</span></span></p>  <p>文章來自: HK01</p>  <p><span style="font-size:14px;"><a href="https://www.hk01.com/兩岸/149254/深圳揭抗癌藥造假-與醫生-合作-推薦假藥給病患-每盒賺上萬元" target="_blank"><span style="color:#0000FF;">https://www.hk01.com/兩岸/149254/深圳揭抗癌藥造假-與醫生-合作-推薦假藥給病患-每盒賺上萬元</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180115]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%b7%b1%e5%9c%b3%e6%8f%ad%e6%8a%97%e7%99%8c%e8%97%a5%e9%80%a0%e5%81%87%ef%bc%9a%e8%88%87%e9%86%ab%e7%94%9f%e3%80%8c%e5%90%88%e4%bd%9c%e3%80%8d%e6%8e%a8%e8%96%a6%e5%81%87%e8%97%a5%e7%b5%a6%e7%97%85/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[另類治療探討>另類治療探討]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%b7%b1%e5%9c%b3%e6%8f%ad%e6%8a%97%e7%99%8c%e8%97%a5%e9%80%a0%e5%81%87%ef%bc%9a%e8%88%87%e9%86%ab%e7%94%9f%e3%80%8c%e5%90%88%e4%bd%9c%e3%80%8d%e6%8e%a8%e8%96%a6%e5%81%87%e8%97%a5%e7%b5%a6%e7%97%85]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[131]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180115]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7165]]></id>
		<title><![CDATA[9歲癌童撐到妹妹出生「送上吻別」：會變天使守護她 / Brave Bailey fights cancer long enough to meet baby sister]]></title>
		<content><![CDATA[<p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="color:#000000;"><strong><span style="font-size:26px;">9歲癌童撐到妹妹出生「送上吻別」：會變天使守護她&nbsp; </span></strong></span></p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; background-color: rgb(255, 255, 255);">在面對癌症的侵蝕，一個成人都不見得可以有堅強的意志力，何況是一個孩子。英國9歲男童貝利(Brave Bailey)在1年多前的夏天被診斷出非霍奇金淋巴瘤，而且已經是第三期，主治醫師當時認定，即便再多的化療都不一定可以痊癒，但最後貝利卻依靠著「想看未出世的妹妹」出生的意志力，突破的醫師的預言，替妹妹洗澡後，嚥下最後一口氣離世。</span></span></span></p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><br style="box-sizing: border-box; margin: 0px; padding: 0px; border: none;" /> &nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="color:#000000;"><span style="font-size:16px;">根據英國《鏡報》報導，貝利在得知自己得到癌症，生命也正在一點一滴的流逝時，他並沒有放棄求生的意志，堅持要看到自己的妹妹來的世界上。在過去的15個月中努力的做化療，用著樂觀心面對，因為在他的內心有個支撐他下去的動力，就是妹妹的出生，甚至貝利已經幫妹妹取好名字，叫做Millie。</span></span></p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <div class="fb-quote fb_iframe_widget" fb-iframe-plugin-query="app_id=146858218737386&amp;container_width=1903&amp;href=https%3A%2F%2Fwww.ettoday.net%2Fnews%2F20180112%2F1091891.htm&amp;locale=zh_TW&amp;sdk=joey" fb-xfbml-state="rendered" style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; display: inline-block; position: absolute; left: 525px; top: 1619px;">&nbsp;</div>  <p>&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="color:#000000;"><span style="font-size:16px;">去年8月開始貝利的病況開始惡化，邁向了第四期癌症，醫生認為他的生命只剩下幾天頂多幾周，但貝利還是不放棄，甚至在期待妹妹出生時，還開始計劃自己的喪禮要如何舉行。就這樣靠著吃要跟化療，貝利終於等到妹妹出生，打破了醫生的預言。</span></span></p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="color:#000000;"><span style="font-size:16px;">妹妹Millie終於在去年11月出生，貝利立刻開心的抱著妹妹、唱歌給妹妹聽，但不到幾天貝利病情瞬間惡化，他的父母表示，「貝利在看到妹妹的那一刻，他的生命好像開始快速的消逝。」</span></span></p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="color:#000000;"><span style="font-size:16px;">貝利跟爸媽表示，「我想活下去，但卻只能成為妹妹的守護天使。」在聖誕節前夕，貝利的家人心疼他的煎熬，對著他說「停止吧！」貝利嚥下最後一口氣，眼角還泛著淚，讓爸媽相當不捨。</span></span></p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p style="box-sizing: border-box; font-family: Meiryo, &quot;Meiryo UI&quot;, &quot;Microsoft JhengHei UI&quot;, &quot;Microsoft JhengHei&quot;, sans-serif; margin: 0px; padding: 0px; border: none; outline: 0px; font-size: 13px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">&nbsp;</p>  <p><strong><span style="color:#000000;"><span style="font-size:36px;">Brave Bailey fights cancer long enough to meet baby sister</span></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/a(7).jpg" style="width: 640px; height: 641px;" /></p>  <p style="text-align: center;"><span class="postMeta-author-name"><span class="light">by </span><a href="https://www.metro.news/author/paul_miles/"><font color="#0066cc">Paul Miles</font></a></span> &nbsp;<span class="postMeta-date postMeta-date--desktop meta"><span class="meta-light">Published</span> January 12, 2018</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">A NINE-year-old who battled terminal cancer long enough so he could name his baby sister told his parents shortly before he died: &lsquo;You can only cry for twenty minutes&rsquo;.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Brave Bailey Cooper battled the disease for 15 months and was determined to keep fighting until his new sibling arrived.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Mum Rachel, 28, gave birth in November and Bailey named her Millie.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Tragically, Bailey lost his fight with the disease on Christmas Eve and his proud mum and dad Lee said he smiled all the way through his treatment.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Rachel said: &lsquo;We didn&rsquo;t think he would last that long, but he was determined to meet Millie.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/b.jpg" style="width: 600px; height: 338px;" /></p>  <p style="text-align: center;">New arrival: Bailey gets to meet his new sister &ndash; and named her Millie</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&lsquo;It got to the end of November, and Millie was born. He hugged her and did everything an older brother would do &mdash; change her, wash her, sing to her.&rsquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Bailey&rsquo;s dad Lee, 30, added: &lsquo;Doctors said he was going to go before Millie was born.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&lsquo;He didn&rsquo;t. He fought, and on the way to hospital, he said we should call her Millie.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&lsquo;But the moment after he met her, he began to taper off quickly. He was slipping away.&rsquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">The family knew Bailey was unlikely to survive to celebrate Christmas but encouraged him to write a list of gifts he would like.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">But the unselfish youngster drew up a list of presents for his younger brother, Riley, six, knowing he wouldn&rsquo;t get the chance to play with them himself.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/c.jpg" style="width: 600px; height: 450px;" /></p>  <p style="text-align: center;"><span style="color:#696969;">All together: Bailey Cooper pictured in hospital with brother Riley, sister Millie and parents Lee and Rachel</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">When his grandmother said she wished he could take his place, Bailey told her: &lsquo;That is really selfish Nan. You have grandchildren to take care of.&rsquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">And in their last family get-together the youngster told his parents: &lsquo;You&rsquo;re only allowed to cry for 20 minutes. You have to take care of Riley and Millie.&rsquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Bailey first became ill in the summer of 2016, and after a series of tests was diagnosed with Non-Hodgkin Lymphoma, which develops in the network of vessels and glands in the body.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">By the time it was discovered, it was already in Stage Three.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/d.jpg" style="width: 600px; height: 338px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">Brotherly love: Bailey Cooper in hospital with his younger brother Riley</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Doctors treated the cancer with chemotherapy and steroid medication and were optimistic the youngster would recover.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">But, after a period of remission, Lee and Rachel were handed the devastated blow their son had gone into relapse and no more could be done.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">After being taken to a hospice on December 22, Bailey&rsquo;s family gathered by his bedside and read him stories to keep him company.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&lsquo;By 11.45am on Christmas Eve, we were by his bedside, mum Rachel said.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&lsquo;We knew it was not going to be long. We told him &ldquo;It&rsquo;s time to go Bailey. Stop.&rdquo;&lsquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&lsquo;The moment we said &ldquo;stop&rdquo;, he took his last breath and had just the one tear come out of his eye. It was peaceful.&rsquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>文章來自 : ETtoday新聞雲 / Metro. News</p>  <p>中: <span style="font-size:14px;"><a href="https://www.ettoday.net/news/20180112/1091891.htm" target="_blank"><span style="color:#0000FF;">https://www.ettoday.net/news/20180112/1091891.htm</span></a></span></p>  <p><span style="font-size:14px;">​Eng:&nbsp;<a href="https://www.metro.news/brave-bailey-fights-cancer-long-enough-to-meet-baby-sister/894920/" target="_blank"><span style="color:#0000FF;">https://www.metro.news/brave-bailey-fights-cancer-long-enough-to-meet-baby-sister/894920/</span></a></span></p>  <p style="text-align: center;"><br /> <br /> &nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180115]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/9%e6%ad%b2%e7%99%8c%e7%ab%a5%e6%92%90%e5%88%b0%e5%a6%b9%e5%a6%b9%e5%87%ba%e7%94%9f%e3%80%8c%e9%80%81%e4%b8%8a%e5%90%bb%e5%88%a5%e3%80%8d%ef%bc%9a%e6%9c%83%e8%ae%8a%e5%a4%a9%e4%bd%bf%e5%ae%88%e8%ad%b7/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>病患個案]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[9%e6%ad%b2%e7%99%8c%e7%ab%a5%e6%92%90%e5%88%b0%e5%a6%b9%e5%a6%b9%e5%87%ba%e7%94%9f%e3%80%8c%e9%80%81%e4%b8%8a%e5%90%bb%e5%88%a5%e3%80%8d%ef%bc%9a%e6%9c%83%e8%ae%8a%e5%a4%a9%e4%bd%bf%e5%ae%88%e8%ad%b7]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[132]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180115]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7166]]></id>
		<title><![CDATA[【撐少女定校方？】削髮為癌症病人籌款 畀學校話犯校規處分  /  Girl isolated by Penzance school after charity head shave]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;">【撐少女定校方？】削髮為癌症病人籌款 畀學校話犯校規處分 </span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><strong><span style="font-size:26px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(16).jpg" style="width: 640px; height: 360px;" /></span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">英國康沃爾一名14歲少女為了替慈善癌症組織籌款，不惜剃掉自己一頭金色長髮，但被學校指她違反校規要隔離獨自上課。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">14歲鮑德溫（Niamh Baldwin）替一個專門為癌症患者編織假髮的組織「Little Princess Trust」籌款，於是將一頭長髮剃頭，卻遭到學校指她的「髮型」不合校規而受處分。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">鮑德溫的32歲媽媽安妮卡（Anneka）對女兒被處罰很不滿，說：「這是不公平的處罰，她是一個體貼及有愛心的孩子，當她告知我打算在聖誕節行動時，我感到很驚訝，我覺得這是最勇敢的行為。」她指女兒只有14歲，這個年齡的女孩子都非常緊張自己外表，故當女兒決定剃掉長髮後，家人都為她感到「驕傲」。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">她形容女兒在校內一直受到老師及同學的稱讚，覺得她有禮貌及可愛，這「一切不會因髮型而改變，而對我而言這簡直是歧視，我真的很憤怒」。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">但校方堅持不讓步，校長戴維（Sara Davey）稱校規早已列明學生的儀容規定，學生亦知道違規的後果。如果鮑德溫事前先告知校方，老師就會阻止及建議另一種籌款方法。校長說：「這個政策在我們的校規上已出現了很多年，不容許包括剃頭在內極端的髮型，這在全英國的學校都很常見。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">她更質疑為何家長不在事前先通知校方，如止一來便可避免今天的後果，並強調會與安妮卡商議解決方法。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:26px;"><strong>Girl isolated by Penzance school after charity head shave</strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/a(8).jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">Niamh Baldwin&#39;s hair was judged to be 1cm too short to be included in lessons by her school, her mother said</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p class="story-body__introduction"><span style="font-size:18px;"><strong><span style="color:#000000;">A girl was put into isolation at her school after she had her head shaved for charity.</span></strong></span></p>  <p class="story-body__introduction">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Niamh Baldwin, 14, was taken out of classes by Mounts Bay Academy in Penzance because of the haircut.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">She had donated her hair to the Little Princess Trust, which makes wigs for ill children suffering from hair loss.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">The school said her appearance was &quot;confusing and upsetting&quot; to students, and it was unaware the charity event was taking place.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:18px;"><strong><a class="story-body__link" href="http://www.bbc.co.uk/news/live/uk-england-devon-42543151"><span style="color:#000000;">More news from Devon and Cornwall</span></a><span style="color:#000000;">.</span></strong></span></p>  <div aria-hidden="true" class="bbccom_slot mpu-ad" id="bbccom_mpu_1_2_3"> <div class="bbccom_advert">&nbsp;</div> </div>  <p><span style="color:#000000;"><span style="font-size:16px;">Anneka Baldwin, Niamh&#39;s mother, said her child&#39;s hair style should not decide whether she can be in class.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&quot;I am so upset that the school has made her feel so low,&quot; she said, branding the decision a form of &quot;discrimination&quot;.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/b(1).jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">Niamh Baldwin before her charity head shave </span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">After being put in isolation on Thursday, Niamh did not attend school on Friday due to being upset at the prospect of being put in isolation again, her mother said.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">On Monday her hair was judged to have grown enough for her to be put back into normal classes.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h2 class="story-body__crosshead"><span style="color:#000000;"><strong><span style="font-size:18px;">&#39;So proud&#39;</span></strong></span></h2>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&quot;Although Niamh is back to classes I still feel like the positive and amazing deed she did has been dampened and not praised as it should have been,&quot; Mrs Baldwin said.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">She added she was &quot;so proud&quot; of her daughter, and disagreed with the school&#39;s rules on hair length.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Mounts Bay Academy vice principal Les Hall said Niamh was removed &quot;for a short time&quot; as her appearance was &quot;upsetting and confusing to a number of students and staff&quot;, but was not excluded.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">He added the school had not been made aware about the charity head shave, and the reasons behind the hair cut &quot;were unclear at the time&quot;.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&quot;Niamh was soon after returned to her normal lessons where she is currently studying successfully,&quot; Mr Hall said.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p>文章來自:&nbsp;蘋果日報 / BBS NEWS</p>  <p><span style="font-size:14px;">中: <a href="https://hk.news.appledaily.com/international/realtime/article/20180109/57681191" target="_blank"><span style="color:#0000FF;">https://hk.news.appledaily.com/international/realtime/article/20180109/57681191</span></a></span></p>  <p><span style="font-size:14px;">​Eng :&nbsp;</span><a href="http://www.bbc.com/news/uk-england-cornwall-42609102" target="_blank"><span style="color:#0000FF;">http://www.bbc.com/news/uk-england-cornwall-42609102</span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180115]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e3%80%90%e6%92%90%e5%b0%91%e5%a5%b3%e5%ae%9a%e6%a0%a1%e6%96%b9%ef%bc%9f%e3%80%91%e5%89%8a%e9%ab%ae%e7%82%ba%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e7%b1%8c%e6%ac%be-%e7%95%80%e5%ad%b8%e6%a0%a1%e8%a9%b1/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e3%80%90%e6%92%90%e5%b0%91%e5%a5%b3%e5%ae%9a%e6%a0%a1%e6%96%b9%ef%bc%9f%e3%80%91%e5%89%8a%e9%ab%ae%e7%82%ba%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e7%b1%8c%e6%ac%be-%e7%95%80%e5%ad%b8%e6%a0%a1%e8%a9%b1]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[133]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180115]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7167]]></id>
		<title><![CDATA[中國肺癌猛增 專家指吸煙和廚房煙是主因未提霧霾]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;">中國肺癌猛增 專家指吸煙和廚房煙是主因未提霧霾</span></strong></span></p>  <p>作者 <span itemprop="author" itemscope="" itemtype="http://schema.org/Person"><span itemprop="name"><a class="modeless" href="http://trad.cn.rfi.fr/auteur/%E5%8F%A4%E8%8E%89/"><font color="#0066cc">古莉</font></a> </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><strong><span style="font-size:26px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(17).jpg" style="width: 640px; height: 361px;" /></span></strong></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">上海火車站2017年2月28日</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <div class="intro"> <p><span style="color:#000000;"><span style="font-size:16px;">中國國家癌症中心日前發布2017中國腫瘤現狀和趨勢報告數據顯示，中國今年新增肺癌人數達到80萬，正以每年26.9%的速度增長。肺癌的主因被專家認為是吸煙和廚房煙塵。但霧霾未有被提及。</span></span></p>  <p>&nbsp;</p> </div>  <div itemprop="articleBody"> <div id="mb_video_placement" style="margin: 0px; padding: 0px; border: 0px; border-image: none; width: 1px !important; height: 1px !important;">&nbsp;</div>  <p><span style="color:#000000;"><span style="font-size:16px;">據新華社12月23日報道，在中國城鎮癌症死亡病例中，每3-4人中即有1人是肺癌。專家分析，男性患肺癌主要因為吸煙，女性則因為吸&ldquo;二手煙&rdquo;和廚房油煙而患癌。但新華社的報道未提及這個科學報告是否談到霧霾的影響。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">該報道指出，中國癌症死亡率居前五位的依次為肺癌、胃癌、肝癌、食道癌和結直腸癌。肺癌在男性的癌症發病率已居首位，在女性中也僅次於乳腺癌居第二位。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">報告指出，預防難、發現晚、不好治和不規範，是中國腫瘤防控四大難點。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">專家表示，從正常細胞發展到惡性腫瘤，從癌前病變發展成為侵襲性癌症一般需要１０年或者更長時間。其中癌前病變的一個重要特徵就是具有可逆性。如果能夠在癌前病變階段&ldquo;做文章&rdquo;，就能有效地阻止侵襲性癌症的發生。</span></span></p>  <p>&nbsp;</p> </div>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="font-size:14px;">文章來自: 法國國際廣播電台（RFI）</span></p>  <p><span style="font-size:14px;"><a href="http://trad.cn.rfi.fr/中國/20171224-中國肺癌猛增%20專家指吸煙和廚房煙是主因未提霧霾" target="_blank"><span style="color:#0000FF;">http://trad.cn.rfi.fr/中國/20171224-中國肺癌猛增%20專家指吸煙和廚房煙是主因未提霧霾</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180115]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%ad%e5%9c%8b%e8%82%ba%e7%99%8c%e7%8c%9b%e5%a2%9e-%e5%b0%88%e5%ae%b6%e6%8c%87%e5%90%b8%e7%85%99%e5%92%8c%e5%bb%9a%e6%88%bf%e7%85%99%e6%98%af%e4%b8%bb%e5%9b%a0%e6%9c%aa%e6%8f%90%e9%9c%a7%e9%9c%be/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>統計分析]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%ad%e5%9c%8b%e8%82%ba%e7%99%8c%e7%8c%9b%e5%a2%9e-%e5%b0%88%e5%ae%b6%e6%8c%87%e5%90%b8%e7%85%99%e5%92%8c%e5%bb%9a%e6%88%bf%e7%85%99%e6%98%af%e4%b8%bb%e5%9b%a0%e6%9c%aa%e6%8f%90%e9%9c%a7%e9%9c%be]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[134]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180115]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7168]]></id>
		<title><![CDATA[肺癌4期病人登上尼泊爾美拉峰 / When the Lung Cancer Patient Climbs Mountains]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;">肺癌4期病人登上尼泊爾美拉峰</span></strong></span></p>  <p><span style="font-size:14px;"><span style="color:#808080;">TheNewsLens </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><strong><span style="font-size:26px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(18).jpg" style="width: 640px; height: 384px;" /></span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h5><span style="color:#000000;"><strong><span style="font-size:20px;">你為什麼需要這則新聞</span></strong></span></h5>  <p>&nbsp;</p>  <p class="export"><span style="font-size:16px;">一名肺癌4期患者參加一項基因治療臨床試驗，取得理想療效，他更回復昔日活躍好動的生活方式，登上尼泊爾的美拉峰。他其中一名主診醫生說：「數年前，醫學界根本想像不到這是有可能的。」</span></p>  <p class="export">&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">「統計數字上，能多活一年不大可能，兩年的話，幾乎是奇蹟。」61歲的安迪&middot;林賽（Andy Lindsay）確診肺癌第4期三年了，去年10月15日早上8時，他成功登上海拔6476米的尼泊爾美拉峰（Mera Peak）。</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">林賽的醫療團隊包括波士頓馬薩諸塞州總醫院心贓及腫瘤科主任Tomas Neilan，他批准林賽登山可不是基於「讓一個快要死的人完成心願」，而是判斷他心肺功能正常，而且具有豐富登山經驗。在攻美拉峰前幾個月，林賽去了緬因州和新罕布什爾州登山，數年前到尼泊爾徒步旅行，安全健康的回來。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">林賽之所以能夠做到這些看來同肺癌4期病人無緣的事，主要是因為尖端基因治療臨床試驗（gene therapy clinical trial）成功。該項治療針對特定肺癌組織的突變，能夠阻截身體供給腫瘤養份，令腫瘤縮小。這不能把林賽完全治好，但起碼他的掃描顯示，肺癌病情明顯改善，幾乎沒有症狀。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Tomas Neilan表示，基因治療的成效，改變了癌症專家治療較晚期患者的看法，無論腫瘤專家或病人都可以朝著「能回復較活躍好動生活方式」的方向努力：「這是把第4期肺癌變成與高血壓沒有分別的慢性疾病。」</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">沒有人知道這項臨床試驗成功能夠讓林賽存活多少時間，但現在他的健康顯著改善，可以再做一些自己喜愛的事情，例如騎單車沿海外線旅行、重回樂隊在咖啡室演奏，當然也包括跟朋友一起去尼泊爾登山。</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">那不是件易事。在高海拔地帶，氣壓比海平面低70%，即使最強健的登山客都會出現呼吸困難。此前也沒有數據顯示晚期肺癌病人在高海拔地區會有何反應，Neilan與林賽討論了可能出現的健康問題，並強調：「如果你向一大群醫生徵詢意見，應該會得出很多不同答案。」</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">林賽的另一名醫生是馬薩諸塞州總醫院腫瘤科的Zofia Piotrowska。她指林賽屬於表皮細胞生長因子（<em>EGFR</em>）基因突變的肺癌患者，在非吸煙肺癌患者中比較常見。當林賽在2014年確診時，他接受了第一代標靶藥物治療，反應很好，但不足一年就出現抗藥性。2016年，醫生再次發現他對當時所服藥物有抗藥性，林賽遂決定參加新藥EGF816的臨床試驗。在接受治療數天內，林賽的呼吸已見改善，數個月後，他重拾戶外活動，由於運動增加，身體也變得較強健。</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">Piotrowska醫生在林賽登山前表示，他的肺功能已接近平常人的水平，最大疑問在於一個曾處於晚期肺癌的肺部，在低氣壓環境下會有何反應，以及林賽如何處理這項艱鉅運動帶來的壓力。</span></span></p>  <div data-google-query-id="CMSTtoe62dgCFQY7lgodU8gGsg" id="div-gpt-ad-1497843170358-0-87101"> <div id="google_ads_iframe_/112152674/hk_adasia/hk_adasia_content_inner_0__container__" style="border: 0pt; border-image: none;">&nbsp;</div> </div>  <p><span style="font-size:16px;"><span style="color:#000000;">林賽不敢輕率，在初段停停走走，有時僅僅跟得上登山隊的隊尾，甚至要讓隊員先走，自已慢慢跟著。當體力適應過來，林賽開始發揮耐力，去到海拔5181米時，他已經是全隊中走得較前的一員。</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">到最後一天，全隊人用繩子繫在一起。林賽沉醉於回憶說：「恨那個黑暗中升起的壯麗黎明來得太快，一抹醉人的深紅色照亮所有山峰，包括珠穆朗瑪峰。」</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">在最近一次掃描，醫生證實林賽左右兩邊肺部各有一個生長緩慢的小結節，但林賽暫時沒有任何症狀。他上月回到馬薩諸塞州總醫院，與數名肺癌第4期患者參加會議，聽取研究員講解往後的治療方向。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:26px;"><span style="color:#000000;"><strong>When the Lung Cancer Patient Climbs Mountains</strong></span></span></p>  <p><span style="color:#696969;"><span style="font-size:14px;">The New York Times&nbsp;</span></span></p>  <p><span style="color:#696969;"><span style="font-size:14px;"><span class="byline" itemprop="author creator" itemscope="" itemtype="http://schema.org/Person">By <span class="byline-author" data-byline-name="TODD BALF" itemprop="name">TODD BALF</span></span><time class="dateline" content="2018-01-08T08:04:03-05:00" datetime="2018-01-08T08:04:03-05:00" itemprop="dateModified">JAN. 4, 2018</time> </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(19).jpg" style="width: 640px; height: 426px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span class="caption-text">Andy Lindsay, a lung cancer patient, was among the climbers and porters heading up Mera Glacier in Nepal to Mera High Camp on a three-week trek this fall.</span> </span></span><span class="credit" itemprop="copyrightHolder"><span style="color:#696969;"><span style="font-size:14px;"><span class="visually-hidden">Credit</span> </span></span><span style="color:#A9A9A9;"><span style="font-size:14px;"><span style="font-size:12px;">Margaret Fahey&nbsp;&nbsp;</span></span><span style="font-size:12px;">&nbsp;&nbsp;&nbsp;</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="150" data-total-count="150" id="story-continues-1"><span style="color:#000000;"><span style="font-size:16px;">On Oct. 15 at 8 a.m., Andy Lindsay stood atop 21,247-foot Mera Peak in Nepal, a wildly improbable place for him to be both athletically and medically.</span></span></p>  <p class="story-body-text story-content" data-para-count="150" data-total-count="150">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="201" data-total-count="351"><span style="color:#000000;"><span style="font-size:16px;">Andy, a veteran climber and a friend of mine, had been living with Stage IV lung cancer for three years. &ldquo;To live one year was statistically unlikely, and two years looked like a miracle,&rdquo; he said.</span></span></p>  <p class="story-body-text story-content" data-para-count="201" data-total-count="351">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="310" data-total-count="661"><span style="color:#000000;"><span style="font-size:16px;">He was able to make the climb thanks to the success of a cutting-edge targeted therapy clinical trial. It targeted his specific lung cancer mutation, shutting off the fuel to his tumor&rsquo;s growth and shrinking the tumor. He wasn&rsquo;t cured, but his scans were strikingly improved and he was almost symptom-free.</span></span></p>  <p class="story-body-text story-content" data-para-count="310" data-total-count="661">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064"><span style="color:#000000;"><span style="font-size:16px;">The trip illustrates a shifting landscape both for oncologists and cancer patients exploring a return to active lifestyles. Dr. Tomas Neilan, the director of the cardio-oncology program at Massachusetts General Hospital in Boston, and part of Andy&rsquo;s medical team, said the recent success of these targeted therapy treatments alters the way specialists like him view and treat advanced cancer patients.</span></span></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064"><span style="color:#000000;"><span style="font-size:16px;">&ldquo;They&rsquo;re taking Stage IV cancer and turning it into a chronic disease no different than high blood pressure,&rdquo; he said.</span></span></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064"><span style="color:#000000;"><span style="font-size:16px;">Andy, 61, of Ipswich, Mass., had a window of good health, a honeymoon of indeterminate time during which he could resume the activities he loved. He played in his coffeehouse band, traveled and took long bike rides up the coast. He also accepted a friend&rsquo;s invitation to climb in Nepal.</span></span></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064" style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2(10).jpg" style="width: 640px; height: 480px;" /></span></span></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064" style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span class="caption-text">Jan and Andy Lindsay take a tea break in the Hinku Valley on the third week of their trek.</span> <span class="credit" itemprop="copyrightHolder"><span class="visually-hidden">Credit</span> </span></span></span><span style="color:#A9A9A9;"><span style="font-size:14px;"><span class="credit" itemprop="copyrightHolder"><span style="font-size:12px;">Sandy Walker&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="font-size:12px;"> </span></span></span></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="1064" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="216" data-total-count="1692"><span style="color:#000000;"><span style="font-size:16px;">Over three strenuous weeks he and his wife, Jan, who is a registered nurse and an experienced outdoorswoman, trekked alongside eight other climbers and several guides, most of whom they&rsquo;d traveled with in the past.</span></span></p>  <p class="story-body-text story-content" data-para-count="216" data-total-count="1692">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="152" data-total-count="1844"><span style="color:#000000;"><span style="font-size:16px;">In announcing the trip on his Caring Bridge page to ask for donations to fund lung cancer research, Andy had said there was a slim chance he&rsquo;d summit.</span></span></p>  <p class="story-body-text story-content" data-para-count="152" data-total-count="1844">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="276" data-total-count="2120"><span style="color:#000000;"><span style="font-size:16px;">At the altitude he reached, there&rsquo;s 70 percent less air pressure than at sea level to push air into the lungs. Breathing is hard for the fittest climbers. There was no data on what the high altitude would do to an advanced lung cancer patient: None were found to have tried.</span></span></p>  <p class="story-body-text story-content" data-para-count="276" data-total-count="2120">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="94" data-total-count="2214"><span style="color:#000000;"><span style="font-size:16px;">&ldquo;It&rsquo;s a remarkable achievement,&rdquo; Dr. Neilan said. &ldquo;My colleagues are flabbergasted.&rdquo;</span></span></p>  <p class="story-body-text story-content" data-para-count="94" data-total-count="2214">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="349" data-total-count="2563"><span style="color:#000000;"><span style="font-size:16px;">He gave Andy the O.K. to go to Nepal not as a dying man attempting his last climb but as a person with a deep experience in the mountains who exhibited solid cardiovascular function and health. In the previous months Andy had climbed high peaks in Maine and New Hampshire. Years earlier he&rsquo;d traveled to Nepal for a trekking trip without incident.</span></span></p>  <p class="story-body-text story-content" data-para-count="349" data-total-count="2563">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="331" data-total-count="2894"><span style="color:#000000;"><span style="font-size:16px;">Dr. Neilan, a climber himself, said he found no data around altitude sickness &mdash; the most dangerous and common health risk for climbing in high mountains &mdash; and Andy&rsquo;s conditions. But Dr. Neilan knew that at lower altitude even healthy younger climbers tended to have a greater likelihood of pulmonary edema and cerebral edema.</span></span></p>  <p class="story-body-text story-content" data-para-count="331" data-total-count="2894">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151"><span style="color:#000000;"><span style="font-size:16px;">They reviewed a series of warning signs of altitude-related health problems ranging from coughing up blood to severe, unshakable headache. He gave his blessing but acknowledged: &ldquo;If you polled physicians you might have gotten a lot of different advice.&rdquo;</span></span></p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151" style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/3(8).jpg" style="width: 640px; height: 427px;" /></span></span></p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151" style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span class="caption-text">Jan and Andy Lindsay climbing in October.</span> </span></span><span class="credit" itemprop="copyrightHolder"><span style="color:#696969;"><span style="font-size:14px;"><span class="visually-hidden">Credit</span> </span></span><span style="color:#A9A9A9;"><span style="font-size:14px;"><span style="font-size:12px;">Sandy Walker</span></span><span style="font-size:12px;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span><span style="color:#A9A9A9;"><span style="font-size:12px;"> </span></span></p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="257" data-total-count="3151" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="317" data-total-count="3468"><span style="color:#000000;"><span style="font-size:16px;">Another of Andy&rsquo;s doctors, Dr. Zofia Piotrowska, a medical oncologist at Massachusetts General, said her team wanted to help him go where he wanted to go, knowing the trip&rsquo;s meaning to him. However, if she thought the trip was a &ldquo;medically very unsafe thing to do,&rdquo; she&rsquo;d have asked him not to go, she said.</span></span></p>  <p class="story-body-text story-content" data-para-count="317" data-total-count="3468">&nbsp;</p>  <div class="story-ad ad ad-placeholder nocontent robots-nocontent  hidden" id="story-ad-2"> <div class="accessibility-ad-header visually-hidden"> <p><span style="color:#000000;"><span style="font-size:16px;">Dr. Piotrowska focuses on the type of lung cancer Andy has, which has a mutation in the gene called epidermal growth factor receptor, or EGFR. The EGFR subgroup represents about 15 percent of all non-small-cell lung cancers and is relatively common in &ldquo;never smokers&rdquo; like Andy.</span></span></p>  <p>&nbsp;</p> </div> </div>  <p class="story-body-text story-content" data-para-count="245" data-total-count="3995"><span style="color:#000000;"><span style="font-size:16px;">When he was given his diagnosis in 2014, he was treated with a first-generation EGFR inhibitor, an oral pill that turned off the mutant protein on the surface of the cancer cell. His response was swift, but the remission lasted less than a year.</span></span></p>  <p class="story-body-text story-content" data-para-count="245" data-total-count="3995">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="151" data-total-count="4146"><span style="color:#000000;"><span style="font-size:16px;">In 2016 he enrolled in his current trial after a biopsy showed his cancer had developed a specific mutation to resist the original drug he&rsquo;d been on.</span></span></p>  <p class="story-body-text story-content" data-para-count="151" data-total-count="4146">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="72" data-total-count="4218"><span style="color:#000000;"><span style="font-size:16px;">A newly developed drug known as EGF816 targeted his acquired resistance.</span></span></p>  <p class="story-body-text story-content" data-para-count="72" data-total-count="4218">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="177" data-total-count="4395"><span style="color:#000000;"><span style="font-size:16px;">Within days of being treated, Andy noticed he was breathing better. He resumed his outdoor activities and adventures in the months to follow, doing more as his fitness improved.</span></span></p>  <p class="story-body-text story-content" data-para-count="177" data-total-count="4395">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798"><span style="color:#000000;"><span style="font-size:16px;">Dr. Piotrowska said that before clearing him for the climb, she thought his lung function was pretty close to normal. The question nobody could answer was how lungs that were once filled with cancer would tolerate altitude. Also unanswerable was how he&rsquo;d respond to the exertion and stress of the expedition, which included waking in darkness in subzero temperatures and a 16-hour climb on summit day.</span></span></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798" style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/4(5).jpg" style="width: 427px; height: 641px;" /></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798" style="text-align: center;"><span style="color:#808080;"><span style="font-size:14px;"><span class="caption-text">At the summit of Mera Peak &mdash; altitude 21,247 feet &mdash; Andy Lindsay pays tribute to his cancer team at Massachusetts General Hospital, where gene therapy for his Stage IV lung cancer enabled him to make the climb.</span> </span></span><span class="credit" itemprop="copyrightHolder"><span style="color:#808080;"><span style="font-size:14px;"><span class="visually-hidden">Credit</span> </span></span><span style="color:#A9A9A9;"><span style="font-size:14px;"><span style="font-size:12px;">Sandy Walker&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="font-size:12px;">&nbsp;&nbsp;</span></span></span><span style="color:#A9A9A9;"><span style="font-size:12px;"> </span></span></p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="403" data-total-count="4798" style="text-align: center;">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="75" data-total-count="4873"><span style="color:#000000;"><span style="font-size:16px;">Andy admitted that he was pleasantly surprised that his doctors signed off.</span></span></p>  <p class="story-body-text story-content" data-para-count="75" data-total-count="4873">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="119" data-total-count="4992"><span style="color:#000000;"><span style="font-size:16px;">His most recent scan had confirmed two small, slow-growing nodules, one on each lung. There were no immediate symptoms.</span></span></p>  <p class="story-body-text story-content" data-para-count="119" data-total-count="4992">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="162" data-total-count="5154"><span style="color:#000000;"><span style="font-size:16px;">&ldquo;It&rsquo;s not like we were told to expect these spots to blossom forth while he was gone,&rdquo; his wife said. &ldquo;If we had, it would&rsquo;ve been an absolute no go.&rdquo;</span></span></p>  <p class="story-body-text story-content" data-para-count="162" data-total-count="5154">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="398" data-total-count="5552"><span style="color:#000000;"><span style="font-size:16px;">A longtime ski mountaineering friend, Brian Lambert, invited Andy to join the trip. They felt he&rsquo;d be in good hands: the lead guides were Jim Gudjonson, a longtime alpine guide on several of Andy&rsquo;s previous trips, and Deryl Kelly, an Everest veteran and the head of Parks Canada rescue service who, as an E.M.T., would oversee the clients&rsquo; health on the mountain, along with a team physician.</span></span></p>  <div class="story-ad ad ad-placeholder nocontent robots-nocontent  hidden" id="story-ad-3"> <div class="accessibility-ad-header visually-hidden"> <p>&nbsp;</p> </div> </div>  <p class="story-body-text story-content" data-para-count="205" data-total-count="5757" id="story-continues-6"><span style="color:#000000;"><span style="font-size:16px;">The trip itself was a test. Though Andy went at his own pace the opening week, staying mostly to the rear of the rest of the party as he combined walking steps with periodic &ldquo;rest steps,&rdquo; he struggled.</span></span></p>  <p class="story-body-text story-content" data-para-count="205" data-total-count="5757">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="471" data-total-count="6228"><span style="color:#000000;"><span style="font-size:16px;">He said he was within a day of letting the others advance on the summit without him when his stamina markedly improved. As they crossed the Mera glacier above 17,000 feet he found himself alongside the group&rsquo;s faster members. Although it is poorly understood who acclimatizes well and who doesn&rsquo;t, Andy said he found that he did better at higher altitudes. He likely also benefited from his superb technical skills in using crampons and ice tools on the high glacier.</span></span></p>  <p class="story-body-text story-content" data-para-count="471" data-total-count="6228">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="91" data-total-count="6319"><span style="color:#000000;"><span style="font-size:16px;">And he joked that he might have another useful mutation: &ldquo;I seem to love a sufferfest.&rdquo;</span></span></p>  <p class="story-body-text story-content" data-para-count="91" data-total-count="6319">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="286" data-total-count="6605"><span style="color:#000000;"><span style="font-size:16px;">In ascending on the final day &mdash; the climbers were tethered to one another with rope &mdash; Andy described the despair of a too-fast pace in the darkness melting in the uplift of a spectacular daybreak. The &ldquo;beautiful crimson&rdquo; lit up all the neighboring high peaks, including Everest.</span></span></p>  <p class="story-body-text story-content" data-para-count="286" data-total-count="6605">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="273" data-total-count="6878"><span style="color:#000000;"><span style="font-size:16px;">Late last year, he was among several Stage IV cancer patients invited to a small gathering in Boston of top Massachusetts General researchers who outlined their thinking on future therapies. The researchers were clearly energized by the presence of the pioneering patients.</span></span></p>  <p class="story-body-text story-content" data-para-count="273" data-total-count="6878">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="129" data-total-count="7007"><span style="color:#000000;"><span style="font-size:16px;">&ldquo;This is an example,&rdquo; Dr. Piotrowska said, &ldquo;of something that none of us ever thought would be possible a few years ago.&rdquo;</span></span></p>  <p class="story-body-text story-content" data-para-count="129" data-total-count="7007">&nbsp;</p>  <p class="story-body-text story-content" data-para-count="129" data-total-count="7007">&nbsp;</p>  <div class="addenda" id="addenda"> <div class="story-addendum story-content theme-correction"><span style="font-size:18px;"><span style="color:#000000;"><strong>Correction: January 8, 2018 </strong></span></span>  <p><span style="color:#000000;"><span style="font-size:16px;">An earlier version of this article mistakenly referred to the therapy Andy Lindsay had as gene therapy. It is targeted therapy, which targets and inhibits the EGFR mutation, but does not alter the patient&rsquo;s DNA.</span></span></p> </div> </div>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:14px;"><span style="color:#000000;">​文章來自: TheNewsLens / The New York Times</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size:14px;">中: <a href="https://hk.thenewslens.com/article/87101" target="_blank"><span style="color:#0000FF;">https://hk.thenewslens.com/article/87101</span></a></span></p>  <p>&nbsp;</p>  <p><span style="font-size:14px;">Eng : <a href="https://www.nytimes.com/2018/01/04/well/live/when-the-lung-cancer-patient-climbs-mountains.html?hp&amp;action=click&amp;pgtype=Homepage&amp;clickSource=story-heading&amp;module=second-column-region&amp;region=top-news&amp;WT.nav=top-news" target="_blank"><span style="color:#0000FF;">https://www.nytimes.com/2018/01/04/well/live/when-the-lung-cancer-patient-climbs-mountains.html?hp&amp;action=click&amp;pgtype=Homepage&amp;clickSource=story-heading&amp;module=second-column-region&amp;region=top-news&amp;WT.nav=top-news</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180115]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%82%ba%e7%99%8c4%e6%9c%9f%e7%97%85%e4%ba%ba%e7%99%bb%e4%b8%8a%e5%b0%bc%e6%b3%8a%e7%88%be%e7%be%8e%e6%8b%89%e5%b3%b0-when-the-lung-cancer-patient-climbs-mountains/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>病患個案]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%82%ba%e7%99%8c4%e6%9c%9f%e7%97%85%e4%ba%ba%e7%99%bb%e4%b8%8a%e5%b0%bc%e6%b3%8a%e7%88%be%e7%be%8e%e6%8b%89%e5%b3%b0-when-the-lung-cancer-patient-climbs-mountains]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[135]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180115]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7169]]></id>
		<title><![CDATA[食無定時壓力大 胃癌找上門]]></title>
		<content><![CDATA[<p><span style="color: #000000"><strong><span style="font-size: 26px">食無定時壓力大 胃癌找上門</span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><strong><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/056_01_a_20180112_L.jpg" style="height: 450px; width: 600px" /></span></strong></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">根據醫管局最新發布的數據，胃癌是本港第6大常見癌症，本港每年亦有逾千宗胃癌新症。有醫生表示，不少人誤以為胃癌一定會嘔血，但其實胃癌初期徵狀不明顯，都市人常見的胃痛，已可能是胃癌的警號。三餐不定時、精神壓力大等，均有機會增加患胃癌的風險。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 20px"><span style="color: #000000"><b>胃痛屬病徵之一</b></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">臨床腫瘤科專科醫生陳亮祖表示，胃癌的病徵不明顯，患者發現時可能已是後期，「部分人誤以為胃癌一定會嘔血，但其實未必，即使是都市人常見的胃痛，已可能是患胃癌的迹象，或要做胃鏡來確定是否患病。」此外，不少都市人的生活問題都有影響，例如三餐不定時有機會導致慢性胃炎，而精神壓力則有機會導致胃酸倒流、胃潰瘍等，均可能間接引致胃癌。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">胃部的腫瘤有很多種，陳亮祖表示，常說的胃癌是胃腺細胞癌，此外常見的還有在胃部肌肉的腸胃基質瘤，以及在胃壁的胃淋巴瘤。他指出，幾種腫瘤有不同徵狀，胃癌患者常會感到飽滯、胃痛，容易出現貧血，大便呈黑色，徵狀與胃炎相似；胃淋巴瘤的徵狀與胃癌類似，會出現胃痛及胃炎徵狀；至於腸胃基質瘤，患者的胃、腹部感覺不明顯，大便亦未必有血。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">三種腫瘤的成因及治療亦有不同，腸胃基質瘤成因不明，胃淋巴瘤可能與幽門螺旋桿菌有關，至於胃癌的高危因素則較多，例如長期吃太鹹、醃製食物，少吃菜，有吸煙習慣，體重過重，或遺傳因素等，都可能與胃癌有關。在治療方面，胃淋巴瘤以化療針為主，胃癌及胃腸道基質瘤則主要以手術切除。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 20px"><span style="color: #000000"><b>食素無助防病</b></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">坊間對胃癌有不少謬誤，例如有指因少吃蔬菜容易有胃癌，有人卻稱全素可以預防胃癌；但亦有指食素容易缺乏維他命B12，反而容易導致胃癌。陳亮祖說，兩種做法都是誤解，「未有資料顯示食素可以防止胃癌，部分患者是因為遺傳因素，無法吸收維他命B12而導致貧血，而非因缺乏維他命B12而導致胃癌，所以也不能說食素就會導致胃癌。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">此外，坊間亦有說法指，吃太熱的食物會燙傷消化道黏膜，長此以往有機會演變成癌症。陳亮祖指︰「理論上確是如此，但實際上應該是喉嚨和食道首先出事，其實食物到達胃部需要一段時間，通常都已冷卻。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #a9a9a9"><span style="font-size: 14px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2(11).jpg" style="height: 225px; width: 300px" /></span></span></p>  <p style="text-align: center"><span style="color: #808080"><span style="font-size: 14px">三餐不定時或致慢性胃炎，壓力大有機會致胃酸倒流、胃潰瘍等，均可能間接引致胃癌。（iStock）</span></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="color: #a9a9a9"><span style="font-size: 14px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/3(9).jpg" style="height: 426px; width: 600px" /></span></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="color: #a9a9a9"><span style="font-size: 14px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/4(6).jpg" style="height: 225px; width: 300px" /></span></span></p>  <p style="text-align: center"><span style="color: #808080">陳亮祖醫生</span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="color: #808080"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/5(3).jpg" style="height: 420px; width: 600px" /></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="color: #808080"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/6(4).jpg" style="height: 334px; width: 600px" /></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="font-size: 14px"><span style="color: #808080">編輯：林子豐</span></span></p>  <p><span style="font-size: 14px"><span style="color: #808080">美術：熊偉然</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px"><span style="color: #808080">文章來自: 晴報</span></span></p>  <p><a href="https://skypost.ulifestyle.com.hk/article/1988730/食無定時壓力大%20胃癌找上門" target="_blank"><span style="color: #0000ff"><span style="font-size: 14px">https://skypost.ulifestyle.com.hk/article/1988730/食無定時壓力大%20胃癌找上門</span></span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180116]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%a3%9f%e7%84%a1%e5%ae%9a%e6%99%82%e5%a3%93%e5%8a%9b%e5%a4%a7-%e8%83%83%e7%99%8c%e6%89%be%e4%b8%8a%e9%96%80/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>癌症的誘因]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%a3%9f%e7%84%a1%e5%ae%9a%e6%99%82%e5%a3%93%e5%8a%9b%e5%a4%a7-%e8%83%83%e7%99%8c%e6%89%be%e4%b8%8a%e9%96%80]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[136]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180116]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7170]]></id>
		<title><![CDATA[老火湯不是人人適合　乳癌基金會主席：或增乳癌復發風險]]></title>
		<content><![CDATA[<p><span style="color: #000000"><span style="font-size: 26px"><strong>老火湯不是人人適合　</strong></span></span></p>  <p><span style="color: #000000"><span style="font-size: 26px"><strong>乳癌基金會主席：或增乳癌復發風險</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><span style="font-size: 26px"><strong><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/soup_thumb_20180102_J_1024.jpg" style="height: 361px; width: 640px" /></strong></span></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">有云「民以食為天」，朋友說還有下半句，叫作「食以湯為先」。香港承襲廣東人的文化，也愛以足料的老火湯滋潤進補。雖然近年流行吃外國料理，但老火湯全因其獨有的養生功效，仍有一定的市場。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">老火湯固然滋補，但大家不得不提防它有某些健康風險，最為人知的是老火湯對痛風症病人的影響。由於老火湯多用含肉類的食材，譬如瘦肉、豬骨、豬展等長時間熬煮而成，其中的嘌呤便可能留在湯水中。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">一碗鮮濃滋補的湯水，有可能因此滙聚大量肉類的嘌呤，人體將之代謝會形成尿酸；當腎臟過分攝取尿酸又未能及時排走，便可能在血管中形成結晶，阻礙血液循環，加劇痛風。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">老火湯的健康風險對乳癌康復者來說也不容忽視。乳癌康復者要減低復發風險，就要抑制體內雌激素增長。然而，由於雌激素多儲存於動物的脂肪組織中，而老火湯在烹調過程中除了釋出嘌呤，也會與大量由食材而來的脂肪混和，增加湯水中的脂肪含量。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">為了進補而天天飲用老火湯，也可能令姊妹們不知不覺喝下大量肉類脂肪，不可不察！香港乳癌資料庫也曾列出十大乳癌高危因素，飲食含豐富肉類、乳類製品位列第六；一些用上大量肉類及骨頭、長時間熬成的老火湯，實在不宜飲用過多，也可考慮用滾湯代替。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">老火湯對人體孰好孰壞，視乎大家飲食是否均衡。坊間曾有患癌斷食的講法，謂患癌期間戒口不吃任何肉類，即可「餓死」癌細胞。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">然而，根據北區醫院在2011年的抽樣調查，營養不良的病人在住院日數、再入院率和死亡風險方面，均比低風險病人為高。作為病人，其實只要適量吃肉類，同時避吃其脂肪，攝取足夠營養對抗疾病，即可食得健康。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px"><span style="color: #696969">原文刊於</span><a href="https://skypost.ulifestyle.com.hk/article/1980990/淺談老火湯" target="_blank"><span style="color: #696969">《晴報》</span></a><span style="color: #696969">，標題經TOPick 編輯修改，原題為「淺談老火湯」</span></span></p>  <p><span style="color: #696969"><span style="font-size: 14px">&nbsp;</span></span></p>  <div class="article-detail_extra-info"> <p><span style="color: #696969"><span style="font-size: 14px">撰文 : 霍何綺華 香港乳癌基金會主席</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #696969"><span style="font-size: 14px">文章來自: Topick</span></span></p>  <p><a href="https://topick.hket.com/article/1981296/老火湯不是人人適合　乳癌基金會主席：或增乳癌復發風險?mtc=10027" target="_blank"><span style="color: #0000ff"><span style="font-size: 14px">https://topick.hket.com/article/1981296/老火湯不是人人適合　乳癌基金會主席：或增乳癌復發風險?mtc=10027</span></span></a></p> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180116]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%80%81%e7%81%ab%e6%b9%af%e4%b8%8d%e6%98%af%e4%ba%ba%e4%ba%ba%e9%81%a9%e5%90%88%e3%80%80%e4%b9%b3%e7%99%8c%e5%9f%ba%e9%87%91%e6%9c%83%e4%b8%bb%e5%b8%ad%ef%bc%9a%e6%88%96%e5%a2%9e%e4%b9%b3%e7%99%8c/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>癌症的誘因]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%80%81%e7%81%ab%e6%b9%af%e4%b8%8d%e6%98%af%e4%ba%ba%e4%ba%ba%e9%81%a9%e5%90%88%e3%80%80%e4%b9%b3%e7%99%8c%e5%9f%ba%e9%87%91%e6%9c%83%e4%b8%bb%e5%b8%ad%ef%bc%9a%e6%88%96%e5%a2%9e%e4%b9%b3%e7%99%8c]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[137]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180116]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7171]]></id>
		<title><![CDATA[治療乳癌的化學治療(化療)]]></title>
		<content><![CDATA[<div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><strong><span style="font-size: 24px;">治療乳癌的化學治療(化療)</span></strong></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px; text-align: center;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/her22(1)(1).jpg" style="cursor: default; width: 640px; height: 288px;" /></span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px; text-align: center;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">即是利用抗癌藥物來破壞癌細胞，但同時亦會影響代謝較快的正常細胞。治療分口服和靜脈注射兩種形式，每次療程只需幾天，隨後是數星期的休息。療程的次數需視乎癌症種類及妳對藥物的反應而定。</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><br /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">化療主要應用於以下三種情況：</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><br /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="font-size: 20px;"><strong>1. 手術前</strong></span><br /> 可將比較大的腫瘤先行縮小，之後再動手術。這樣做，可以避免切除整個乳房，轉而只切除部分的乳房。在治癒率方面與手術後再給予化療的效果相似。</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><br /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><strong><span style="font-size: 20px;">2. 手術後</span></strong><br /> 可消滅手術後殘留在身體的癌細胞，降低復發或擴散的可能性。</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><br /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><strong><span style="font-size: 20px;">3. 癌細胞擴散後</span></strong><br /> 可縮小腫瘤，改善症狀，維持生活的質素，以及盡可能延長生命。</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><br /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">如有興趣了解更多關於乳癌的資訊，</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">請參閱：</span><a href="http://her2morrow.com.hk" style="color: rgb(7, 130, 193);" target="_blank"><span style="color: rgb(0, 0, 255);">http://her2morrow.com.hk</span></a></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;">&nbsp;</div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;">安全報告免責聲明<br /> 此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;">請向您的醫生或藥劑師諮詢和報告。<br /> 以上健康教育資訊由羅氏大藥廠香港有限公司提供</span></span></div>  <div style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 13px;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;">(NPM-HK-0074-11-2017)</span></span></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180116]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%b2%bb%e7%99%82%e4%b9%b3%e7%99%8c%e7%9a%84%e5%8c%96%e5%ad%b8%e6%b2%bb%e7%99%82%e5%8c%96%e7%99%82/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%b2%bb%e7%99%82%e4%b9%b3%e7%99%8c%e7%9a%84%e5%8c%96%e5%ad%b8%e6%b2%bb%e7%99%82%e5%8c%96%e7%99%82]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[138]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180116]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7172]]></id>
		<title><![CDATA[打造基因資料庫 5大藥廠金援雷傑納榮]]></title>
		<content><![CDATA[<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/a10a00_p_03_01.jpg" style="width: 550px; height: 362px;" /></p>  <p>&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">《華爾街日報》報導，全球5大藥廠決定各出資1千萬美元，幫助美國生物製藥公司雷傑納榮（Regeneron）提早完成建立基因醫療資料庫的計畫，以加快開發新藥的腳步。</p>  <div id="div-gpt-ad-1489561879560-0" style="border: 0px none; margin: 0px; outline: none 0px; padding: 0px; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif; font-size: 18px; text-align: center;">&nbsp;</div>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">這5間藥廠包括艾伯維（AbbVie）、阿里拉姆（Alnylam Pharmaceuticals）、阿斯特捷利康（AstraZeneca）、生物基因（Biogen）與輝瑞（Pfizer）。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">雷傑納榮去年與英國藥廠葛蘭素史克（GlaxoSmithKline）、英國生物樣本庫（UK Biobank）決定合作打造基因醫療資料庫。他們希望結合英國生物樣本庫收集的50萬名英國民眾DNA樣本與病歷，幫助科學家尋找致病基因、開發抵抗疾病的新藥。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">而雷傑納榮在此合作案裡負責50萬名民眾的基因定序（gene sequencing）工作，原本計劃於2022年前完成，而在5大藥廠決定挹注資金後，基因資料庫的完成日期可望提早至明年底前。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">根據英國生物庫去年的預估，完成50萬人基因定序的經費約需1.5億美元。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">雷傑納榮的發言人表示，在基因資料庫對外公開前，這5間出資藥廠能享有6至12個月的資料庫獨家使用權。雷傑納榮預計最快於今年公開5萬至10萬個基因資料樣本，並打算在2020年前將全部資料對外公布，讓所有科學家都能使用這些珍貴數據。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">雷傑納榮總裁揚科普洛斯（George D. Yancopoulos）表示，此資料庫幫助他們了解致病基因，藉此預測藥物臨床試驗成效，並大幅改善藥物研發與相關研究效率。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">雷傑納榮指出，他們早在2014年便已從事大規模基因定序工作，去年為逾25萬名民眾完成基因定序，該公司聘雇50至100名員工負責此項工作，其中多數人專司分析、運算基因資料。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">(工商時報)</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><a href="http://www.chinatimes.com/newspapers/20180110000280-260203" target="_blank">http://www.chinatimes.com/newspapers/20180110000280-260203</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180118]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%89%93%e9%80%a0%e5%9f%ba%e5%9b%a0%e8%b3%87%e6%96%99%e5%ba%ab-5%e5%a4%a7%e8%97%a5%e5%bb%a0%e9%87%91%e6%8f%b4%e9%9b%b7%e5%82%91%e7%b4%8d%e6%a6%ae/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>國際視野 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%89%93%e9%80%a0%e5%9f%ba%e5%9b%a0%e8%b3%87%e6%96%99%e5%ba%ab-5%e5%a4%a7%e8%97%a5%e5%bb%a0%e9%87%91%e6%8f%b4%e9%9b%b7%e5%82%91%e7%b4%8d%e6%a6%ae]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[139]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180118]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7173]]></id>
		<title><![CDATA[女士注意！6個子宮頸癌疑團大解謎]]></title>
		<content><![CDATA[<p><span style="color: #000000"><strong><span style="font-size: 26px">女士注意！6個子宮頸癌疑團大解謎 </span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><strong><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1516008672_44ae.jpg" style="height: 360px; width: 640px" /></span></strong></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="font-size: 16px"><span style="color: #000000">子宮頸癌與後生女無關？女士有固定性伴侶就不會中招？不少女士對婦科檢查都難以啟齒，甚至逃避檢查。婦產科專科醫生靳嘉仁表示，年輕女士最容易感染可致子宮頸癌的「人類乳頭瘤狀病毒」（HPV病毒），故要採取預防措施，包括進行安全性行為、接種預防疫苗、定期進行帕氏抹片檢查及避免吸煙等，一旦出現不尋常的陰道出血更要盡快求醫。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px"><span style="color: #000000">記者：梁麗兒</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000"><strong><span style="font-size: 20px">【子宮頸癌第7位女性常見癌症】</span></strong></span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">2015年本港有500宗子宮頸癌新症，為女性第7位常見癌症。2015年及16年分別有169人及151人因子宮頸癌死亡，只有更年期婦女才會染病純屬誤解，曾有最年輕的個案僅得30歲，病人很早有性行為及有吸煙習慣，屬患病高風險一族。外國研究顯示，26至30歲及46至55歲兩個年齡群組，均最易感染HPV病毒，估計前者屬開始有性行為或性行為較密的年齡，或無做足安全性行為措施，所以年輕女士亦有染病風險。雖然子宮頸癌發病年齡為53歲，但經性交感染可致癌的HPV病毒，例如HPV16、HPV18這兩種高危病毒，可早於年青期，故要盡早採取預防措施。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000"><strong><span style="font-size: 20px">【有固定伴侶不一定可倖免】</span></strong></span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">減少性伴侶數目，可以減低感染HPV病毒風險，但不代表有固定性伴侶、或「初戀情人係我老公」的女性士沒有患子宮頸癌的風險。若固定性伴侶過往曾受感染，或男士以前的性伴侶曾中招，都可經性接觸將病毒傳播開去，故女士對子宮頸癌應保持警覺。已知有頻密性行為、較早有性行為例如15、16歲、有多個性伴侶、曾感染性病、免疫力低、有吸煙習慣的女士，均是患子宮頸癌的高危族。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000"><strong><span style="font-size: 20px">【出血為可察覺症狀】</span></strong></span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">子宮頸癌早期並無症狀，但有些人會出現不正常的陰道出血，如月經之間或性交後出血，需多加留意。女性閉經後再出血，或有帶血絲分泌物，無論出血量多少或顏色深淺，都應盡快求醫。如腫瘤擴散，或壓著其他器官，可出現大小便困難，或背痛、腳部水腫等不適。現時有不少患者是經帕氏抹片檢查，發現有早期病變或癌症，故越早診斷，可減低惡化成癌症或出現擴散等風險。對早期病情，盡早治療，也可以減低子宮切除的可能性。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000"><strong><span style="font-size: 20px">【無性經驗都會患子宮頸癌】</span></strong></span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">子宮頸癌有9成原因與經性交感染HPV病毒有關，餘下原因包括吸煙、遺傳因素等，所以即使無性經驗，都有機會罹患子宮頸癌，故一旦有陰道出血等症狀都應盡快求醫。吸煙不但可影響肺部健康，增加肺癌風險，與子宮頸癌也息息相關，因為女性每個月的子宮頸細胞會不斷更新，煙的致癌物會藉此乘虛而入，避免吸煙或接觸二手煙，都有助預防子宮頸癌。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000"><strong><span style="font-size: 20px">【有性經驗也可考慮注射疫苗】</span></strong></span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">注射預防疫苗為其中一個預防方法，現有疫苗最多可預防感染9種HPV病毒，建議9歲或以上人士已可接種，最有效是在未有性經驗之前。即使已有性經驗，若未曾感染相關的9種病毒都適合注射。有性經驗的女性，若計劃注射疫苗，可先做帕氏抹片檢查，了解有否患癌或癌前病變，配合「HPV病毒基因測試」，確定有否感染相關病毒。診所每月平均有100宗相關測試，約1至2成病人感染1至2種HPV病毒，其餘沒有感染，建議無感染HPV病毒及無子宮頸癌的女性可接種疫苗。若感染了高危HPV病毒，則需自行考慮是否打針。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000"><strong><span style="font-size: 20px">【安全性行為及定期檢查】</span></strong></span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">安全性行為固然重要，但也不要定期檢查，因為男士即使用了安全套，亦未能完全覆蓋生殖器官，故女士不能百分百預防感染HPV病毒，建議有性接觸開始至64歲，應定期進行帕氏抹片檢查，例如每年做檢查，連續兩次檢查結果均正常，建議以後可每隔2至3年再檢查。65歲或以上曾有性經驗、並且從未接受過上述檢查的婦女，即使已停經、多年無性行為或已做結紮手術，都應諮詢醫生意見，了解要否做檢查。另外，已接種疫苗人士也要定期做檢查。</span></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><strong><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1516008674_8070.jpg" style="height: 426px; width: 640px" /></span></strong></span></p>  <p style="text-align: center">婦產科專科醫生靳嘉仁建議女性要定期進行帕氏抹片檢查，及早診治子宮頸癌。（李潤芳攝)</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><strong><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1516008677_bf08.jpg" style="height: 426px; width: 640px" /></span></strong></span></p>  <p style="text-align: center">子宮頸癌可引致患者出現不尋常陰道出血。（李潤芳攝)</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><strong><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1515999915_7907.png" style="height: 341px; width: 640px" /></span></strong></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="font-size: 14px"><span style="color: #808080"><strong>文章來自: 蘋果新聞</strong></span></span></p>  <p><span style="font-size: 14px"><a href="https://hk.news.appledaily.com/local/realtime/article/20180118/57703234" target="_blank"><span style="color: #0000ff"><strong>https://hk.news.appledaily.com/local/realtime/article/20180118/57703234</strong></span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180119]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%a5%b3%e5%a3%ab%e6%b3%a8%e6%84%8f%ef%bc%816%e5%80%8b%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8c%e7%96%91%e5%9c%98%e5%a4%a7%e8%a7%a3%e8%ac%8e/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>癌症的誘因]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%a5%b3%e5%a3%ab%e6%b3%a8%e6%84%8f%ef%bc%816%e5%80%8b%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8c%e7%96%91%e5%9c%98%e5%a4%a7%e8%a7%a3%e8%ac%8e]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[140]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180119]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7174]]></id>
		<title><![CDATA[抗癌新招 激光「燒斷」癌細胞偽足阻其轉移 / Thwarting Metastasis by Breaking Cancer’s Legs with Gold Rods]]></title>
		<content><![CDATA[<p><span style="color: #000000"><strong><span style="font-size: 26px">抗癌新招 激光「燒斷」癌細胞偽足阻其轉移</span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><strong><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2-28-600x400.jpg" style="height: 400px; width: 600px" /></span></strong></span></p>  <p style="text-align: center">電子掃瞄顯微鏡下拍攝到的癌細胞，長有大量的絲狀偽足，使它們能在人體內轉移。（NIH）</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">【大紀元2018年01月15日訊】（大紀元記者張妮編譯報導）</span><a href="http://www.epochtimes.com/b5/tag/%e7%99%8c%e7%97%87.html"><span style="color: #000000">癌症</span></a><span style="color: #000000">研究領域頂尖的一批科學家們正在研究一種利用納米「金棒」注入患處，並結合激光熱療的治癌方案，不僅能完成局部治療而不傷害健康細胞，還能有效阻斷癌細胞</span><a href="http://www.epochtimes.com/b5/tag/%e8%bd%89%e7%a7%bb.html"><span style="color: #000000">轉移</span></a><span style="color: #000000">。該研究已在老鼠體內、以及人體癌細胞實驗室培養皿試驗都獲成功，等待進一步臨床人體試驗。</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">很多</span><a href="http://www.epochtimes.com/b5/tag/%e7%99%8c%e7%97%87.html"><span style="color: #000000">癌症</span></a><span style="color: #000000">病人在接受治療後，都是被可惡的癌症</span><a href="http://www.epochtimes.com/b5/tag/%e8%bd%89%e7%a7%bb.html"><span style="color: #000000">轉移</span></a><span style="color: #000000">奪走了生命。因此科學家在研究，如果能找到有效的阻止癌細胞轉移的方式，就會極大地提高癌症的治癒率。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">美國國家科學院院士Mostafa El-Sayed引領來自佐治亞理工學院（Gatech）、佐治亞州立大學的科學家們進行的，近期發佈在《美國國家科學院院刊》（PNAS）上的報告揭示了他們的成果進展。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h2><strong><span style="font-size: 20px"><span style="color: #000000">治療原理</span></span></strong></h2>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">研究者們解釋說，如果把人體細胞放大來看，它們就像一個個由薄膜包裹著的充滿著液體的球體，裡面漂浮著細胞器。細胞內還有支撐細胞形態、提供各種功能的細胞骨架。而這些支架帶有許多稱為絲狀偽足的剛毛突起，從細胞壁上延伸出來，幫助正常細胞在它們所屬的人體器官上移動。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">但在癌變的細胞上，這些部份通常處於過渡生長狀態，比如會長出大量的絲狀偽足。「這些板狀偽足和絲狀偽足給了癌細胞用於移動的『腿』，使它們能在人體內轉移。」研究者之一、生化分析系畢業生Yue Wu說。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">該團隊研究的治療方案，就是向癌變患處注入納米「金棒」。所謂納米金棒，就是細到只有數十億分之一米的黃金材料，納米就是其體積極其微小的意思。這種納米材料分兩步來對付癌細胞。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">第一步，將這些材料注入患處讓它們「裹住」癌細胞。這種材料表面附有RGD肽，使其更易與一種稱為整聯蛋白的細胞蛋白質結合。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">「這些納米棒綁定整聯蛋白，阻斷它們的功能。這樣它們就無法引導細胞骨架不斷生長板狀和絲狀偽足。」另一位研究者、數據信息生物學博士後助理Yan Tang說。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">這就減緩了癌細胞的繁殖速度，而且該過程不會影響正常的細胞。「（因為）某些特定的整聯蛋白只在癌細胞上大量存在，而正常細胞上並不多見。」該研究的主要作者之一Moustafa Ali說。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h2><strong><span style="font-size: 20px"><span style="color: #000000">激光微熱治療</span></span></strong></h2>  <p><span style="color: #000000"><span style="font-size: 16px">第二步，研究者們用近紅外光（NIR）照射患處，這一療程明顯地停止了癌細胞的轉移。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">「細胞不會吸收這種光，但是納米黃金材料會吸收，吸收後會升溫，繼而熔化它們綁定的癌細胞，摧毀板狀和絲狀偽足。」Ali說，「在這次試驗中我們並沒有殺死癌細胞。因為那樣我們就看不到這個方法是否會阻止癌細胞的轉移了。如果需要，我們可以調整療程為殺死癌細胞的模式。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">前一個在動物體內進行的試驗中效果不大好，使用的溫度太高了，「導致發炎，這樣就只能進行一個療程了。」Ali說，「結果雖然大部份癌細胞被殺死了，但是還有少數活下來了，後期還會轉移。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">「而新採用的較溫和的療法不會傷害皮膚或機體組織，這樣就能進行多個療程，能更徹底地阻斷癌細胞遷移的能力。」研究員Ronghu Wu說。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">研究者們預計該療法將來適用於頭、頸、乳腺和皮膚癌，能夠局部注入納米金材料，再加以激光低熱熱療，而不像化療讓整個機體都很受傷。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">這樣低熱激光大約能擊中埋入組織中2至3厘米深的納米金材料，Ali說「最深能擊入4至5厘米的患處吧」。對於更深部位的腫瘤，「可能需要光纖或內鏡激光設備。」 El-Sayed說。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">而將納米材料直接注入血液中目前來看還不可行。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">該研究團隊之前在PNAS上發表了成功治療老鼠的研究論文。接受治療的老鼠在15個月後，沒有發現任何對納米金材料的毒性反應。「大部份去了肝臟和脾臟，但這些器官仍正常工作，老鼠一年多後仍健康存活。」</span></span></p>  <p>&nbsp;</p>  <p>責任編輯：朱涵儒</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><strong><span style="font-size: 26px">Thwarting Metastasis by Breaking Cancer&rsquo;s Legs with Gold Rods </span></strong></span></p>  <p>By Ben Brumfield | <span class="date-display-single" content="2017-06-26T00:00:00-04:00" datatype="xsd:dateTime" property="dc:date">June 26, 2017</span> <span class="location">&bull; Atlanta, GA </span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #000000"><strong><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2-28-600x400(1).jpg" style="height: 400px; width: 600px" /></span></strong></span></p>  <p style="text-align: center">&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">A dying cancer cell with filopodia stretched out to its right. The protrusions help&nbsp;cancer migrate. Stock NIH NCMIR image. The image does not display a cell treated in the Georgia Tech study. Credit:&nbsp;NIH-funded image of HeLa cell / National Center for Microscopy and Imaging Research / Thomas Deerinck / Mark Ellisman. Use may require permission.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;Your cancer has metastasized. I&rsquo;m sorry,&rdquo; is something no one wants to hear a doctor say.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">Cancer cells </span><a href="http://www.cancerresearchuk.org/about-cancer/coping/physically/how-can-cancer-kill-you" target="_blank"><span style="color: #000000">kill most often</span></a><span style="color: #000000"> by crawling away from their original tumors to later re-root in vital parts of the body in a process called </span><a href="http://www.cancer.net/navigating-cancer-care/cancer-basics/what-metastasis" target="_blank"><span style="color: #000000">metastasis</span></a><span style="color: #000000">. Now, a research team led by the Georgia Institute of Technology </span><a href="http://www.pnas.org/content/early/2017/06/21/1703151114" target="_blank"><span style="color: #000000">has developed a new treatment</span></a><span style="color: #000000"> to thwart cancer&#39;s spread through the body by, in a sense, breaking cancer cells&rsquo; legs.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">Cancer cells often cover themselves with bristly leg-like protrusions that enable them to creep. The researchers have used minuscule gold rods heated gently by a laser to mangle the protrusions, </span><a href="http://www.pnas.org/cgi/doi/10.1073/pnas.1703151114" target="_blank"><span style="color: #000000">according to a new study</span></a><span style="color: #000000">. The treatment prevented cell migration, a key mechanism in metastasis, in experiments on common laboratory cultures (<em>in vitro</em>) of cancerous human cells.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">The method could potentially, in the future, offer clinicians going after individual tumors a weapon to combat cancer&rsquo;s deadly spread at the same time. The medical field is currently less than well-equipped to stop metastasis.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;If cancer stays in a tumor in one place, you can get to it, and it&rsquo;s not so likely to kill the patient, but when it spreads around the body, that&rsquo;s what really makes it deadly,&rdquo; said lead researcher </span><a href="http://www.chemistry.gatech.edu/faculty/El-Sayed/" target="_blank"><span style="color: #000000">Mostafa El-Sayed, Julius Brown Chair and Regents Professor</span></a><span style="color: #000000"> at Georgia Tech&rsquo;s </span><a href="https://www.chemistry.gatech.edu/" target="_blank"><span style="color: #000000">School of Chemistry and Biochemistry.</span></a></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">The treatment can also easily kill cancer cells, but in this experiment, it was vital to specifically show that it greatly slowed cell migration. The method is not scheduled for human testing.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h4><span style="font-size: 16px"><span style="color: #000000"><strong>Halting cancer softly</strong></span></span></h4>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">The experimental treatment also spared healthy cells, in these and in prior experiments, making the method potentially much less </span><a href="https://www.cancer.gov/publications/patient-education/chemo-side-effects" target="_blank"><span style="color: #000000">taxing on patients than commonly used chemotherapy</span></a><span style="color: #000000">. In past tests in animal models, the researchers have uncovered no toxic side effects from the gold used in the treatment, and have found no observable damage to healthy tissue from the low-energy laser.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">And they did not see recurrence of the treated cancer.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;The method appears to be very effective as a locally administered treatment that also protects the body from cancer&rsquo;s spread away from the treated tumors, and it is also very mild, so it can be applied many times over if needed,&rdquo; El-Sayed said.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">El-Sayed, </span><a href="https://www.chemistry.gatech.edu/people/wu/ronghu" target="_blank"><span style="color: #000000">co-lead author Ronghu Wu</span></a><span style="color: #000000">, and first authors Yue Wu and Moustafa Ali published the results of their current <em>in vitro</em> experiments, a new development in </span><a href="http://www.sciencedirect.com/science/article/pii/S030438350800325X" target="_blank"><span style="color: #000000">photothermal gold nanorod therapy</span></a><span style="color: #000000">, on June 26, 2017, in the </span><a href="http://www.pnas.org/cgi/doi/10.1073/pnas.1703151114" target="_blank"><span style="color: #000000">Proceedings of the National Academy of Sciences.</span></a><span style="color: #000000"> The research was funded by the National Science Foundation and the National Institutes of Health.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h4><span style="font-size: 16px"><span style="color: #000000"><strong>How it works: Icky legs</strong></span></span></h4>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">To understand how the treatment works, let&rsquo;s take a close-up look at a cell and some things that happen to it in malignant cancer.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">Many people think of cells as watery balloons &mdash; fluid encased in a membrane sheath with organelles floating around inside. But that picture is incomplete. Cells have support grids called </span><a href="https://www.youtube.com/watch?v=4BAGI6LbHeo" target="_blank"><span style="color: #000000">cytoskeletons</span></a><span style="color: #000000"> that give them form and that have functions.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">The cytoskeletons also form bristly </span><a href="http://www.cellmigration.org/topics/protrusion.shtml" target="_blank"><span style="color: #000000">protrusions called filopodia, which extend out from a weave of fibers called lamellipodia</span></a><span style="color: #000000"> that are on the cell&rsquo;s fringes. The protrusions normally help healthy cells shift their location in the tissue that they are part of.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">But in malignant cancer, normally healthy cell functions often lunge into destructive overdrive. Lamellipodia and filopodia are wildly overproduced.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;All these lamellipodia and filopodia give the cancer cells legs,&rdquo; said Yue Wu, a graduate student in bioanalytical chemistry. &ldquo;The metastasis requires those protrusions, so the cells can travel.&rdquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h4><span style="font-size: 16px"><span style="color: #000000"><strong>How it works: Sticky rods</strong></span></span></h4>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">The </span><a href="https://www.ncbi.nlm.nih.gov/pubmed/20967876" target="_blank"><span style="color: #000000">gold nanorods</span></a><span style="color: #000000"> thwart the protrusions in two ways. The rods are comprised of a small collection of gold atoms &ndash; nano refers to something being just billionths of meters (or feet) in size.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">First, El-Sayed&rsquo;s nanorods are introduced locally, where they encumber the leggy protrusions on cancerous cells. The rods are coated with molecules (</span><a href="https://en.wikipedia.org/wiki/Arginylglycylaspartic_acid" target="_blank"><span style="color: #000000">RGD-peptide</span></a><span style="color: #000000">s) that make them stick specifically to a type of cell protein called </span><a href="https://www.mechanobio.info/topics/mechanosignaling/cell-matrix-adhesion/integrin-mediated-signalling-pathway/" target="_blank"><span style="color: #000000">integrin</span></a><span style="color: #000000">.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;The targeted nanorods tied up the integrin and blocked its functions, so it could not keep guiding the cytoskeleton to overproduce lamellipodia and filopodia,&rdquo; said Yan Tang, a postdoctoral assistant in computational biology who worked on the study. The binding of the integrin alone slowed down the migration of malignant cells.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">But healthy cells were not targeted. &ldquo;There are certain, specific integrins that are overproduced in cancerous cells,&rdquo; said Moustafa Ali, one of the study&rsquo;s first authors. &ldquo;And you don&rsquo;t find them so much in healthy cells.&rdquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h4><span style="font-size: 16px"><span style="color: #000000"><strong>How it works: Gentle laser heating</strong></span></span></h4>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">In the second phase, researchers hit the gold nanoparticles with a low-energy laser of near-infrared (NIR) light. It brought the migration of the cancer cells to an observable halt.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;The light was not absorbed by the cells, but the gold nanorods absorbed it, and as a result, they heated up and partially melted cancer cells they are connected with, mangling lamellipodia and filopodia,&rdquo; Ali said. &ldquo;It didn&rsquo;t kill all the cells, not in this experiment. If we killed them, we would not have been able to observe whether we stopped them from migrating or not.&rdquo;</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">If desired, the treatment can also be adjusted to kill the cells.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">Early experiments in animal models <em>in vivo</em> with hotter lasers didn&rsquo;t work as well. &nbsp;&ldquo;That caused inflammation, which made it possible to heat one time only,&rdquo; Ali said. &ldquo;As a result, that high temperature would wipe out many cancer cells, but not all of them. Some hidden ones might have survived, and also still been able to migrate.&rdquo;</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;This gentle laser didn&rsquo;t burn the skin or damage tissue, so it could be dosed multiple times and more thoroughly stop the cancer cells from being able to travel,&rdquo; said researcher Ronghu Wu.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h4><span style="font-size: 16px"><span style="color: #000000"><strong>Medical possibilities</strong></span></span></h4>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">The researchers presently envision treating head, neck, breast, and skin cancers with direct, local nanorod injections combined with the low-power near-infrared laser, which can hit the gold nanorods 2-3 centimeters (a bit under or over an inch) deep inside tissue. &ldquo;But it could go as deep as 4-5 centimeters,&rdquo; Ali said.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">Deeper tumors could conceivably be treated with deeper injections of nanorods. &ldquo;Then you&rsquo;d need to go in with a fiber optic or endoscopic laser,&rdquo; El-Sayed said. Injecting the nanorods directly into the bloodstream as a broad treatment would not currently be a viable option.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">El-Sayed&rsquo;s group has previously published <em>in vivo</em>&nbsp;experiments in mice </span><a href="http://www.pnas.org/content/114/15/E3110" target="_blank"><span style="color: #000000">in the Proceedings of the National Academy of Sciences together with Emory University School of Medicine</span></a><span style="color: #000000">. That study showed no observable toxicity from the gold in mice 15 months after treatment.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&ldquo;A lot of it ended up in the liver and spleen,&rdquo; El-Sayed said. &ldquo;But the functions of these organs appeared intact upon examination, and treated mice were alive and healthy over a year later.&rdquo;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h4><span style="font-size: 16px"><span style="color: #000000"><strong>Presidential honors</strong></span></span></h4>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">Mostafa El-Sayed is one of the world&rsquo;s most highly decorated and cited living chemists, and a pioneer of nanoscience and technology. Among his many recognitions are </span><a href="https://www.nsf.gov/news/special_reports/medalofscience50/el-sayed.jsp" target="_blank"><span style="color: #000000">the President&rsquo;s National Medal of Science, awarded by President George W. Bush</span></a><span style="color: #000000">, and the </span><a href="http://www.news.gatech.edu/2015/07/06/mostafa-el-sayed-wins-2016-priestley-medal" target="_blank"><span style="color: #000000">Priestley Medal</span></a><span style="color: #000000">, the American Chemical Society&rsquo;s highest honor. </span><a href="https://www.cos.gatech.edu/hg/item/584568" target="_blank"><span style="color: #000000">President Barack H. Obama appointed El-Sayed to the President&rsquo;s National Medal of Science Committee</span></a><span style="color: #000000">. El-Sayed also participated in the nomination of chemistry </span><a href="https://www.nobelprize.org/nobel_prizes/chemistry/laureates/1999/zewail-facts.html" target="_blank"><span style="color: #000000">Nobel Laureate Ahmed Zewail. </span></a></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">El-Sayed is known throughout physical chemistry for &ldquo;</span><a href="http://pubs.acs.org/doi/pdf/10.1021/jp111892y" target="_blank"><span style="color: #000000">El-Sayed&rsquo;s Rule</span></a><span style="color: #000000">,&rdquo; which handles complexities of electron spin orbits, and which has found a lasting place in photochemistry textbooks. After losing his wife to cancer in 2005, El-Sayed dedicated his knowledge and research to ending the scourge.</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><a href="http://www.rh.gatech.edu/news/584146/report-cancer-and-technology-highlights-georgia-tech-research" target="_blank"><span style="color: #000000">Also read: Cancer and Technology</span></a></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><a href="http://www.rh.gatech.edu/news/583569/punching-cancer-rna-knuckles" target="_blank"><span style="color: #000000">Also read: Punching Cancer with RNA Knuckles</span></a></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000"><em>The following authors also contributed to this research: Haopeng Xiao and Tiegang Han from Georgia Tech, and Kuangcai Chen and Ning Fang from Georgia State University. This research was funded by the National Science Foundation Division of Chemistry (grants 1608801, CAREER Award CHE-1454501), and the National Institutes of Health Nanotechnology Study Section (grant 1R01GM115763). Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies.</em></span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">&nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #696969"><span style="font-size: 14px">文章來自:大紀元 / Georgia Tech</span></span></p>  <p>中 : <a href="http://www.epochtimes.com/b5/18/1/15/n10058064.htm" target="_blank"><span style="color: #0000ff"><span style="font-size: 14px">http://www.epochtimes.com/b5/18/1/15/n10058064.htm</span></span></a></p>  <p>Eng : <span style="font-size: 14px"><a href="http://www.news.gatech.edu/2017/06/26/thwarting-metastasis-breaking-cancers-legs-gold-rods" target="_blank"><span style="color: #0000ff">http://www.news.gatech.edu/2017/06/26/thwarting-metastasis-breaking-cancers-legs-gold-rods</span></a></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180119]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%8a%97%e7%99%8c%e6%96%b0%e6%8b%9b-%e6%bf%80%e5%85%89%e3%80%8c%e7%87%92%e6%96%b7%e3%80%8d%e7%99%8c%e7%b4%b0%e8%83%9e%e5%81%bd%e8%b6%b3%e9%98%bb%e5%85%b6%e8%bd%89%e7%a7%bb-thwarting-metastasis-by-b/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%8a%97%e7%99%8c%e6%96%b0%e6%8b%9b-%e6%bf%80%e5%85%89%e3%80%8c%e7%87%92%e6%96%b7%e3%80%8d%e7%99%8c%e7%b4%b0%e8%83%9e%e5%81%bd%e8%b6%b3%e9%98%bb%e5%85%b6%e8%bd%89%e7%a7%bb-thwarting-metastasis-by-b]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[141]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180119]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7175]]></id>
		<title><![CDATA[每月藥費過萬如何負擔?]]></title>
		<content><![CDATA[<p style="text-align: center"><span style="font-size: 16px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/55678.jpg" style="height: 424px; width: 640px" /></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px">近日多位重量級醫學界人士都表示，新一代癌症藥物非常昂貴，非一般家庭可以負擔，幸而近年關愛基金逐步將有效的癌症藥物納入資助範圍，令合資格患者有機會採用新一代藥物，重燃生命的希望。鄭生便是其中之一。</span><br /> <br /> &nbsp;</p>  <p><span style="font-size: 16px">50歲的鄭生是的士司機，靠一部的士養活一家五口，屬中低收入家庭。近日，他頻頻咳嗽，且體重下降，體力下降，影響工作。在太太催促下，他終往求醫，結果竟確診第三期肺癌，令他頓感晴天霹靂。</span><br /> <br /> &nbsp;</p>  <p><span style="font-size: 16px">醫生進一步為鄭生檢查，發現他所患的屬於EGFR基因突變型肺癌，建議他採用已被美國治療指引納入一線治療的新一代標靶藥物。「醫生說新一代標靶藥物對這類肺癌的成效較好 ⋯⋯但每月藥費『萬萬聲』，我們揸的士的，又要養家，怎能負擔得起？所以，我當時對醫生說：『多謝你的建議，但我真的負擔不來。』」</span><br /> <br /> &nbsp;</p>  <p><span style="font-size: 16px">幸而，其時關愛基金剛剛拓闊藥物名單，將專門針對EGFR基因突變型肺癌的阿法替尼（Afatinib）納入資助範圍，令鄭生可以及時展開療程。「我是非常感恩的，現在我的病情已被控制住，而且沒有明顯副作用，所以我可以繼續工作，照顧家庭。」如你身邊人不幸患上肺癌，請提醒他們向主診醫生查詢關愛基金有否資助他們所需的藥物。</span><br /> &nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180119]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%af%8f%e6%9c%88%e8%97%a5%e8%b2%bb%e9%81%8e%e8%90%ac%e5%a6%82%e4%bd%95%e8%b2%a0%e6%93%94/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%af%8f%e6%9c%88%e8%97%a5%e8%b2%bb%e9%81%8e%e8%90%ac%e5%a6%82%e4%bd%95%e8%b2%a0%e6%93%94]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[142]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180119]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7176]]></id>
		<title><![CDATA[未來一直來：15個你沒發覺，卻正在改變生活的未來新科技]]></title>
		<content><![CDATA[<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/alia00_p_02_01.jpg" style="width: 400px; height: 548px;" /></p>  <p>&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">現代社會最流行的就是以「每個人為特殊個體」來重視的「客製化」概念，神奇的是，未來或許連看病、治療也能客製化！世界各國正如火如荼發展的「精準醫療」便是疾病治療客製化的關鍵。到底疾病治療要怎麼客製化？</p>  <div id="div-gpt-ad-1489561879560-0" style="border: 0px none; margin: 0px; outline: none 0px; padding: 0px; font-family: &quot;Microsoft JhengHei&quot;, sans-serif; font-size: 18px; text-align: center;">&nbsp;</div>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">根據美國國家衛生研究院（National Institutes of Health，NIH）的說明，精準醫療是指將個人的基因變異、環境和生活形態納入疾病的治療與預防。相對於既有針對「標準化病患」（average patient）的「標準治療策略」（one-size-fits-all）可能只對於部分病患有效，精準醫療大量使用基因變異的大數據，協助研發者和醫生可以根據這些分子層次的細微差異，提高疾病的預防率和治癒率。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">「精準醫療」的構想源於2015年1月，當時的美國總統歐巴馬在國情咨文演講中宣布啟動，美國預計於2016年投入2.15億美元，募集100萬人的基因資料，研究基因變異對人體健康和疾病形成的影響，以更深入了解疾病形成的機制，期待能精準地開發相對應的藥物，提高治癒率。目前，由美國臨床腫瘤學會（ASCO）主導成立的CancerLinQ計畫，已累積75萬個癌症病例資訊，利用數據共享，引領未來癌症的治療方向。</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="background-color: rgb(255, 255, 255);">（摘自本書P128～P129）</span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180123]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%9c%aa%e4%be%86%e4%b8%80%e7%9b%b4%e4%be%86%ef%bc%9a15%e5%80%8b%e4%bd%a0%e6%b2%92%e7%99%bc%e8%a6%ba%ef%bc%8c%e5%8d%bb%e6%ad%a3%e5%9c%a8%e6%94%b9%e8%ae%8a%e7%94%9f%e6%b4%bb%e7%9a%84%e6%9c%aa%e4%be%86/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>好書分享]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%9c%aa%e4%be%86%e4%b8%80%e7%9b%b4%e4%be%86%ef%bc%9a15%e5%80%8b%e4%bd%a0%e6%b2%92%e7%99%bc%e8%a6%ba%ef%bc%8c%e5%8d%bb%e6%ad%a3%e5%9c%a8%e6%94%b9%e8%ae%8a%e7%94%9f%e6%b4%bb%e7%9a%84%e6%9c%aa%e4%be%86]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[143]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180123]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7177]]></id>
		<title><![CDATA[狡猾至極！為了轉移，癌細胞竟然會偽裝成免疫細胞，難怪T細胞會讓它在眼皮子底下溜走 | 科學大發現]]></title>
		<content><![CDATA[<p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:26px;"><strong><span style="margin: 0px; font-family: 新細明體;">《自然》：狡猾至極！為了轉移，癌細胞竟然會偽裝成免疫細胞，難怪</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">T</span><span style="margin: 0px; font-family: 新細明體;">細胞會讓它在眼皮子底下溜走</span><span style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;"> <span lang="EN-US" style="margin: 0px;">| </span></span><span style="margin: 0px; font-family: 新細明體;">科學大發現</span></strong></span></span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;"><span style="font-size:14px;"><span style="color:#696969;"><span class="rich_media_meta meta_original_tag" id="copyright_logo">Original</span> <i>2018-01-18</i> <i>朱爽爽</i> </span><a class="rich_media_meta rich_media_meta_link rich_media_meta_nickname" href="https://mp.weixin.qq.com/s/7pSsMiqqf-sY2GqrjjJnQg##" id="post-user"><span style="color:#696969;">奇点网</span></a></span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;"><strong><span style="font-size:18px;"><span style="color:#000000;"><span style="margin: 0px; font-family: 新細明體;">癌細胞才是真正的&ldquo;戲精&rdquo;。</span></span></span></strong></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">我們在很多電影中都看到過這樣的橋段，某個殺人犯行兇被發現，並被大量員警包圍走投無路時，往往會通過模仿員警開著警車逃離犯罪現場。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">很遺憾，癌細胞可能就是這一經典橋段的鼻祖。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">就在昨天，來自康奈爾醫學中心的</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Lewis C. Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士與紀念斯隆凱特琳癌症中心的研究人員合作在《自然》雜誌上發表了一篇超級重磅的研究。</span><b><span style="margin: 0px; font-family: 新細明體;">他們找到了癌細胞轉移的遺傳學機制。</span></b></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><b><span style="margin: 0px; font-family: 新細明體;">他們發現，</span><span style="margin: 0px; font-family: 新細明體;">癌細胞的轉移是由染色體不穩定性驅動。高度不穩定的染色體可以主動啟動癌細胞基因組中的炎症相關通路，使其表現出免疫細胞的特點並獲得轉移能力</span></b><span style="margin: 0px; font-family: 新細明體;">。這不僅使癌細胞成功逃避了</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">T</span><span style="margin: 0px; font-family: 新細明體;">細胞的追殺，</span><span lang="EN-US" style="background: white; margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="background: white; margin: 0px; font-family: 新細明體;">博士懷疑，</span><b><span style="margin: 0px; font-family: 新細明體;">當機體出現感染或病原微生物入侵時，這些癌細胞還很有可能還會像免疫細胞一樣遷移到感染部位形成轉移灶</span></b><span style="margin: 0px; font-family: 新細明體;">（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">1</span><span style="margin: 0px; font-family: 新細明體;">）。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px; text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span lang="EN-US" style="margin: 0px;"><font face="新細明體"><img _width="100%" data-fail="0" data-ratio="1" data-src="http://mmbiz.qpic.cn/mmbiz_jpg/g1rJAV614wxeCA6vN8IYvSn7FMvQnPvds0ayDEJiazjpJVKqia2MW7M5z5xqF5vTPMXcS5w5NtIZhofibNRWqItXw/0?wx_fmt=jpeg" data-type="jpeg" data-w="640" src="http://www.cancerinformation.com.hk/ufiles/Image/1(20).jpg" style="width: 500px; height: 500px;" v_shapes="_x0000_i1025" /></font></span></span></span></p>  <p style="background: white; margin: 0px; text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士</span></span></span></p>  <p style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><strong><span style="font-size:18px;"><span style="color:#000000;"><span style="margin: 0px; font-family: 新細明體;">說到這一研究，就不得不提一下染色體不穩定性了。</span></span></span></strong></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">所謂染色體不穩定性，就是指癌細胞相比于正常細胞，其細胞在進行分裂時很容易丟失或者得到一整條染色體或者染色體片段，這是人類惡性腫瘤的普遍特徵之一。此前的研究表明，染色體不穩定性，引起的染色體數目不平衡是導致抑癌基因失活的重要機制。因此，有學者認為，染色體不穩定性可能是早期腫瘤形成的重要機制（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">2</span><span style="margin: 0px; font-family: 新細明體;">）。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">而近年來，大量的研究表明，染色體不穩定性不僅與早期腫瘤的形成密切相關，在癌細胞的轉移中，它也插上了一腳</span><b><span style="margin: 0px; font-family: 新細明體;">。</span></b><span style="margin: 0px; font-family: 新細明體;">具體來說，人們發現，</span><b><span style="margin: 0px; font-family: 新細明體;">那些容易發生遠端轉移的惡性腫瘤細胞，都表現出高度的染色體不穩定性</span></b><span style="margin: 0px; font-family: 新細明體;">（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">3</span><span style="margin: 0px; font-family: 新細明體;">）。不過此前人們並不清楚染色體不穩定到底是癌細胞轉移的原因還是結果。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px; text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px;"><font face="新細明體"><img _width="100%" data-fail="0" data-ratio="0.6" data-src="http://mmbiz.qpic.cn/mmbiz_jpg/g1rJAV614wxeCA6vN8IYvSn7FMvQnPvdL95iaHLBJbficby0N2Y38DOztibkoFJgics0WVlmnRzgNpcibTeCC7J9bYw/0?wx_fmt=jpeg" data-type="jpeg" data-w="640" src="http://www.cancerinformation.com.hk/ufiles/Image/2(12).jpg" style="width: 500px; height: 300px;" v_shapes="_x0000_i1026" /></font></span></span></span></p>  <p style="background: white; margin: 0px; text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">因此為了探究染色體不穩定性與癌細胞轉移之間的關係，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士開始了本次實驗。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">首先，通過對</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">72</span><span style="margin: 0px; font-family: 新細明體;">對原發性腫瘤以及轉移灶癌細胞的基因資料進行基因完整性分析（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">wGGI</span><span style="margin: 0px; font-family: 新細明體;">），對乳腺癌的原發灶和轉移灶進行染色體組型分析，以及對局部晚期頭頸部鱗狀細胞癌患者的原發灶和轉移灶進行病理分析。</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士發現，的確，相比于原發性腫瘤，轉移灶癌細胞的染色體不穩定性顯著提高。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">隨後，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士便開始深入研究染色體不穩定性在癌細胞轉移過程中的作用。此前的研究表明，微管解聚酶驅動蛋白</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">KIF2B</span><span style="margin: 0px; font-family: 新細明體;">可以維持細胞染色體穩定（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">4</span><span style="margin: 0px; font-family: 新細明體;">）。因此，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士首先建立了三種癌細胞模型，一種是正常的高轉移性癌細胞，一種是染色體不穩定性稍微被抑制高轉移性癌細胞，最後一種是染色體不穩定性顯著被抑制的高轉移性癌細胞（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">KIF2B</span><span style="margin: 0px; font-family: 新細明體;">高表達）。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">隨後，通過將這些癌細胞注射到裸鼠乳房中，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士發現，正常的高轉移性癌細胞很快就在裸鼠的肺部，骨頭，大腦中形成了轉移灶，</span><b><span style="margin: 0px; font-family: 新細明體;">一般</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">70</span></b><b><span style="margin: 0px; font-family: 新細明體;">天左右</span></b><span style="margin: 0px; font-family: 新細明體;">，</span><b><span style="margin: 0px; font-family: 新細明體;">小鼠就因癌細胞轉移而死</span></b><span style="margin: 0px; font-family: 新細明體;">。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">然而，讓</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士感到不可思議的是，那些染色體穩定的高轉移性癌細胞注射進入裸鼠乳房後，雖然癌細胞的增殖速度並沒有受到影響，但是其轉移能力卻被顯著抑制，很少形成轉移灶，</span><b><span style="margin: 0px; font-family: 新細明體;">並且這些裸鼠一直活到了</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">210</span></b><b><span style="margin: 0px; font-family: 新細明體;">天左右，是對照組的近三倍。這也意味著，癌細胞的轉移就是由染色體不穩定驅動的</span></b><span style="margin: 0px; font-family: 新細明體;">。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px; text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><span lang="EN-US" style="margin: 0px;"><font face="新細明體"><img _width="100%" data-fail="0" data-ratio="0.7939778" data-src="http://mmbiz.qpic.cn/mmbiz_png/g1rJAV614wxeCA6vN8IYvSn7FMvQnPvdbr8wktXVdU97ibYCnWuQnLiaiajmAnKvmlytOdbsIHAGgiaJ9symiasIBcQ/0?wx_fmt=png" data-type="png" data-w="631" src="http://www.cancerinformation.com.hk/ufiles/Image/3(10).jpg" style="width: 500px; height: 397px;" v_shapes="_x0000_i1027" /></font></span></span></span></p>  <p style="background: white; margin: 0px; text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><span style="margin: 0px; font-family: 新細明體;">注入染色體穩定癌細胞的小鼠生存時間顯著延長（藍色）</span></span></span></p>  <p style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><strong><span style="font-size:18px;"><span style="color:#000000;"><span style="margin: 0px; font-family: 新細明體;">但是染色體不穩定性是如何驅動癌細胞轉移的呢？</span></span></span></strong></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">通過對染色體穩定的以及染色體不穩定的三陰性乳腺癌細胞細胞進行全轉錄組測序分析，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士發現，相比於低轉移性染色體穩定的癌細胞，高轉移性染色體不穩定的癌細胞內有</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">1584</span><span style="margin: 0px; font-family: 新細明體;">個基因的表達顯著上調。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">通過整合單細胞</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">RNA</span><span style="margin: 0px; font-family: 新細明體;">測序的結果，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士發現，這些基因主要涉及兩個重要的通路，一個是降低癌細胞黏附性的上皮間質轉化通路，</span><b><span style="margin: 0px; font-family: 新細明體;">而另一個就是炎症反應通路</span></b><span style="margin: 0px; font-family: 新細明體;">。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">隨後進一步的研究發現，這些染色體不穩定的癌細胞，會產生大量的</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">DNA</span><span style="margin: 0px; font-family: 新細明體;">碎片通過微核分泌到細胞質中。我們都知道，</span><b><span style="margin: 0px; font-family: 新細明體;">正常情況下，細胞質中是不會出現</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">DNA</span></b><b><span style="margin: 0px; font-family: 新細明體;">的；一旦細胞質內出現了</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">DNA</span></b><b><span style="margin: 0px; font-family: 新細明體;">碎片，就會馬上啟動</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">cGAS-sting</span></b><b><span style="margin: 0px; font-family: 新細明體;">通路，誘發炎症反應召集</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">T</span></b><b><span style="margin: 0px; font-family: 新細明體;">細胞來消滅這些細胞，</span></b><span style="margin: 0px; font-family: 新細明體;">這也是放療發揮作用的重要機制（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">5</span><span style="margin: 0px; font-family: 新細明體;">）。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">顯然，癌細胞並不屬於正常情況。</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士發現，這些染色體高度不穩定癌細胞細胞質中的</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">DNA</span><span style="margin: 0px; font-family: 新細明體;">碎片，雖然會啟動</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">cGAS-sting</span><span style="margin: 0px; font-family: 新細明體;">通路，但是隨後不會啟動經典的核因數&kappa;</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">B</span><span style="margin: 0px; font-family: 新細明體;">通路。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">相反，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士發現，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">cGAS-sting</span><span style="margin: 0px; font-family: 新細明體;">通路會啟動非經典的核因數&kappa;</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">B</span><span style="margin: 0px; font-family: 新細明體;">通路，促使</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">p52</span><span style="margin: 0px; font-family: 新細明體;">基因的表達，</span><b><span style="margin: 0px; font-family: 新細明體;">使癌細胞的基因表達特徵與骨髓先天性免疫細胞具有某些相似性，並且可以逃避</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">T</span></b><b><span style="margin: 0px; font-family: 新細明體;">細胞的追殺</span></b><span style="margin: 0px; font-family: 新細明體;">。同時，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士還發現，</span><b><span style="margin: 0px; font-family: 新細明體;">抑制</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">cGAS-sting</span></b><b><span style="margin: 0px; font-family: 新細明體;">通路可以顯著抑制癌細胞轉</span></b><span style="margin: 0px; font-family: 新細明體;">移。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p align="center" style="background: white; margin: 0px; text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><span lang="EN-US" style="margin: 0px;"><font face="新細明體"><img data-copyright="0" data-fail="0" data-ratio="0.66625" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/g1rJAV614wxeCA6vN8IYvSn7FMvQnPvdkCf9vYgtWqDA9O3EgyDlYu4xfC3A6llnPp7XBmZNicVDuv3T272CVibQ/0?wx_fmt=jpeg" data-type="jpeg" data-w="800" src="http://www.cancerinformation.com.hk/ufiles/Image/4(7).jpg" style="width: 500px; height: 333px;" v_shapes="_x0000_i1028" /></font></span></span></span></p>  <p align="center" style="background: white; margin: 0px; text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><span style="margin: 0px; font-family: 新細明體;">滲入細胞質中的</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">DNA</span><span style="margin: 0px; font-family: 新細明體;">碎片（綠色）</span></span></span></p>  <p align="center" style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p align="center" style="background: white; margin: 0px; text-align: center;">&nbsp;</p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">因此，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士懷疑，染色體高度不穩定的癌細胞通過主動啟動</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">cGAS-sting</span><span style="margin: 0px; font-family: 新細明體;">通路，誘導大量的骨髓先天性免疫細胞聚集。這樣以來，</span><b><span style="margin: 0px; font-family: 新細明體;">癌細胞不僅可以通過模仿骨髓先天性免疫細胞來逃脫</span></b><b><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">T</span></b><b><span style="margin: 0px; font-family: 新細明體;">細胞的追殺，同時還能能夠像骨髓先天性免疫細胞一樣，遷移到其他感染部位形成轉移灶</span></b><span style="margin: 0px; font-family: 新細明體;">。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">正如本文的一作，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Samuel F. Bakhoum</span><span style="margin: 0px; font-family: 新細明體;">博士所說，&ldquo;癌細胞可以模仿免疫細胞。這使它們避免了隨後炎症反應帶來的致命後果。這就像罪犯進入警車離開到處都是員警的犯罪現場，避免被捕一樣（</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">6</span><span style="margin: 0px; font-family: 新細明體;">）。&rdquo;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span style="margin: 0px; font-family: 新細明體;">總而言之，</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">Cantley</span><span style="margin: 0px; font-family: 新細明體;">博士的研究闡明了染色體不穩定性驅動癌細胞轉移的具體機制。這也為未來癌症的治療開闢了全新的靶點，畢竟大家也知道</span><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">90%</span><span style="margin: 0px; font-family: 新細明體;">癌症的死亡都是轉移導致的。</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;"><span style="color:#000000;"><span style="font-size:16px;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">&nbsp;</span></span></span></p>  <p style="background: white; margin: 0px;"><span style="margin: 0px; color: rgb(160, 160, 160); font-family: 新細明體; font-size: 7pt;">參考資料：</span></p>  <p style="background: white; margin: 0px;"><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">1.https://www.nature.com/articles/nature25432</span></p>  <p style="background: white; margin: 0px;"><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">2.Sheltzer J M, Ko J H, Replogle J M, et al. Single-chromosome gains commonly function as tumor suppressors[J]. Cancer cell, 2017, 31(2): 240-255.</span></p>  <p style="background: white; margin: 0px;"><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">3.Turajlic S, Swanton C. Metastasis as an evolutionary process[J]. Science, 2016, 352(6282): 169-175.</span></p>  <p style="background: white; margin: 0px;"><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">4.Bakhoum S F, Thompson S L, Manning A L, et al. Genome stability is ensured by temporal control of kinetochore</span><span style="margin: 0px; color: rgb(160, 160, 160); font-family: 新細明體; font-size: 7pt;">&ndash;</span><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">microtubule dynamics[J]. Nature cell biology, 2009, 11(1): 27-35.</span></p>  <p style="background: white; margin: 0px;"><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">5.Deng L, Liang H, Xu M, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors[J]. Immunity, 2014, 41(5): 843-852.</span></p>  <p style="background: white; margin: 0px;"><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">6.https://www.mskcc.org/blog/escape-artists-cancer-cells-mimic-immune-cell-activity-spread</span></p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;">&nbsp;</p>  <p style="background: white; margin: 0px;"><span lang="EN-US" style="margin: 0px; color: rgb(160, 160, 160); font-family: &quot;Microsoft YaHei&quot;; font-size: 7pt;">​</span><span style="font-size:14px;"><span style="color:#696969;"><span lang="EN-US" style="margin: 0px; font-family: &quot;Microsoft YaHei&quot;;">文章來自:&nbsp;</span></span><a class="rich_media_meta rich_media_meta_link rich_media_meta_nickname" href="https://mp.weixin.qq.com/s/7pSsMiqqf-sY2GqrjjJnQg##" id="post-user"><span style="color:#696969;">奇点网</span></a></span></p>  <p style="background: white; margin: 0px;"><a href="https://mp.weixin.qq.com/s/7pSsMiqqf-sY2GqrjjJnQg" target="_blank"><span style="color:#0000FF;"><span style="font-size:14px;">https://mp.weixin.qq.com/s/7pSsMiqqf-sY2GqrjjJnQg</span></span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180123]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%8b%a1%e7%8c%be%e8%87%b3%e6%a5%b5%ef%bc%81%e7%82%ba%e4%ba%86%e8%bd%89%e7%a7%bb%ef%bc%8c%e7%99%8c%e7%b4%b0%e8%83%9e%e7%ab%9f%e7%84%b6%e6%9c%83%e5%81%bd%e8%a3%9d%e6%88%90%e5%85%8d%e7%96%ab%e7%b4%b0/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>國際視野 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%8b%a1%e7%8c%be%e8%87%b3%e6%a5%b5%ef%bc%81%e7%82%ba%e4%ba%86%e8%bd%89%e7%a7%bb%ef%bc%8c%e7%99%8c%e7%b4%b0%e8%83%9e%e7%ab%9f%e7%84%b6%e6%9c%83%e5%81%bd%e8%a3%9d%e6%88%90%e5%85%8d%e7%96%ab%e7%b4%b0]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[144]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180123]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7178]]></id>
		<title><![CDATA[健康假日飲食生活小帖士]]></title>
		<content><![CDATA[<h2><strong><span style="font-size:26px;"><a href="https://afcr.org.hk/zh-hant/content/%E5%81%A5%E5%BA%B7%E5%81%87%E6%97%A5%E9%A3%B2%E9%A3%9F%E7%94%9F%E6%B4%BB%E5%B0%8F%E5%B8%96%E5%A3%AB"><span style="color:#000000;">健康假日飲食生活小帖士</span></a></span></strong></h2>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div class="content"> <div class="field field-name-body field-type-text-with-summary field-label-hidden"> <div class="field-items"> <div class="field-item even"> <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family:arial,helvetica,sans-serif;">節假日是走親訪友，與親朋共享歡 聚時光的最佳時間。但是排得滿滿 的日程難免會使人感到緊張和疲 勞。健康專家提醒，緊張、勞累和 高脂飲食等綜合因素的長期作用，可能會增加您罹患癌症的風險。因此，亞洲癌症研究基金會為您提供 以下的帖士，幫助您度過一個更加健康，歡樂的節假日。堅持遵循這 些健康生活飲食方式更將有助於預防癌症。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <section class="twelve columns" id="main"> <div class="region region-content"> <div class="block block-system" id="block-system-main"> <div class="content"> <article class="node node-article node-promoted clearfix" id="node-1271"> <div class="entry"> <div class="content"> <div class="field field-name-body field-type-text-with-summary field-label-hidden"> <div class="field-items"> <div class="field-item even"> <p class="rtecenter"><span style="color:#000000;"><img alt="" src="https://afcr.org.hk/sites/afcr.org.hk/files/images/fruits&amp;veggies(1).jpg" style="width: 100px; height: 67px; float: left; margin: 5px;" /></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>多吃蔬菜水果，少吃肉類。</strong></span>顏色鮮豔的蔬菜和水果富含抗氧化劑，有助於預防癌症。火雞肉是健康的肉類選擇。若要減少脂肪攝入，可去掉皮。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>飲酒適量。</strong></span>節假日的餐桌上少不了各種 酒類。但是酒精飲品不僅含有大量的 糖和熱量，經常飲酒還可能增加患癌風險。因此，男性每天飲酒不應超過2 杯。為減少乳癌風險，女性每週飲酒不應超過3杯。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p class="rtecenter"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="https://afcr.org.hk/sites/afcr.org.hk/files/images/shutterstock_79351525.jpg" style="width: 100px; height: 136px; float: left; margin: 5px;" /></span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>選用健康的食用油烹調綠色蔬菜。菠菜，西蘭花，四季豆和深綠色蔬菜均有助於健康。</strong></span>烹調時請盡量選用亞麻油，胡桃油和芥花籽油等健康的食用油。您還可以嘗試用特級初榨橄欖油淋在新鮮蔬菜上，味道非常鮮美。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><strong><span style="font-size:18px;">多吃野生三文魚，金槍魚或鯖魚。</span></strong>這些 魚類富含Omega-3不飽和脂肪酸，對維 護人體細胞正常功能，預防癌症均有所助益。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>吃一點乾果。</strong></span>核桃，杏仁一類的干果是蛋白質和健康脂肪的極好來源，可以在正餐間當作零食吃。但是健康的脂肪也是脂肪，因此要注意不能過量食用。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>避免食用白麵粉做成的麵食。</strong></span>白麵粉做 成的麵食熱量高，營養少，且不易消 化。因此請盡量選擇由粗麵粉或雜糧麵粉做成的麵食。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p class="rtecenter"><strong><span style="font-size:18px;"><span style="color:#000000;"><img alt="" src="https://afcr.org.hk/sites/afcr.org.hk/files/images/shutterstock_81566332.jpg" style="width: 100px; height: 150px; float: left; margin: 5px;" /></span></span></strong></p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><strong><span style="font-size:18px;">選擇富含纖維的食物! 例如全麥，豆 類，大麥，或小扁豆等食物纖維含量就很高。</span></strong>另外，您的節日大餐中還可多包 括如無花果乾，蔓越苺幹和杏乾等高纖維食品。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>注意糖的攝入量，慎重選擇高脂肪甜點。</strong></span>選擇甜點時應注意營養的均衡。可 以吃一塊質量好的黑巧克力，或水煮梨作為甜點。此外，即使您準備好好地犒 勞自己，也最好適可而止，並在餐後適量增加鍛煉的時間，消耗掉多餘的卡路 里。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>餐前先飲16安士水。</strong></span>脫水也會使人產生 飢餓感。每天飲8杯8安士的水對維持人體細胞的正常功能非常重要。</span></span></span></p>  <p>&nbsp;</p>  <p class="rtecenter"><strong><span style="font-size:18px;"><span style="color:#000000;"><img alt="" src="https://afcr.org.hk/sites/afcr.org.hk/files/images/shutterstock_10022128.jpg" style="width: 120px; height: 80px; float: left; margin: 5px;" /></span></span></strong></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><strong><span style="font-size:18px;">參加聚餐之前先吃一點食物。</span></strong>這會有助於消除飢餓感，不至於在聚餐時飢腸轆轆，狼吞虎咽。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>開懷大笑。</strong></span>在緊張的節奏中盡量抽出時 間享受生活。大笑是最好的藥物。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>運動。</strong></span>運動是保持身體健康，預防癌症的有效方式。走步，慢跑，騎車，打壁球，練瑜伽，或者任何能讓您身體動起 來的運動都是有益的！每週運動5次， 每次30分鐘以上，對您的健康大有裨益。你還可以嘗試將走步或騎車等運動 作為一項家庭節日傳統，讓每次家庭聚 會都倍增樂趣。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>慢下來。</strong></span>吃飯時放慢速度，多享受與家人和朋友在一起的時光。關掉電視，電話和其他電器！慢慢地吃飯能夠讓身體有充足的反應時間，意識到自己已經吃 飽了。細嚼慢嚥可以幫助您的身體維持 穩定的新陳代謝。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p class="rtecenter"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="https://afcr.org.hk/sites/afcr.org.hk/files/images/shutterstock_48431401%20(1).jpg" style="width: 100px; height: 67px; float: left; margin-left: 5px; margin-right: 5px;" /></span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-size:18px;"><strong>休息。</strong></span>每天保持至少7小時的睡眠，並儘量遵照身體的自然規律作息。夜間進食和飲酒會影響睡眠。</span></span></span></p> </div> </div> </div> </div> </div> </article> </div> </div> </div> </section>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p> </div> </div> </div>  <div class="form-item form-type-item"><span style="color:#696969;"><span style="font-size:14px;"><label>語言 </label> Chinese, Traditional</span></span></div>  <div class="form-item form-type-item">&nbsp;</div>  <div class="form-item form-type-item">&nbsp;</div>  <div class="form-item form-type-item"><span style="color:#696969;"><span style="font-size:14px;">文章來自: 亞洲癌症研究基金會有限公司</span></span></div>  <div class="form-item form-type-item"><span style="font-size:14px;"><a href="https://afcr.org.hk/zh-hant/content/健康假日飲食生活小帖士" target="_blank"><span style="color:#0000FF;">https://afcr.org.hk/zh-hant/content/健康假日飲食生活小帖士</span></a></span></div> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180123]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%81%a5%e5%ba%b7%e5%81%87%e6%97%a5%e9%a3%b2%e9%a3%9f%e7%94%9f%e6%b4%bb%e5%b0%8f%e5%b8%96%e5%a3%ab/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>健康教育]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%81%a5%e5%ba%b7%e5%81%87%e6%97%a5%e9%a3%b2%e9%a3%9f%e7%94%9f%e6%b4%bb%e5%b0%8f%e5%b8%96%e5%a3%ab]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[145]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180123]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7179]]></id>
		<title><![CDATA[意念治洪水除腫瘤　強國Seafood吸千名學員]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;">意念治洪水除腫瘤 強國Seafood吸千名學員</span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><iframe allow="encrypted-media" frameborder="0" gesture="media" height="420" scrolling="no" src="http://www.pearvideo.com/video_1253691" width="650"></iframe></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">中國深圳去年底一場名為「全息能量療愈」的培訓活動上，「導師」表示只須持續揮手，7天後就可將體內腫瘤化掉，並且能遠程療愈患者。有女學員則自言接受培訓後，曾在杭州暴雨水災時，通過意念阻止了洪水氾濫，更吸引了近千名學員自費聽課。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">《梨視頻》指出，由廣西某培訓機構舉辦的「全息能量療愈」培訓活動為期5日，課程內容包括「非藥物療愈」、「傳統文化」、「科學教育觀」等。所有課程都須出席者自費，費用由每人1398人民幣到1798元人民幣（約6360到8180台幣）不等，即使費用不低，依然有近千人出席。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">「你就想手發光，腫瘤一拿化掉，回到光明，化掉。連做7天，去查一下。」台上自稱導師的文國強在培訓中表示，只要患者運用自身意念，配合上述動作，就能取走身上腫瘤。而在場民眾聽過「導師」的分享後，隨即一片掌聲雷動。「像以前我在長沙做療愈演講，有1個小姐跑到我房間來，坐下來說你幫我看下我的1個瘤。」他表示對方患有「很大的一個瘤子，雞蛋那麼大」，但參加過講座後短短兩天，經過上述療法後，就發現身上腫瘤已經消失。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">此外，還有一名女學員上台分享自己的事件，表示媽媽得到子宮頸癌，「我當下就跟『上面』連接，然後我媽媽說，那個地方變軟了，檢查的時候醫生一看，腫瘤沒啦」。這名女學員還提到，因為對公婆不孝順，導致女兒身患嚴重肺炎、哮喘，「去年參加初級班的活動時，我一個念頭連接了宇宙的能量，她的哮喘當下就治好了」，更誇張的是她說曾在杭州暴雨水災時，通過意念阻止了洪水氾濫。片段隨即引發網友嘩然</span></span>。（即時新聞中心／綜合報導）</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(21).jpg" style="width: 500px; height: 304px;" /></span></span></p>  <p style="text-align: center;">引自《梨視頻》</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2(13).jpg" style="width: 500px; height: 357px;" /></p>  <p style="text-align: center;">引自《梨視頻》</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/3(11).jpg" style="width: 500px; height: 357px;" /></p>  <p style="text-align: center;">引自《梨視頻》</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/4(8).jpg" style="width: 500px; height: 357px;" /></p>  <p style="text-align: center;">引自《梨視頻》</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/5(4).jpg" style="width: 500px; height: 357px;" /></p>  <p style="text-align: center;">引自《梨視頻》</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:14px;"><span style="color:#000000;">（</span>即時新聞中心／綜合報導）</span></p>  <p><span style="font-size:14px;">文章來自:&nbsp;蘋果日報</span></p>  <p><span style="font-size:14px;"><a href="https://tw.appledaily.com/new/realtime/20180117/1280682/" target="_blank"><span style="color:#0000FF;">https://tw.appledaily.com/new/realtime/20180117/1280682/</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180123]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%84%8f%e5%bf%b5%e6%b2%bb%e6%b4%aa%e6%b0%b4%e9%99%a4%e8%85%ab%e7%98%a4%e3%80%80%e5%bc%b7%e5%9c%8bseafood%e5%90%b8%e5%8d%83%e5%90%8d%e5%ad%b8%e5%93%a1/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[另類治療探討>另類治療探討]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%84%8f%e5%bf%b5%e6%b2%bb%e6%b4%aa%e6%b0%b4%e9%99%a4%e8%85%ab%e7%98%a4%e3%80%80%e5%bc%b7%e5%9c%8bseafood%e5%90%b8%e5%8d%83%e5%90%8d%e5%ad%b8%e5%93%a1]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[146]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180123]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7180]]></id>
		<title><![CDATA[3D影像呈現腫瘤　南韓醫界結合AR應用]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>3D影像呈現腫瘤 南韓醫界結合AR應用</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:26px;"><strong><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/a(9).jpg" style="width: 640px; height: 360px;" /></strong></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">在南韓就有醫院把「擴增實境」結合骨科手術，讓醫師在切除骨瘤前，能更精確掌握腫瘤位置，把誤差降到最小；另外也有業者透過擴增實境，來教導小朋友該如何正確刷牙，讓小孩子在玩遊戲破關中喜歡刷牙，也不用再讓父母傷腦筋。</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">韓各界現在開始廣泛結合擴增實境，像在首爾大學醫院就將擴增實境，運用在骨瘤手術上，只要將核磁共振檢查出來的報告數據，輸入在特別開發的程式上，就能在患部上投影，以3D影像呈現腫瘤。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">首爾大學盆唐醫院整形外科醫師表示，他們現在開發的擴增實境應用，是保持了原有的術前檢查系統的優點再去開發的，病人不用再額外分擔費用，比起一般手術，可將移除正常組織的可能性降到更低。這樣的作法，可以幫助醫生在術前更精準的掌握腫瘤的大小和位置，下刀的準確度增加兩成，減少移除正常組織的可能</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">另外也有業者腦筋動得快，用擴增實境教小孩怎麼「刷牙」，就是看準很多父母不知道該如何教小朋友正確刷牙，業者就研發出這看似像是玩遊戲的App，電動牙刷已經不夠看，智慧牙刷能夠偵測小朋友的動作正不正確，另外還有卡通化設計，把刷牙包裝成像是闖關遊戲一樣，讓小朋友自然而然養成刷牙習慣。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">其實不只是刷牙，像是投影在教科書上的3D影像，都能幫助小孩建構空間概念，念起書來更有趣。而在視訊通話功能裡，可以點選AR筆功能，直接在影像上畫圖和指引，讓有需要操作精密機械的工作人員，可以更有效率的溝通。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">開發商表示，這能讓相隔兩地的人在出現問題時適時幫助另一方，可以用在很多地方，像是在出差時或是工業上在安裝組裝東西時。比起虛擬實境還需要添購額外的裝置，可以直接在手機上呈現的AR更能被民眾接受，南韓更預估在2020年AR市場可達12億美元。</span></span></p>  <p>&nbsp;</p>  <p><br /> &nbsp;</p>  <p>文章來自: TVBS News</p>  <p><span style="font-size:14px;"><a href="https://news.tvbs.com.tw/tech/855794" target="_blank"><span style="color:#0000FF;">https://news.tvbs.com.tw/tech/855794</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180123]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/3d%e5%bd%b1%e5%83%8f%e5%91%88%e7%8f%be%e8%85%ab%e7%98%a4%e3%80%80%e5%8d%97%e9%9f%93%e9%86%ab%e7%95%8c%e7%b5%90%e5%90%88ar%e6%87%89%e7%94%a8/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>國際視野 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[3d%e5%bd%b1%e5%83%8f%e5%91%88%e7%8f%be%e8%85%ab%e7%98%a4%e3%80%80%e5%8d%97%e9%9f%93%e9%86%ab%e7%95%8c%e7%b5%90%e5%90%88ar%e6%87%89%e7%94%a8]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[147]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180123]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7181]]></id>
		<title><![CDATA[中國傳統墨汁有抗癌功效 / Ancient ink for cancer treatment]]></title>
		<content><![CDATA[<p><strong><span style="color: #000000"><span style="font-size: 26px">中國傳統墨汁有抗癌功效</span></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(22).jpg" style="height: 332px; width: 600px" /></p>  <p style="text-align: center"><span style="font-size: 14px"><span style="color: #696969">墨除了用于繪畫，還具有治療疾病的作用。圖為清代著名畫家鄭板橋的《墨竹圖》。（公有領域）</span></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">【大紀元2018年01月24日訊】</span></span><span style="font-size: 16px"><span style="color: #000000">（大紀元記者張秉開編譯報導）</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">中國傳統</span><a href="http://www.epochtimes.com/b5/tag/%e5%a2%a8.html"><span style="color: #000000">墨</span></a><span style="color: #000000">汁的藥效引起科學家的興趣。一項研究指出，墨汁具有抗癌功效，其機制與其所含納米顆粒有關。</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px"><span style="color: #000000">據健康網站professorhealth 1月23日報導，人們都知道，在中國</span><a href="http://www.epochtimes.com/b5/tag/%e5%82%b3%e7%b5%b1%e6%96%87%e5%8c%96.html"><span style="color: #000000">傳統文化</span></a><span style="color: #000000">中，黑黑的</span><a href="http://www.epochtimes.com/b5/tag/%e5%a2%a8.html"><span style="color: #000000">墨</span></a><span style="color: #000000">可用來表現極為優美的藝術，例如中國書法和水墨畫。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="font-size: 20px"><span style="color: #000000">科學家也關注墨汁的藥用效果，並嘗試探討其藥理機制。</span></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">《美國化學會OMEGA刊》</span></span><span style="color: #000000"><span style="font-size: 16px">（ACS Omega）一篇報告說 .</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">墨汁對於癌症向淋巴結的擴散和轉移，具有非侵入性的治療作用，也就是說墨汁是一種不會給患者造成傷害的有效抗癌藥物。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">癌細胞經常會從淋巴管向病灶外轉移。對此，西方醫學主要使用手術切除方法進行治療，但是副作用大，而且無法控制復發。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">因此，近年來出現非侵入性光熱療法（PTT），來抗擊癌細胞轉移。該方法使用納米材料來殺死癌細胞，但是這些納米材料有毒、難以加工生產和價格昂貴。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">科學家發現，中國墨汁具有類似光熱療法納米材料的作用，卻無毒且價格便宜，有用於治療癌症的潛力。</span></span><span style="color: #000000"><span style="font-size: 16px">中國墨汁的制備原理是煤煙、松煙與明膠等混合，也就是製成碳元素、水和膠的混合物。</span></span><span style="color: #000000"><span style="font-size: 16px">研究者選擇胡開文墨（Hu-Kaiwen ink），對此加以分析。胡開文墨汁創於清朝乾隆年間，距今已有近250年的生產歷史。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">科學家發現，這種中國傳統工藝製作的黑色混合液體含有納米顆粒，其中碳原子形成薄層結構。胡開文墨汁在激光下加溫後，溫度可以升高至55攝氏度（131華氏度）。</span></span><span style="color: #000000"><span style="font-size: 16px">因此，這種墨汁經過光熱療法（PTT）所用的激光照射，能夠在實驗條件下殺死癌細胞，而且墨汁顆粒具有探測癌細胞的作用。科學家希望將墨汁用于開發抗癌新療法。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">實際上，中國以墨汁為藥的歷史超過一千年。據宋朝開國皇帝指定修撰的藥典《開寶本草》記載，好墨可以入藥。</span></span><span style="color: #000000"><span style="font-size: 16px">按照中醫理論，墨的藥味「辛、平」，可歸入心、肝和腎三個臟器所屬的經絡，具有止血、消腫的功效，可用于孕婦产后血晕等疾患。＃</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>責任編輯：林妍</p>  <p>&nbsp;</p>  <p><strong><span style="color: #000000"><span style="font-size: 26px">&nbsp;</span></span></strong></p>  <h1><strong><span style="color: #000000"><span style="font-size: 26px">Ancient ink for cancer treatment</span></span></strong></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><strong><span style="color: #000000"><span style="font-size: 26px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2(14).jpg" style="height: 480px; width: 319px" /></span></span></strong></p>  <div class="image-caption"><span style="color: #696969">Traditional Chinese ink is made of nanoparticles and thin layers of carbon that could help treat cancer.</span></div>  <p style="text-align: center"><span style="color: #696969"><small class="image-credit"><font size="2">Credit: toonman/Shutterstock.com </font></small></span></p>  <p style="text-align: center">&nbsp;</p>  <p>&nbsp;</p>  <p>&ldquo;<a href="http://pubs.acs.org/doi/full/10.1021/acsomega.7b00993"><font color="#0066cc">New Application of Old Material: Chinese Traditional Ink for Photothermal Therapy of Metastatic Lymph Nodes</font></a>&rdquo;<br /> <i>ACS Omega</i></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000">For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in <i>ACS Omega</i> that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.</span></p>  <p>&nbsp;</p>  <p><span style="color: #000000">As cancer cells leave a tumor, they frequently make their way to lymph nodes, which are part of the immune system. In this case, the main treatment option is surgery, but this can result in complications. Photothermal therapy (PTT) is an emerging noninvasive treatment option in which nanomaterials are injected and accumulate in cancer cells. A laser heats up the nanomaterials, and this heat kills the cells. Many of these nanomaterials are expensive, difficult-to-make and toxic. However, a traditional Chinese ink called Hu-Kaiwen ink (Hu-ink) has similar properties to the nanomaterials used in PTT. For example, they are the same color, and are both carbon-based and stable in water. So Wuli Yang and colleagues wanted to see if Hu-ink could be a good alternative material for PTT.</span></p>  <p>&nbsp;</p>  <p><span style="color: #000000">The researchers analyzed Hu-ink and found that it consists of nanoparticles and thin layers of carbon. When Hu-ink was heated with a laser, its temperature rose by 131 degrees Fahrenheit, much higher than current nanomaterials. Under PPT conditions, the Hu-ink killed cancer cells in a laboratory dish, but under normal conditions, the ink was non-toxic. This was also the scenario observed in mice with tumors. The researchers also noted that Hu-ink could act as a probe to locate tumors and metastases because it absorbs near-infrared light, which goes through skin.</span></p>  <p>&nbsp;</p>  <p>The authors acknowledge funding from the <a href="http://www.nsfc.gov.cn/publish/portal1/"><font color="#0066cc">National Natural Science Foundation of China</font></a> and the <a href="http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm"><font color="#0066cc">Key Technologies R&amp;D Program of China</font></a>.</p>  <p>&nbsp;</p>  <p><i>Note: ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies.</i></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><i>文章來自: 大紀元 / ACS</i></p>  <p><span style="font-size: 14px"><i>中 : <a href="http://www.epochtimes.com/b5/18/1/23/n10082070.htm" target="_blank"><span style="color: #0000ff">http://www.epochtimes.com/b5/18/1/23/n10082070.htm</span></a></i></span></p>  <p><span style="font-size: 14px"><i>ENG: <a href="https://www.acs.org/content/acs/en/pressroom/presspacs/2017/acs-presspac-september-27-2017/ancient-ink-for-cancer-treatment.html" target="_blank"><span style="color: #0000ff">https://www.acs.org/content/acs/en/pressroom/presspacs/2017/acs-presspac-september-27-2017/ancient-ink-for-cancer-treatment.html</span></a></i></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180124]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%ad%e5%9c%8b%e5%82%b3%e7%b5%b1%e5%a2%a8%e6%b1%81%e6%9c%89%e6%8a%97%e7%99%8c%e5%8a%9f%e6%95%88-ancient-ink-for-cancer-treatment/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%ad%e5%9c%8b%e5%82%b3%e7%b5%b1%e5%a2%a8%e6%b1%81%e6%9c%89%e6%8a%97%e7%99%8c%e5%8a%9f%e6%95%88-ancient-ink-for-cancer-treatment]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[148]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180124]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7182]]></id>
		<title><![CDATA[Cellink以3D列印製造腫瘤以對抗癌症 / Cellink Turns to 3D Printing Tumors to Combat Cancer]]></title>
		<content><![CDATA[<p class="article_header" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px"><span style="color: #000000"><strong><span style="font-size: 26px">Cellink以3D列印製造腫瘤以對抗癌症</span></strong></span></p>  <p class="p-t-15" style="padding-left: 0px"><span style="color: #696969"><span style="font-size: 14px">陳智德 <time>2018-01-24</time></span></span></p>  <p class="p-t-15" style="padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="text-align: center; padding-left: 0px"><span style="color: #696969"><span style="font-size: 14px"><time><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(23).jpg" style="height: 401px; width: 600px" /></time></span></span></p>  <p class="p-t-15" style="text-align: center; padding-left: 0px"><span style="color: #696969">Cellink希望能夠用實驗用腫瘤取代大量的動物測試。Cellink </span></p>  <p class="p-t-15" style="text-align: center; padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="text-align: center; padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="text-align: center; padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="padding-left: 0px"><span style="font-size: 16px"><span style="color: #000000">瑞典生物科技公司Cellink設計出生物墨水(biological ink)，可被各種不同3D列印機用於製造不同種類的細胞組織，目前正研究以3D列印製造腫瘤以對抗癌症。此將能看到實際上腫瘤如何生長，以及如何對不同治療做出反應。</span></span></p>  <p class="p-t-15" style="padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="padding-left: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px"><span style="font-size: 16px"><span style="color: #000000">Cellink的最新活動已引發3D列印界內外的極大興趣。該公司日前宣布，已與法國公司CTI Biotech簽署合作協議，製造可用於藥品檢測的腫瘤。透過將生物墨水與病患癌細胞混合的方式，在不危害人體健康下進行對腫瘤的深入研究。</span></span></p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px"><span style="font-size: 16px"><span style="color: #000000">目前Cellink生產生物列印的鼻子及耳朵，用於化妝品與醫學研究，並製造由人體器官細胞組成的立方體，讓研究人員對進行實驗。</span></span></p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px"><span style="font-size: 16px"><span style="color: #000000">製造新藥對抗癌症既是公眾的優先考慮，但因癌症細胞存活於病患體內，病患並非皆能接受試驗性地服用新藥對抗癌症，使得新藥發展緩慢，並可能會扼殺創新概念，或為他人的進展製造障礙，因此製造用於藥品檢測的腫瘤擁有深遠的意義。</span></span></p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px"><span style="font-size: 16px"><span style="color: #000000">Cellink盼未來能列印人體器官，儘管該公司承認可能還要再等15~20年。使用生物墨水製造的腫瘤進行測試，能讓研究人員擺脫許多道德問題，並降低此類研究活動的相關成本。</span></span></p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px"><span style="font-size: 16px"><span style="color: #000000">Cellink希望能夠用實驗用腫瘤取代大量的動物測試，不僅可開發處理癌症腫瘤的新方式，且能讓醫學研究人員對個人化的癌症治療方法展開研究，減少治療造成的副作用。</span></span></p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px">&nbsp;</p>  <p class="main_p" style="padding-bottom: 0px; padding-top: 0px; padding-left: 0px; padding-right: 0px"><span style="font-size: 16px"><span style="color: #000000">該公司創辦人Erik Gatenholm與Hector Martinez Avila也創造售價最低僅10,000美元的組織3D列印機，引發大量的需求。</span></span></p>  <p class="p-t-15" style="text-align: center; padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="text-align: center; padding-left: 0px">&nbsp;</p>  <p class="p-t-15" style="text-align: center; padding-left: 0px">&nbsp;</p>  <h1 class="entry-title"><span style="color: #000000"><strong><span style="font-size: 26px">Cellink Turns to 3D Printing Tumors to Combat Cancer</span></strong></span></h1>  <p><span style="font-size: 12px">by <span class="author vcard"><a href="https://3dprint.com/author/hannah-rose-mendoza/" rel="author" title="Posts by Hannah Rose Mendoza"><font color="#0066cc">Hannah Rose Mendoza</font></a></span> | <span class="published">Jan 9, 2018</span> | <a href="https://3dprint.com/category/3d-printing/" rel="category tag"><font color="#0066cc">3D Printing</font></a>, <a href="https://3dprint.com/category/health-3d-printing/" rel="category tag"><font color="#0066cc">Medical 3D Printing</font></a>, <a href="https://3dprint.com/category/science-technology/" rel="category tag"><font color="#0066cc">Science &amp; Technology</font></a> |</span></p>  <div class="leaderboard_pos2"><!-- /12983626/3dprint-728x90_2 --><!--<a href="https://goo.gl/SZTCC1" target="_blank"><img src="//3dprint.com/ads/3DPrint_Banner_envisiontec_12202017-03-01.png" style="display:block;"></a> --></div>  <div class="leaderboard_pos2">&nbsp;</div>  <div class="leaderboard_pos2">&nbsp;</div>  <div class="leaderboard_pos2">It may seem counterintuitive, but the Swedish biotech company <a href="https://cellink.com/"><font color="#0066cc">Cellink</font></a> is actually fabricating tumors in an effort to combat cancer. The company, which exploded on the scene in 2016, has risen to fame as a result of their biological ink, designed to be used by a variety of 3D printers to create different types of cell tissues. The founders, Erik Gatenholm and Hector Martinez Avila, then went on to create a tissue printing 3D printer that sells for only $10k and the demand has been phenomenal.</div>  <div class="leaderboard_pos2">&nbsp;</div>  <div class="leaderboard_pos2">&nbsp;</div>  <div class="leaderboard_pos2">&nbsp;</div>  <div class="leaderboard_pos2" style="text-align: center"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/a(10).jpg" style="height: 395px; width: 640px" /></div>  <div class="leaderboard_pos2" style="text-align: center"><span style="color: #696969">The market for bioprinting is expected to triple between 2016 and 2021, to around $1,33 bn. </span></div>  <div class="leaderboard_pos2" style="text-align: center"><span style="color: #696969">[Image courtesy of Cellink]</span></div>  <div class="leaderboard_pos2" style="text-align: center">&nbsp;</div>  <div class="leaderboard_pos2" style="text-align: center">&nbsp;</div>  <div class="leaderboard_pos2" style="text-align: center">&nbsp;</div>  <div class="leaderboard_pos2" style="text-align: center"> <p style="text-align: left">The company has been in the news so often, it&rsquo;s nearly exhausting trying to keep up, but their latest activity is one that has garnered great interest both in and outside of the 3D printing community. The company announced on Monday that they have signed a partnership with <a href="https://ctibiotech.com/"><font color="#0066cc">CTI Biotech</font></a>, a French company based in Lyon, to fabricate tumors that can be used for pharmaceuticals testing. The ability to mix their own inks with cells from patients&rsquo; cancers will allow them to produce tumors that can be subjected to intense research without endangering human lives. As Gatenholm explained in an <a href="http://nordic.businessinsider.com/swedens-hottest-biotech-company-cellink-is-launching-a-revolutionary-treatment-for-cancer--/"><font color="#0066cc">interview with Business Insider Nordic</font></a>:</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <blockquote> <p style="text-align: left"><span style="font-size: 14px"><strong>&ldquo;You will be able to see how a tumor grows and how it would respond to different treatments. It&rsquo;s a very relevant and a realistic model for research.&rdquo;</strong></span></p> </blockquote>  <p style="text-align: left">&nbsp;</p>  <p style="text-align: left">&nbsp;</p>  <p><span style="color: #696969"><span style="font-size: 14px"><strong><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/b(2).jpg" style="height: 338px; width: 600px" /></strong></span></span></p>  <p><span style="color: #696969">Cellink sells both the 3D printers and the bio-ink. The printers are priced between $10,000 and $39,000. [Image courtesy of Cellink]</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: left"><span style="color: #000000">Currently, Cellink produces bioprinted noses and ears for cosmetics and medical research, as well as creating cubes comprised of cells that can allow researchers to experiment with human organ cells. Branching out into the production of tumors is less of a leap and more of an expansion, and the implications are profound. Developing new medicines to combat cancer is both a high priority for the public and something that can only necessarily proceed slowly as the cancer itself lives inside of a person, who cannot simply be subject to any and all ideas about what might combat the disease. This means that a slow, cautious approach can strangle some innovative ideas or simply create interminable roadblocks to the advancement of others.</span></p>  <p style="text-align: left">&nbsp;</p>  <p style="text-align: left"><span style="color: #000000">The ability to use bioink to create tumors frees researchers of the many ethical concerns associated with testing as well as reduces the costs associated with such research activities. Currently, a great deal of the medical testing being undertaken to advance cancer treatments occurs on animals, something that Cellink hopes will be able to be replaced with these made-in-the-lab tumors. The driving idea is that not only will new methods of addressing cancerous tumors be able to be developed, but that also medical researchers can begin to explore personalized means of delivering cancer treatments, hopefully with fewer negative side effects.</span></p>  <p style="text-align: left">&nbsp;</p>  <p style="text-align: left">&nbsp;</p>  <p style="text-align: left">&nbsp;</p>  <p><span style="color: #000000"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/c(1).jpg" style="height: 364px; width: 640px" /></span></p>  <p><span style="color: #696969">Cellink&rsquo;s founders Hector Martinez Avila (left) and Erik Gatenholm (right), with Cellink CCO Ariel Kramer at Nasdaq First North for the IPO. [Image courtesy of Business Insider Nordic]</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: left"><span style="color: #000000">This effort is part of Cellink&rsquo;s mission to be a global leader in bioprinting and to change the face of medicine as we know it. In addition, they hope to one day be able to print human organs, although, Gatenholm admits, that possibility is still most likely 15 to 20 years in the future. Interest in their ideas has been strong and confidence in their company continues to grow, as demonstrated by the fact that only 10 months after the company was founded, there was a </span><a href="http://nordic.businessinsider.com/from-idea-to-nasdaq-in-less-than-a-year---cellink-is-swedens-newest-international-success-2016-11/"><span style="color: #000000">1000% oversubscription to their IPO</span></a><span style="color: #000000">. During their first year, they have already reached profitability, something not common for tech startups.</span></p>  <p>&nbsp;</p>  <p style="text-align: left"><em><span style="color: #000000">What do you think of this news? Let us know your thoughts; join the discussion of this and other 3D printing topics at </span><a href="http://www.3dprintboard.com/"><span style="color: #000000">3DPrintBoard.com&nbsp;</span></a><span style="color: #000000">or share your thoughts below.</span></em></p>  <p style="text-align: left">&nbsp;</p>  <p style="text-align: left">&nbsp;</p>  <p style="text-align: left">&nbsp;</p>  <p style="text-align: left"><span style="color: #696969">文章來自: 物聯網 - 智慧城市 / 3Dprint.com</span></p>  <p style="text-align: left"><span style="color: #696969">中: </span><span style="font-size: 12px"><a href="https://www.digitimes.com.tw/iot/article.asp?cat=158&amp;id=0000522680_X9U7ROVH7DAP4D1R7EOV4" target="_blank"><span style="color: #0000ff">https://www.digitimes.com.tw/iot/article.asp?cat=158&amp;id=0000522680_X9U7ROVH7DAP4D1R7EOV4</span></a></span></p>  <p style="text-align: left"><span style="font-size: 12px">ENG : <a href="https://3dprint.com/199654/cellink-3d-printing-tumors/" target="_blank"><span style="color: #0000ff">https://3dprint.com/199654/cellink-3d-printing-tumors/</span></a></span></p> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180124]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/cellink%e4%bb%a53d%e5%88%97%e5%8d%b0%e8%a3%bd%e9%80%a0%e8%85%ab%e7%98%a4%e4%bb%a5%e5%b0%8d%e6%8a%97%e7%99%8c%e7%97%87-cellink-turns-to-3d-printing-tumors-to-combat-cancer/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[cellink%e4%bb%a53d%e5%88%97%e5%8d%b0%e8%a3%bd%e9%80%a0%e8%85%ab%e7%98%a4%e4%bb%a5%e5%b0%8d%e6%8a%97%e7%99%8c%e7%97%87-cellink-turns-to-3d-printing-tumors-to-combat-cancer]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[149]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180124]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7183]]></id>
		<title><![CDATA[治療乳癌的標靶治療]]></title>
		<content><![CDATA[<p><strong style="line-height: 39px; font-family: Verdana, Geneva, sans-serif; font-size: 26px; background-color: rgb(255, 255, 255);">治療乳癌的外科手術</strong></p>  <p><strong style="line-height: 39px; font-family: Verdana, Geneva, sans-serif; font-size: 26px; background-color: rgb(255, 255, 255);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/her22(1)(1)131.jpg" style="width: 600px; height: 270px;" /></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">標靶藥物對特定的癌細胞有針對性，能夠識別、鎖定並針對攻擊癌細胞，不會對正常細胞造成傷害。標靶藥物可能會與化療或其他治療一起使用，以提升療效。</span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 20px;"><strong>治療乳癌的標靶藥大致上可分為四種：</strong></span></span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;抗 HER2 標靶藥物</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;抗血管增生藥物</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;mTOR 抑制劑</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;CDK4/6 抑制劑</span></span></div>  <div>&nbsp;</div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">由於標靶藥物對特定的癌細胞有針對性，所以不是所有患者都適用，妳需要向醫生了解妳的情況是否可選擇標靶治療。醫生一般都會先做活組織檢驗，以了解病人的病變是否有標靶藥可以產生作用的受體。</span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">如有興趣了解更多關於乳癌的資訊，</span></span></div>  <div><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">請參閱：<a href="http://her2morrow.com.hk/" target="_blank">http://her2morrow.com.hk/</a></span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;">安全報告免責聲明<br /> 此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，請向您的醫生或藥劑師諮詢和報告。<br /> 以上健康教育資訊由羅氏大藥廠香港有限公司提供 (NPM-HK-0074-11-2017)</span></span></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180131]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%b2%bb%e7%99%82%e4%b9%b3%e7%99%8c%e7%9a%84%e6%a8%99%e9%9d%b6%e6%b2%bb%e7%99%82/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%b2%bb%e7%99%82%e4%b9%b3%e7%99%8c%e7%9a%84%e6%a8%99%e9%9d%b6%e6%b2%bb%e7%99%82]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[150]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180131]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7184]]></id>
		<title><![CDATA[英國大學研究利用病毒　刺激免疫系統攻擊腦腫瘤細胞]]></title>
		<content><![CDATA[<h1><span style="color: #000000"><strong><span style="font-size: 26px">【以毒攻毒】英國大學研究利用病毒　刺激免疫系統攻擊腦腫瘤細胞</span></strong></span></h1>  <div class="article_info nocontent"> <div class="editor"><span style="color: #696969">撰文： 張子傑</span></div>  <div class="date"><span style="color: #696969">發佈日期：2018-01-04 22:24</span></div>  <div class="date"><span style="color: #696969">最後更新日期：2018-01-04 22:24</span></div> </div>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1.png" style="height: 360px; width: 640px" /></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <h2><strong><span style="color: #000000">英國一隊醫學團隊研究治療腦癌的新方式&mdash;&mdash;注入病毒，刺激人體免疫系統攻擊癌細胞。這個「以毒攻毒」的方法，初步已見成效，科研人員正計劃進行更大型臨床實驗。</span></strong></h2>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div class="article_content__module module_paragraph"> <p><span style="color: #000000"><span style="font-size: 16px">腦腫瘤對於大眾來說，聽起來令人絕望，通常末期腦腫瘤患者只有數月的存活期，治療方面離不開手術和化療。最近英國有大學研究新療法，以病毒刺激免疫系統，再攻擊癌細胞，成效顯著。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">這個研究由英國利茲大學（University of Leeds）腫瘤科專家負責，原理是將呼腸孤病毒（reovirus）以注射點滴方式進入血管，再接近癌細胞，刺激人體免疫系統抵抗癌細胞。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">研究人員表示，腦腫瘤細胞和人體細胞相似，而且擅於欺騙免疫系統，因此難於偵測，反而病毒易於被免疫系統發現，可望成為消滅腫瘤的王牌。</span></span></p> </div>  <p><!-- /108346865/HK01_ForTracking_1x1 --></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div id="div-gpt-ad-1477371174339-0" style="height: 1px; width: 1px">&nbsp;</div>  <div style="margin: 15px 0px"><span style="color: #000000"><span style="font-size: 16px">傳統化療方式最大的難處，是腦部血腦屏障的特殊結構影響藥物作用的速度與效率，今次研究的最大突破是發現病毒不受這個天然限制影響，可以直接滲入腦部，大為提升治療成效。</span></span></div>  <div class="article_content__module nocontent"> <p><span style="color: #000000"><span style="font-size: 16px">研究人員找來9位即將接受腦腫瘤移除手術的病人參與，在手術前數天注入病毒，其後發現所有參加者的腦內均有病毒刺激免疫系統的跡象，連有「殺手」之稱的T細胞也有參與攻擊癌細胞，結果令人滿意。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">報告指出，注射病毒只會引起像感冒徵狀的副作用，對於病人來說，影響可謂非常輕微。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">研究結果刊登於《科學轉化醫學期刊》（Science Translational Medicine），團隊將會展開更大規模的臨床試驗，以改善和延長患者的生命為目標。</span></span></p> </div>  <div class="article_content__module nocontent"> <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div class="related_article__list__item"> <p>&nbsp;</p>  <p><span style="font-size: 16px">文章來自: </span>香港01</p>  <p><span style="font-size: 16px"><a href="https://www.hk01.com/%E5%9C%8B%E9%9A%9B/146648" target="_blank"><span style="color: #0000ff">https://www.hk01.com/%E5%9C%8B%E9%9A%9B/146648</span></a></span></p> </div> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180131]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%8b%b1%e5%9c%8b%e5%a4%a7%e5%ad%b8%e7%a0%94%e7%a9%b6%e5%88%a9%e7%94%a8%e7%97%85%e6%af%92%e3%80%80%e5%88%ba%e6%bf%80%e5%85%8d%e7%96%ab%e7%b3%bb%e7%b5%b1%e6%94%bb%e6%93%8a%e8%85%a6%e8%85%ab%e7%98%a4/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%8b%b1%e5%9c%8b%e5%a4%a7%e5%ad%b8%e7%a0%94%e7%a9%b6%e5%88%a9%e7%94%a8%e7%97%85%e6%af%92%e3%80%80%e5%88%ba%e6%bf%80%e5%85%8d%e7%96%ab%e7%b3%bb%e7%b5%b1%e6%94%bb%e6%93%8a%e8%85%a6%e8%85%ab%e7%98%a4]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[151]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180131]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7185]]></id>
		<title><![CDATA[【了解乳癌】乳癌復發擴散 新殺手鐧再抗戰]]></title>
		<content><![CDATA[<p><strong><span style="font-size: 26px"><span style="color: #000000">【了解乳癌】乳癌復發擴散 新殺手鐧再抗戰</span></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><strong><span style="font-size: 26px"><span style="color: #000000"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/6b65a38f97bf3b1eeed436f3f2df1563.jpg" style="height: 550px; width: 400px" /></span></span></strong></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="font-size: 18px"><span style="color: #000000">【明報專訊】對付癌症，醫生法寶盡出：手術、化療、電療、標靶治療，務求殺滅癌細胞；但當癌症復發、擴散，用上第二、三、四線化療效果不顯注，標靶治療出現抗藥性&hellip;&hellip;醫生就要宣布投降？</span></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 18px"><span style="color: #000000">當癌細胞步步進逼，醫生還有什麼殺手鐧？</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 20px"><strong><span style="color: #000000">新趨勢：荷爾蒙合併抑制劑治療減副作用</span></strong></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 18px"><strong><span style="color: #000000">■個案</span></strong></span></p>  <p><span style="font-size: 18px"><strong><span style="color: #000000">遇上高毒性腫瘤</span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">現年40歲的張女士，和丈夫育有3個小孩，生活本是十分滿足快樂。4年前的聖誕，她發現左邊乳房出現了一硬塊，起初不為意，但硬塊生長得很快，數周內長到幾厘米大。乳腺外科醫生馬上安排穿刺化驗和乳腺造影檢查，報告很快就確定了張女士患上乳癌，直徑約5厘米。她選擇全乳腺切除術，術中發現腋下淋巴有癌細胞，故此腋下淋巴腺亦做了清除手術。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">張女士的病理分析發現，腫瘤直徑達5.5厘米，腫瘤組織學屬於毒性較高的低分化類型（Grade 3），腋下淋巴群中有兩個受癌細胞侵入。腫瘤生物標記結果為荷爾蒙受體（ER+、PR+）陽性，HER2陰性，顯示癌細胞生長速度的「Ki-67細胞增殖因子指數」高達70%（普通乳癌中位數約15%）。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">張女士的腫瘤分化度低，復發和擴散風險較高，因此，手術後張女士接受了8個周期（16星期）輔助化學治療和放射治療，亦開始了荷爾蒙治療。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="font-size: 18px"><span style="color: #000000">術後兩年復發 擴散全身</span></span></strong></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">完成化療和放射治療後，張女士按建議服用荷爾蒙藥，生活漸回正軌。可是兩年後，張女士持續咳嗽，運動後盆骨也持續疼痛。醫生馬上安排全身正電子掃描，不幸發現廣泛的腫瘤復發及擴散，影響多段脊骨、盆骨、肋骨、肺和肝臟。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">張女士和家人都希望盡快開始治療。醫療團隊也認同應盡快開始系統性治療，但需要先再抽取腫瘤樣本化驗。研究顯示，腫瘤生物標記在乳癌復發時有大約40%會出現變化，當中有一半會影響治療用藥的決定。在張女士身上，團隊最擔心是腫瘤的荷爾蒙受體由陽性轉為陰性，如此的話荷爾蒙治療就不再適用。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">團隊在分析影像後決定在盆骨抽取化驗。病理醫生在樣本進行免疫組織學化驗，確定腫瘤源頭來自乳癌，且荷爾蒙受體維持陽性。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>文：林泰忠（香港大學臨牀腫瘤科臨牀助理教授）</p>  <p>圖：受訪者提供</p>  <p>編輯：王翠麗</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px">文章來自: 明報</span></p>  <p><span style="font-size: 14px"><a href="https://health.mingpao.com/?p=12034" target="_blank"><span style="color: #0000ff">https://health.mingpao.com/?p=12034</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180131]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e3%80%90%e4%ba%86%e8%a7%a3%e4%b9%b3%e7%99%8c%e3%80%91%e4%b9%b3%e7%99%8c%e5%be%a9%e7%99%bc%e6%93%b4%e6%95%a3-%e6%96%b0%e6%ae%ba%e6%89%8b%e9%90%a7%e5%86%8d%e6%8a%97%e6%88%b0/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e3%80%90%e4%ba%86%e8%a7%a3%e4%b9%b3%e7%99%8c%e3%80%91%e4%b9%b3%e7%99%8c%e5%be%a9%e7%99%bc%e6%93%b4%e6%95%a3-%e6%96%b0%e6%ae%ba%e6%89%8b%e9%90%a7%e5%86%8d%e6%8a%97%e6%88%b0]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[32]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180131]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7186]]></id>
		<title><![CDATA[全球癌症存活率升 台灣這些癌死亡率較高]]></title>
		<content><![CDATA[<p><strong><span style="font-size: 26px"><span style="color: #000000">全球癌症存活率升 台灣這些癌死亡率較高</span></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center"><strong><span style="font-size: 26px"><span style="color: #000000"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/BTWD2S7B.jpg" style="height: 360px; width: 640px" /></span></span></strong></p>  <p>中央社 健康 / NOWnews</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="color: #000000"><span style="font-size: 16px">中央社巴黎31日綜合外電報導</span></span></strong></p>  <p><span style="color: #000000"><span style="font-size: 16px">根據今天公布的一項重大評論，世界各地癌症存活率逐步上升，但各國之間存在相當大的差距。與其他地區相比，台灣黑色素瘤、淋巴惡性腫瘤和骨髓惡性腫瘤的患者存活率較低。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="color: #000000"><span style="font-size: 16px">法新社報導</span></span></strong></p>  <p><span style="color: #000000"><span style="font-size: 16px">根據發表於醫學期刊「刺胳針」（The Lancet）的CONCORD-3研究，兒童癌症存活率的上升幅度及各國差距特別大。這項研究涵蓋71個國家及18種癌症相關數據。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">舉例來說，罹患腦瘤的兒童5年存活率，已從2000年至2004年期間的54%，全面提高到2010年至2014年的超過60%。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">美國、丹麥、瑞典和斯洛伐克共和國癌症存活率則成長到80%，甚至更高。不過在墨西哥和巴西，2010年至2014年期間，罹患腦瘤的兒童存活率不到40%。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">此外，在台灣，肝癌5年存活率僅27.9%；與其他地區相比，東亞黑色素瘤、淋巴惡性腫瘤和骨髓惡性腫瘤5年存活率普遍較低，台灣上述腫瘤的5年存活率分別為52.1%、50.5%及33.4%。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">研究執筆人在聲明中說：「這可能反映出，診斷和治療服務的普遍性及品質。」</span></span></p>  <p><span style="color: #000000"><span style="font-size: 16px">研究顯示，世界各地乳癌患者的存活率也全面提高。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">美國和澳洲2010年至2014年期間，女性乳癌患者的5年存活率為90%，有16個西歐國家則提高到85%，東歐國家則維持在71%。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">印度乳癌存活率在同一時期則上升到66%。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>（譯者：周莉芳/核稿：陳昱婷）1070131</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px">文章來自: 中央社 健康 / NOWnews</span></p>  <p><span style="font-size: 14px"><a href="https://www.nownews.com/news/20180131/2693369" target="_blank"><span style="color: #0000ff">https://www.nownews.com/news/20180131/2693369</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180131]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%85%a8%e7%90%83%e7%99%8c%e7%97%87%e5%ad%98%e6%b4%bb%e7%8e%87%e5%8d%87-%e5%8f%b0%e7%81%a3%e9%80%99%e4%ba%9b%e7%99%8c%e6%ad%bb%e4%ba%a1%e7%8e%87%e8%bc%83%e9%ab%98/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>統計分析]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%85%a8%e7%90%83%e7%99%8c%e7%97%87%e5%ad%98%e6%b4%bb%e7%8e%87%e5%8d%87-%e5%8f%b0%e7%81%a3%e9%80%99%e4%ba%9b%e7%99%8c%e6%ad%bb%e4%ba%a1%e7%8e%87%e8%bc%83%e9%ab%98]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[33]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180131]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7187]]></id>
		<title><![CDATA[從醫療科技展談台灣的精準醫療]]></title>
		<content><![CDATA[<p><span style="color: #000000"><span style="font-size: 26px"><strong>從醫療科技展談台灣的精準醫療</strong></span></span></p>  <p><span style="color: #696969">作者：裴有恆（物聯網講師、研發創新教練）2018.01.26</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #696969"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/8179fed2-c02b-4427-bbfc-f453dcbc0e51.jpg" style="height: 350px; width: 610px" /></span></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">2017年的12月電腦展規模不大，反倒是同時在南港展覽館四樓，舉行了醫療科技展。我特別在最後一天下午趕去參觀，想了解這次展覽的重點，而我看到的是基因療法的進展。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">來參展的醫院系統不少，也有很多生物科技醫療廠商，其中，針對基因科學，我印象最深的有兩家廠商：麗寶基因跟華聯基因晶片。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">根據醫學研究，發現癌症受到基因的影響，據醫學上估計，5-10%的癌症，都有來自於遺傳上的基因變異。而最近最有名的案例，就是美國女影星安潔莉娜．裘莉因為母親在56歲死於卵巢癌，外祖母和一個姨母也因衛癌症奪走了生命，安潔莉娜．裘莉經過癌症基因檢測後，發現自己患乳腺癌的風險機率為87%，而患卵巢癌的風險機率為50％，所以2013年她進行了乳房切除手術，2015年她又進行了卵巢與輸卵管摘除手術。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">最近很多醫院也開始導入基因數據分析療法，針對癌症病患的基因做人工智慧分析後，再量身打造提供對應的藥物及治療方式，麗寶基因就是提供這樣基因檢測與數據分析整套方案的公司。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">台北榮總在2017年8月份宣布癌症標靶用藥檢測服務正式上線，透過此工具，各類癌症患整集醫生可以了解哪類藥物最適合患者，增加治療選擇。而這樣的成果，正是2012年起台北榮總與麗寶基因共同投入癌症基因體醫學實驗室的結果，2014年底提供小細胞肺癌、大腸直腸癌，全面性用藥評估等個人化基因檢測，現在更增加全面性癌症標靶用藥相關突變基因檢測服務、全方位癌症基因檢測、腫瘤全面性409基因檢測&hellip;等等，而檢測後的基因體，將透過臨床焦點分析基因診斷平台OncoMed143來做個人化分析診斷。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">OncoMed143平台利用高通量次世代基因定序平台，針對143個腫瘤關鍵基因於單一流程中同時進行DNA、RNA檢測，其中包括49個基因拷貝數變異分析、22個融合基因變異分析，使用Oncomine Knowledge Base資料庫。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">Oncomine Knowledge Base資料庫是目前全世界最大的腫瘤數據庫，是由美國密西根大學的Hovelson等人與ThermoFisher的研究人員，合作開發針對癌症研究，並且可以提供相關用藥資訊。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">在當場的觀察中，我發現台北癌症中心也導入類似的系統，這也證明這樣的做法很受歡迎，而這樣的做法中基因檢測晶片其實佔了很重要的角色，而華聯基因晶片是台灣這方面的代表。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">華聯的基因晶片事華聯生物科技公司所推出的基因檢測晶片，華聯生物科技公司推廣染色體晶片，癌症、慢性、肥胖等基因檢測。精準醫療中，必須要有好的基因檢測技術，而這必須用到基因檢測晶片，而華聯就是世界上少數具備有這樣晶片技術的公司。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">從麗寶基因跟華聯生物科技的展示，就知道台灣在這方的實力不弱，雖然現在基因檢測的Oncomine Knowledge Base資料庫是來自美國，但據我所知台灣也有很多人正在往這方面努力，搭配台灣強大的醫療技術，可以看出台灣在精準醫療將有很光明的未來。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px"><span style="color: #000000">文章來自: 康健</span></span></p>  <p><span style="font-size: 14px"><a href="https://www.commonhealth.com.tw/blog/blogTopic.action?nid=2666" target="_blank"><span style="color: #0000ff">https://www.commonhealth.com.tw/blog/blogTopic.action?nid=2666</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180131]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%be%9e%e9%86%ab%e7%99%82%e7%a7%91%e6%8a%80%e5%b1%95%e8%ab%87%e5%8f%b0%e7%81%a3%e7%9a%84%e7%b2%be%e6%ba%96%e9%86%ab%e7%99%82/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%be%9e%e9%86%ab%e7%99%82%e7%a7%91%e6%8a%80%e5%b1%95%e8%ab%87%e5%8f%b0%e7%81%a3%e7%9a%84%e7%b2%be%e6%ba%96%e9%86%ab%e7%99%82]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[34]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180131]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7188]]></id>
		<title><![CDATA[新癌症戰爭：後基因解碼時代，化療將成過去？]]></title>
		<content><![CDATA[<p><span style="color: #000000"><span style="font-size: 26px"><strong>新癌症戰爭：後基因解碼時代，化療將成過去？</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #696969"><span style="font-size: 12px"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/pxxngi5stuk1es0d4l8f06g8hpsiga.jpg" style="height: 384px; width: 640px" /></span></span></p>  <h5 style="text-align: center"><span style="font-size: 14px"><span style="color: #696969">基因圖譜揭祕10多年後，「精準醫學」世紀來臨。四種趨勢突飛猛進的新醫療改變了傳統醫療作法，然而許多新發明代價不菲，醫療體系是否負擔得起成疑。</span></span></h5>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px">文：柯若（David Crow）｜財訊雙週刊 第 541 期</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">1990年人類基因圖譜解碼後，醫師們就預測精準醫學時代要來臨了，病患可以針對特定的基因突變而量身打造，特別是癌症治療領域。今天，在完整的基因圖譜揭曉後14年，一些科學家認為精準醫療紀元終於來到；這意味著新一代的標靶藥浮現，可能顛覆癌症的主流療法化療。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">關鍵的轉折點在於，科學家發現：腫瘤的分子特性（如基因特質）比腫瘤出現的部位（如肺部或乳房）還重要；在下一階段的對抗癌症戰爭中，生物學重於解剖學。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">今年5月，美國食品暨藥物管理局（FDA）首次通過針對腫瘤基因特質，而非部位的治療藥物──默克製藥公司的免疫治療藥物Keytruda，癌症病人的基因特徵只要符合，都可以使用。這類「泛癌症」抗癌藥，幾乎針對各類腫瘤都有的罕見基因缺陷對症下藥。明年初，第二種「泛癌症」抗癌藥在生化科技公司Loxo Oncology取得許可後可望問世。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h5><span style="color: #000000"><span style="font-size: 20px"><strong>癌症新藥　去化療時代來臨</strong></span></span></h5>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">美國臨床腫瘤學會醫療長席斯基說：「化療是具有試驗性的方法──只要一般病人有某種療效，就推用到每位病人；如今我們已經逐漸不這麼做了。」這種轉變是因為「生物標誌化合物」（biomarker）科技的發明，它可迅速辨識腫瘤基因和蛋白體相關線索，讓醫師對症下藥。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">雖然兩個名詞經常互用，但「精準醫療」不應與「個別化醫療」的未來領域混淆。後者指的是針對個別病人病情特製抗癌藥，例如諾華製藥的嵌合抗原受體重組T細胞免疫療法。精準醫療則指的是不斷探查腫瘤以預期腫瘤是否會針對某一特殊藥物或療法有反應。這種藥物可能正在臨床實驗中使用，也可能是一種行之有年的既有產品，但最早卻是為完全不同類型的癌症而研發。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h5><span style="color: #000000"><strong><span style="font-size: 20px">日新月異　精準醫療4趨勢</span></strong></span></h5>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">以下四種趨勢可能會把現階段突飛猛進的精準醫療，轉變為標準化的醫療作法：</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px"><span style="font-size: 18px"><strong>一、診斷──腫瘤的界定。</strong></span>傳統上，腫瘤專家根據他們顯微鏡的觀察來界定腫瘤種類：腫瘤的大小如何？細胞核與腫瘤大小的相對比例？這些問題的答案往往決定病人怎麼接受治療。</span></span></p>  <div id="div-gpt-ad-1497843170358-0-88729">&nbsp;</div>  <p><span style="color: #000000"><span style="font-size: 16px">但是醫師與醫療主管說，在基因圖譜排序價格下降、製藥公司針對個別癌症基因突變研發小眾標靶藥物日新月異之際，分子測試會變得愈來愈常見。默克製藥最資深科學家帕穆特說：「靠顯微鏡歸類腫瘤的方法沒什麼道理，我們已經說了幾10年，我愈來愈認為我們會以分子方式來界定腫瘤。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">分子測試在肺癌和乳癌等癌症上已常見，醫師可以辨識每一次的基因突變。可能與癌症出現有關的基因不下數百，下一代的基因排序測試可以一舉篩檢出單一的腫瘤組織樣本，提供診斷醫師一個全面性的輪廓。美國診斷公司Thermo Fisher總裁戈斯瓦米說：「一舉數得的資訊豐富無比。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">羅氏大藥廠旗下的Foundation Medicine也研發出一種可以篩檢324種癌症基因的測試，等待FDA的批准。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">只是分子測試昂貴，美國只有12％的病人接受全面基因排序圖；Foundation的測試費是5,800美元，其他單是一、兩種基因的測試費也要幾百美元。部分醫師也擔心這類測試徒然製造出一堆他們不理解的數據。席斯基說：「反對者認為這類測試的結果無人知道如何詮釋、不知如何針對它採取行動。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px"><span style="font-size: 18px"><strong>二、標靶藥──對準突變。</strong></span>如果精密的基因測試變得更普遍，可能揭示數百種超級高標靶藥物紀元的來臨。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">康乃狄克州生化集團Loxo研發的這類藥物Larotrectinib，最近受到腫瘤專家和華爾街的垂青，它的股票過去12個月漲了251％。此藥是為腫瘤中有TRK基因突變的小群癌症病人所設計。這種突變很罕見，一些專家估計在0.5％的癌症中猖獗，但無論是哪一部位的腫瘤中都見得到它。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">超高標靶藥物高度有效，在癌症研究中產生前所未聞的成果。在最近刊出的臨床實驗報告中，這種藥物在76％的病人身上不是縮小了腫瘤，就是制止了腫瘤的生長，因此預料FDA明年很快便會批准使用。Loxo商務長納登說：「希望明年會有另外五種這類藥物出現。」FDA一旦通過Larotrectinib，它會是出現突變的各類癌症病人的第一批「泛癌症」抗癌藥物。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">不過，「精準醫療」不只是與新藥有關而已，它也與找出對既有抗癌藥物最可能有反應的癌症有關。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">目前美國有三百多名病人，只要身上的「生物標誌化合物」顯示可能對抗癌藥有反應，美國臨床腫瘤學會就同意醫師在他們身上使用對一種癌症有效的合法抗癌藥物，來治療另一種癌症。羅氏大藥廠的Herceptin 1998年之後被拿來治療HER2基因異常的乳癌病人，但其他類型癌症病人即使體內出現同樣的突變卻無福消受，如今範圍已擴及肺癌、大腸癌或其他的病症。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h5><strong><span style="font-size: 20px"><span style="color: #000000">新解方　有效追蹤癌細胞突變</span></span></strong></h5>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px"><span style="font-size: 18px"><b>三、液態切片檢查</b></span>──癌症形狀改變的掌握。下一代的診斷即使可為病人身上的腫瘤提供一個全面性的基因圖譜，抗癌路上一道主要的障礙仍在：腫瘤會惡性地改變形體，會先靜悄悄地培養出藥物抗體，繼而全面反撲。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">醫師問診後所作的判斷無論多正確，可能幾個月內就變得不是那麼回事，等復發性癌細胞出現時，治療往往為時已晚。定期反覆篩檢貴得令人卻步，也可能不切實際，因為病人得經歷數次危險的切片手術採取新的細胞樣本。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">一個新起的解決辦法是液態切片檢查──癌症血液測試，檢測腫瘤「吐出」的DNA微小碎片。輝瑞藥廠免疫腫瘤部門負責人畢秀夫說：「我們知道癌細胞不斷分裂、轉變或死亡，死時DNA會跑到血液循環裡，即使只有不到1％，都可以從周邊血液中查出；如果出現突變，是可以檢查出來的。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">輝瑞最近宣布與加州的Guardant Health合作，業界公認它是市場上液態切片最準確的。Guardant合作的對象也包括默氏、阿斯特捷利康（AstraZeneca）等大藥廠合作，後者希望在他們的臨床實驗中使用Guardant的液態切片測試。Guardant產品Guardant 360可以測試出73種與癌症有關的基因改變。該公司最近宣布測試範圍會增到五百種基因。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">席斯基表示，這種測試只需兩小瓶血液就能進行，只是如何規律、經常性地操作仍有一些限制。他說：「每一次治療後都得檢查腫瘤變化情形，有了液態切片，我們可以容易地重複測試，長期追蹤癌細胞變化情形。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">但是費用也是主要的問題所在。Guardant 360的價格是5,400美元，要說服保險公司和醫療體系大量採用與掏腰包，不是那麼容易。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h5><strong><span style="font-size: 20px"><span style="color: #000000">新理論　腫瘤特質比位置還重要</span></span></strong></h5>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px"><span style="font-size: 18px"><b>四、數據挖掘</b></span>──創建「癌症彭博社」。腫瘤基因特質比腫瘤部位重要，這個新理論可能表示腫瘤醫學須要重新整頓。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">Abbvie腫瘤部門副總裁戈登說：「傳統上我們都以人體解剖學概念思考癌症，從什麼時間點我們已經開始移轉到生物學角度來思考？因此現在你不只是乳癌醫師，更是HER2（基因異常）專科醫師。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">不過，有些腫瘤專家和醫療主管認為這一天的到來還早：藥物只是治療癌症的一種方法，必須注意腫瘤位置的理由也很多。席斯基說：「並不會出現一股革命風潮，突然重組國內的每一家癌症中心，拿下「乳癌防治中心」的招牌，換上「HER2診所」的招牌。」</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">對許多在人體基因圖譜解密之前接受醫療訓練的腫瘤專家來說，要跟上癌症分子特徵相關的龐大研究，十分辛苦。如果類似Larotrectinib的數百種小眾藥物取代了今天普遍使用、種類不多的大眾抗癌藥，尋覓正確的抗癌療法可能更困難。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">一些大型癌症治療中心試圖以舉行定期腫瘤會診評估來解決問題，例如熟悉HER2異常的乳癌醫師，可能在過程中察覺到前列腺癌症專家漏失的問題。不過，這個途徑大規模複製不易，Foundation Medicine、Thermo Fisher之類的下一代診斷藥商正在研發一種「癌症的彭博社」── 一名病患的檢驗結果可以自動產生一系列的選擇，可從既有藥物到實驗治療的選項中採納合適者。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">Foundation Medicine醫療長米勒（Vince Miller）說：「徒有不同凡響的檢驗不夠，因為有時醫生也不知道他們檢驗的意義在哪裡；他們可能時間不夠，可能不知道所有的實驗治療，或可能太忙；我們研發很多支援工具，可以打破這些藩籬。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px">文章來自: TheNewsLens</span></p>  <p><span style="font-size: 14px"><a href="https://hk.thenewslens.com/article/88729" target="_blank"><span style="color: #0000ff">https://hk.thenewslens.com/article/88729</span></a></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180131]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%96%b0%e7%99%8c%e7%97%87%e6%88%b0%e7%88%ad%ef%bc%9a%e5%be%8c%e5%9f%ba%e5%9b%a0%e8%a7%a3%e7%a2%bc%e6%99%82%e4%bb%a3%ef%bc%8c%e5%8c%96%e7%99%82%e5%b0%87%e6%88%90%e9%81%8e%e5%8e%bb%ef%bc%9f/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%96%b0%e7%99%8c%e7%97%87%e6%88%b0%e7%88%ad%ef%bc%9a%e5%be%8c%e5%9f%ba%e5%9b%a0%e8%a7%a3%e7%a2%bc%e6%99%82%e4%bb%a3%ef%bc%8c%e5%8c%96%e7%99%82%e5%b0%87%e6%88%90%e9%81%8e%e5%8e%bb%ef%bc%9f]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[35]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180131]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7189]]></id>
		<title><![CDATA[吸煙男攝過量維B增肺癌風險]]></title>
		<content><![CDATA[<p><span style="color: #000000"><span style="font-size: 26px"><strong>吸煙男攝過量維B增肺癌風險</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center"><span style="color: #696969"><span style="font-size: 26px"><strong><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/26aa7p11.jpg" style="height: 524px; width: 640px" /></strong></span></span></p>  <p style="text-align: center"><span style="color: #696969">■梁慧思指市民從日常均衡飲食中，已可攝取足夠的維他命B。李潤芳攝 </span><a href="https://www.facebook.com/ApplePhotographers" target="_photographer"><span style="color: #696969"><img height="18" src="https://staticlayout.appledaily.hk/web_images/layout/photojouralist%20icon_18x18.jpg" width="18" /></span></a></p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p style="text-align: center">&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">【本報訊】維他命補充劑究竟對健康有益定有害？美國一項最新研究則發現，吸煙男性長時間服用高劑量維他命B，包括B6、B12可增加患肺癌風險。香港大學家庭醫學及基層醫療系榮譽臨床助理教授蔡國淦表示，正服用相關補充劑病人，包括神經病變致手腳痹痛人士，宜先諮詢醫生意見，不應貿然停服影響病情。有吸煙習慣病人最好戒煙，避免增加肺癌風險。</span></span></p>  <p>&nbsp;</p>  <p><br /> <span style="font-size: 16px"><span style="color: #000000">美國俄亥俄州立大學（Ohio State University）預防癌症部門，在2000至2002年間邀請華盛頓州約7.7萬名50至76歲人士，參與一項長時間追蹤研究，分析飲食及生活習慣與健康關係。結果發現有808宗入侵性肺癌個案，逾3,200名受訪男煙民中，有139人患肺癌。</span> </span><!--please only add this icon at the end of the article --></p>  <div class="clear">&nbsp;</div>  <p><!--please only add this icon at the end of the article --></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div class="ArticleContent_Outer"> <div class="ArticleContent"> <div class="ArticleContent_Inner"> <h2><strong><span style="color: #000000"><span style="font-size: 20px">高劑量多處方予貧血者</span></span></strong></h2>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">分析指出，男性長時間（平均10年）服用高劑量維他命B6及B12，可增加肺癌風險三至四成。男煙民的相關風險更高，以維他命B6為例，若每日攝取多於20毫克，肺癌風險增加八成。維他命B12則每日攝取多於55微克，肺癌風險可增近一倍。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">蔡指，健康的壯年人正常可從均衡飲食攝取足夠維他命B，不建議服用坊間維他命B補充劑。若要食用亦應諮詢醫生意見，留意產品標籤，包括是否屬高劑量產品，自行評估相關風險。</span></span></p>  <p>&nbsp;</p>  <p><span style="color: #000000"><span style="font-size: 16px">臨床上高劑量維他命B多處方予神經病變或貧血病患者，例如因糖尿病或骨骼退化引致手腳痹痛、無力等問題。蔡稱由於維他命B對神經系統傳導有幫助，有機會改善病情，故不建議病人貿然停藥，以免影響病情，宜先諮詢醫生意見。研究人員仍在了解維他命B與肺癌關係，目前吸煙及遺傳基因仍是肺癌主因，故正服用維他命B補充劑的病人宜盡快戒煙。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><br /> <span style="color: #696969"><span style="font-size: 14px">■記者梁麗兒</span></span></p> </div> </div> </div>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #696969"><span style="font-size: 14px"><strong>文章來自: 蘋果日報</strong></span></span></p>  <p><span style="font-size: 14px"><a href="https://hk.news.appledaily.com/local/daily/article/20180126/20285738" target="_blank"><span style="color: #0000ff">https://hk.news.appledaily.com/local/daily/article/20180126/20285738</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180131]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%90%b8%e7%85%99%e7%94%b7%e6%94%9d%e9%81%8e%e9%87%8f%e7%b6%adb%e5%a2%9e%e8%82%ba%e7%99%8c%e9%a2%a8%e9%9a%aa/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>癌症的誘因]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%90%b8%e7%85%99%e7%94%b7%e6%94%9d%e9%81%8e%e9%87%8f%e7%b6%adb%e5%a2%9e%e8%82%ba%e7%99%8c%e9%a2%a8%e9%9a%aa]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[36]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180131]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7190]]></id>
		<title><![CDATA[【運氣用盡】元旦中獎780萬擬買車投資 美「幸運兒」病逝過唔到1月]]></title>
		<content><![CDATA[<p><strong><span style="font-size:26px;"><span style="color:#000000;"><span style="text-align: left; text-transform: none; line-height: 30px; text-indent: 0px; letter-spacing: normal; font-family: PMingLiu,mingliu,&quot;細明體_HKSCS-ExtB&quot;,&quot;Ming(for ISO10646)ExtB&quot;,Arial,Helvetica,sans-serif; font-style: normal; font-variant: normal; font-weight: 700; text-decoration: none; word-spacing: 0px; display: inline !important; white-space: normal; orphans: 2; float: none; -webkit-text-stroke-width: 0px; background-color: transparent;">【運氣用盡】元旦中獎780萬擬買車投資 美「幸運兒」病逝過唔到1月 </span></span></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1517284663_d609(2).jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;">&nbsp;</p>  <div class="anv-video-container-flash" id="anvp61322380-video-container-flash-container" style="background: none; text-align: center; font-family: sans-serif;">&nbsp;</div>  <p style="background-color: transparent; color: rgb(51, 51, 51); font-family: PMingLiu,mingliu,&amp;quot;細明體_HKSCS-ExtB&amp;quot;,&amp;quot;Ming(for ISO10646)ExtB&amp;quot;,Arial,Helvetica,sans-serif; font-size: 15px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: 1.2px; line-height: 22.5px; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="text-align: left; text-transform: none; text-indent: 0px; letter-spacing: 1.2px; font-family: PMingLiu,mingliu,&quot;細明體_HKSCS-ExtB&quot;,&quot;Ming(for ISO10646)ExtB&quot;,Arial,Helvetica,sans-serif; font-style: normal; font-variant: normal; font-weight: 400; text-decoration: none; word-spacing: 0px; display: inline !important; white-space: normal; orphans: 2; float: none; -webkit-text-stroke-width: 0px; background-color: transparent;">「獎金可以幫輕我，我沒有奢華大計，我會買輛貨車、還債和為將來投資。」51歲薩瓦塔諾（Donald Savastano）今個月初領取支票時對未來仍充滿憧憬。他還透露自己12月在一間便利店看到「快樂百萬富翁」刮刮樂彩券後，突然想試試運氣，於是花了10美元（78港元）購買那彩券，結果贏得100萬美元獎金，除稅後領取66萬美元（514萬港元）獎金。</span></span></span></p>  <p style="background-color: transparent; color: rgb(51, 51, 51); font-family: PMingLiu,mingliu,&amp;quot;細明體_HKSCS-ExtB&amp;quot;,&amp;quot;Ming(for ISO10646)ExtB&amp;quot;,Arial,Helvetica,sans-serif; font-size: 15px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: 1.2px; line-height: 22.5px; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="text-align: left; text-transform: none; text-indent: 0px; letter-spacing: 1.2px; font-family: PMingLiu,mingliu,&quot;細明體_HKSCS-ExtB&quot;,&quot;Ming(for ISO10646)ExtB&quot;,Arial,Helvetica,sans-serif; font-style: normal; font-variant: normal; font-weight: 400; text-decoration: none; word-spacing: 0px; display: inline !important; white-space: normal; orphans: 2; float: none; -webkit-text-stroke-width: 0px; background-color: transparent;">薩瓦塔諾是自僱木工匠，師承父親，他坦言一直沒有退休計劃，因此打算拿來作退休金，可惜原來他的未來沒那麼長遠，他得獎後懷疑因不適看病，赫然得知自己有末期癌症。</span></span></span></p>  <p style="background-color: transparent; color: rgb(51, 51, 51); font-family: PMingLiu,mingliu,&amp;quot;細明體_HKSCS-ExtB&amp;quot;,&amp;quot;Ming(for ISO10646)ExtB&amp;quot;,Arial,Helvetica,sans-serif; font-size: 15px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: 1.2px; line-height: 22.5px; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="text-align: left; text-transform: none; text-indent: 0px; letter-spacing: 1.2px; font-family: PMingLiu,mingliu,&quot;細明體_HKSCS-ExtB&quot;,&quot;Ming(for ISO10646)ExtB&quot;,Arial,Helvetica,sans-serif; font-style: normal; font-variant: normal; font-weight: 400; text-decoration: none; word-spacing: 0px; display: inline !important; white-space: normal; orphans: 2; float: none; -webkit-text-stroke-width: 0px; background-color: transparent;">刮刮樂的便利店員工斯科特（Danielle Scott）說：「他是自僱，沒有保險，我想他身體感到不適了一段日子，當他領取獎金後就找醫生。他有朋友來告訴我，他病情嚴重，有腦和肺癌要住院留醫，他們（他的朋友）當時都估計他命不久矣。」</span></span></span></p>  <p style="background-color: transparent; color: rgb(51, 51, 51); font-family: PMingLiu,mingliu,&amp;quot;細明體_HKSCS-ExtB&amp;quot;,&amp;quot;Ming(for ISO10646)ExtB&amp;quot;,Arial,Helvetica,sans-serif; font-size: 15px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: 1.2px; line-height: 22.5px; margin-bottom: 15px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="text-align: left; text-transform: none; text-indent: 0px; letter-spacing: 1.2px; font-family: PMingLiu,mingliu,&quot;細明體_HKSCS-ExtB&quot;,&quot;Ming(for ISO10646)ExtB&quot;,Arial,Helvetica,sans-serif; font-style: normal; font-variant: normal; font-weight: 400; text-decoration: none; word-spacing: 0px; display: inline !important; white-space: normal; orphans: 2; float: none; -webkit-text-stroke-width: 0px; background-color: transparent;">薩瓦塔諾上周五在家中病逝，當時家人陪伴在側，媽媽要白頭人送黑頭人。斯科特慨歎：「希望那筆錢讓其家人可給他最好的，他是好人，那是他應得的，只遺憾得獎後的時光太短。」</span></span></span></p>  <p>&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><font face="PMingLiU"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1517284666_d5f9.jpg" style="width: 500px; height: 319px;" /></font></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><font face="PMingLiU"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1517284669_b594.jpg" style="width: 500px; height: 253px;" /></font></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><font face="PMingLiU"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1517284672_9953.jpg" style="width: 500px; height: 500px;" /></font></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><font face="PMingLiU">​文章來自:&nbsp;</font>蘋果日報</p>  <p><a href="https://hk.news.appledaily.com/international/realtime/article/20180131/57770686" target="_blank"><span style="color:#0000FF;">https://hk.news.appledaily.com/international/realtime/article/20180131/57770686</span></a></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180201]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e3%80%90%e9%81%8b%e6%b0%a3%e7%94%a8%e7%9b%a1%e3%80%91%e5%85%83%e6%97%a6%e4%b8%ad%e7%8d%8e780%e8%90%ac%e6%93%ac%e8%b2%b7%e8%bb%8a%e6%8a%95%e8%b3%87-%e7%be%8e%e3%80%8c%e5%b9%b8%e9%81%8b%e5%85%92/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e3%80%90%e9%81%8b%e6%b0%a3%e7%94%a8%e7%9b%a1%e3%80%91%e5%85%83%e6%97%a6%e4%b8%ad%e7%8d%8e780%e8%90%ac%e6%93%ac%e8%b2%b7%e8%bb%8a%e6%8a%95%e8%b3%87-%e7%be%8e%e3%80%8c%e5%b9%b8%e9%81%8b%e5%85%92]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[37]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180201]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7191]]></id>
		<title><![CDATA[《柳葉刀》：跨越15年，71國近3800萬癌症患者，18種癌症各國最新5年生存率變化趨勢發佈，中國形勢不容樂觀 | 臨床大發現]]></title>
		<content><![CDATA[<p><span style="font-family: times new roman, times, serif"><strong><span style="color: #000000"><span style="font-size: 26px"><span style="background: white">《柳葉刀》：跨越15年，71國近3800萬癌症患者，18種癌症各國最新5年生存率變化趨勢發佈，中國形勢不容樂觀 | 臨床大發現 </span></span></span></strong></span></p>  <p><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="color: #696969"><span style="background: white"><span style="line-height: 11.5pt"><span lang="EN-US">Original </span></span></span></span></span></span><span style="background: white"><span style="line-height: 11.5pt"><span lang="EN-US" style="font-size: 8pt"><span style="font-family: &quot;Microsoft YaHei&quot;"><st1_chsdate day="31" islunardate="False" isrocdate="False" month="1" w_st="on" year="2018"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="color: #696969">2018-01-31</span></span></span></st1_chsdate></span></span></span></span><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="background: white"><span style="line-height: 11.5pt"><span style="color: #696969"><span lang="EN-US"> </span>朱爽爽&nbsp;</span><span style="color: #696969">奇點網 </span></span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="background: white"><span style="line-height: 11.5pt"><b><span style="font-size: 1pt"><span style="color: black"><span style="display: none">奇点网</span></span></span></b><span style="font-size: 1pt"><span style="color: black"><span style="display: none"> <img alt="" id="js_profile_qrcode_img" src="" style="height: 24pt; width: 24pt" /></span></span></span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="background: white"><span style="line-height: 11.5pt"><span lang="EN-US" style="font-size: 1pt"><span style="color: black"><span style="display: none">WeChat ID </span></span></span><span lang="EN-US" style="font-size: 1pt"><span style="color: black"><span style="display: none">geekheal_com</span></span></span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="background: white"><span style="line-height: 11.5pt"><span lang="EN-US" style="font-size: 1pt"><span style="color: black"><span style="display: none">Intro </span></span></span><span style="font-size: 1pt"><span style="color: black"><span style="display: none">链接全球创新医疗</span></span></span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">就在今天，史上最新，最全的癌症生存資料來了。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">由美國癌症協會，瑞士癌症研究基金會，美國國家癌症研究所等機構贊助的<span lang="EN-US">2000 - 2014</span>年全球癌症生存趨勢監測計畫（<span lang="EN-US">CONCORD</span>計畫）第三階段的資料發表在權威醫學期刊《柳葉刀》雜誌上。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white"><b><span lang="EN-US">CONCORD3</span></b><b>計畫包括了</b><b><span lang="EN-US">2000-2014</span></b><b>年共</b><b><span lang="EN-US">15</span></b><b>年間</b><b><span lang="EN-US">71</span></b><b>個國家共</b><b><span lang="EN-US">3750</span></b><b>萬份確診癌症患者的個人醫療記錄</b>，涉及成人食管癌，胃癌，結腸癌，直腸癌，肝癌，胰腺癌，肺癌，乳腺癌，子宮頸癌，卵巢癌，前列腺癌，黑色素瘤，腦癌，白血病，淋巴瘤以及兒童腦癌，白血病，淋巴瘤共<span lang="EN-US">18</span>種癌症。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white"><span lang="EN-US"><em><img alt="" id="_x0000_i1026" src="http://www.cancerinformation.com.hk/ufiles/Image/640.jpg" style="height: 426px; width: 640px" /></em></span></span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="color: #696969"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="background: white">中國科學院腫瘤研究所副主</span></span></span></span><span style="background: white"><span style="font-size: 7pt"><span style="font-family: 新細明體"><st1_personname productid="任陳萬青" w_st="on"><span style="color: #696969"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif">任陳萬青</span></span></span></st1_personname></span></span></span><span style="color: #696969"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="background: white">教授參與本次研究</span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">下面，就讓我們一起來看一下最新的<span lang="EN-US">2010</span>年<span lang="EN-US">-2014</span>年五年間不同國家不同類型癌症的生存情況。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">總的來說，全球癌症<span lang="EN-US">5</span>年生存率在穩步前進，但不同國家地差距仍舊很明顯。其中對於絕大多數癌症來說，<b>美國，加拿大，澳大利亞，新西蘭以及芬蘭，冰島，挪威等國家的</b><b><span lang="EN-US">5</span></b><b>年生存率仍舊位居世界前列</b>。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">例如美國乳腺癌患者的生存率超過<span lang="EN-US">90%</span>，而大部分國家都在<span lang="EN-US">80%</span>左右。<b>特別地，芬蘭兒童急性淋巴細胞白血病的</b><b><span lang="EN-US">5</span></b><b>年生存率已經超過了</b><b><span lang="EN-US">95%</span></b><b>，而我國僅有</b><b><span lang="EN-US">57.7%</span></b><b>。</b></span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">值得一提的是，<b>胃腸道癌症</b><b><span lang="EN-US">5</span></b><b>年存活率較高的地區主要在亞洲</b>。其中在韓國，胃癌的<span lang="EN-US">5</span>年生存率高達<span lang="EN-US">68.9%</span>遠高於<span lang="EN-US">20%-40%</span>的平均水準，結腸癌<span lang="EN-US">5</span>年生存率高達<span lang="EN-US">71.8%</span>，直腸癌<span lang="EN-US">5</span>年生存率高達<span lang="EN-US">71.1%</span>均位居前列。而我國的結腸癌和直腸癌五年生存率僅有<span lang="EN-US">57.6%</span>和<span lang="EN-US">56.9%</span>，均處於平均水準。此外，食管癌在日本的生存率最高，達<span lang="EN-US">36%</span>。肝癌在我國臺灣地區的生存率最高達到了<span lang="EN-US">27.9%</span>，是大陸的兩倍。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white"><span lang="EN-US"><em><img alt="" id="_x0000_i1027" src="http://www.cancerinformation.com.hk/ufiles/Image/2(15).jpg" style="height: 1089px; width: 550px" /></em></span></span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="color: #696969"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="background: white"><span style="background: white">不同國家乳腺癌的</span><span lang="EN-US"><span style="background: white">5</span></span><span style="background: white">年生存狀況，灰色代表非洲，深紅色代表南美洲，紅色代表北美洲，黃色代表亞洲，藍色代表歐洲，綠色代表澳洲</span></span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">而在所有癌症中，生存率最低的，依舊是胰腺癌，肺癌，食管癌，胃癌，肝癌，和成人腦癌這些老大難，絕大多數國家的五年生存率都在<span lang="EN-US">40%</span>以下。同時胰腺癌繼續蟬聯癌症之王的寶座，<b>幾乎所有國家胰腺癌患者的</b><b><span lang="EN-US">5</span></b><b>年生存率都沒有超過</b><b><span lang="EN-US">15%</span></b><b>，甚至很多發達國家也都在</b><b><span lang="EN-US">10%</span></b><b>以下。</b></span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">與此相反，所有類型癌症中，生存率最高的主要是，乳腺癌，前列腺癌以及兒童血液腫瘤，很多國家這幾類癌症的<span lang="EN-US">5</span>年生存率都在<span lang="EN-US">80%</span>以上。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">而對於我們中國來說，雖然絕大多數癌症的生存率一直在穩步上升，但總體而言，患者的生存情況仍舊不容樂觀。例如，我國胃癌患者的<span lang="EN-US">5</span>年生存率雖然從<span lang="EN-US">2000-04</span>年的<span lang="EN-US">30.2%</span>提高到<span lang="EN-US">2010-2014</span>年的<span lang="EN-US">35.9%</span>，但這仍舊只有韓國的一半。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">同時，<b>我國兩大高發癌症，肝癌和肺癌的</b><b><span lang="EN-US">5</span></b><b>年生存率，仍舊沒有多大改善</b>。例如，肝癌的<span lang="EN-US">5</span>年生存率僅從<span lang="EN-US">2000-2004</span>年時的<span lang="EN-US">11.7%</span>上升到<span lang="EN-US">2010-1014</span>年的<span lang="EN-US">14.1%</span>，是我國臺灣地區的一半。而肺癌的<span lang="EN-US">5</span>年生存率，僅從<span lang="EN-US">2000-2004</span>年的<span lang="EN-US">18.7%</span>上升到<span lang="EN-US">2010-2014</span>年的<span lang="EN-US">19.8%</span>，處於<span lang="EN-US">10%-20%</span>的平均範圍之內。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">特別地，在兒童腫瘤這一領域，我們離其他國家還有很長的一段距離。舉個例子，此項研究所涉及的三種兒童癌症，包括兒童腦癌，急性淋巴細胞白血病以及淋巴瘤等在許多國家的<span lang="EN-US">5</span>年生存率都在<span lang="EN-US">80%</span>，<span lang="EN-US">90%</span>甚至以上，而我國的生存率大約只有一半。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white"><span lang="EN-US"><em><img alt="" id="_x0000_i1028" src="http://www.cancerinformation.com.hk/ufiles/Image/3(12).jpg" style="height: 966px; width: 500px" /></em></span></span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="color: #696969"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="background: white"><span style="background: white">我國急性淋巴細胞白血病兒童的</span><span lang="EN-US"><span style="background: white">5</span></span><span style="background: white">年生存狀況堪憂，深紅色代表南美洲，紅色代表北美洲，黃色代表亞洲，藍色代表歐洲，綠色代表澳洲</span></span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">而在這些問題上，我們可能需要學習一下韓國和丹麥。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">在<span lang="EN-US">2000</span>年前，丹麥癌症患者的<span lang="EN-US">5</span>年生存率低的可怕。包括胃癌，結腸癌，直腸癌，乳腺癌和前列腺癌等多種癌症，丹麥患者的<span lang="EN-US">5</span>年生存率明顯低於其他國家的患者。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">然而，自從<span lang="EN-US">2000</span>年，<span lang="EN-US">2005</span>年以及<span lang="EN-US">2011</span>年，丹麥大力推行國家癌症計畫，專注於推進癌症的早期篩查後，丹麥癌症患者的生存率就大幅上升，截至到本次實驗中，丹麥絕大多數癌症的<span lang="EN-US">5</span>年生存率都與其他北歐國家持平，位居世界前列。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">同樣地，韓國也是如此。大家都知道，韓國是結腸癌高發國家。自<span lang="EN-US">1999</span>年，韓國開始推行國家癌症篩查計畫，為<span lang="EN-US">40</span>歲以上的人提供每兩年一次的<span lang="EN-US">CT</span>檢查或結腸鏡檢查。從那時起，韓國胃腸道癌患者的<span lang="EN-US">5</span>生存率便顯著提高，<b>其中胃癌患者</b><b><span lang="EN-US">5</span></b><b>年生存率，由</b><b><span lang="EN-US">2000-04</span></b><b>年的</b><b><span lang="EN-US">48.6%</span></b><b>提高到了</b><b><span lang="EN-US">2010-14</span></b><b>年的</b><b><span lang="EN-US">68.9%</span></b><b>，漲幅超過</b><b><span lang="EN-US">20%</span></b><b>。而結腸癌，直腸癌的生存率也都提高了</b><b><span lang="EN-US">10%</span></b><b>以上，位居全球前列。</b></span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white"><span lang="EN-US"><em><img alt="" id="_x0000_i1029" src="http://www.cancerinformation.com.hk/ufiles/Image/4(9).jpg" style="height: 982px; width: 500px" /></em></span></span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt"><span style="color: #696969"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><span style="background: white">不同國家結腸癌的<span lang="EN-US">5</span>年生存狀況，灰色代表非洲，深紅色代表南美洲，紅色代表北美洲，黃色代表亞洲，藍色代表歐洲，綠色代表澳洲</span></span></span></span></p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="text-align: center; margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p style="margin: 0cm 0cm 0pt"><span style="font-family: times new roman, times, serif"><span style="color: #000000"><span style="font-size: 16px"><span style="background: white">總的來說，<span lang="EN-US">CONCORD</span>計畫詳細的提供了，<span lang="EN-US">2000</span>年<span lang="EN-US">-2014</span>年<span lang="EN-US">15</span>年間，不同類型癌症的具體生存趨勢。雖然全球癌症<span lang="EN-US">5</span>年生存率在穩步提高，不過不同國家地區的差異依舊很大。而這也為日後不同國家的癌症控制策略的制定提供了一些指導。</span></span></span></span></p>  <p style="margin: 0cm 0cm 0pt">&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: #696969"><span style="font-size: 14px"><span style="font-family: times new roman, times, serif"><strong><span style="background: white">文章來自: </span></strong></span>奇點網 </span></span></p>  <p><a href="https://mp.weixin.qq.com/s/y3kwbluRA4twLHU-PYHdBA" target="_blank"><span style="color: #0000ff"><span style="font-size: 14px">https://mp.weixin.qq.com/s/y3kwbluRA4twLHU-PYHdBA</span></span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180201]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e3%80%8a%e6%9f%b3%e8%91%89%e5%88%80%e3%80%8b%ef%bc%9a%e8%b7%a8%e8%b6%8a15%e5%b9%b4%ef%bc%8c71%e5%9c%8b%e8%bf%913800%e8%90%ac%e7%99%8c%e7%97%87%e6%82%a3%e8%80%85%ef%bc%8c18%e7%a8%ae%e7%99%8c%e7%97%87/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>統計分析]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e3%80%8a%e6%9f%b3%e8%91%89%e5%88%80%e3%80%8b%ef%bc%9a%e8%b7%a8%e8%b6%8a15%e5%b9%b4%ef%bc%8c71%e5%9c%8b%e8%bf%913800%e8%90%ac%e7%99%8c%e7%97%87%e6%82%a3%e8%80%85%ef%bc%8c18%e7%a8%ae%e7%99%8c%e7%97%87]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[38]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180201]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7192]]></id>
		<title><![CDATA[凝聚飲食業界力量 推廣無煙飲食文化]]></title>
		<content><![CDATA[<p><span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">為保障飲食業員工及公眾健康，香港吸煙與健康委員會（委員會）於2017年10月推出「無煙飲食力量」計劃，並獲多個業界組織支持，以及由戒煙服務機構提供協助，希望透過為業界設立「星級無煙食肆」認證及鼓勵公眾參與「無煙有食神挑戰菜」食譜創作比賽，加強飲食業界宣揚無煙文化的角色，將無煙信息傳遞予不同持份者，推動更多吸煙人士戒煙。計劃吸引近百間食肆及飲食業公司加入成為「星級無煙食肆」，包括飲食集團、快餐店、茶餐廳、健康食品連鎖店、卡拉OK集團、甜品店、小食店及酒吧等，受惠員工人數超過12,700人。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">委員會於今日(2月2日)舉行「無煙飲食力量」頒獎典禮，以表揚實施傑出無煙措施的「特選星級無煙食肆」及嘉許「無煙有食神挑戰菜」的得獎者。主禮嘉賓包括衞生署控煙辦公室主管李培文醫生、香港吸煙與健康委員會主席鄺祖盛及副主席伍婉婷。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">衞生署控煙辦公室主管李培文醫生致辭時表示，工作間為僱員每日逗留時間最長地方之一，飲食業公司或食肆若能訂定無煙政策，提供戒煙支援予吸煙的員工，不單可以保障員工健康，更可提升工作效率及建立正面的企業形象，履行社會責任。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">委員會主席鄺祖盛指出，「飲食業現時有超過24萬多名從業員，調查發現當中近半數的中式酒樓廚房員工及約三成的樓面員工有吸煙習慣，委員會度身訂造『無煙飲食力量』計劃，以協助飲食業公司及食肆實施各項無煙措施，支持員工戒煙。同時，亦鼓勵市民透過分享美食宣傳無煙信息和支持身邊的吸煙人士戒除煙癮。」</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">近百間「星級無煙食肆」推行各具特色的無煙措施，當中六間更獲選為「特選星級無煙食肆」，透過多元化的措施包括與戒煙員工簽署戒煙約章、推出員工戒煙獎勵計劃、提供戒煙轉介、於「健康無煙日」向員工派發水果、邀請成功戒煙的管理層分享戒煙心得及於社交平台分享無煙信息等，以凝聚員工、業界及市民大眾的力量，共同營造支持無煙飲食文化的氛圍。其中一間食肆更自發性於户外用餐位置全面禁煙，以保障食客及員工免受二手煙及三手煙的影響，獲選為「特選無煙户外食肆」，希望為業界樹立榜樣。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">此外，「無煙有食神挑戰菜」邀請公眾分享一道成本約一包捲煙價錢(約港幣六十元)的美食佳餚，鼓勵市民宣傳無煙信息和支持身邊的吸煙人士戒煙。比賽共收到超過60份食譜作品，既有創意又有營養，並吸引逾1,400位市民透過社交平台參與投票，支持「食煙不如食好餸」。而藝人阮小儀亦與冠軍得主一同到街頭邀請市民試食得獎煮意「無油無煙蔬果福袋」，分享無煙生活的重要性，得到不少正面迴響。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">香港大學公共衞生學院社會醫學講座教授暨羅旭龢基金教授(公共衞生學) 林大慶教授於活動中向飲食業界講解戒煙好處及對抗煙癮的貼士。歌手林奕匡、JW(王灝兒)及葉巧琳則透過遊戲，鼓勵市民以美食佳餚發放「無煙飲食力量」，幫助身邊的吸煙人士戒除煙癮。另外，無煙飲食達人楊尚友及成功戒煙的廚師盧沛華分享吸煙對飲食業從業員的影響，鼓勵大家重投無煙健康生活。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">如欲了解「無煙飲食力量」計劃詳情，請瀏覽</span><a href="http://www.smokefree.hk/catering" style="margin: 0px; padding: 0px; font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">www.smokefree.hk/catering</a><span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">圖片說明</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <img alt="一眾主禮嘉賓凝聚業界、員工及食客為飲食業注入無煙力量。" height="284" src="http://www.smokefree.hk/UserFiles/Image/press_release/photo/2018/pr20180202_1.jpg" style="border: 0px; font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" title="一眾主禮嘉賓凝聚業界、員工及食客為飲食業注入無煙力量。" width="500" /><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">一眾主禮嘉賓凝聚業界、員工及食客為飲食業注入無煙力量。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <img alt="近百間食肆及飲食公司加入成為「星級無煙食肆」，致力推廣無煙飲食文化。" height="215" src="http://www.smokefree.hk/UserFiles/Image/press_release/photo/2018/pr20180202_2.jpg" style="border: 0px; font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" title="近百間食肆及飲食公司加入成為「星級無煙食肆」，致力推廣無煙飲食文化。" width="600" /><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">近百間食肆及飲食公司加入成為「星級無煙食肆」，致力推廣無煙飲食文化。</span><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <img alt="香港大學公共衞生學院社會醫學講座教授暨羅旭龢基金教授(公共衞生學)林大慶教授、無煙飲食達人楊尚友及盧沛華分享戒煙好處及對抗煙癮的貼士。" height="340" src="http://www.smokefree.hk/UserFiles/Image/press_release/photo/2018/pr20180202_3.jpg" style="border: 0px; font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" title="香港大學公共衞生學院社會醫學講座教授暨羅旭龢基金教授(公共衞生學)林大慶教授、無煙飲食達人楊尚友及盧沛華分享戒煙好處及對抗煙癮的貼士。" width="500" /><br style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;" /> <span style="font-family: 新細明體, 細明體, Arial, Helvetica, sans-serif; font-size: 14px;">香港大學公共衞生學院社會醫學講座教授暨羅旭龢基金教授(公共衞生學)林大慶教授、無煙飲食達人楊尚友及盧沛華分享戒煙好處及對抗煙癮的貼士。</span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180202]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%87%9d%e8%81%9a%e9%a3%b2%e9%a3%9f%e6%a5%ad%e7%95%8c%e5%8a%9b%e9%87%8f-%e6%8e%a8%e5%bb%a3%e7%84%a1%e7%85%99%e9%a3%b2%e9%a3%9f%e6%96%87%e5%8c%96/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%87%9d%e8%81%9a%e9%a3%b2%e9%a3%9f%e6%a5%ad%e7%95%8c%e5%8a%9b%e9%87%8f-%e6%8e%a8%e5%bb%a3%e7%84%a1%e7%85%99%e9%a3%b2%e9%a3%9f%e6%96%87%e5%8c%96]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[39]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180202]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7193]]></id>
		<title><![CDATA[醫療界更新治療目標 二代標靶藥抑制白血病 達MR4.5不再惡化]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;">醫療界更新治療目標 二代標靶藥抑制白血病 達MR4.5不再惡化</span></strong></span></p>  <p><span style="color:#696969;"><span style="font-size:14px;">撰文： 鄧曦雯</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/40adffab0f76ba4c92f117e6ec5aa8e0.jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:20px;">俗稱血癌的白血病在本港癌症殺手中雖然僅居第10位，但曾有學者表示，在2030年患白血病人數將會急增兩倍，亦有年輕化趨勢，值得大眾關注。香港醫院藥劑師學會會長崔俊明和血液及血液腫瘤科醫生廖崇瑜於22日向公眾解釋公私營醫療一同更新的白血病治療目標──MR4.5，讓病人能得到更適切治療。</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="font-size:20px;"><span style="color:#000000;">症狀似感冒易被忽略 壯年最大機會患白血病 </span></span></strong></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">白血病的症狀並不明顯，與感冒症狀相似，易感疲累及體重無故下降，以及因脾臟引起的左側胸胸骨下脹痛等。由於症狀不明顯，大部分患者都是透過健康檢查發現患病，大多人發病時約50歲，而且有年輕化趨勢。逾百分之八十的香港病例都是在白血病的初期，即慢性期發現，病情尚可受控；一旦病情進入加速期或急性期，病人已經錯過了最佳的治療時機，對藥物反應變差，可能需要骨髓移植方可保命。</span> </span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><strong><span style="font-size:20px;">標靶藥物可提升存活率 </span></strong></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">香港現時約有800個慢性骨髓性白血病患者，每年新增至少50宗新症。數字將會繼續攀升，但廖崇瑜表示這並非壞事。他指2001年起岀現的標靶藥物，把病人存活率提高，因此由2001年起，由白血病而死亡的個案由高峰期的147個銳減至35個，病人數字則不斷上升，反映白血病人的存活率增加，比以前活得更長久。 </span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><strong><span style="font-size:20px;">新藥降低癌細胞水平 減少醫療成本及對病人傷害 </span></strong></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">談及癌症，許多市民會以為必定是不治之症，其實要醫治白血病或血癌並非想像中困難。隨著醫療進步，白血病，尤其是慢性骨髓性白血病的治療方法，已經由服用傳統的抗癌藥物或骨髓移植手術，演變成服用含細胞訊息傳導抑制劑成分的標靶藥物，治療的效用大大提升，令患者只要定時服藥，隔三個月檢查一次並且達標，便可以如同常人一般生活。 </span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">服用第二代，亦是最新一代藥物尼洛替尼（Nilotinib）及達沙替尼（Dasatinib）在2011於香港得到批准發售，已經有臨床數據支持，可以在服用藥物3個月後令壞基因及癌細胞減少九成，甚至在六年內有56%患者到達MR 4.5的水平。 </span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">MR（Molecular Response，即分子反應）指的是導致白血細胞不正常地大量增生，並且無法正常地凋亡的「費城染色體」在患者血液內的比例，以MR 1代表遞減九成，即只剩下10%的費城染色體計算，MR 2 代表剩下1%，如此類推，MR 4.5只剩下0.0032%的費城染色體，即血液內的壞白血球數量只有治療前的三萬分之一。在目前的科研結果中，在MR 4.5水平下惡化到急性期的個案為零，病人的存活率也大大提高，在已持續8年的研究中達92%。&nbsp; </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/980e212a51b3e650af26b4fed174671a.jpg" style="width: 640px; height: 480px;" /></p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;">血液及血液腫瘤科醫生廖崇瑜表示病人數字增加並非壞事。（鄧曦雯攝） </span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><strong><span style="font-size:20px;">最新藥物花費800元一日 與服舊藥相差六千倍 </span></strong></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">由於第一代標靶藥物伊馬替尼（Imatinib）的專利權已經過去，現時病人只需繳付十多元，公立醫院便可為病人提供16個星期的藥物，相比較快見效的第二代藥物，每日花費相差逾千倍。因此廖崇瑜指醫生在處方時會考慮病人的經濟狀況，若個別病人對新藥岀現抗藥性亦可能會轉服舊藥。目前未有科研支持，先服新一代藥物然後換藥會否影響病情，他勸喻病人切勿胡亂停藥或換藥。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">最新藥物每粒需要約400元，每天需要服用兩粒，以三個月檢測一次的間距計算，三個月內可能需要花費逾72,000元方可初見成效，一般市民難以負擔。但政府已經將最新藥物納入藥物名冊，市民如有需要，可於公立醫院確診後向關愛基金醫療援助項目申請資助，經過入息審查後可以獲得部分或全額資助。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:14px;">文章來自: HK01</span></span></p>  <p><span style="font-size:14px;"><a href="https://www.hk01.com/港聞/152073/醫療界更新治療目標-二代標靶藥抑制白血病-達MR4-5不再惡化" target="_blank"><span style="color:#0000FF;">https://www.hk01.com/港聞/152073/醫療界更新治療目標-二代標靶藥抑制白血病-達MR4-5不再惡化</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180205]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%86%ab%e7%99%82%e7%95%8c%e6%9b%b4%e6%96%b0%e6%b2%bb%e7%99%82%e7%9b%ae%e6%a8%99-%e4%ba%8c%e4%bb%a3%e6%a8%99%e9%9d%b6%e8%97%a5%e6%8a%91%e5%88%b6%e7%99%bd%e8%a1%80%e7%97%85-%e9%81%94mr4-5%e4%b8%8d/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%86%ab%e7%99%82%e7%95%8c%e6%9b%b4%e6%96%b0%e6%b2%bb%e7%99%82%e7%9b%ae%e6%a8%99-%e4%ba%8c%e4%bb%a3%e6%a8%99%e9%9d%b6%e8%97%a5%e6%8a%91%e5%88%b6%e7%99%bd%e8%a1%80%e7%97%85-%e9%81%94mr4-5%e4%b8%8d]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[40]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180205]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7194]]></id>
		<title><![CDATA[新一代抗CD20抗體藥物助濾泡性淋巴癌復發患者延長壽命]]></title>
		<content><![CDATA[<p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 26px;"><span style="line-height: 39px;"><b><span style="margin: 0px;"><span style="line-height: 39px;"><span style="font-family: 新細明體;">新一代抗</span><font face="Calibri">CD20</font><span style="font-family: 新細明體;">抗體藥物助濾泡性淋巴癌復發患者延長壽命</span></span></span></b></span></span></span></p>  <p style="margin: 0px 0px 11px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/98765.jpg" style="width: 600px; height: 338px;" /></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><span style="line-height: 24px;"><font color="#000000"><span style="margin: 0px;"><span style="line-height: 24px;"><font face="新細明體">淋巴癌</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">(Lymphoma),&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">是血液系統的惡性疾病之一</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">可分為何傑金氏淋巴癌</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">&nbsp;(Hodgkin&rsquo;s lymphoma)&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">和非何傑金氏淋巴癌</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">(non-Hodgkin&rsquo;s lymphoma),&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">後者可根據其生長及擴散的速度再分為慢性和急性兩大類</font></span></span></span><sup><span style="margin: 0px;"><span style="line-height: 20px;"><font face="Calibri">1</font></span></span></sup><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">。</font></span></span></span>&nbsp;<span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">濾泡性淋巴癌是最常見的慢性淋巴癌</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">好發於年齡約</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">50</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">多歲的患者</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">最常見的症狀為頸部</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">腹股溝或腋下淋巴結腫脹。</font></span></span></span></font></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><span style="line-height: 24px;"><font color="#000000"><span style="margin: 0px;"><span style="line-height: 24px;"><font face="新細明體">隨著醫學的進步發展，醫學界在濾泡性淋巴癌的治療上已取得不俗的成績。</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">現時的治療方法主要有三種，分別是放射治療，化學治療以及較新的標靶治療</font></span></span></span><sup><span style="margin: 0px;"><span style="line-height: 20px;"><font face="Calibri">3</font></span></span></sup></font><font face="新細明體"><span style="margin: 0px; color: black;"><span style="font-family: DengXian;">。</span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font color="#000000">標靶藥物利妥昔單抗</font></span></span></font><font color="#000000"><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">(rituximab),&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">透過與</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">B</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">淋巴細胞表面抗原</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">CD20</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">結合</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">引起免疫反應</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">令癌細胞凋亡</font></span></span></span><sup><span style="margin: 0px;"><span style="line-height: 20px;"><font face="Calibri">2</font></span></span></sup><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">。</font></span></span></span>&nbsp;<span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">在化療配合利妥昔單抗的治療下</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">濾泡性淋巴癌的存活期有了明顯的提高</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">很多病人可存活長達</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">15</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">年</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">甚至更久。</font></span></span></span></font></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><span style="line-height: 24px;"><font color="#000000"><span style="margin: 0px;"><span style="line-height: 24px;"><font face="新細明體">濾泡性淋巴癌大多無法治癒</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">即使它對治療的反應良好</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">仍然會不間斷地復發</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">使得患者需要在他們的一生中多次接受治療。根據個人病情</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">復發後的患者可選擇單用利妥昔單抗或與化學治療</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">/</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">放射治療並用。隨著新藥物的不斷問世</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">患者尚有不少新葯可以嘗試</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">其中包括新一代抗</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">CD20</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">抗體藥物阿托珠單抗</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">(obinutuzumab)<sup>4</sup></font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">。</font></span></span></span>&nbsp;<span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">阿托珠單抗是在利妥昔單抗的基礎上</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">通過分子工程對抗體進行改造和修飾</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">從而增強抗體與免疫細胞的親和力</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">加強殺滅癌細胞的能力</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">令治療效果得到進一步提升</font></span></span></span><sup><span style="margin: 0px;"><span style="line-height: 20px;"><font face="Calibri">5</font></span></span></sup><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">。</font></span></span></span>&nbsp;<span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">研究證實</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">用於接受利妥昔單抗治療後無效或病情出現惡化的濾泡性淋巴癌患者</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">阿托珠單抗配合抗癌藥苯達莫司汀</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">&nbsp;(bendamustine)</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">作治療</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">及後再單用阿托珠單抗作持續治療有助延長患者的存活期</font></span></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">,&nbsp;</font></span></span><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">降低病情惡化風險，這種合併療法的療效較單一使用苯達莫司汀的理想</font></span></span></span><sup><span style="margin: 0px;"><span style="line-height: 20px;"><font face="Calibri">6</font></span></span></sup><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><font face="新細明體">。</font></span></span></span></font></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <div style="border-bottom: 1.5pt solid windowtext; padding: 0cm 0cm 1pt;"> <p style="border: medium; margin: 0px; padding: 0cm;">&nbsp;</p> </div>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><span style="margin: 0px;"><font color="#000000"><font face="新細明體">安全報告免責聲明</font></font></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><span style="margin: 0px;"><font color="#000000"><font face="新細明體">此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，請向您的醫生或藥劑師諮詢和報告。</font></font></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><font color="#000000"><span style="margin: 0px;"><font face="新細明體">以上健康教育資訊由羅氏大藥廠香港有限公司提供</font></span><span style="margin: 0px;"><font face="Calibri">&nbsp;(NPM-HK-0079-01-2018)</font></span></font></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><font color="#000000"><font face="Calibri">Valid until&nbsp;</font></font></span><font color="#000000"><font face="Calibri"><font size="3"><st1_chsdate day="29" islunardate="False" isrocdate="False" month="11" w_st="on" year="2019"><span style="font-size: 16px;">29/11/2019</span></st1_chsdate></font></font></font><span style="font-size: 16px;"><font color="#000000"><font face="Calibri">&nbsp;or until change is required in accordance with the regulatory requirements, whichever comes first.</font></font></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><span style="line-height: 24px;"><span style="margin: 0px;"><span style="line-height: 24px;"><font color="#000000"><font face="Calibri">References:</font></font></span></span></span></span></p>  <p style="margin: 0px 0px 0px 48px;"><span style="font-size: 16px;"><span style="line-height: 24px;"><span style="color: rgb(0, 0, 0);"><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><span style="margin: 0px;"><font face="新細明體">1.</font>&nbsp;</span></span></span></span><font face="Calibri"><span lang="FR" style="margin: 0px;"><span style="line-height: 24px;">Adult Non-Hodgkin Lymphoma Treatment (PDQ&reg;). Patient Version.&nbsp;</span></span><span style="margin: 0px;"><span style="line-height: 24px;">Available at:&nbsp;</span></span></font></span><a href="https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032605/" target="_blank"><span style="color: rgb(0, 0, 255);"><span style="margin: 0px;"><span style="line-height: 24px;"><span style="text-decoration-line: none;">https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032605/</span></span></span></span></a><span style="color: rgb(0, 0, 0);"><span style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">.</font></span></span></span></span></span></p>  <p style="margin: 0px 0px 0px 48px;">&nbsp;</p>  <p style="margin: 0px 0px 0px 48px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="line-height: 24px;"><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><span style="margin: 0px;"><font face="新細明體">2.</font>&nbsp;</span></span><font face="Calibri">Johnson P and Glennie M. The mechanism of action of rituximab in the elimination of tumor cells.&nbsp;<i>Semin Oncol</i>&nbsp;2003;20(1 Suppl 2):3-8.</font></span></span></span></span></span></p>  <p style="margin: 0px 0px 0px 48px;">&nbsp;</p>  <p style="margin: 0px 0px 0px 48px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="line-height: 24px;"><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><span style="margin: 0px;"><font face="新細明體">3.</font>&nbsp;</span></span><font face="Calibri">Adult Non-Hodgkin Lymphoma Treatment (PDQ&reg;). Health Professional Version. Available at: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032836</font></span></span></span></span></span></p>  <p style="margin: 0px 0px 0px 48px;">&nbsp;</p>  <p style="margin: 0px 0px 0px 48px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="line-height: 24px;"><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><span style="margin: 0px;"><font face="新細明體">4.</font>&nbsp;</span></span><font face="Calibri">Gazyva (obinutuzumab) [Hong Kong Product Information]. Hong Kong. Roche; July 2016</font></span></span></span></span></span></p>  <p style="margin: 0px 0px 0px 48px;">&nbsp;</p>  <p style="margin: 0px 0px 0px 48px;"><span style="font-size: 16px;"><span style="line-height: 24px;"><span style="color: rgb(0, 0, 0);"><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><span style="margin: 0px;"><font face="新細明體">5.</font>&nbsp;</span></span></span></span></span><font face="Calibri"><i><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=M%C3%B6ssner%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20194898"><span style="color: rgb(0, 0, 0);"><span lang="DE" style="margin: 0px;"><span style="line-height: 24px;"><span style="text-decoration-line: none;">M&ouml;ssner E</span></span></span></span></a><span style="color: rgb(0, 0, 0);"><span lang="DE" style="margin: 0px;"><span style="line-height: 24px;">,&nbsp;</span></span></span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Br%C3%BCnker%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20194898"><span style="color: rgb(0, 0, 0);"><span lang="DE" style="margin: 0px;"><span style="line-height: 24px;"><span style="text-decoration-line: none;">Br&uuml;nker P</span></span></span></span></a><span style="color: rgb(0, 0, 0);"><span lang="DE" style="margin: 0px;"><span style="line-height: 24px;">,&nbsp;</span></span></span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Moser%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20194898"><span style="color: rgb(0, 0, 0);"><span lang="DE" style="margin: 0px;"><span style="line-height: 24px;"><span style="text-decoration-line: none;">Moser S</span></span></span></span></a><span style="color: rgb(0, 0, 0);"><span lang="DE" style="margin: 0px;"><span style="line-height: 24px;">, et al.&nbsp;</span></span></span></i><span style="color: rgb(0, 0, 0);"><span style="margin: 0px;"><span style="line-height: 24px;">Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity.&nbsp;</span></span></span></font><a href="https://www.ncbi.nlm.nih.gov/pubmed/20194898" title="Blood."><span style="color: rgb(0, 0, 0);"><i><span style="margin: 0px;"><span style="line-height: 24px;"><span style="text-decoration-line: none;">Blood.</span></span></span></i></span></a><span style="color: rgb(0, 0, 0);"><font face="Calibri"><i>&nbsp;</i><span style="margin: 0px;"><span style="line-height: 24px;">2010 Jun 3;115(22):4393-402.</span></span></font></span></span></span></p>  <p style="margin: 0px 0px 0px 48px;">&nbsp;</p>  <p style="margin: 0px 0px 11px 48px;"><span style="font-size: 16px;"><span style="line-height: 24px;"><span style="color: rgb(0, 0, 0);"><span style="margin: 0px;"><span style="line-height: 24px;"><span style="font-family: DengXian;"><span style="margin: 0px;"><font face="新細明體">6.</font>&nbsp;</span></span></span></span><span lang="FR" style="margin: 0px;"><span style="line-height: 24px;"><font face="Calibri">Sehn LH, Chua N, Mayer J, et al. Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a&nbsp;randomised, controlled, open-label, multicentre, phase 3 trial.&nbsp;</font></span></span></span><a href="https://www.ncbi.nlm.nih.gov/pubmed/27345636" title="The Lancet. Oncology."><span style="color: rgb(0, 0, 0);"><i><span style="margin: 0px;"><span style="line-height: 24px;"><span style="text-decoration-line: none;">Lancet Oncol.</span></span></span></i></span></a><span style="color: rgb(0, 0, 0);"><font face="Calibri"><i>&nbsp;</i><span style="margin: 0px;"><span style="line-height: 24px;">2016 Aug;17(8):1081-1093.</span></span></font></span></span></span></p>  <div>&nbsp;</div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180206]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%96%b0%e4%b8%80%e4%bb%a3%e6%8a%97cd20%e6%8a%97%e9%ab%94%e8%97%a5%e7%89%a9%e5%8a%a9%e6%bf%be%e6%b3%a1%e6%80%a7%e6%b7%8b%e5%b7%b4%e7%99%8c%e5%be%a9%e7%99%bc%e6%82%a3%e8%80%85%e5%bb%b6%e9%95%b7/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%96%b0%e4%b8%80%e4%bb%a3%e6%8a%97cd20%e6%8a%97%e9%ab%94%e8%97%a5%e7%89%a9%e5%8a%a9%e6%bf%be%e6%b3%a1%e6%80%a7%e6%b7%8b%e5%b7%b4%e7%99%8c%e5%be%a9%e7%99%bc%e6%82%a3%e8%80%85%e5%bb%b6%e9%95%b7]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[41]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180206]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7195]]></id>
		<title><![CDATA[編者的話 ( 57 ) 職場同路人]]></title>
		<content><![CDATA[<div style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><img alt="" src="http://www.cancerinformation.com.hkhttp://www.cancerinformation.com.hk/ufiles/Image/IMG-20180208-WA0037-11.jpg" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; width: 600px; height: 450px;" /></div>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">右二 : Molly Wu / Roche - Human Resources Director<br /> 左一 : Irene Kwan /&nbsp;<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;;">Roche - Senior Officer, Patient Empowerment</span><br /> 右一 : Pelly Young / Cacnerinformation.com.hk<br /> 左二 : Katy Tong / Cancerinformation.com.hk</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 16px;">(&nbsp;</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;;">癌症資訊網歡迎有興趣聘用同路人的企業</span>和我們聯络&nbsp;<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;;">，</span>&nbsp;<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;;">分享我們的親身經驗。)</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">根據香港政府統計署最新資料指出，香港總人口截至2017年年中約有7,389.5千人，勞動人口和就業人口分別為3,960.4千人和 3,850.8千人，就業率則為2.9%，相對全球失業率，情況不算嚴重，然而坊間總是出現「有工無人做，有人無工做」的怪現象，許多老闆級更揚言︰「就算調高價錢都請不了人，年輕人嫌辛苦不入行或不想打工，要求人工高、工時少，福利佳兼不能受罵。」癌症資訊網就鼓勵大企業人事部或中小企業老闆不妨考慮顧用同路人回歸職場，他/她們有經驗和能力，曾經歷生死邊緣，做事更起勁，策動力更強，因為總想把時間善於利用，爭取生活與工作平衡，生產效率更高。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>香港人拼搏精神 &mdash; 「勤與靈活」</strong></span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">根據2015年衛生署或醫院管理局香港癌症資料統計中心發放最新資料，惡性腫瘤(即癌症)屬於致死榜首，新症及死亡分別是30,318宗個案14,316宗。發病人的年齡組合多是40歲以上，這群人是工作人口最有價值的一群，然而因為得病而無奈退下職場，並因面對治療上的經濟壓力，有機會變成無助、沮喪和孤單，產生許多負面情緒。許多醫生都告訴我們「治病先醫心，人生變得有希望才能戰勝癌魔」，若有同路人能得到機會回歸職埸，重新建立自信和有精神寄託，一方面能補貼生活和治療費用；另一方面寄情工作分散精緒，自覺不是病人，也能增強抗癌戰鬥力。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">事實上，香港面對經濟轉營，求才若渴，同路人大多曾是職場精英或是勞動人口，可緩減勞工短缺的燃眉之急，只要僱主能體諒同路人的身體狀況，可以實行彈性上班時間、家庭辦工室、時薪工作或合約制等，都是可行的方法，我們公司現時就僱用了10名同路人工作，成效不錯。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>各國對同路人支援的借鏡</strong></span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">綜觀世界各地支援同路人的措施和方法，可作為香港政府和各大企業的借鏡。例如德國政府的支援政策就十分著力，目前德國癌病人口約400萬，但政府會提供6週帶薪病假，3年法定健康保險支付的疾病津貼，相當於總收入70%，當地企業家會援助病人以創造一定的工作機會、多樣化工作方式以貼合他們的治療和生活需要。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">加拿大人於2016年約有20.2萬人患癌，當地設有人權委員會受理就業歧視類投訴，許多巿鎮則用行政條例鼓勵企業聘用癌症康復者工作，給予一定比率和年限的稅收優惠。鼓勵家庭醫生、專科醫生為康復者開具如實的身體健康證明。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">日本癌症病患約20萬人，75%受控制的病患希望能繼續工作，於是當地政府會透過以下途徑協助他們找工︰(1)積極派遣社會保險勞務人士到各地區定點醫院，為他們提供相關工作知識和幫助，現約有120個諮詢點，將會繼續增加。(2)促進醫院和國家所屬介紹工作機構「HelloWork」聯合找工作，2013年日本厚生勞動省推行了「癌症患者等長期療養者就職支援試點事業」,「HelloWork」職員每週去醫院一次，對剛入院或需要定期診療者提供諮詢，按他們需求而介紹工作。(3)患者也可向社會福祉師諮詢醫療保險、僱傭保險等問題，醫務人員會提供治療內容及健康管理方面的注意事項等，再替他們找尋專業知識程度較高的工作。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">美國2017年有168萬新症，美政府制定高質量醫療保險政策，故她鼓勵個人和公司購買醫療保險，讓個人和公司皆有保障。這除了能幫助患癌員工承擔治療費用外，還可以為公司保留人才，繼續效力公司。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">香港特區政府可借鏡以上國家的援助措施或方案，選取適合的方法協助同路人重回職場工作，利己利人以達雙贏效果。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>香港企業和社會福利不足照顧同路人</strong></span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">醫生們常強調癌症不是絶症，因為醫學昌明，發現得早的存活機會大增，甚至變成如糖尿病似的長期病。「授人以魚，不如授之以漁」是許多路人的最佳寫照，他/她們希望活得有尊嚴，不是讓人以憐憫之心待之，若本地企業能對同路人提供一些就業機會，才是真正幫助和支持他們勇敢抗癌的最佳方案。</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">支持同路人重返職場, 過回普通人生活，最終社會增加多一份勞動力，何樂而不為呢﹗</span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: medium;">Alan Ng</span></p>  <div style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"> <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: medium;">編輯 ( 8-2-2018 )</span></p> </div>  <p style="border: 0px none; margin: 0px; padding: 0px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180208]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%b7%a8%e8%80%85%e7%9a%84%e8%a9%b1-57-%e8%81%b7%e5%a0%b4%e5%90%8c%e8%b7%af%e4%ba%ba/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%b7%a8%e8%80%85%e7%9a%84%e8%a9%b1-57-%e8%81%b7%e5%a0%b4%e5%90%8c%e8%b7%af%e4%ba%ba]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[42]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180208]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7196]]></id>
		<title><![CDATA[HER2 型乳癌是什麼？]]></title>
		<content><![CDATA[<div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><strong><span style="font-size: 24px;">HER2 型乳癌是什麼？</span></strong></span></span><br style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;" /> &nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: center; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;"><span style="font-size: 14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/her22(1)(1).jpg" style="cursor: default; height: 288px; width: 640px;" /></span></span></span></div>  <div style="background-color: transparent; color: rgb(51, 51, 51); font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: center; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">在本港，約 20%乳癌個案是「較惡」的 HER2 型乳癌。HER2 (第二型人類表皮生長因子受體)自然地存在於乳房細胞內，是一種附在細胞表面的受體。正常細胞會製造少量的 HER2 受體，用作接收生長因子，將生長訊息由細胞外傳送至細胞內，以控制細胞生長。</span></span></div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><br style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;" /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">當乳腺細胞有過量 HER2 受體，令細胞不受控制地增生，最終演化成腫瘤，這就是 HER2 型 (又稱 HER2 過度表現或 HER2 陽性) 乳癌。與其他種類的乳癌相比，HER2 型乳癌腫瘤的生長及擴散速度比較快，在有對抗 HER2 的標靶藥物治療之前，患者的存活期一般較短。</span></span></div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><br style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px;" /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">HER2 型乳癌患者可接受針對 HER2 受體的標靶藥物治療。抗 HER2 標靶藥物分為口服、靜脈注射和皮下注射三大類，可從癌細胞表面或進入癌細胞內，截斷 HER2 受體的生長訊息傳遞，從而抑制癌細胞的生長。目前已有數種針對 HER2 型乳癌的標靶藥物，醫生會根據患者的不同情況，去選擇最合適的標靶藥物組合。</span></span></div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">如有興趣了解更多關於乳癌的資訊，</span></span></div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">請參閱：</span></span><span style="font-size: 16px;"><a href="http://her2morrow.com.hk" style="color: rgb(7, 130, 193);" target="_blank"><span style="color: rgb(0, 0, 255);">http://her2morrow.com.hk</span></a></span></div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;">&nbsp;</div>  <div style="background-color: transparent; color: rgb(51, 51, 51); cursor: text; font-family: sans-serif,Arial,Verdana,&amp;quot;Trebuchet MS&amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 20.8px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;">安全報告免責聲明<br /> 此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，請向您的醫生或藥劑師諮詢和報告。<br /> 以上健康教育資訊由羅氏大藥廠香港有限公司提供 (NPM-HK-0074-11-2017)</span></span></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180214]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/her2-%e5%9e%8b%e4%b9%b3%e7%99%8c%e6%98%af%e4%bb%80%e9%ba%bc%ef%bc%9f/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[her2-%e5%9e%8b%e4%b9%b3%e7%99%8c%e6%98%af%e4%bb%80%e9%ba%bc%ef%bc%9f]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[43]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180214]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7197]]></id>
		<title><![CDATA[數十萬癌症病人苦等適切治療]]></title>
		<content><![CDATA[<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/6543(1).jpg" style="width: 500px; height: 297px;" /></p>  <p>&nbsp;</p>  <p style="margin: 6px 0px; font-family: Helvetica, Arial, sans-serif; color: rgb(29, 33, 41); font-size: 15px; background-color: rgb(255, 255, 255);">患病時，總希望得到最好的治療，好讓盡早痊癒，重回生命正軌。無奈由於香港癌症治療政策上的落後及不足，使本港的癌症病人淪為三等病人，日復一日地等待檢查、等待治療、等待藥物。</p>  <p style="margin: 6px 0px; font-family: Helvetica, Arial, sans-serif; color: rgb(29, 33, 41); font-size: 15px; background-color: rgb(255, 255, 255);">&nbsp;</p>  <div class="text_exposed_show" style="display: inline; font-family: Helvetica, Arial, sans-serif; color: rgb(29, 33, 41); font-size: 15px; background-color: rgb(255, 255, 255);"> <p style="margin: 0px 0px 6px; font-family: inherit;">在僅餘的生命時光，我們不甘心坐以待斃。為着自己，也為着其他病友，我們一班癌症病人及家屬自行組織起來，於去年7月組成全港首個專注倡議改革香港癌症策略的組織「癌症策略關注組」。過去大半年，我們四出跟政策制訂者、立法會議員、醫護人員及市民大眾訴說我們的故事，好讓社會明白我們的困境，更希望促成新政府運用全新思維去改革現時的癌控政策。我們期待新政府於快將公布的《財政預算案》能為癌症病人做得更多，讓本港數以十萬計癌症病人的生命重現曙光。</p>  <p style="margin: 0px 0px 6px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;"><strong>輪候治療時間漫長</strong></p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">耐心等候本是美德，但患上癌症卻萬萬等不得，只有愈早醫治才有望得到更佳治療效果。然而，香港癌症病人到公立醫院就診時往往要長期等待，等得愈久，只會愈容易錯過治療黃金期，甚或有病人的病情原屬初期，但因得不到適時治療，導致癌細胞出現轉移，使治療變得更為困難。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">根據政府2016年1月至12月的數字，現時絕大部分大腸癌症患者要輪候76天才能獲得首次治療，乳癌及鼻咽癌病人則分別要等待64天及54天。癌症病人等待期間要承受很大的精神壓力，病人及家屬終日惶恐不安，大大影響生活質素甚至病人的治療質素。癌病症人多等一天才獲治療，便等於虛耗多一天的存活機會。政府只有盡早改革現時的癌症策略，才能拯救更多病人。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">作為癌症患者與家屬，我們更能體會先進及適切藥物對治療病情的重要性。然而，現時醫管局往往要5年才將癌症新藥納入藥物名冊及安全網，讓病人能夠使用並獲得部分資助，而要納作專用藥物讓病人得到全額資助的話，更要8年才能成事。與其他先進國家比較，香港病人要等候較英國長3倍、澳洲長4倍的時間才能獲得資助使用新藥。而歐盟於2003至2014年通過了26種涉及治療香港十大癌症的主要藥物，但本港醫管局只將其中三分一藥物納入資助範圍，令基層及中下層病人無法及時使用多種新藥。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">關注組前成員胡先生的處境正好反映本港不少癌症病人等不到藥物苦況。胡先生於2014年9月底，因身體多處地方持續不斷腫痛，輾轉求醫後終確診患上急性骨髓白血病（AML）。後來經過大半年治療，病情漸趨穩定，不過2016年6月，癌病再次復發，他的人生頓時再次跌入谷底。「首次確診時尚有藥物可以使用，但經歷治療後，得悉原來公營醫院只有一種藥物用作治療AML。當復發再用時，療效會因癌細胞已產生抗藥性而大打折扣，幾乎等同『無得醫』，感覺有如被判死刑。」</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">關注組相信只有本港政府願意改革現時整個已落後於形勢的癌症策略，不再讓癌症病人空等，才能提升癌症治療成效，令病人獲得更佳的支援服務。因此我們期待新政府可把癌控改革列為今屆政府的工作重點之一，並於稍後公布的首份《財政預算案》中，撥出足夠資源以應對現時癌症病人面對長久等候治療的困境。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">首先，為使癌症病人可更易更快獲處方有效新藥，醫管局可考慮為癌症藥物設立專屬的「快捷藥物引進機制」。當現時藥物名冊上的藥物無法有效醫治有關癌症時，醫生可透過新藥試驗計劃，將治癌經驗較先進的地方，如英國、美國或歐盟等地已認可的癌症新藥引進香港給病人使用。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;"><strong>公私營合作緩壓力</strong></p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">政府同時應加強撒瑪利亞基金與關愛基金對癌症病人藥物支出的財政支援，以減輕他們的沉重財政負擔。現時已有不少病友反映申請有關基金時，財務審批以家庭為計算單位的不合理情況。我們促請政府修改相關安排，改以配偶為計算單位，方能讓更多有需要的癌症病人順利通過申請門檻。另外病人所需分擔藥費的比率，亦應由現時每年可動用財務資源的20%下調至10%。有關安排相信可以減輕病人的財務負擔，安心開展治療。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">另一方面，政府應可考慮增設「癌症醫療費用免稅額」，以補助癌症病人及其家人於治療期間要減少工作，甚至離職而帶來的沉重經濟負擔。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">最後，關注組亦促請政府要加大力度推動治療癌症服務的公私營合作，以便更有效調動醫護資源為病人服務。合作形式可以由政府為公院病人提供部分費用資助，而私家醫院或醫療中心則給予折扣優惠，相信可鼓勵經濟能力稍高的公院癌症病人有效分流至私營醫療系統接受檢查、化驗及診症服務。公私營合作不單可以加快有關病人接受診斷及治療的速度，同時亦有望縮短其他留在公院的病人輪候時間，紓緩公營醫療系統的壓力。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">我們深深明白，改革癌控政策是一個全港性的議題，單靠病人組織發聲實在難以成事，因此我們希望透過不同的會面、討論及交流，促成各方合作，一起正視癌症病人困境，並了解現時制度和政策帶來的問題。而政府對幫助病人抓緊癌症的治療黃金期，紓緩他們面對長久等候治療及藥物的無助困境上更是責無旁貸。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">我們懇切期待政府的回應。</p>  <p style="margin: 6px 0px; font-family: inherit;">&nbsp;</p>  <p style="margin: 6px 0px; font-family: inherit;">撰文：癌症策略關注組</p> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180222]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%95%b8%e5%8d%81%e8%90%ac%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e8%8b%a6%e7%ad%89%e9%81%a9%e5%88%87%e6%b2%bb%e7%99%82/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%95%b8%e5%8d%81%e8%90%ac%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e8%8b%a6%e7%ad%89%e9%81%a9%e5%88%87%e6%b2%bb%e7%99%82]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[44]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180222]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7198]]></id>
		<title><![CDATA[癌症治療新時代（上）免疫療法新藥誕生]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-family:times new roman,times,serif;"><strong><span style="font-size:26px;">癌症治療新時代（上）免疫療法新藥誕生</span></strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><a class="print" href="https://zh.cn.nikkei.com/industry/scienceatechnology/23734-2017-02-17-15-59-02.html?tmpl=component&amp;print=1&amp;page=" rel="nofollow" style="color: rgb(48, 69, 103); text-decoration-line: none; display: block; float: left; height: 21px; margin-right: 2px; overflow: hidden; text-indent: -999em; width: 21px; background-image: url(&quot;../images/ico/ico_Details01.gif&quot;); background-repeat: no-repeat;" title="Print"><span style="color:#000000;">PRINT</span></a><a class="email" href="https://zh.cn.nikkei.com/component/mailto/?tmpl=email&amp;link=aHR0cDovL2NuLm5pa2tlaS5jb20vaW5kdXN0cnkvc2NpZW5jZWF0ZWNobm9sb2d5LzIzNzM0LTIwMTctMDItMTctMTUtNTktMDIuaHRtbA==" style="color: rgb(48, 69, 103); text-decoration-line: none; display: block; float: left; height: 21px; margin-right: 2px; overflow: hidden; text-indent: -999em; width: 21px; background-image: url(&quot;../images/ico/ico_Details02.gif&quot;); background-repeat: no-repeat;" title="Email"><span style="color:#000000;">EMAIL</span></a></p>  <p>&nbsp;</p>  <p padding:=" " style=" margin:="><span style="color:#000000;"><span style="font-size:16px;">癌症的治療將發生翻天覆地的變化。日本研究人員的成果將催生劃時代的新藥。通過分析龐大的患者基因信息，尋找最佳治療方法的嘗試也在進行之中。在邊忍受副作用邊接受治療的患者中，一部分人的情況已開始改變，延長患者生命也不再是稀罕事。</span></span></p>  <p>&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">「打擊太大了，一連哭了好幾天」，住在東京的44歲的佐藤小百合在2011年被主治醫生告知肺癌復發。她在34歲時被查出肺癌，復發時正處於術後觀察期。醫生表示微小的腫瘤分散在她的身體各處。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><strong><span style="font-size:20px;"><span style="color:#000000;">腫瘤幾乎消失</span></span></strong></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">「不能讓孩子看到我丟人的樣子」，佐藤決定積極與病魔抗爭。但在1年半後腫瘤增大，她開始接受抗癌藥治療。雖然病情停止惡化，但佐藤飽受全身疼痛等副作用的折磨。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <table style="border-collapse: collapse; border-spacing: 0px; margin-right: auto; margin-left: auto;"> 	<tbody> 		<tr> 			<td style="text-align: center;"><span style="font-size:16px;"><span style="color:#000000;"><img alt="" src="https://zh.cn.nikkei.com/images/2017/02/0213/0213-14-1-L.jpg" style="border: 0px;" /></span></span></td> 		</tr> 		<tr> 			<td style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><strong>佐藤小百合在練習聲樂（東京）</strong></span></span></td> 		</tr> 	</tbody> </table>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">後來，佐藤參加了美國製藥企業默沙東日本法人進行的癌症免疫藥臨床試驗，擺脫了病痛的折磨。這款名為「Keytruda」的癌症免疫藥最早在2月15日上市。雖然帶來了濕疹等輕微的副作用，但在2年後的圖像檢查中已幾乎看不到腫瘤。佐藤重新開始練習在短期大學學習的聲樂，並計劃在癌症患者面前演唱。她説，「希望（我的歌聲）能鼓勵到大家」。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">癌症免疫藥利用了人體排除異物的免疫功能。癌細胞為了避免自身受到攻擊，會抑制人體免疫功能。癌症免疫藥會打破對免疫細胞的壓制，提高身體對癌細胞的攻擊力。雖然昂貴的價格讓很多患者望而卻步，但小野藥品工業的癌症免疫藥「Opdivo」和「Keytruda」等正在國內外進行審批。被美國食品藥品管理局（FDA）指定為「劃時代的新藥」。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">抗癌藥具有延長患者生命的效果，但幾乎沒有徹底治癒的情況。癌症免疫藥被認為能長期抑制癌症。癌症中期患者即使使用抗癌藥，最多也只能延長一年半左右的生命。但癌症免疫藥如果生效，延長3年以上的情況也不少見。兵庫縣立癌症中心呼吸內科部長裏內美彌子吃驚地表示，「原來沒有能這麼長時間抑制復發的藥物」。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">癌症免疫藥的研發以京都大學名譽教授本庶佑名的發現為基礎。本庶發現了癌細胞對免疫功能的抑制，被視為諾貝爾獎的有力候選人。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">癌細胞躲避免疫功能攻擊的其他發現也在臨床應用中得到推進。大阪大學的研究團隊已開始進行臨床試驗，研究覆蓋在癌細胞周圍保護其不受免疫功能攻擊的特殊細胞。發現這種特殊細胞的大阪大學特聘教授坂口志文也被視為諾貝爾獎候選人。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="color:#000000;"><span style="font-size:20px;"><strong>效果因人而異</strong></span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">這種治療方法讓保護癌細胞的細胞失效，利用免疫功能攻擊毫無防備的癌細胞。被宣告只有大約1年半生命的白血病晚期患者試用這種方法後，病情恢復到了可以正常生活的水平。大阪大學講師江副幸子錶示，「期待新療法可以用來治療目前無藥可醫的患者」。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">日本癌症免疫學會理事長、慶應義塾大學教授河上裕認為，「癌症治療的模式發生了轉變」。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">不過，癌症免疫藥有效的患者最多只有30%左右，也有出現嚴重副作用的情況，必須提前篩選出有望生效的患者。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">京都大學教授小川誠司等人開發了預測癌症免疫藥「Opdivo」效果的技術。鹿兒島大學教授石塚賢治等人正致力於通過臨床試驗，確認在白血病患者身上的有效性。不過，這種預測方法並不適用於所有患者，需要開發更加優秀的技術。</span></span></p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px;"><span style="font-size:16px;"><span style="color:#000000;">全球目前有1000多個正在進行中的新癌症免疫藥的臨床試驗。劃時代的新藥研發在不斷發展。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, times, serif;">文章來自: </span><font color="#221714" face="Times New Roman"><span style="font-size: 16px; letter-spacing: 1.5px;"><b>NIKKEI</b></span></font></p>  <p><span style="font-family:times new roman,times,serif;"><span style="font-size:14px;"><a href="https://zh.cn.nikkei.com/industry/scienceatechnology/23734-2017-02-17-15-59-02.html" target="_blank"><span style="color:#000000;">https://zh.cn.nikkei.com/industry/scienceatechnology/23734-2017-02-17-15-59-02.html</span></a></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180224]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%e6%96%b0%e6%99%82%e4%bb%a3%ef%bc%88%e4%b8%8a%ef%bc%89%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95%e6%96%b0%e8%97%a5%e8%aa%95%e7%94%9f/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>免疫療法]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%e6%96%b0%e6%99%82%e4%bb%a3%ef%bc%88%e4%b8%8a%ef%bc%89%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95%e6%96%b0%e8%97%a5%e8%aa%95%e7%94%9f]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[45]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180224]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7199]]></id>
		<title><![CDATA[癌症治療新時代（下）個體化精準用藥]]></title>
		<content><![CDATA[<p><span style="font-size:26px;"><strong><span style="color:#000000;"><span style="font-weight: 700; ">癌症治療新時代（下）個體化精準用藥</span></span></strong></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="font-size:16px;"><span style="color:#000000;">在位於富士山麓的靜岡縣立靜岡癌症中心的一個房間裏，電腦螢幕上顯示著不同顏色的字母「A」、「G」、「C」、「T」。診斷技術開發研究部部長浦上研一介紹説，「這是癌症患者的基因信息分析結果」。</span></span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <table style="border-collapse: collapse; border-spacing: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;  width: 8.82px; margin-right: auto; margin-left: auto;"> 	<tbody> 		<tr> 			<td style="width: 10.82px; text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><img alt="" src="https://zh.cn.nikkei.com/images/2017/02/0214/0214-16-L.jpg" style="border: 0px;" /></span></span></td> 		</tr> 		<tr> 			<td style="width: 10.82px; text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><strong>用於分析患者基因的晶片（靜岡縣長泉町靜岡癌症中心）</strong></span></span></td> 		</tr> 	</tbody> </table>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;"><span style="font-family:arial,helvetica,sans-serif;"><strong><span style="font-size:20px;">個體化醫療盛行</span></strong></span></span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;"><span style="font-size:16px;">靜岡癌症中心在患者的協助下，分析正常組織和癌組織，並研究關於發病和惡化的基因變異。從2014年開始，共調查了約3000人。目的是實現「個體化醫療」，為每位患者選擇最佳治療方法。</span></span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">癌症的起因被認為是基因異常。以壓力過大和吸煙等為誘因，細胞的基因受損發生變化，最終變得無法控制而癌變。相關基因數量龐大，不同患者的基因變異方式也各不相同。目前已有針對大腸和肺等不同臟器的不同治療方法，但如果致病基因相同的話，用於其他臟器的抗癌藥也可能生效。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">「身體狀況變好了」，一位家住京都的50多歲女性從2016年5月開始在京都大學醫院接受個體化醫療。這位女性罹患十二指腸癌，雖然接受了手術和抗癌藥治療，但一直沒有效果。2015年底，京都大學醫院調查了其基因，獲悉用肺癌的治療藥物似乎能達到比較好的效果。隨著用藥和治療，癌症停止了進一步惡化，該女子興奮地表示「我打算4月份就回公司上班」。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">個體化醫療以普通抗癌藥沒有效果的患者為對象。截至目前，對大約140人進行了基因分析，發現了對80%患者可能有效的藥物。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">低成本的基因高速分析裝置正在普及，癌症研究取得了飛躍發展。另一方面，人們也認識到了癌症的複雜性。對病灶進行研究發現，不斷變異的基因會因細胞而異。歐美和亞洲患者容易發生變異的基因也不同。要想對抗複雜的癌症，需要利用龐大的數據選擇治療方法。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">個體化醫療在海外也很盛行。美國以100多萬人為對象，英國以10萬人為對象正在進行基因分析。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">日本也在推進大規模的項目。2015年，國立癌症研究中心啟動了「SCRUM-Japan」項目，獲得了日本全國超過240家的醫療機構和15家製藥企業等各方面的協助。針對肺癌、大腸癌、胃癌、食道癌等病症，按照基因分析結果選擇有望取得效果的抗癌藥。該項目有5000多名患者參加。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">患者可以通過企業和醫生實施的臨床試驗試用新的藥物，並且有助於新藥審批進程的加快。從4月份開始，兩年內將再徵集5000人參加。國立癌症研究中心東醫院呼吸內科主任後藤功一表示，「個體化醫療已經在日本紮根」。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;"><span style="font-family:arial,helvetica,sans-serif;"><strong><span style="font-size:20px;">逃不脫的宿命</span></strong></span></span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">不過，基因分析不在醫保範圍內，而且不是所有分析結果都對治療有幫助。如果新的抗癌藥物在日本國內尚未獲得審批，並且沒有實施臨床試驗的情況下，將産生昂貴的由個人負擔的診療費用。儘管研究發現了大量癌症成因的基因變異，但適合的藥物還很少。順天堂大學教授加藤俊介表示，「有些患者對此過於期待。有必要提前作出解釋」。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#000000;">東京大學名譽教授黑木登志夫指出，「癌症對於人類這樣的多細胞生物就是一種宿命。只要活著就無法避免」。如何選擇與癌症共存，怎樣才能克服疾病的痛苦呢？選擇什麼樣的治療方法和生活方式，如何籌集治療費用？這些是每個人都要思考的問題。</span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="color:#696969;"><span style="font-size:14px;">文章來自: <b>NIKKEI</b></span></span></p>  <p style="margin: 0px; padding: 0px; color: rgb(51, 50, 49); font-family: &quot;microsoft yahei&quot;, &quot;Hiragino Sans GB&quot;, &quot;Heiti SC Medium&quot;, &quot;黑體-簡 Medium&quot;, 黑體-簡, &quot;Heiti SC&quot;, &quot;Heiti TC Medium&quot;, &quot;&amp;#40658;體-繁 Medium&quot;, &quot;Heiti TC&quot;, &quot;&amp;#40658;體-繁&quot;, 宋體, Tahoma, Verdana, Arial; font-size: 16px;"><span style="font-size:14px;"><a href="https://zh.cn.nikkei.com/industry/scienceatechnology/23748-2017-02-20-13-56-04.html" target="_blank"><span style="color:#000080;">https://zh.cn.nikkei.com/industry/scienceatechnology/23748-2017-02-20-13-56-04.html</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180224]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%e6%96%b0%e6%99%82%e4%bb%a3%ef%bc%88%e4%b8%8b%ef%bc%89%e5%80%8b%e9%ab%94%e5%8c%96%e7%b2%be%e6%ba%96%e7%94%a8%e8%97%a5/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>免疫療法]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%e6%96%b0%e6%99%82%e4%bb%a3%ef%bc%88%e4%b8%8b%ef%bc%89%e5%80%8b%e9%ab%94%e5%8c%96%e7%b2%be%e6%ba%96%e7%94%a8%e8%97%a5]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[46]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180224]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7200]]></id>
		<title><![CDATA[日本癌症治療（1）根據遺傳基因用藥]]></title>
		<content><![CDATA[<p><span style="font-family:arial,helvetica,sans-serif;"><span style="color:#000000;"><span style="font-size:26px;"><strong><span style="font-weight: 700;">日本癌症治療（1）根據遺傳基因用藥</span></strong></span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">1月16日，在日本最先進的癌症治療醫院&mdash;&mdash;日本國立癌症研究中心（位於東京都中央區）的會議室，臨床醫生與研究人員們的目光都集中前方的螢幕上。他們看的不是癌症的病灶圖像而是用數字和字母顯示的遺傳基因數據。「我覺得這種藥一定適合這位患者」，醫生們從發現的遺傳基因異常的類型中選出了預計最有效的癌症治療藥物。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp; &nbsp;&nbsp;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0131-14-L.jpg" style="width: 600px; height: 568px;" /></p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:14px;">日本國立癌症研究中心的尖端醫療科科長山本根據癌症的基因組討論候選治療藥&nbsp; </span></span><span style="color:#696969;"><span style="font-size:14px;">&nbsp;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;&nbsp;</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">對於治療選項有限的患者，我們希望儘量提供更有效的藥物」，該研究中心中央醫院尖端醫療科科長山本升（51歲）如此表示。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp; &nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">這正是基於癌症患者的遺傳基因信息來選擇最合適治療的「癌症基因組醫療」。在相關領域，歐美國家先行一步，日本剛剛啟動臨床研究，不過該治療法被認為將來可能成為癌症治療最主流的手段。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;&nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">癌症是正常細胞的遺傳基因因某種原因受損發病，不過到底會出現何種異常卻是因人而異。也就是説，同樣罹患肺癌，但遺傳基因的異常可能存在多種類型。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;&nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">與過去連同正常細胞一起攻擊的抗癌藥不同，最近推出的利用生物技術的癌症治療藥物可以因遺傳基因的不同而産生不同的療效。即使患病部位不同，如果遺傳基因的異常類型相同，則可以採用同一種藥物進行治療。如今的癌症治療已從根據胃和腸等不同器官分別展開治療轉變為基於遺傳基因決定藥物的治療。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;&nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">在日本，每年有超過100萬人罹患癌症。從一生中罹患癌症的幾率來看，男性約為3分之2，女性約為2分之1。由於早期發現和劃時代的癌症免疫藥物的出現，目前日本的癌症治癒率達到60%。雖然癌症不再是「不治之症」，不過依然是威脅人類生命的大敵。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;&nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp; &nbsp; 日本將癌症基因組醫療定位為2017年度起的「第三期癌症對策推進基本計劃」的支柱。日本國立癌症研究中心理事長中釜齊（61歲）充滿期待地表示，調查疑難癌症、罕見癌症和進行性癌症患者的基因組，「則能夠選擇高效的治療方法，或許能夠為人類與癌症鬥爭劃上歷史句號」。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">要實現在任何一所醫院都能接受癌症基因組醫療，必須讓醫保覆蓋癌症相關遺傳基因的檢測。目前，在日本僅檢測遺傳基因的費用就超過70萬日元（約合人民幣4萬元），如果適用於醫保則可以大大減輕患者的負擔。山本等人從2013年開始啟動臨床研究，研究團隊在中央醫院調查超過100種癌症相關遺傳基因，力爭為決定針對患者的治療方針提供參考。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">日本國立癌症研究中心計劃從2018年4月開始將遺傳基因檢測作為先進醫療啟動，正加緊收集相關數據，以獲得日本政府的批准。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:14px;">文章來自: NIKKEI</span></p>  <p><span style="font-size:14px;"><a href="https://zh.cn.nikkei.com/industry/scienceatechnology/29094-2018-02-11-05-00-30.html" target="_blank"><span style="color:#000080;">https://zh.cn.nikkei.com/industry/scienceatechnology/29094-2018-02-11-05-00-30.html</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180224]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%ef%bc%881%ef%bc%89%e6%a0%b9%e6%93%9a%e9%81%ba%e5%82%b3%e5%9f%ba%e5%9b%a0%e7%94%a8%e8%97%a5/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%ef%bc%881%ef%bc%89%e6%a0%b9%e6%93%9a%e9%81%ba%e5%82%b3%e5%9f%ba%e5%9b%a0%e7%94%a8%e8%97%a5]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[47]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180224]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7201]]></id>
		<title><![CDATA[日本癌症治療(2)臉部識別技術發現癌症]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>日本癌症治療(2)臉部識別技術發現癌症</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">「在臉部識別領域能拿世界第一的話，應該也能應用到診斷癌症吧？」，2014年底，在日本國立癌症研究中心中央醫院（位於東京中央區），內視鏡科科長齋藤豐（51歲）和醫生山田真善（39歲）説出的這句話成為了一切的開端。NEC醫療解決方案事業部高級經理上條憲一（55歲）則決定遊説自己公司的技術團隊進行開發。此後2年多，雙方通過聯合研究，開發出了可實時發現大腸癌和癌症前一階段病變的內視鏡診斷輔助系統，並力爭在2019年度將其推向實際應用。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp; &nbsp;&nbsp;</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0202-13-L.jpg" style="width: 600px; height: 457px;" /></p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#000000;">通過人工智慧發現癌症的系統的開發者、NEC的今岡(左)和上條（川崎市）</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">NEC在利用人工智慧（AI）來區分特定的人物的人臉識別技術上的精準度達到99％以上。上條憲一邀請與其一同開展技術開發工作的是此前共事過的日本臉部識別領域的頭號專家、日本數據科學研究所首席研究員今岡仁（47歲）。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;&nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">人臉部的眼睛、鼻子和嘴等的位置是固定的。但是，癌症卻難以把握特徵。今岡起初一直有一個念頭，那就是「如果不行，就果斷拒絕」。不過，他卻堅持嘗試著利用典型病變的圖像、通過人體組織紋理來發現癌症的計算方法。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">結果，「癌症的特徵看起來正逐漸顯現」（山田）。另一方面，今岡認為如果利用臉部識別的經驗，性能將進一步提高。他讓人工智慧學習了5000例內視鏡圖像，反覆進行試驗。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">一方面，對開發中的診斷系統追求「熟練醫生般性能」的山田不斷指出問題。雖然這讓今岡感覺「試驗一直在被要求修正」，但他並沒有打退堂鼓。在不斷努力下，早期癌症和癌前病變的發現率提高到了98％。這相當於已經能夠通過開發的系統識別「癌症的面孔」。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">日本産業技術綜合研究所（茨城縣筑波市）的人工智慧研究中心主任研究員野裏博和（42歲）表示，與一般的臉部識別相比，雖然癌症診斷輔助系統在人工智慧和圖像識別的組合方面沒有什麼區別，但結果是「逆向思維起到了幫助」。胃癌的診斷輔助系統並非找出異常，而是發現正常組織，將除此以外視為異常。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">讓野裏受到鼓舞的是病理醫生的一句話。這位平時診斷是否患癌的病理醫生説「我們也在診斷正常症狀」。野裏曾希望成為一名臨床檢驗醫師。他發揮當時的人脈，經常跑去東邦大學醫療中心佐倉醫院（位於千葉縣佐倉市），並在此過程中受到了啟發。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">正常組織的圖像也會有色差等，並非完全一樣。通過改進計算方法，不斷讓病理醫生看到成果，然後獲得新圖像，這樣的開發持續了約7年。今後將與企業合作，力爭推向實用化。野裏未能成為檢驗醫師，但貫徹了「為醫療作出貢獻」的初衷。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 14px;">文章來自: NIKKEI</span></p>  <p><a href="https://zh.cn.nikkei.com/industry/scienceatechnology/29137-2018-02-12-05-00-20.html" target="_blank"><span style="color:#000080;"><span style="font-size: 14px;">https://zh.cn.nikkei.com/industry/scienceatechnology/29137-2018-02-12-05-00-20.html</span></span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180224]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%822%e8%87%89%e9%83%a8%e8%ad%98%e5%88%a5%e6%8a%80%e8%a1%93%e7%99%bc%e7%8f%be%e7%99%8c%e7%97%87/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%822%e8%87%89%e9%83%a8%e8%ad%98%e5%88%a5%e6%8a%80%e8%a1%93%e7%99%bc%e7%8f%be%e7%99%8c%e7%97%87]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[48]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180224]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7202]]></id>
		<title><![CDATA[日本癌症治療（3）新創企業顯活力]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>日本癌症治療（3）新創企業顯活力</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">日本的藥品開發新創企業Cordia Therapeutics的社長三宅洋（47歲）忙於新的癌症治療候選藥物的數據整理，從年初以來就一直在神奈川縣藤澤市的辦公室裏埋頭工作。通過在細胞內傳遞遺傳信息的分子的多餘部分被切除的反應方式，使癌細胞死亡。這一技術最早將在2018年夏季開始臨床試驗。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0205-01-L.jpg" style="width: 600px; height: 457px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><span style="font-size:14px;">為開發抗癌藥物而對蛋白質進行分析（神奈川縣藤澤市Cordia Therapeutics）</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;三宅洋和同事等6人曾在日本武田藥品工業從事藥品開發，2017年11月創建了Cordia，當月月底就成功融資12億日元。進行注資的包括武田藥品、京都大學Innovation Capital公司和2家日本銀行的風險資本。三宅洋幹勁十足地表示，「準備開展大型企業做不到的研究」。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;在2016年7月武田藥品決定將癌症藥品研發部門集中到美國時，三宅洋就已經在關注與遺傳信息相關的候選新藥。武田藥品也人認為這些候選物質大有前景，通過向已經離開公司的三宅洋等人提供資金支持的方式來謀求繼續研發。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">癌症治療業務以往多是大型企業在開展，但近年來出現了很多新創企業的身影。在製藥方面，需要不斷地從數以十萬計的候選物質中篩選，探究針對不同病變如何進行作用才會産生突破性成果。這種工作的成功概率幾乎和彩票中大獎一樣低。通過個人的鑒別也可能發掘出很有效果的物質和治療方法，探究水平的優劣並不受企業規模影響。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">「也許會有人覺得這是魯莽的挑戰，但我們將朝著最終目標盡最大的努力」，1月19日，日本電商樂天的社長三木谷浩史（52歲）作為美國醫療新創企業Aspyrian Therapeutics的會長而做出上述發言。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Aspyrian正在將美國國立衛生研究院主任研究員小林久隆（56歲）開發的癌症「光免疫療法」進行商業化。三木谷浩史為治療父親的胰腺癌而在世界各地奔走，他在5年前遇到小林久隆，由於這一緣分而主動擔任會長。樂天也決定向Aspyrian出資。該公司的療法除了美國藥事管理部門優先審查外，在日本也決定進行臨床試驗。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">源自新創企業的大型癌症療法接連問世，拯救了許多生命。不過，出資方往往急於看到結果。「如果只追求收益的話，不如去搞房地産」，從事藥品開發支持的iPS Portal社長村山升作（68歲）説得非常中肯。藥品開發新創企業有時會展現出超越大型藥企的創新能力。培育者是否具有長遠眼光將受到考驗。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif; font-size: 14px;">文章來自: NIKKEI</span></p>  <p><a href="https://zh.cn.nikkei.com/industry/scienceatechnology/29141-2018-02-13-05-04-20.html" target="_blank"><span style="color:#000080;"><span style="font-family: Verdana, Geneva, sans-serif; font-size: 14px;">https://zh.cn.nikkei.com/industry/scienceatechnology/29141-2018-02-13-05-04-20.html</span></span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180224]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%ef%bc%883%ef%bc%89%e6%96%b0%e5%89%b5%e4%bc%81%e6%a5%ad%e9%a1%af%e6%b4%bb%e5%8a%9b/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%ef%bc%883%ef%bc%89%e6%96%b0%e5%89%b5%e4%bc%81%e6%a5%ad%e9%a1%af%e6%b4%bb%e5%8a%9b]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[49]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180224]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7203]]></id>
		<title><![CDATA[日本癌症治療（4）讓患者繼續工作]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>日本癌症治療（4）讓患者繼續工作</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">「只靠醫生和患者努力是不夠的。如果企業不做出改變，社會還是老樣子」， 日本保險公司LifeNet Insurance社長岩瀨大輔（41歲）在2017年夏季被NPO法人Florence代表理事駒崎弘樹（38歲）的上述講話所打動。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">岩瀨在2017年10月主動擔任代表發起人，成立了匯總幫助患者的措施和煩惱的團體「癌ally部」。「ally」意為朋友、夥伴。團體的名字蘊涵了「宣告與在職患者做朋友，希望像社團活動一樣愉快參與」的願望。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0205-02-L.jpg" style="width: 600px; height: 419px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><span style="font-size:14px;">各家公司的人事負責人在癌ally部討論如何為治療癌症的員工提供支持（1月29日）</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">癌ally部的首次討論會共有約50人參加，包括41家公司的人事負責人等。在1月29日的第2次討論會上，設想員工因癌症而停職，討論了企業如何應對。一位在外資企業人事部工作的女性（35歲）非常認真地聽取討論，她表示，「最近有同事因為治療乳腺癌而離職。不知道該制定怎樣的支援制度，希望與各公司共同分擔這一難題」。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">日本金融服務企業Credit Saison率先採取舉措，對於因癌症而停職一個月以上的員工，提供包括縮短工作時長、限制出差等在內的復職計劃。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp; &nbsp; </span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp;</span></span><span style="color: rgb(0, 0, 0); font-size: 16px;">一名女</span><span style="color:#000000;"><span style="font-size:16px;">員工（38歲）因治療乳腺癌而利用過這一制度，她感激地説：「可以安心治療，不用急於復職。不然的話即使勉強開始工作，也得麻煩同事費心照顧」。該公司戰略人事部則強調這一制度的意義稱，「不僅僅是留住優秀人才，治療後復職的人員工作熱情高，能積極給公司做貢獻」。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">「在10年前，患者的就業問題還沒有得到關注」，為癌症患者就業提供支援的一般社團法人CSR Project的代表櫻井Naomi（50歲）回憶説。櫻井也曾因患乳腺癌而被迫離職。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">對於患者的就業問題，經過櫻井等人的不斷呼籲，2012年日本政府終於在癌對策推進基本計劃中寫入了就業支援。同時，在勞動方式改革的推動下，建立支援制度的企業迅速增加。根據櫻井等人的調查，確診後希望繼續就業卻被解聘或離職、換工作的患者在2006年佔到39%，到2016年則減少到24%。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">企業的應對也在不斷改變。不過櫻井仍在繼續追問，「是否已經形成可在萬一情況下採用的靈活制度」、「對中小企業和個體經營者的支持也很薄弱，應當摒棄&lsquo;癌症患者不能工作&rsquo;的觀念」。櫻井等人推動政府和企業採取行動、在患者和企業間架起橋樑的工作沒有結束。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif; font-size: 14px;">文章來自: NIKKEI</span></p>  <p><a href="https://zh.cn.nikkei.com/industry/scienceatechnology/29158-2018-02-14-05-05-20.html" target="_blank"><span style="color:#000080;"><span style="font-family: Verdana, Geneva, sans-serif; font-size: 14px;">https://zh.cn.nikkei.com/industry/scienceatechnology/29158-2018-02-14-05-05-20.html</span></span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180224]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%ef%bc%884%ef%bc%89%e8%ae%93%e6%82%a3%e8%80%85%e7%b9%bc%e7%ba%8c%e5%b7%a5%e4%bd%9c/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%97%a5%e6%9c%ac%e7%99%8c%e7%97%87%e6%b2%bb%e7%99%82%ef%bc%884%ef%bc%89%e8%ae%93%e6%82%a3%e8%80%85%e7%b9%bc%e7%ba%8c%e5%b7%a5%e4%bd%9c]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[50]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180224]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7204]]></id>
		<title><![CDATA[早期乳癌的治療]]></title>
		<content><![CDATA[<div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;"><strong style="line-height: 24px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 36px; font-size: 24px;">早期乳癌的治療</span></strong></span></span><br style="line-height: 19.5px;" /> &nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(105, 105, 105);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-size: 14px;"><img alt="" src="http://www.cancerinformation.com.hkhttp://www.cancerinformation.com.hk/ufiles/Image/her22(1)(1).jpg" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; width: 640px; height: 288px;" /></span></span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif; text-align: center;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">早期乳癌泛指腫瘤可以手術切除 (一般包括第 1-3 期)，故手術是治療早期乳癌的關鍵元素，而術前及術後的輔助治療均可為妳帶來潛在益處。</span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;"><strong style="line-height: 24px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 30px; font-size: 20px;">術前輔助治療</span></strong></span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><br style="line-height: 19.5px;" /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">又稱術前治療，即手術前給予的治療，可能包括化療、標靶藥物或荷爾蒙治療。</span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><br style="line-height: 19.5px;" /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;"><strong style="line-height: 24px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 30px; font-size: 20px;">早期乳癌的患者可選擇先接受術前治療，</span></strong></span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;"><strong style="line-height: 24px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 30px; font-size: 20px;">術前治療的潛在益處可能包括：</span></strong></span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><br style="line-height: 19.5px;" /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">&bull;&nbsp;在手術前縮小腫瘤甚至清除癌細胞</span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><br style="line-height: 19.5px;" /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">&bull;&nbsp;將無法以手術切除的腫瘤轉變為可以接受手術</span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><br style="line-height: 19.5px;" /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">&bull;&nbsp;將原本需要進行大範圍切除的手術範圍縮小，以達到保留乳房的目的</span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;"><strong style="line-height: 24px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 30px; font-size: 20px;">術後輔助治療</span></strong></span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><br style="line-height: 19.5px;" /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">即手術後給予的治療，可能包括化療、標靶藥物、放射治療或荷爾蒙治療。目的在於消滅手術後在身體可能殘留的癌細胞，以降低復發或擴散的可能性。</span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">如有興趣了解更多關於乳癌的資訊，</span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">請</span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 0);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">參閱：<a href="http://her2morrow.com.hk/" target="_blank">http://her2morrow.com.hk/</a></span></span></div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;">&nbsp;</div>  <div style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(105, 105, 105);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 24px; font-size: 16px;">安全報告免責聲明<br style="line-height: 24px;" /> 此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，請向您的醫生或藥劑師諮詢和報告。<br style="line-height: 24px;" /> 以上健康教育資訊由羅氏大藥廠香港有限公司提供 (NPM-HK-0074-11-2017)</span></span></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180227]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%97%a9%e6%9c%9f%e4%b9%b3%e7%99%8c%e7%9a%84%e6%b2%bb%e7%99%82/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%97%a9%e6%9c%9f%e4%b9%b3%e7%99%8c%e7%9a%84%e6%b2%bb%e7%99%82]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[51]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180227]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7205]]></id>
		<title><![CDATA[亞洲首張抗癌保單 國壽開賣]]></title>
		<content><![CDATA[<h1 id="h1" style="border: 0px none; margin: 0px; outline: none 0px; padding: 15px 10px; font-family: &quot;Microsoft Yahei&quot;, sans-serif; font-weight: bold; line-height: 1.3em; color: rgb(255, 255, 255); font-size: 26px;"><span style="font-size:36px;"><span style="color:#000000;"><strong>亞洲首張抗癌保單 國壽開賣</strong></span></span></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><strong><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/a39a00_t_01_02.jpg" style="width: 640px; height: 818px;" /></strong></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-family: &quot;Microsoft JhengHei&quot;, sans-serif; font-size: 18px;">首年手術支付日額3倍 　國內重大傷病領卡情況</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div class="article_info clear-fix" style="border: 0px none; margin: -4px 0px 10px; outline: none 0px; padding: 0px 20px 0px 0px; zoom: 1; font-size: 15px; color: rgb(102, 102, 102); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">&nbsp;</div>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:16px;"><span style="color:#000000;">全亞洲首張確定罹患癌症後還能投保的健康險（俗稱醫療險）問世。國泰人壽1日宣布，開賣首張癌後醫療專屬保單，提供已確定罹癌者住院及手術保障，估計可造福國內逾43萬名癌友，走過漫漫抗癌路。</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:16px;"><span style="color:#000000;">根據衛福部國民健康署所公布的2015年癌症登記年報顯示，2015年新發生癌症人數為10萬5,156人，比2014年增加2,009人，罹癌人數持續創新高；癌症時鐘已經加快到平均每隔五分鐘就有一人罹癌，但國壽表示，因為醫療科技的進步，罹癌之後的存活期間愈來愈長，已經逐漸成為「慢性病」，但是罹癌後一般是無法投保健康險，醫療保障相對欠缺。</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:16px;"><span style="color:#000000;">為照顧到這些已確定罹癌或罹癌後已逐漸康復的國人，國壽推出亞洲、甚至可能是全球首張罹癌後可投保的健康險，即「弱體保單」，提供手術醫療理賠金、住院日額理賠等保障，最高可投保日額2千元，投保首年若有手術即可支付日額三倍，門診手術一倍的理賠金，保單滿一周年後，住院即有日額理賠，加護病房則是兩倍。</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:16px;"><span style="color:#000000;">國壽舉例，如乳癌零期或第一期的患者，五年存活率達97％及95％，但一般只要確定罹癌就無法再投保健康險，未來若因其他疾病開刀或住院，即無法有相關保險保障，因此決定針對罹癌族群提供專屬醫療險保障。</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:16px;"><span style="color:#000000;">同時，國壽也統計，如乳癌患者平均每年住院天數是47.9天，另外肺癌約11天，胃癌約15天，若能有住院日額保障，即可減輕經濟負擔，或提升住院品質；另外也有不少癌症患者經治療後痊癒，之後還是可能面臨其他醫療保障需求。</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:16px;"><span style="color:#000000;">國壽這張癌後專屬醫療險會比一般健康保戶的保費略高，但重點是國內目前唯一確定罹癌後還能投保的健康險，但保戶必須確定除罹癌以外，並沒有癱瘓、肝硬化（非肝癌患者）、中風、帕金森氏症、心衰竭等，以控管承保風險。</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:16px;"><span style="color:#000000;">這張保單如40歲女性剛確定罹患癌症或二、三年前罹患癌症，都可以投保，日額1千元、繳費20年期來看，一年保費約1.7萬元，男性則約2萬元，投保30天後即享有手術保險金，一次為日額三倍，即3千元，一年後有每次住院日額1千元的保障。</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><span style="font-size:14px;"><span style="color:#696969;">文章來自: (工商時報)</span></span></p>  <p style="border: 0px none; margin: 0px 0px 30px; outline: none 0px; padding: 0px; font-size: 18px; line-height: 1.7; color: rgb(0, 0, 0); font-family: &quot;Microsoft JhengHei&quot;, sans-serif;"><a href="http://www.chinatimes.com/newspapers/20180302000464-260208" target="_blank"><span style="color:#000080;">http://www.chinatimes.com/newspapers/20180302000464-260208</span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180303]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%ba%9e%e6%b4%b2%e9%a6%96%e5%bc%b5%e6%8a%97%e7%99%8c%e4%bf%9d%e5%96%ae-%e5%9c%8b%e5%a3%bd%e9%96%8b%e8%b3%a3/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>保險]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%ba%9e%e6%b4%b2%e9%a6%96%e5%bc%b5%e6%8a%97%e7%99%8c%e4%bf%9d%e5%96%ae-%e5%9c%8b%e5%a3%bd%e9%96%8b%e8%b3%a3]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[52]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180303]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7206]]></id>
		<title><![CDATA[營養師及護理師響應捐髮 造福癌友]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;"><span style="font-family: Arial, Helvetica, sans-serif;">營養師及護理師響應捐髮 造福癌友</span></span></strong></span></p>  <p>&nbsp;</p>  <div class="pic_750" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; text-align: center; color: rgb(0, 0, 0); font-size: 18px;"> <div class="pic_750_inner" style="margin: 15px 0px; padding: 10px; border: 1px solid rgb(218, 218, 218); outline: 0px; font-style: inherit; font-family: inherit; display: inline-block;"><span style="color:#000000;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/32773867.jpg" style="width: 640px; height: 427px;" /></span><span style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-family: inherit; font-size: 14px; display: block; caption-side: bottom; text-align: left;"><span style="color: rgb(105, 105, 105); font-family: inherit; font-style: inherit; text-align: center;">衛生福利部台中醫院營養室主任盧靜詩經常接觸癌症患者，感受癌友為落髮所苦，於是加入捐髮行列，將一頭長髮剪掉，造福癌症病友。（台中醫院提供）中央社記者郝雪卿傳真　107年3月2日</span></span></div> </div>  <p style="margin: 10px 0px 15px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; width: 760px; color: rgb(66, 66, 66); font-size: 18px; line-height: 30px;">&nbsp;</p>  <p style="margin: 10px 0px 15px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; width: 760px; color: rgb(66, 66, 66); font-size: 18px; line-height: 30px;"><span style="color:#000000;">（中央社記者郝雪卿台中2日電）衛生福利部台中醫院營養室主任盧靜詩與護理科主任林紹雯經常接觸癌症患者，感受癌友為落髮所苦，兩人加入捐髮行列，累計捐髮長度逾210公分，造福很多癌症病友。<br /> <br /> 盧靜詩在擔任營養師期間，因為接觸癌症病患，聽到病患為落髮所苦，一向只留長髮的她，鼓起勇氣將頭髮捐出，改以短髮造型示人。林紹雯也因工作接觸癌友而加入捐髮行列，兩人捐髮長度累計超過210公分，而且還帶動院內捐髮風氣。<br /> <br /> 盧靜詩表示，在台中醫院工作時，因為參與腫瘤照護團隊，接觸了許多癌症病友，每次會談時，總聽到癌症病友分享心情，談到落髮之苦更是潸然淚下，她除了幫病友提供營養諮詢之外，更默默思考自己可以多做些什麼，剛好看到捐髮的新聞，便決定效法，默默將頭髮留到超過腰部，捐出長達36公分的頭髮，改以清爽短髮亮相，其他醫院同事也被感動，加入捐髮行列。</span><br /> <br /> <span style="color:#000000;">林紹雯指出，因為護理工作接觸安寧病房，看到癌症病患分享心情點滴，總想著自己除了護理專業上的協助外，是否還能為癌友多做一些事情，後來發現捐髮是可行的，很開心自己做到了。<br /> <br /> 兩人的捐髮義行獲得院內同事的響應，營養師林淑湄說，聽聞院內同事捐髮的消息，覺得捐髮是個相當有意義的活動，也開始留起長頭髮，並鼓勵女兒加入捐髮行列，這些年來與女兒一起捐髮累計3次，每次都捐30公分以上。<br /> <br /> 對於捐髮，她們異口同聲表示，一頂真髮做成的假髮就要新台幣1萬多元，若能捐出自己的長髮，就能夠幫助癌症病友省錢，又能改變外觀與心情，除了助人，也讓自己變得更快樂，今後她們還會繼續努力蓄髮，分享美麗。(編輯:孫承武)1070302</span></p>  <p style="margin: 10px 0px 15px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; width: 760px; color: rgb(66, 66, 66); font-size: 18px; line-height: 30px;">&nbsp;</p>  <p style="margin: 10px 0px 15px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; width: 760px; color: rgb(66, 66, 66); font-size: 18px; line-height: 30px;">&nbsp;</p>  <p style="margin: 10px 0px 15px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; width: 760px; color: rgb(66, 66, 66); font-size: 18px; line-height: 30px;"><span style="font-size:14px;"><span style="color:#696969;">文章來自:&nbsp; 中央通訊社&nbsp;</span></span> &nbsp; &nbsp; &nbsp; &nbsp;</p>  <p style="margin: 10px 0px 15px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; width: 760px; color: rgb(66, 66, 66); font-size: 18px; line-height: 30px;"><span style="font-size:14px;"><a href="http://www.cna.com.tw/news/aloc/201803020161-1.aspx" target="_blank"><span style="color:#000080;">http://www.cna.com.tw/news/aloc/201803020161-1.aspx</span></a></span></p>  <p><span style="color: rgb(105, 105, 105); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 14px;">衛生福利部台中醫院營養室主任盧靜詩經常接觸癌症患者，感受癌友為落髮所苦，於是加入捐髮行列，將一頭長髮剪掉，造福癌症病友。（台中醫院提供）中央社記者郝雪卿傳真　107年3月2日</span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180303]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%87%9f%e9%a4%8a%e5%b8%ab%e5%8f%8a%e8%ad%b7%e7%90%86%e5%b8%ab%e9%9f%bf%e6%87%89%e6%8d%90%e9%ab%ae-%e9%80%a0%e7%a6%8f%e7%99%8c%e5%8f%8b/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>同行者之歌]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%87%9f%e9%a4%8a%e5%b8%ab%e5%8f%8a%e8%ad%b7%e7%90%86%e5%b8%ab%e9%9f%bf%e6%87%89%e6%8d%90%e9%ab%ae-%e9%80%a0%e7%a6%8f%e7%99%8c%e5%8f%8b]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[53]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180303]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7207]]></id>
		<title><![CDATA[免疫檢查點療法 抗癌新利器 / Cancer “vaccine” makes tumours vanish / Injection helps the immune system obliterate tumors, at least in mice]]></title>
		<content><![CDATA[<h2 style="margin: 0px; padding: 0px 135px 0px 0px; color: rgb(34, 34, 34); letter-spacing: 1px; font-family: &quot;Microsoft YaHei&quot;, 微软雅黑体, &quot;Microsoft JhengHei&quot;, 微軟正黑體, Arial, Helvetica, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 32px; line-height: 1.3; text-align: justify;"><span style="color:#000000;">免疫檢查點療法 抗癌新利器</span></h2>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">今年1月31日，史丹福大學醫學院(Stanford University School of Medicine)，免疫治療權威羅納&bull;利維(Ronald Levy)教授與其研發團隊在國際重量級期刊《Science Translation Medicine》發表了一種革命性的新型免疫檢查點治療方式。這種新方式只需「局部、單次、低劑量」的投以免疫檢查點藥物，即可治癒多種不同類型的小鼠腫瘤，更成功讓小鼠對腫瘤產生全身性的免疫治療效果。鑑於此療法在動物實驗取得的驚人成效，史丹佛大學目前已著手進行臨床試驗準備，預計前期將招收15位淋巴癌病患進行人體實驗，並視實驗進展再擴及到其他腫瘤治療。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">羅納教授所使用的是「OX40抗體」與「CpG DNA」兩種藥物的複合配方(後簡稱-復合藥物)。其中OX40蛋白是T細胞上一個重要的免疫檢查點蛋白，與目前主流的PD1/PDL1抑制藥物不同，OX40蛋白對免疫系統像是油門開關，而抗體藥物與OX40的結合將打開此開關，進而活化CD4與CD8-T細胞的功能。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">CpG DNA是細菌體內常見的未甲基化特殊DNA序列，主要與TLR9接受器結合並活化多種免疫細胞，CpG DNA過去即被證明在腫瘤治療上具顯著療效，然而由於藥物無法專一性運送至病灶，而系統性注射又容易導致副作用過強等問題，因此CpG DNA過去大多被當成疫苗佐劑使用。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">在90隻接受復合藥物治療的淋巴癌小鼠上，有87隻小鼠腫瘤如奇蹟般地消失，更驚人的是，當他們將複合藥物直接注射於單一腫瘤位置後，小鼠身上不同位置的同源腫瘤也會同樣完全消失。這證明此療法具如疫苗般的全身性效果，有很大機會用於轉移性癌症治療。除此之外，羅納教授更進一步在乳腺癌，結腸癌，黑色素癌小鼠模式上進行測試，也都看到類似的治療效果。這暗示此復合藥物可能是能用於各種癌症治療的革命性療法。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">2月2日，默沙東大藥廠公布2017年財報，其主力產品KEYTRUDA去年銷售成長172%，狂賣近40億美元，而其對手藥物-必治妥大藥廠的OPDIVO，銷售也成長30%達49.5億美元。免疫檢查點藥物無疑已成為當前腫瘤治療最耀眼的明星，然而明星光環下，藥物應答率的不彰與昂貴的藥價，一直是免疫檢查點療法最大的瓶頸。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">以KEYTRUDA為例，平均藥物應答率只有20-30%，然而治療方式卻是每三周一次施打每單位體重(公斤)2毫克的劑量，一直投藥到腫瘤消失為止，其療程可能長達1年，而藥物總花費高達300萬-400萬台幣。反觀本文中的複合藥物，不僅在小鼠試驗中展現了驚人的96.6%的治癒率，且如疫苗般僅需「局部、單次、低劑量」的治療方式，大幅下修藥物需求與治療花費，同時也能有效避免高劑量、長期且持續性給予免疫檢查點單抗藥物所帶來的副作用。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">目前所有的免疫檢查點藥物療程與大部分的結合治療研究，都是沿用傳統癌症藥物的邏輯，以高劑量持續的全身性給藥方式。這種治療方式，對於生物體複雜的免疫系統或許不是最好的選擇。去年10月15日，在《Clinical Cancer Research》和《Cancer Immunology Research》上，同日發表的兩篇文章便發現，合併兩種免疫檢查點藥物治療時，兩藥分別投藥的時間將嚴重影響治療效果，一味持續性的給藥反有不利影響。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">本篇研究更進一步證明，真正成功的免疫治療應該是打帶跑(hit-and-run)，不需要長期且持續性的提供藥物刺激。只要搭配正確的藥物配方與施打方式，後續的長期治療由被活化的免疫細胞接手即可。雖然複合藥物在人體的療效仍待驗證，然已為未來免疫治療開啟了新的契機，藉由「局部、單次、低劑量」藥物治療，一次性的根治腫瘤將不是夢想。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">免疫檢查點療法從第一個藥物YERVOY被美國FDA核准上市後，短短幾年已有六個單抗藥物被核准上市，分別針對CTLA4、PD1與PDL1等標的，用於治療超過10種不同的癌症。近年中國國家食品藥品監管局也動作積極，繼去年底受理了信達生物製藥所生產之PD-1單抗藥物上市申請後，1月18日更快速批准了李氏大藥廠PD-L1單抗藥物之臨床批件。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">然而在各方積極追逐效價更高、結合力更強、效果更持久的各種免疫檢查點單抗藥物的同時，或許我們更應該靜心思考，免疫檢查點療法仍屬早期發展階段，許多相關的分子機制科學界仍是一知半解，我們很可能至今仍未弄清楚免疫檢查點藥物這項武器的正確使用方法。</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;"><span style="color:#000000;">（作者是鑽石生技投資分析室分析師）</span></p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <p style="margin: 20px 0px; color: rgb(68, 68, 68); font-family: Helvetica, &quot;Heiti TC&quot;, &quot;Segoe UI&quot;, Meiryo, 微軟正黑體; font-size: 18px; letter-spacing: 1px; text-align: justify;">&nbsp;</p>  <h1 class="page-title" style="box-sizing: inherit; font-size: 48px; margin: 20px 0px 0px; font-family: fortescue_proregular, Georgia, Times, &quot;Times New Roman&quot;, serif; color: rgb(55, 58, 60); word-wrap: break-word; width: 835px;"><strong><span style="color:#000000;"><span style="font-size:26px;">Cancer &ldquo;vaccine&rdquo; makes tumours vanish</span></span></strong></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><strong><span style="font-size:20px;"><span style="color:#000000;">A DNA-antibody combination banishes cancer in mouse models, with human trials about to start. Andrew Masterson reports.</span></span></strong></p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/180201-cancer-full.jpg" style="width: 640px; height: 427px;" /></span></span></p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;">A vaccine effective against a wide range of cancers is one step nearer.<br /> GOMBERT, SIGRID/GETTY IMAGES</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">A combination of a tiny segment of DNA and a specific antibody injected into a solid tumour has been shown to remove not only the target tumour, but also others in the body, at least in mice.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">So confident are they of the effectiveness of their approach, scientists at the Stanford University School of Medicine in the US are this month starting a clinical trial using human patients.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Like several other treatments, the combination therapy, reported in the journal Science Translational Medicine, prompts the body&rsquo;s own immune system to tackle tumours. However, unlike others, it functions as a one-size-fits-all strategy. To a significant extent, it seems, it is not necessary to first identify the type of cancer involved.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&ldquo;When we use these two agents together, we see the elimination of tumours all over the body,&rdquo; says oncologist Ronald Levy, one of the authors of the study.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&ldquo;This approach bypasses the need to identify tumour-specific immune targets and doesn&rsquo;t require wholesale activation of the immune system or customisation of a patient&rsquo;s immune cells.&rdquo;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">The Stanford team&rsquo;s strategy works by exploiting the curiously ambivalent relationship between cancer tumours and immune cells called T cells. The latter function to attack bodily invaders through detecting abnormal proteins.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Initially the T cells will recognise such proteins on the surface of cancer cells and enter the developing tumour. However, as the tumour continues to grow, T cell activity drops off. In a sense, the immune system gives up.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Levy and his colleagues found a way to reactivate the moribund T cells. To do this, they inject a target tumour with a couple of micrograms of a short stretch of DNA called a CpG oligonucleotide. This works with nearby immune cells to activate a receptor called OX40 on the surface of the T cells.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">CpG oligonucleotide is already used to bolster several types of cancer treatment.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">At this point, the second agent &ndash; an antibody that binds to OX40 &ndash; comes into action, revivifying T cells, but only those within the tumour. This is important, because the combination effectively generates a cohort of immune cells pre-programmed to attack only cancer-specific proteins.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Once the process is under way, the scientists report, the tumour-hungry T cells leave the initial site and distribute through the body, attacking any and all other similar tumours they find.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&ldquo;Our approach uses a one-time application of very small amounts of two agents to stimulate the immune cells only within the tumour itself,&rdquo; explains Levy.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&ldquo;In the mice, we saw amazing, body-wide effects, including the elimination of tumours all over the animal.&rdquo;</span></span></p>  <p><br /> <span style="color:#000000;"><span style="font-size:16px;">The therapy has been trialled against several different types of cancers in mice. The first trial involved 90 animals with lymphoma tumours on both sides of their bodies. In each, only one tumour was treated. The paper details that 87 out of the 90 were cured. The cancer returned in three cases, but went into permanent remission after a second treatment.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">Mice carrying breast, colon and melanoma tumours were also treated successfully. Trials were also conducted on mice genetically engineered to develop multiple breast cancers. In many cases treating the first tumour to appear prevented others arising.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">While the treatment is effective against a range of cancers, each application conditions T cells to fight only one. Tests on mice with two types of tumour found that only the type treated went into remission, leaving the other unaffected.</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&ldquo;This is a very targeted approach,&rdquo; Levy says. &ldquo;Only the tumour that shares the protein targets displayed by the treated site is affected. We&rsquo;re attacking specific targets without having to identify exactly what proteins the T-cells are recognising.&rdquo;</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">An initial human trial will get underway soon, with the researchers looking to recruit about 15 patients with low-grade lymphoma.</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h1 class="article__headline" style="box-sizing: inherit; font-size: 2rem; margin: 0px 0px 15px; font-family: &quot;Roboto Condensed&quot;, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><span style="color:#000000;"><strong><span style="font-size:26px;">Injection helps the immune system obliterate tumors, at least in mice</span></strong></span></h1>  <p class="byline byline--article" style="box-sizing: inherit; margin: 0px; width: 682px; font-weight: bold; color: rgb(102, 102, 102); font-size: 0.875rem; font-family: &quot;Roboto Condensed&quot;, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;">By&nbsp;<a href="http://www.sciencemag.org/author/mitch-leslie" style="box-sizing: inherit; background-color: transparent; color: rgb(55, 88, 138); text-decoration-line: none;">Mitch Leslie</a></p>  <p class="byline byline--article" style="box-sizing: inherit; margin: 0px; width: 682px; font-weight: bold; color: rgb(102, 102, 102); font-size: 0.875rem; font-family: &quot;Roboto Condensed&quot;, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;">&nbsp;</p>  <p class="byline byline--article" style="box-sizing: inherit; margin: 0px; width: 682px; font-weight: bold; color: rgb(102, 102, 102); font-size: 0.875rem; font-family: &quot;Roboto Condensed&quot;, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;">&nbsp;</p>  <div class="caption__text" style="box-sizing: inherit; display: inline; color: rgb(102, 102, 102); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; font-size: 14px;"> <p style="box-sizing: inherit; margin: 0px; width: 100%; display: inline; text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/immunothereapy_16x9.jpg" style="width: 640px; height: 360px;" /></p>  <p style="box-sizing: inherit; margin: 0px; width: 100%; display: inline; text-align: center;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 0px; width: 100%; display: inline; text-align: center;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Tumors are growing on each side of this mouse&rsquo;s body just behind its forelegs.&nbsp;</p> </div>  <p style="text-align: center;"><span class="credit" style="box-sizing: inherit; font-size: 0.6875rem; -webkit-box-flex: 1; flex: 1 1 25%; color: gray; text-align: right; text-transform: uppercase; margin: 0px; font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;">SAGIV-BARFI&nbsp;<i style="box-sizing: inherit;">ET AL</i>./<cite style="box-sizing: inherit;">SCIENCE TRANSLATIONAL MEDICINE</cite></span></p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">Our immune cells can destroy tumors, but sometimes they need a kick in the pants to do the job. A study in mice describes a new way to incite these attacks by injecting an immune-stimulating mixture directly into tumors. The shots trigger the animals&rsquo; immune system to eliminate not only the injected tumors, but also other tumors in their bodies.</span></span></p>  <p>&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">&ldquo;This is a very important study,&rdquo; says immunologist Keith Knutson of the Mayo Clinic in Jacksonville, Florida, who wasn&rsquo;t connected to the research. &ldquo;It provides a good pretext for going into humans.&rdquo;</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;"><span style="font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;">To bring the wrath of the immune system down on tumors, researchers have tried shooting them up with a variety of molecules and viruses. So far, however, almost every candidate they&rsquo;ve tested hasn&rsquo;t worked in people.</span></span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">Hoping to develop a more potent approach, medical oncologist Ron Levy of Stanford University in Palo Alto, California, and colleagues used mice to test the cancer-fighting capabilities of some 20 molecules, including several types of antibodies that activate immune cells. The researchers first induced tumors by inserting cancer cells just below the skin at two different locations on the animals&rsquo; abdomens. After tumors started growing at both sites, the scientists injected the molecules, alone or in combination, into one tumor in each mouse. They then tracked the responses of both tumors.</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <div class="article__body" style="box-sizing: inherit; width: 682px; overflow: hidden; word-wrap: break-word; min-width: 0%; font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; font-size: 16px;"> <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">A pair of molecules&mdash;a type of DNA snippet called CpG and an antibody against the immune cell protein OX40&mdash;produced the best results. &ldquo;On their own, they do almost nothing, but the combination is synergistic,&rdquo; Levy says. When the researchers injected the two molecules into mouse tumors,&nbsp;</span><a href="http://stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.aan4488" style="box-sizing: inherit; background-color: transparent; color: rgb(55, 88, 138); text-decoration-line: none; font-weight: bold;"><span style="color:#000000;">they disappeared in less than 10 days</span></a><span style="color:#000000;">. In less than 20 days, the noninjected tumors had also vanished, the team reports online today in&nbsp;<cite style="box-sizing: inherit;">Science Translational Medicine</cite>.</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">The two molecules rouse different immune cells. The DNA snippet stimulates dendritic cells, which help instigate counterattacks against tumors. OX40 functions as a throttle for T cells, another type of immune cell crucial for battling tumors, and the anti-OX40 antibodies rev up these cells.</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">Levy and his colleagues also tested the approach in a strain of mouse prone to breast tumors. If the animals harbored two tumors, injecting the mixture into one tumor curbed the growth of the second. Moreover, the combo prevented any new breast tumors from appearing.</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">&ldquo;We think that this particular combination will be very effective in patients,&rdquo; Levy says. He predicts that it could work against a variety of cancers. Because the combination destroys other tumors besides the injected one, it might eliminate metastases, or the secondary tumors that result when cancer spreads, he says.</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">&ldquo;The data is very impressive, particularly for the uninjected tumors,&rdquo; says cancer immunologist Drew Pardoll of the Bloomberg-Kimmel Institute for Cancer Immunotherapy in Baltimore, Maryland, who wasn&rsquo;t connected to the study. The researchers &ldquo;deserve a lot of credit&rdquo; for testing the approach in the mice that spontaneously develop breast tumors, he says, which more closely mimic how cancer arises in humans.</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;"><span style="font-size:16px;"><span style="color:#000000;">The big question is whether the approach works in people, as most rodent cancer therapies don&rsquo;t translate to humans. Levy and his colleagues are about to find out. They are launching a clinical trial to evaluate the safety of their approach and gauge its effectiveness in patients with lymphoma, a cancer of the lymphatic system.</span></span></p>  <p style="box-sizing: inherit; margin: 15px 0px; width: 682px;">&nbsp;</p>  <div>&nbsp;</div> </div>  <footer class="article__foot" style="box-sizing: inherit; width: 682px; overflow: hidden; word-wrap: break-word; min-width: 0%; font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; font-size: 16px;"> <p style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-size: 14px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; color: rgb(105, 105, 105);">文章來自:&nbsp;</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; color: rgb(105, 105, 105); outline: none; font-family: Helvetica, Arial, &quot;LiHei Pro&quot;, 新細明體, PMingLiU, sans-serif;">&nbsp; &nbsp;&nbsp;</span></span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-size: 14px; color: rgb(105, 105, 105);">(</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-size: 14px; color: rgb(105, 105, 105); outline: none; font-family: Helvetica, Arial, &quot;LiHei Pro&quot;, 新細明體, PMingLiU, sans-serif;"><a href="https://money.udn.com/" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; text-decoration-line: none; color: rgb(34, 34, 34); line-height: 21px; outline: none;">經濟日報</a>)&nbsp;&nbsp;</span><a href="https://money.udn.com/money/story/10162/2999947" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; text-decoration-line: none; color: inherit; line-height: 19.5px;" target="_blank"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 128);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-size: 14px;">https://money.udn.com/money/story/10162/2999947</span></span></a></p>  <p style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(0, 0, 128);"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-size: 14px;">(</span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; color: rgb(105, 105, 105); font-family: Helvetica, Arial, &quot;LiHei Pro&quot;, 新細明體, PMingLiU, sans-serif; font-size: 14px;">COSMOS)&nbsp;</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-family: Helvetica, Arial, &quot;LiHei Pro&quot;, 新細明體, PMingLiU, sans-serif; font-size: 14px;"><a href="https://cosmosmagazine.com/biology/cancer-vaccine-makes-tumours-vanish" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; text-decoration-line: none; color: inherit; line-height: 21px;" target="_blank"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; color: rgb(0, 0, 128);">https://cosmosmagazine.com/biology/cancer-vaccine-makes-tumours-vanish</span></a></span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;"><span style="color:#696969;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-family: Helvetica, Arial, &quot;LiHei Pro&quot;, 新細明體, PMingLiU, sans-serif; font-size: 14px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px;">(SCIENCE)&nbsp;</span></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px; font-family: Helvetica, Arial, &quot;LiHei Pro&quot;, 新細明體, PMingLiU, sans-serif; font-size: 14px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 21px;"><a href="http://www.sciencemag.org/news/2018/01/injection-helps-immune-system-obliterate-tumors-least-mice" target="_blank"><span style="color:#000080;">http://www.sciencemag.org/news/2018/01/injection-helps-immune-system-obliterate-tumors-least-mice</span></a></span></span></p>  <p style="border: 0px none; margin: 0px; padding: 0px; line-height: 19.5px; color: rgb(69, 69, 69); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p> </footer>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;">.</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180303]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%85%8d%e7%96%ab%e6%aa%a2%e6%9f%a5%e9%bb%9e%e7%99%82%e6%b3%95-%e6%8a%97%e7%99%8c%e6%96%b0%e5%88%a9%e5%99%a8-cancer-vaccine-makes-tumours-vanish-injection-helps-the-immune-syste/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>免疫療法]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%85%8d%e7%96%ab%e6%aa%a2%e6%9f%a5%e9%bb%9e%e7%99%82%e6%b3%95-%e6%8a%97%e7%99%8c%e6%96%b0%e5%88%a9%e5%99%a8-cancer-vaccine-makes-tumours-vanish-injection-helps-the-immune-syste]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[54]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180303]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7208]]></id>
		<title><![CDATA[老師患癌後無法負擔貴藥　望當局加快新藥審批]]></title>
		<content><![CDATA[<p><strong><span style="color:#000000;"><span style="font-size:26px;">老師患癌後無法負擔貴藥 望當局加快新藥審批</span></span></strong></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/KakaoTalk_20180301_155637112_1024.jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;">有團體呼籲醫管局應加快新藥審批程序，並降低申請關愛基金的門檻。</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);">不少人聞癌色變，有高學歷的54歲血癌患者因患癌失業2年受盡歧視，亦因未能負擔昂貴藥費被迫「食平藥」。有團體呼籲醫管局應加快新藥審批程序，並降低申請關愛基金的門檻。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);">今年54歲的血癌患者胡先生於14年確診急性骨髓白血病，透露雖曾有已註冊的新藥可治病，但因屬自費藥物，藥費每月需2萬元。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);">&nbsp;</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; background-color: rgb(250, 250, 250); text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/KakaoTalk_20180301_155551358_1024.jpg" style="width: 640px; height: 360px;" /></span></span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; background-color: rgb(250, 250, 250); text-align: center;"><span style="font-size:14px;"><span style="color:#696969;">胡老師患癌後無法負擔貴藥，望當局加快新藥審批。</span></span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; background-color: rgb(250, 250, 250); text-align: center;">&nbsp;</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="color:#000000;">他曾任德育及公民教育老師，擁碩士學位，是家庭經濟支柱，但自患癌後家庭經濟出現問題，坦言無法負擔貴藥，只能服食另一款有傷肝傷腎副作用的抗真菌藥物。他自言，每月家庭收入曾不足1萬元，現與太太租樓過活。</span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="color:#000000;">他說，患癌康復後曾在2年間找工作，寄多封求職信，但部分僱主甫聽說他患癌，便面色一變，沒人願聘請。直至上年11月，他終獲快餐店聘請為兼職，但因低技術工作手部出現勞損。他希望政府可加快引入新藥進安全網速度，並做好復康跟進工作。</span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="color:#000000;">港怡醫院營運總監邱家駿醫生表示，現時新藥即使在香港註冊，但部分可花幾年時間才可納入醫管局安全網；關愛基金或撒瑪利亞基金亦只資助10多種治療癌症藥物，認為醫管局應優化制度，加強引入新藥效率，並提高審批藥物透明度。</span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="color:#000000;">心血會主席何君寧舉例，以治標慢性骨髓白血病為例，某款標靶藥從納入醫管局業物名冊到納入安全網，花了超過15年，在此以前病人需每月自費2萬元。</span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="color:#000000;">癌症策略關注組負責人麥嘉欣指，政府於財案中預留5億元檢討病人藥費分擔機制是第一步，但政府應有新思維，改變癌症策略。他表示，癌症病人一般面對「三等」問題，即「等首次治療」、「等新藥」及「等錢」，認為政府應加快新藥審批程序，加強公私營合作，並降低申請關愛基金的門檻。</span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="color:#000000;">立法會議員張超雄指，現時庫房水浸，5億元撥款是太遲及太少，稱「癌病不揀人」，隨時讓患者傾家蕩產，認為政府「與其派錢，不如派藥」。</span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);">&nbsp;</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="color:#696969;"><span style="font-size:14px;">文章來自: Topick</span></span></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"><span style="font-size:14px;"><a href="https://topick.hket.com/article/2020761" target="_blank"><span style="color:#000080;">https://topick.hket.com/article/2020761</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180303]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%80%81%e5%b8%ab%e6%82%a3%e7%99%8c%e5%be%8c%e7%84%a1%e6%b3%95%e8%b2%a0%e6%93%94%e8%b2%b4%e8%97%a5%e3%80%80%e6%9c%9b%e7%95%b6%e5%b1%80%e5%8a%a0%e5%bf%ab%e6%96%b0%e8%97%a5%e5%af%a9%e6%89%b9/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%80%81%e5%b8%ab%e6%82%a3%e7%99%8c%e5%be%8c%e7%84%a1%e6%b3%95%e8%b2%a0%e6%93%94%e8%b2%b4%e8%97%a5%e3%80%80%e6%9c%9b%e7%95%b6%e5%b1%80%e5%8a%a0%e5%bf%ab%e6%96%b0%e8%97%a5%e5%af%a9%e6%89%b9]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[55]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180303]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7209]]></id>
		<title><![CDATA[【一直樂觀】女作家10度確診患癌 不敵病魔終年45歲]]></title>
		<content><![CDATA[<h1><strong><span style="font-size:26px;"><span style="color:#000000;">【一直樂觀】女作家10度確診患癌 不敵病魔終年45歲</span></span></strong>&nbsp;</h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><a href="/ufiles/files/%E3%80%90%E4%B8%80%E7%9B%B4%E6%A8%82%E8%A7%80%E3%80%91%E5%A5%B3%E4%BD%9C%E5%AE%B610%E5%BA%A6%E7%A2%BA%E8%A8%BA%E6%82%A3%E7%99%8C%20%E4%B8%8D%E6%95%B5%E7%97%85%E9%AD%94%E7%B5%82%E5%B9%B445%E6%AD%B2%20%20%E5%8D%B3%E6%99%82%E6%96%B0%E8%81%9E%20%20%E5%9C%8B%E9%9A%9B%20%2020180304%20(1).mp4"><iframe align="middle" allow="encrypted-media" allowfullscreen="" frameborder="1" gesture="media" height="480" scrolling="no" src="/ufiles/files/%E3%80%90%E4%B8%80%E7%9B%B4%E6%A8%82%E8%A7%80%E3%80%91%E5%A5%B3%E4%BD%9C%E5%AE%B610%E5%BA%A6%E7%A2%BA%E8%A8%BA%E6%82%A3%E7%99%8C%20%E4%B8%8D%E6%95%B5%E7%97%85%E9%AD%94%E7%B5%82%E5%B9%B445%E6%AD%B2%20%20%E5%8D%B3%E6%99%82%E6%96%B0%E8%81%9E%20%20%E5%9C%8B%E9%9A%9B%20%2020180304%20(1).mp4" width="680"></iframe></a></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p class="ArticleIntro">&nbsp;</p>  <p class="ArticleIntro"><span style="color:#000000;"><span style="font-size:16px;">愛爾蘭布雷（Bray）一名女作家因家族遺傳患上乳癌，她多次對抗病魔仍不果，先後十度確診患癌，她近日抗癌近11年後終不敵病魔離開人世，終年僅45歲。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">漢尼根（Emma Hanningan）2005年被診斷出帶有「BRCA1」基因，意味著她患上乳癌及卵巢癌的風險，比其他女性分別高出85%及50%，她決定做手術切除雙乳及兩邊卵巢，希望阻截癌魔，翌年仍不幸地確診患上乳癌。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">她隨後接受輻射療程數月後，醫生曾稱她病情已受控，但可惜病情隨後仍多次復發，令她先後十度確診患癌。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">她2014年受訪時稱，她臥病在床時才發現到自己的寫作天份，令她能天馬行空地創造屬於自己的世界及人物。她當時更說：「癌魔並非每次都贏，我就是個活生生的證明。它入侵我的身體，但我永遠不會容許它入侵我的腦海。我不會在深宵徹夜想著我的死亡。癌症不能定義我。」她亦透露親友及醫療團隊一直在背後支持她，有助她保持樂觀心態。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">漢尼根今年1月在網上坦承已步入生命最後時光，但她仍流露著不屈不撓的正面態度，指如今她感受到愛比一切更重要。她更隨即幫慈善機構公開籌募協助乳癌病人的費用，最終在兩周內籌得10萬歐元（96萬港元）。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">該慈善機構「Breast Cancer Ireland」上周六在社交網站上宣佈漢尼根離世的消息，不少人留言悼念，她的出版社更承諾將她最新著作《給我女兒們的信》（Letters to My Daughters）的盈利全數捐至慈善機構。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>文章來自: 英國《每日郵報》&nbsp;<img src="https://staticlayout.appledaily.hk/web_images/layout/art_end.gif" /></p>  <p><a href="https://hk.news.appledaily.com/international/realtime/article/20180304/57901857" target="_blank"><span style="color:#0000FF;">https://hk.news.appledaily.com/international/realtime/article/20180304/57901857</span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180305]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e3%80%90%e4%b8%80%e7%9b%b4%e6%a8%82%e8%a7%80%e3%80%91%e5%a5%b3%e4%bd%9c%e5%ae%b610%e5%ba%a6%e7%a2%ba%e8%a8%ba%e6%82%a3%e7%99%8c-%e4%b8%8d%e6%95%b5%e7%97%85%e9%ad%94%e7%b5%82%e5%b9%b445%e6%ad%b2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>病患個案]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e3%80%90%e4%b8%80%e7%9b%b4%e6%a8%82%e8%a7%80%e3%80%91%e5%a5%b3%e4%bd%9c%e5%ae%b610%e5%ba%a6%e7%a2%ba%e8%a8%ba%e6%82%a3%e7%99%8c-%e4%b8%8d%e6%95%b5%e7%97%85%e9%ad%94%e7%b5%82%e5%b9%b445%e6%ad%b2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[56]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180305]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7210]]></id>
		<title><![CDATA[身體數據庫補足最後一哩！AI智慧醫療崛起]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>身體數據庫補足最後一哩！AI智慧醫療崛起</strong></span></span></p>  <p><span style="font-size:12px;"><a class="author" href="https://www.bnext.com.tw/author/1921" style="box-sizing: border-box; color: black; text-decoration-line: none; font-family: &quot;Roboto Condensed&quot;, fantasy, 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 16px;"><span style="color:#696969;">張殿文&nbsp;</span></a><span style="color:#696969;"><span class="item" style="box-sizing: border-box; margin-left: 15px; font-family: &quot;Roboto Condensed&quot;, fantasy, 微軟正黑體, Arial, Helvetica, sans-serif;">2018.03.01</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(24).jpg" style="width: 640px; height: 424px;" /></p>  <p style="text-align: center;"><span style="color:#696969;">隨著人體數據庫資料越來越完善，下一個要起飛的人工智慧應用領域就在：醫療。</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">去年底，蘋果營運長威廉斯（Jeff Williams）來台參加台積電30週年紀念會，指出醫療生技將是蘋果未來十年大計，因感測元件的技術突破，讓Apple Watch成了智慧醫療先鋒。然而，這只是蘋果布局智慧醫療的一小部分，也僅是眾多跨足智慧醫療的科技巨頭其中一員。與其說智慧手錶是人工智慧的展現，不如說是人體數據成就了智慧手錶。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">近來，愈來愈多科學家和創業者相繼投入健康（Health）、人工智慧（AI）結合的新藍海「AIoH」，從基因編輯到感測晶片，瞄準人類各種病症變化。台大癌中心院長鄭安理認為，現今人工智慧高度發展，未來在醫療領域的應用也更加值得期待。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">MIT研究員張鋒指出，若是沒有數位科技的運算演進、精確顯示，有些醫學層面的突破相當困難，基因工程研究就是一例。現在，基因已經可以透過「編輯」，讓結構重新轉變，使得基因研究進入新階段。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">無獨有偶，台大分子生醫影像研究中心主任曾文毅就是用人工智慧的影像辨識技術，判讀人類1千億個神經元細胞的連結通路，並且偵測神經纖維的方向及長度，進而防止各種腦部病變。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:20px;"><strong>身體就是五感AI使用介面</strong></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">伴隨人工智慧的技術突破，舉凡人體最重要的五種接受器──眼、耳、鼻、舌、身，都可以透過智慧裝置感測，並把抽象的色、聲、香、味、觸，以具體數據呈現。像工研院開發的電子鼻，從受試者呼出的氣體中，是否含有較多的硫化物、胺類和短鏈脂肪酸，就可朝向尿毒症、肝硬化、肺炎、肺結核四種疾病判別。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">愛立信的趨勢研究顯示，身體就是使用者介面（Your Body is the User Interface）的應用趨勢，將在今年變得顯著且重要。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">首先，從人類的心跳開始。聯發科打造的全球第一款六合一智慧健康晶片，可蒐集光電容積脈搏波發出的生物信號，僅需約60秒即可測量六項生理數據，適用於早期診斷、預防中風及心臟疾病等等。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">其次，由睡眠呼吸切入。為了解決現代人長期睡眠品質不好的問題，大立光結合哈佛醫學院動態生醫指標研究中心ECG技術，成立大立雲康，利用演算法加上心率監測睡眠，在家裡就可進行偵測。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">再來，從皮膚開始著手。史丹佛大學團隊發明皮膚癌AI診斷軟體，經過近13萬次測試，結果與21位臨床醫生的專業判斷幾無差異。因影像資料愈來愈多，機器學習技術又不斷進化，提升了圖像辨識準確度。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">最後，是最複雜的腦波。由台北科技大學、北醫大共同成立的智慧大腦科技中心，專注發展腦機介面技術，協助漸凍人與外界溝通，未來將結合認知神經科學研究與自駕車科技，期望能降低交通事故發生率。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><strong><span style="font-size:20px;">醫療AI的發展比想像快很多</span></strong></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">前Google人工智慧負責人吳恩達表示：「過去AI主要是在資訊技術的領域發揮，未來將會跨越到更多領域應用！」其中，在健康AI上的最新突破，就是利用深度學習方法診斷肺炎，他所發現的演算法可以診斷14種病症，比放射科專家單獨診斷的準確率更高。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">李開復則認為，AI的「中期發展」就是應用在醫療產業上。醫療科技之所以排在金融科技後，主要是金融數據的產生和模式沒有阻礙，而醫療領域在這方面還有段路要走。但智慧醫療AI的發展，仍會比家居、汽車更快進入成熟期，因有許多診療服務可用AI替代。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">吳恩達和李開復，正是鴻海布局AI的前鋒。不久前，郭台銘在臨時股東會上，意外透露「下一張網」的計畫。他說：「我們的第二張網，就是醫療互聯網！」</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">健康AI，儼然已成為科技產業最重要的出口。醫療產業是鴻海集團的M次集團所主導，過去鴻海從「3C」到「6C」，從來沒有出現過「M」這個字母，或許一年前，郭台銘都還不確定「醫療物聯網」會這麼重要，將成為全球最大電子製造商的下一張藍圖。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">事實上，「網路」結合「醫療」的概念不新，而且阿里巴巴併購了200家診所，還是不得其門而入，但郭台銘敢說醫療是鴻海世代計畫的「第二張網」，說明鴻海已感受到全球科技巨頭的「連動」。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="font-size:20px;"><span style="color:#000000;">身體數據庫補足AI最後一哩</span></span></strong></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">台北醫大管理學院院長謝邦昌指出，身體發出的信號和診斷紀錄，被台灣的健保制度完整保存下來，「台灣健保」因而成為台灣產業發展下一步的重要利器。面對人口變化，基因科學進步，全民健保這個大數據庫，正好補上醫事在人工智慧的最後一哩。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">在全球的醫療數位發展過程之中，原本領先的大廠如IBM、奇異等等，因為大數據時代來臨而重新洗牌，微軟、Google、蘋果等在網路時代急起直追。進入AI時代，大數據庫更加重要，也難怪有人描述，IBM的華生系統雖然在美中最先進的醫療中心布局，但最後還是要與台灣合作，才有用武之地。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">健康AI，將掀起新一波醫界改革，在照護體系和新藥開發上，透過導入大數據與機器學習技術，電腦輔助的藥物篩選與設計全面強化，可望縮短新藥開發時程，提高成功機率，新藥開發將邁入「3.0時代」。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">除了美國和中國的網路巨頭，韓國也計劃在今年投入百億台幣預算，發展以基因體和腦科學為主的人工智慧，要成為全球製藥和健康照護領域的巨擘。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">醫界出身的副總統陳建仁指出，全球人口老化速度加劇，經濟合作暨發展組織（OECD）報告指出生技相關產值將占各先進國家GDP的一半以上，台灣可結合資通訊科技、精密機械與材料的優勢進行布局，以科技啟動全新的健康AI產業，打造新興「兆元」產業。</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">綜觀而論，沒有什麼產業比得上健康AI，更值得台灣接棒發展了。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><strong><span style="font-size:20px;">數位健康照護產業服務生態概觀</span></strong></span></span></p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:16px;"><strong><span style="font-size:20px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/img-1519877718-96472.jpg" style="width: 640px; height: 624px;" /></span></strong></span></span><br /> <span style="color:#696969;">以患者使用的科技軟體為中心，輔以目前進步飛速的人工智慧技術，圓心外的其他科技則根據使用者的不同、提升個別患者照護品質或其改善照護系統的價值差異，而大致歸類為以專業人員為主的科技，以及以組織為主的科技。電子健康紀錄涵蓋整套系統，凸顯其在任何數位策略中都扮演著重要角色<span style="font-size:16px;">。</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="font-size:14px;"><span style="color:#696969;">陳美如、黃巧秀/製作</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="font-size:14px;"><span style="color:#696969;">文章來自: 數位時代</span></span></p>  <p><a href="https://www.bnext.com.tw/article/48332/ai-health-care" target="_blank"><span style="color:#0000FF;">https://www.bnext.com.tw/article/48332/ai-health-care</span></a></p>  <div class="container-fluid bg_img_sty01 feature_picture_box" style="box-sizing: border-box; padding: 0px; margin: 31.6563px auto; max-width: 900px; min-width: 320px; width: 900px; position: relative; text-align: center; background-position: center center; background-size: cover; background-repeat: no-repeat; font-family: &quot;Roboto Condensed&quot;, fantasy, 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 16px; background-image: url(&quot;https://media.bnextmedia.com.tw/image/album/2018-03/img-1519878549-31391.jpg&quot;);"> <div class="img_src" style="box-sizing: border-box; background-color: rgba(0, 0, 0, 0.35); display: inline-block; padding: 5px 10px; position: absolute; right: 0px; color: rgb(255, 255, 255); bottom: 0px; font-size: 13px;">Shutterstock</div> </div>  <div class="content htmlview" style="box-sizing: border-box; position: relative; font-family: &quot;Roboto Condensed&quot;, fantasy, 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 16px;"> <div class="layout_sty01 container-fluid" style="box-sizing: border-box; padding: 0px 20px; margin: 20px auto 0px; max-width: 1440px; min-width: 320px; width: 1440px; display: flex;"> <div class="left" style="box-sizing: border-box; display: inline-block; vertical-align: top; width: 1022px; padding-right: 56px; position: relative; padding-left: 196px;"> <div class="share_block_sty03 vertical sticky_elem_box" style="box-sizing: border-box; position: absolute; width: 55px; top: 0px; left: 0px; bottom: 0px;"> <div class="sticky_elem" style="box-sizing: border-box; margin: 20px 0px 50px;"> <div class="share_box share_box_sty01 vertical" style="box-sizing: border-box;">&nbsp;</div>  <div class="share_box share_box_sty01 vertical" style="box-sizing: border-box;">&nbsp;</div> </div> </div> </div> </div> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180305]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%ba%ab%e9%ab%94%e6%95%b8%e6%93%9a%e5%ba%ab%e8%a3%9c%e8%b6%b3%e6%9c%80%e5%be%8c%e4%b8%80%e5%93%a9%ef%bc%81ai%e6%99%ba%e6%85%a7%e9%86%ab%e7%99%82%e5%b4%9b%e8%b5%b7/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>好書分享]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%ba%ab%e9%ab%94%e6%95%b8%e6%93%9a%e5%ba%ab%e8%a3%9c%e8%b6%b3%e6%9c%80%e5%be%8c%e4%b8%80%e5%93%a9%ef%bc%81ai%e6%99%ba%e6%85%a7%e9%86%ab%e7%99%82%e5%b4%9b%e8%b5%b7]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[57]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180305]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7211]]></id>
		<title><![CDATA[罕見病聯盟予特發肺纖維化患者平買藥物　付兩年藥費後可免費用藥]]></title>
		<content><![CDATA[<h1 style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; vertical-align: baseline; color: rgb(0, 0, 0);"><span style="color:#000000;"><span style="font-size:26px;"><strong>罕見病聯盟予特發肺纖維化患者平買藥物　付兩年藥費後可免費用藥</strong></span></span></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/dcacc28bf395b632cf25df41456ed0fb.jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="color: rgb(102, 102, 102); font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; font-size: 14px;">香港罕見疾病聯盟公布，針對罕見病特發性肺纖維化提供「特發肺纖愛心送暖用藥計劃」，讓在公私營醫療機構求診的患者能以較相宜價錢用藥，並在用藥兩年後免費用藥。（陳倩婷攝）</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <div class="article_content__module article_summary" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 20px; padding: 0px; border-width: 0px 0px 1px; border-top-style: initial; border-right-style: initial; border-bottom-style: solid; border-left-style: initial; border-top-color: initial; border-right-color: initial; border-bottom-color: rgb(214, 214, 214); border-left-color: initial; border-image: initial; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 19px; line-height: inherit; font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; vertical-align: baseline; color: rgb(0, 0, 0); clear: both;"> <h2 class="article_summary_pt" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 10px 20px; padding: 0px 0px 0px 15px; border: 0px; font-style: inherit; font-variant: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; display: block; background: url(&quot;../images/img_article_summary_pt.png&quot;) 0px 5px / auto 19px no-repeat;transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">罕見疾病近期備受社會關注，尤其患「脊髓肌肉萎縮症」(SMA)的佩珊，親筆寫公開信予特首林鄭月娥，引起公眾關注。近日公布的財政預算案，亦預留了5億元資助罕見疾病及極昂貴藥物，當局亦即將引入個別疾病的藥物抵港。</span></span></h2>  <p>&nbsp;</p>  <h2 class="article_summary_pt" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 10px 20px; padding: 0px 0px 0px 15px; border: 0px; font-style: inherit; font-variant: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; display: block; background: url(&quot;../images/img_article_summary_pt.png&quot;) 0px 5px / auto 19px no-repeat;transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">政府落實罕見病相關措施之際，另一邊廂，香港罕見疾病聯盟今日（7日）公布，針對罕見病特發性肺纖維化提供「特發肺纖愛心送暖用藥計劃」，讓在公私營醫療機構求診的患者能以較相宜價錢用藥，並在用藥兩年後免費用藥。</span></span></h2> </div>  <div data-google-query-id="CLTvpoTR2dkCFZ4ZKgodcEkPOw" id="div-gpt-ad-1477371174339-0" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 16px; line-height: inherit; font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; vertical-align: baseline; color: rgb(0, 0, 0); height: 1px; width: 1px;"> <div id="google_ads_iframe_/108346865/HK01_ForTracking_1x1_0__container__" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0pt none; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline;">&nbsp;</div> </div>  <p>&nbsp;</p>  <div class="article_content__module module_paragraph" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 20px; padding: 0px; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 16px; line-height: inherit; font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; vertical-align: baseline; clear: both; color: rgb(0, 0, 0);"> <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 20px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="color:#000000;"><span style="font-size:16px;">特發肺纖維化是呼吸系統疾病，呼吸系統科專科醫生溫志堅指，特發肺纖的存活率大約3至5年，比多種癌症更低，香港現時有約350名特發肺纖患者。</span></span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 20px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="color:#000000;"><span style="font-size:16px;">香港罕見疾病聯盟今次聯同呼吸系統科專科醫生、非牟利社區藥房及藥廠合作，將新研發的藥物「尼達尼布」引進公私營醫療市場，這種藥物2016年已於衞生署註冊，但未被納入藥物名冊內，即病人要自付藥物全費。溫志堅引研究結果指，服用尼達尼布的特發肺纖患者每年肺功能下降率能減低五成，藥物亦有效減低急性發病率達68%。</span></span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="color:#000000;"><span style="font-size:16px;">在新計劃下，特發肺纖患者在私家專科醫生求診後，可由該醫生直接出藥及收費，若在公立醫院求診的患者，可持藥物處方到指定非牟利社區藥房配藥。患者首24個月需自付藥費，若在公營醫療機構求診，第6、12、16、20及24個月免藥費，第25個月起免藥費，直至醫生改變處方為止。</span></span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; overflow-wrap: break-word; text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/5b96fd386023b653d83bda1807175a8b.jpg" style="width: 640px; height: 480px;" /></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; overflow-wrap: break-word; text-align: center;"><span style="color: rgb(102, 102, 102); font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; font-size: 14px; text-align: center;">曾建平建議醫管局盡快將特發肺纖的新藥納入安全網，令更多病人受惠。（陳倩婷攝）</span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; overflow-wrap: break-word; text-align: center;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; overflow-wrap: break-word; text-align: center;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; overflow-wrap: break-word; text-align: center;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; overflow-wrap: break-word;"><span style="color:#000000;"><span style="font-size:20px;"><strong style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width;">促醫管局盡快納入安全網</strong></span></span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; overflow-wrap: break-word;">&nbsp;</p> </div>  <div class="article_content__module module_rightside_content" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 20px; padding: 0px; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 16px; line-height: inherit; font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; vertical-align: baseline; clear: both; display: inline-block; width: 700px; color: rgb(0, 0, 0);"> <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="color:#000000;"><span style="font-size:16px;">罕病聯盟會長曾建平先生指，雖然近日多了聲音關注罕見病人，但不能指望特首親自與每個病人見面，「政府有政府做嘢，民間都想做多啲」，他建議醫管局盡快將特發肺纖的新藥納入安全網，令更多病人受惠，又希望今次民間計劃推出後，可令更多藥廠及機構關注罕見病患者的需要。</span></span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p> </div>  <div class="article_content__module module_paragraph" style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 20px; padding: 0px; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 16px; line-height: inherit; font-family: &quot;Noto Sans TC&quot;, &quot;Heiti TC&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Roboto Sans&quot;, Helvetica, Arial, sans-serif; vertical-align: baseline; clear: both; color: rgb(0, 0, 0);"> <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px 0px 20px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="color:#000000;"><span style="font-size:16px;"><strong style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width;">參與計劃名單</strong>：<br style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width;" /> 全港的註冊呼吸系統科專科醫生</span></span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="color:#000000;"><span style="font-size:16px;"><strong style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width;">指定非牟利社區藥房</strong>：<br style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width;" /> 香港藥學服務基金配安心藥房<br style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width;" /> 香港聖公會麥理浩天人中心慈惠社區藥房<br style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width;" /> 聖雅各福群會惠澤社區藥房</span></span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;">&nbsp;</p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="font-size:14px;">文章來自: 香港01</span></p>  <p style="transition-duration: 0.5s; transition-property: left, right, top, bottom, height, width; margin: 0px; padding: 0px; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline; letter-spacing: 1px; text-align: justify; overflow-wrap: break-word;"><span style="font-size:14px;"><a href="https://www.hk01.com/港聞/165778/罕見病聯盟予特發肺纖維化患者平買藥物-付兩年藥費後可免費用藥" target="_blank"><span style="color:#0000FF;">https://www.hk01.com/%E6%B8%AF%E8%81%9E/165778/</span></a></span></p> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180307]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%bd%95%e8%a6%8b%e7%97%85%e8%81%af%e7%9b%9f%e4%ba%88%e7%89%b9%e7%99%bc%e8%82%ba%e7%ba%96%e7%b6%ad%e5%8c%96%e6%82%a3%e8%80%85%e5%b9%b3%e8%b2%b7%e8%97%a5%e7%89%a9%e3%80%80%e4%bb%98%e5%85%a9%e5%b9%b4/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[城中活動>其它機構活動]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%bd%95%e8%a6%8b%e7%97%85%e8%81%af%e7%9b%9f%e4%ba%88%e7%89%b9%e7%99%bc%e8%82%ba%e7%ba%96%e7%b6%ad%e5%8c%96%e6%82%a3%e8%80%85%e5%b9%b3%e8%b2%b7%e8%97%a5%e7%89%a9%e3%80%80%e4%bb%98%e5%85%a9%e5%b9%b4]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[58]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180307]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7212]]></id>
		<title><![CDATA[定期檢查 嚴防乳癌復發]]></title>
		<content><![CDATA[<pre> <span style="color:#000000;"><span style="font-size:26px;"><strong>定期檢查 嚴防乳癌復發</strong></span></span></pre>  <div class="article-details__function" style="box-sizing: ; width: 917px; height: 34px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 14px;"> <div class="article-details__date-time float-left" style="box-sizing: border-box; float: left;"><span style="box-sizing: border-box; font-size: 16px; vertical-align: middle; line-height: 34px; color: rgb(153, 153, 153); font-family: Arial, sans-serif;">2018/03/05</span></div>  <div class="article-details__function-btn float-right" style="box-sizing: border-box; float: right;">&nbsp;</div> </div>  <div class="article-details__body" style="box-sizing: border-box; clear: both; padding: 15px 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 14px;"> <div class="article-detail__img" style="box-sizing: border-box;"> <div class="article-detail__img-container" style="box-sizing; ; margin-bottom: 0px !important;"> <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p>  <p style="text-align: center;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p> <picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/027_01_a_20180305_L.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/027_01_a_20180305_L(1).jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; width: 640px; height: 481px; text-align: center;" /></picture>  <p style="text-align: center;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p>  <p style="text-align: center;">&nbsp;</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px;">&nbsp;</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px;"><span style="color:#000000;"><span style="font-size:16px;">乳癌是本港女性頭號殺手，但亦是最能以藥物控制的癌症之一，正因如此，不少乳癌患者都認為乳癌「易醫」，或會輕視復發風險。患乳癌的著名國際巨星相隔25年後復發的案例，提醒了乳癌患者注意復發風險，作定期檢查。</span></span></p> </div>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><span style="font-size:20px;"><strong><span style="box-sizing: border-box; font-weight: 700;">7成患者 誤解乳癌易治好</span></strong></span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">去年，經典歌舞電影《油脂》女主角、69歲澳洲女星Olivia Newton John在社交網站表示乳癌復發。她於1992年患上乳癌，康復後更於澳洲成立「癌病研究中心」，關注癌症病人並宣揚抗癌信息。時隔25年，去年她因感背痛前往檢查，竟發現乳癌復發並擴散到骶骨。</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">「癌症資訊網乳癌關愛組」去年7月發布的調查指出，本港75%乳癌患者認為乳癌較易治療、生存率較高及較高機會康復，62%人認為即使癌症不幸復發或擴散，仍比其他癌症易治療，反映市民的誤解。臨床腫瘤科專科梁廣泉醫生指，雖然乳癌對藥物的反應好，是較容易以藥物控制的癌症，但復發始終比原發難醫治。據香港乳癌基金會提供數字，乳癌復發的死亡率為2成。</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">梁醫生指，乳癌根據細胞特質可分為4類︰導管A型、導管B型、HER2型、及三陰型；其中，導管A型可以很遲才復發，遠至初次病發後10至15年仍有一定復發機會。他估計Olivia Newton John屬於導管A型，但相隔20多年後再復發並不常見。他解釋，腫瘤惡性程度、乳癌期數、及類型均會影響復發率。</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">香港乳癌基金會創會人張淑儀醫生指，乳癌復發可分為局部和遠端兩類。局部復發是癌細胞進入乳房淋巴，一般是可醫治的；遠端復發則是癌細胞入血管擴散至內臟器官，如肝、骨和腦，足以致命。復發特徵包括乳房出現硬塊、骨痛、咳嗽、肚脹等。</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><strong><span style="font-size:20px;"><span style="box-sizing: border-box; font-weight: 700;">有個案 28年後腫瘤轉移</span></span></strong></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">梁廣泉醫生的一名女病人於1985年、31歲那年確診左邊乳房有腫瘤，屬第二期癌症，有早期淋巴轉移；同年她進行全乳切除手術，之後有進行電療及服食荷爾蒙藥。至28年後，2013年時，近60歲的她覺得右邊盆骨痛，檢查之下竟發現癌症出現骨轉移，由頭骨、肋骨、至腰骨等都有癌細胞，抽針確認了是乳房腫瘤轉移，荷爾蒙受體及HER2受體均呈陽性反應。幸而立即使用標靶藥及化療令其病情受控，目前病情仍在控制中。</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#000000;"><span style="font-size:16px;">該病人在復發前的身體都是健康的，身體徵狀或飲食上都沒見有明顯問題，一直相安無事。梁強調定期檢查非常重要，以此個案為例，時隔28年再復發是非常少見的，及早發現對於醫治復發非常重要，如有懷疑應該立即求診。</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#696969;"><span style="font-size:14px;">記者︰黃詠雯</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#696969;"><span style="font-size:14px;">編輯：林子豐</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="color:#696969;"><span style="font-size:14px;">美術：熊偉然</span></span></p>  <div class="article-detail__img-container" style="box-sizing: ; margin-bottom: 0px !important;"> <p style="text-align: center;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p>  <p style="text-align: center;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p> <picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><span style="color:#696969;"><span style="font-size:14px;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/05JKA003__20180305_S.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/05JKA003__20180305_S.jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; width: 300px; height: 225px; text-align: center;" /></span></span></picture>  <p class="article-detail__img-caption" style="box-sizing: border-box; margin: 0px 0px 30px; padding: 15px 20px; background: rgb(223, 223, 223); color: rgb(85, 85, 85); font-size: 18px; line-height: 30px; text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">醫生指過往曾有研究指運動可減低患乳癌風險，故建議康復者保持適量運動。（iStock）</span></span></p> </div>  <div class="article-detail__img-container" style="box-sizing: ; margin-bottom: 0px !important;"> <p><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p>  <p>&nbsp;</p> <picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/027_01_e_20180305_L.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/027_01_e_20180305_L.jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; width: 600px; height: 379px; text-align: center;" /></picture>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: center;">&nbsp;</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: center;">&nbsp;</p> </div>  <div class="article-detail__img-container" style="box-sizing: ; margin-bottom: 0px !important;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/027_01_b_20180305_L.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/027_01_b_20180305_L.jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; width: 600px; height: 326px;" /></picture>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p> </div>  <div class="article-detail__img-container" style="box-sizing: ; margin-bottom: 0px !important;"> <p style="text-align: center;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p> <picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/05JKA001__20180305_S.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/05JKA001__20180305_S.jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; width: 300px; height: 225px; text-align: center;" /></picture>  <p class="article-detail__img-caption" style="box-sizing: border-box; margin: 0px 0px 30px; padding: 15px 20px; background: rgb(223, 223, 223); color: rgb(85, 85, 85); font-size: 18px; line-height: 30px; text-align: center;">梁廣泉醫生</p> </div>  <div class="article-detail__img-container" style="box-sizing: ; margin-bottom: 0px !important;"> <p><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p>  <p>&nbsp;</p> <picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/05JKA002__20180305_S.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/05JKA002__20180305_S.jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; text-align: center; width: 300px; height: 225px;" /></picture>  <p class="article-detail__img-caption" style="box-sizing: border-box; margin: 0px 0px 30px; padding: 15px 20px; background: rgb(223, 223, 223); color: rgb(85, 85, 85); font-size: 18px; line-height: 30px; text-align: center;">張淑儀醫生</p> </div>  <div class="article-detail__img-container" style="box-sizing: ; margin-bottom: 0px !important;"> <p><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"></picture></p>  <p>&nbsp;</p> <picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/027_01_c_20180305_L.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/027_01_c_20180305_L.jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; width: 600px; height: 450px;" /></picture>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p> </div>  <div class="article-detail__img-container" style="box-sizing:  margin-bottom: 0px !important;"><picture class="photoswipe-img" style="box-sizing: border-box; cursor: pointer;"><img alt="" class="lazyloaded" data-src="https://resource01.ulifestyle.com.hk/res/v3/image/content/2020000/2022678/027_01_d_20180305_L.jpg" src="http://www.cancerinformation.com.hk/ufiles/Image/027_01_d_20180305_L.jpg" style="box-sizing: border-box; border: 0px; vertical-align: middle; display: block; margin: 0px auto; max-width: 100%; max-height: 100%; width: 600px; height: 348px;" /></picture>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p> </div>  <div class="article-detail_extra-info" style="box-sizing: border-box;"> <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">欄名: Healthy Life</p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="font-size:14px;"><span style="color:#696969;">文章來自: 晴報</span></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;"><span style="font-size:14px;"><a href="https://skypost.ulifestyle.com.hk/article/2022678/定期檢查%20嚴防乳癌復發" target="_blank"><span style="color:#0000FF;">https://skypost.ulifestyle.com.hk/article/2022678/定期檢查%20嚴防乳癌復發</span></a></span></p>  <p style="box-sizing: border-box; margin: 0px 0px 30px; font-size: 18px; line-height: 30px; text-align: justify;">&nbsp;</p> </div> </div> </div>  <div class="article-detail_facebook-like" style="box-sizing: border-box; font-size: 18px; color: rgb(0, 153, 255); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif;">&nbsp;</div>  <p>&nbsp;</p>  <p>&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180307]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%ae%9a%e6%9c%9f%e6%aa%a2%e6%9f%a5-%e5%9a%b4%e9%98%b2%e4%b9%b3%e7%99%8c%e5%be%a9%e7%99%bc/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>健康教育]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%ae%9a%e6%9c%9f%e6%aa%a2%e6%9f%a5-%e5%9a%b4%e9%98%b2%e4%b9%b3%e7%99%8c%e5%be%a9%e7%99%bc]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[59]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180307]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7213]]></id>
		<title><![CDATA[香港乳癌基金會賽馬會乳健中心（九龍）正式啟用 為九龍新界婦女 為九龍新界婦女提供乳健檢查及乳癌患者支援服務]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>香港乳癌基金會賽馬會乳健中心（九龍）正式啟用 為九龍新界婦女 為九龍新界婦女提供乳健檢查及乳癌患者支援服務</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">香港乳癌基金會賽馬會乳健中心（九龍）於今日（3 月 8 日）正式啟用，為九龍及新 界區婦女提供更便捷和全面的乳健檢查及乳癌支援服務。中心啟用之日，適逢國際婦 女節及香港乳癌基金會投入服務 13 週年，是婦女齊為健康喝采的日子。 </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">主禮嘉賓<strong>行政長官林鄭月娥女士</strong>在啟幕禮上致辭，讚揚基金會多年來透過提升大眾 對乳癌的認識、推廣乳健教育及乳健檢查，為乳癌患者及病人家屬提供支援等，以 致力減低本地乳癌威脅。她表示：「乳癌已成為本港婦女最常見的癌症，所以政府 十分重視乳癌防治及乳健意識的推廣。隨着香港乳癌基金會賽馬會乳健中心（九 龍）正式啟用，在九龍及新界區生活的婦女將可更容易獲得乳健檢查服務和乳健教 育活動。政府現聯同醫學界需要掌握更多研究和數據，探討是否適宜在本港為一般 風險、無症狀的婦女推行全民乳癌普查。在取得結論之前，篩查服務提供者需要詳 細為考慮篩查的婦女講解有關好處、風險和局限等，以便婦女作出合適的選擇。」 </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><strong>香港賽馬會董事周松崗爵士</strong>表示：「馬會是全球十大慈善捐助機構之一，一直關注市 民大眾的健康，過去十年捐助逾十五億港元於癌症相關項目，希望從預防癌症，以至 治療方面，都積極投入資源。馬會與香港乳癌基金會合作無間，自 2010 年起，先後 捐助超過一億港元，成立位於北角及牛池灣的兩所乳健中心，並推行乳房健康教育及 檢查服務，提高大眾對乳癌的認識和關注。」 </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">在香港賽馬會慈善信託基金支持下，九龍中心得以順利落成，並將推行「賽馬會乳妳 同行計劃」，估計 3 年內可為 36,000 多名女士服務，當中包括為 5,000 名低收入或經 濟有困難人士提供免費乳房 X 光造影及檢查。 </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><strong>香港乳癌基金會主席霍何綺華女士</strong>在啟幕禮上強調香港應加強癌症防控措施：「及早 發現，治療關鍵。由於初期乳癌的治療和護理都較簡單，及早偵測乳癌有助降低創傷 及醫療費用，以及提高存活率。」她建議政府探討全民乳癌普查的可能性；基金會亦 提倡加強公私營醫療協作，消除公立醫院乳癌診斷服務的輪候時間，讓癌症病人可以 使用像基金會提供的社區診斷服務，及早得到治療。她亦鼓勵乳癌患者及其身邊親友 主動向基金會的乳癌支援中心，尋求協助。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:20px;"><strong>拓展服務 在九龍新界推動乳健文化 </strong></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">九龍中心坐落於牛池灣，是基金會繼位於北角的香港中心後，第二個一站式服務中 心。根據香港乳癌基金會最新資料顯示，受訪乳癌患者有近六成確診時居於新界， 23%在九龍居住。她們普遍缺乏乳房檢查習慣，在確診前分別有逾四成和七成人從未 自我檢查乳房和接受乳房Ｘ光造影檢查，明顯高於港島區患者的三成和五成比率。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">2011 年數字也顯示：居於住戶入息偏低地區的乳癌患者，有高達八成從未進行過乳 房 X 光造影檢查；他們當中不少確診時乳癌期數已屆晚期，以黃大仙、觀塘、新界北 區和深水埗的患者為例，有 14% 至 18%確診時已屬晚期乳癌。 </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">香港乳癌基金會 3 年前籌劃在九龍興建服務中心。其後基金會分別獲政府撥地和香 港賽馬會慈善信託基金撥款資助，遂落實在牛池灣現址興建樓高兩層的香港乳癌基 金會賽馬會乳健中心（九龍），主要為婦女提供專業、適時而又價格相宜的乳健檢 查和患者支援服務。 九龍中心設有乳房 X 光造影機及超聲波掃描儀器，並由專業醫護人員主理，如有需 要會安排醫生會診。九龍中心的 2 樓是乳癌支援中心，提供地方予乳癌患者及其家 人和照顧者接受支援和交流抗癌經驗，患者也可使用淋巴水腫指數測量及護理服 務。中心亦設有義工室，讓乳癌康復者可以擔任義工，提供輔導熱線等服務，與患 者分享抗癌經歷。 </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:20px;"><strong>香港乳癌基金會 13 年來為您服務 </strong></span></span></p>  <p>&nbsp;</p>  <ul> 	<li><span style="color:#000000;"><span style="font-size:16px;">  為乳癌患者及其家屬提供超過 117,736 次支援服務； </span></span></li> 	<li><span style="color:#000000;"><span style="font-size:16px;">  向逾 81,153 人次提供乳健教育講座； </span></span></li> 	<li><span style="color:#000000;"><span style="font-size:16px;">  提供 48,603 次乳健檢查風險評估、乳健檢查、醫生會診和各項診斷等服務，包 括向 19,025 女士提供免費乳健檢查，當中為 888 個案確診乳癌； </span></span></li> 	<li><span style="color:#000000;"><span style="font-size:16px;">  收集超過 20,333 個本地乳癌個案的數據，協助乳癌患者、醫生、大眾和政府全 面和深入地了解本地乳癌狀況。 </span></span></li> </ul>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">（上述數字截止 2018 年 2 月 28 日）</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1(25).jpg" style="width: 450px; height: 337px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">圖片說明： 香港乳癌基金會賽馬會乳健中心（九龍）開幕禮適逢基金會 13 週年和國際婦女日，邀得香 港特區首位女行政長官林鄭月娥女士主禮，與近百嘉賓同慶。林太在簽名牆上簽名留念。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/2(16).jpg" style="width: 450px; height: 308px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">位於牛池灣的香港乳癌基金會賽馬會乳健中心（九龍）於 3 月 8 日正式啟幕，為九龍及新界 區的婦女提供便捷而全面的乳健檢查服務和乳癌支援服務。行政長官林鄭月娥女士、食物及 衛生局局長陳肇始教授和香港賽馬會董事周松崗爵士，在香港乳癌基金會贊助人梁紹鴻博士、 創會人張淑儀醫生和主席霍何綺華女士陪同下主持揭幕儀式。</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/3(13).jpg" style="width: 450px; height: 303px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">行政長官林鄭月娥女士在香港乳癌基金會創會人張淑儀醫生和主席霍何綺華女士陪同 下，參觀香港乳癌基金會賽馬會乳健中心（九龍），包括各種支援乳癌患者、康復者及 其家人的服務和設施，以及滿載祝福和鼓勵的心意咭牆。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/4(10).jpg" style="width: 450px; height: 298px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">香港乳癌基金會大使陳寶珠女士、陳美齡博士和琦琦女士現身香港乳癌基金會賽馬會 乳健中心（九龍）的啟幕禮，呼籲婦女愛錫自己，關注乳房健康，並鼓勵大家使用九龍 中心提供的乳健檢查服務和乳癌支援服務。 </span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/5(5).jpg" style="width: 450px; height: 301px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">一位已離世陳寶珠女士的粉絲支持寶珠支持基金會，其遺產管理人今天向香港乳癌基 金會賽馬會乳健中心（九龍）捐出港幣二十萬元。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180310]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%a6%99%e6%b8%af%e4%b9%b3%e7%99%8c%e5%9f%ba%e9%87%91%e6%9c%83%e8%b3%bd%e9%a6%ac%e6%9c%83%e4%b9%b3%e5%81%a5%e4%b8%ad%e5%bf%83%ef%bc%88%e4%b9%9d%e9%be%8d%ef%bc%89%e6%ad%a3%e5%bc%8f%e5%95%9f%e7%94%a8/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[城中活動>其它機構活動]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%a6%99%e6%b8%af%e4%b9%b3%e7%99%8c%e5%9f%ba%e9%87%91%e6%9c%83%e8%b3%bd%e9%a6%ac%e6%9c%83%e4%b9%b3%e5%81%a5%e4%b8%ad%e5%bf%83%ef%bc%88%e4%b9%9d%e9%be%8d%ef%bc%89%e6%ad%a3%e5%bc%8f%e5%95%9f%e7%94%a8]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[60]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180310]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7214]]></id>
		<title><![CDATA[家中輕鬆自我採細胞樣本 驗子宮頸癌零尷尬]]></title>
		<content><![CDATA[<header class="entry-header" style="color: rgb(68, 68, 68); font-family: &quot;open sans&quot;, serif; font-size: 16px;"> <h1 class="entry-title" style="border: 0px; font-variant: inherit; font-stretch: inherit; font-family: &quot;open sans&quot;, sans-serif; font-size: 32px; font-style: inherit; margin: 0px; outline: 0px; padding: 5px 0px 0px; vertical-align: baseline; color: rgb(51, 51, 51);"><strong><span style="color:#000000;"><span style="font-size:26px;">家中輕鬆自我採細胞樣本 驗子宮頸癌零尷尬</span></span></strong></h1> </header>  <div class="below-entry-meta" style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: inherit; font-family: &quot;open sans&quot;, serif; font-size: 16px; margin: 0px; outline: 0px; padding: 0px 0px 20px; vertical-align: baseline; color: rgb(68, 68, 68);"><span class="posted-on" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px 10px 0px 0px; vertical-align: baseline;"><a href="https://health.mingpao.com/?p=12508" rel="bookmark" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-size: 12px; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; color: rgb(136, 136, 136); text-decoration-line: none;" title="11:13"><span style="color:#696969;">&nbsp;<time class="entry-date published" datetime="2018-03-12T11:13:20+00:00">2018年3月12日</time></span></a></span><span style="color:#696969;">&nbsp;</span><span class="tag-links" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px 10px 0px 0px; vertical-align: baseline;"><a href="https://health.mingpao.com/?tag=%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8c" rel="tag" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-size: 12px; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; color: rgb(136, 136, 136); text-decoration-line: none;"><span style="color:#696969;">子宮頸癌</span></a><span style="color:#696969;">,&nbsp;</span><a href="https://health.mingpao.com/?tag=%e7%b4%b0%e8%83%9e%e6%a8%a3%e6%9c%ac" rel="tag" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-size: 12px; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; color: rgb(136, 136, 136); text-decoration-line: none;"><span style="color:#696969;">細胞樣本</span></a><span style="color:#696969;">,&nbsp;</span><a href="https://health.mingpao.com/?tag=hpv%e7%97%85%e6%af%92" rel="tag" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-size: 12px; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; color: rgb(136, 136, 136); text-decoration-line: none;"><span style="color:#696969;">HPV病毒</span></a><span style="color:#696969;">,&nbsp;</span><a href="https://health.mingpao.com/?tag=%e6%9f%8f%e6%b0%8f%e6%8a%b9%e7%89%87" rel="tag" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-size: 12px; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; color: rgb(136, 136, 136); text-decoration-line: none;"><span style="color:#696969;">柏氏抹片</span></a></span></div>  <div class="below-entry-meta" style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: inherit; font-family: &quot;open sans&quot;, serif; font-size: 16px; margin: 0px; outline: 0px; padding: 0px 0px 20px; vertical-align: baseline; color: rgb(68, 68, 68);">&nbsp;</div>  <div class="below-entry-meta" style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: inherit; font-family: &quot;open sans&quot;, serif; font-size: 16px; margin: 0px; outline: 0px; padding: 0px 0px 20px; vertical-align: baseline; color: rgb(68, 68, 68); text-align: center;"><span style="font-size:16px;"><span style="color:#000000;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/de984596d77f5d4777c7950c13ff2ec1.jpg" style="width: 640px; height: 607px; float: left;" /></span></span></div>  <div class="below-entry-meta" style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: inherit; font-family: &quot;open sans&quot;, serif; font-size: 16px; margin: 0px; outline: 0px; padding: 0px 0px 20px; vertical-align: baseline; color: rgb(68, 68, 68); text-align: center;">&nbsp;</div>  <div class="addtoany_share_save_container addtoany_content_top" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-style: inherit; font-weight: inherit; margin: -10px 0px 20px; outline: 0px; padding: 0px; vertical-align: baseline; clear: both;"> <div class="a2a_kit a2a_kit_size_28 addtoany_list" data-a2a-title="家中輕鬆自我採細胞樣本 驗子宮頸癌零尷尬" data-a2a-url="https://health.mingpao.com/?p=12508&amp;utm_source=share&amp;utm_campaign=healthtracking" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 28px; font-family: inherit; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; display: inline; touch-action: manipulation; text-align: center;"><span style="font-size:16px;"><span class="a2a_label" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; clip: rect(1px, 1px, 1px, 1px); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); overflow: hidden; height: 1px; width: 1px; display: inline-block; float: none; border-radius: 4px; opacity: 1; position: absolute !important;"><span style="color:#000000;">Facebook<span style="font-family: inherit; font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit;">Telegram</span><span style="font-family: inherit; font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit;">WhatsApp</span><span style="font-family: inherit; font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit;">WeChat</span><span style="font-family: inherit; font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit;">Line</span><span style="font-family: inherit; font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit;">LinkedI</span></span><a class="a2a_button_google_plus" href="https://health.mingpao.com/#google_plus" rel="nofollow noopener" style="font-family: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; border: 0px; font-stretch: inherit; line-height: inherit; margin: 0px; outline: 0px; padding: 0px 4px; vertical-align: middle; color: rgb(24, 128, 115); text-decoration-line: none; box-shadow: none; display: inline-block; cursor: pointer;" target="_blank" title="Google+"><span style="color:#000000;">Googl</span></a><a class="a2a_button_email" href="https://health.mingpao.com/#email" rel="nofollow noopener" style="font-family: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; border: 0px; font-stretch: inherit; line-height: inherit; margin: 0px; outline: 0px; padding: 0px 4px; vertical-align: middle; color: rgb(24, 128, 115); text-decoration-line: none; box-shadow: none; display: inline-block; cursor: pointer;" target="_blank" title="Email"><span style="color:#000000;">Ema</span></a><span style="font-family: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; border: 0px; font-stretch: inherit; line-height: inherit; margin: 0px; outline: 0px; padding: 0px 4px; vertical-align: middle; color: rgb(0, 0, 0); text-decoration-line: none; box-shadow: none; display: inline-block; cursor: pointer;"><a class="a2a_button_print" href="https://health.mingpao.com/#print" rel="nofollow" style="font-family: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; border: 0px; font-stretch: inherit; line-height: inherit; margin: 0px; outline: 0px; padding: 0px 4px; vertical-align: middle; color: rgb(24, 128, 115); text-decoration-line: none; box-shadow: none; display: inline-block; cursor: pointer;" target="" title="Print">P</a></span><span style="color: rgb(0, 0, 0); font-family: inherit; font-style: inherit; font-variant-ligatures: inherit; font-variant-caps: inherit; font-weight: inherit;">【明報專訊】子宮頸癌，主要原因是子宮頸內細胞感染到HPV病毒，最有效的篩查方法為定期的子宮頸細胞檢查（又稱柏氏抹片）。香港中文大學醫學院賽馬會公共衛生及基層醫療學院教授黃麗儀指出，不少女士抗拒接受這種檢驗，導致篩查覆蓋率偏低，而中大引入的HPV自我採檢，正好讓女士可安心在家中自行採集化驗樣本。負責的研究人員估計，成功推行的話，可有助提升覆蓋率至九成，幫助女士及早發現早期子宮頸癌</span></span></span></div> </div>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline; text-align: center;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="color:#000000;"><span style="font-size:16px;">子宮頸癌是女性十大癌症之一，於2015年在香港女性最常見癌症中排第7位，2015年的新症共有500宗。成因主要與感染人類乳頭瘤病毒（Human PapillomaVirus，HPV）有關，當子宮頸內細胞感染到HPV病毒，免疫系統又未能將它消滅，病毒便會破壞子宮頸細胞，引發子宮頸上皮內瘤（Cervical Intra-epithelial Neoplasia，CIN），即癌前病變，經過一段長時間，就有可能發展成為子宮頸癌，過程一般長達5至20年。</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="color:#000000;"><span style="font-size:16px;">要預防HPV病毒感染，主要依靠注射子宮頸癌預防疫苗，並以柏氏抹片及早篩檢。根據2014/15年度人口健康調查顯示，25至64歲群組中，僅47%婦女在過去3年曾接受子宮頸癌篩檢，黃麗儀指出，不少女性因為羞於接受抹片檢查，或擔心採檢過程複雜耗時，所以抗拒到診所或化驗所接受定期檢驗，導致整體篩查率偏低。「為了提升篩檢普及程度，不少國家例如荷蘭、澳洲、瑞典、日本等，也推出自我採檢工具，讓女士在家中自我採集子宮頸細胞，再郵寄到化驗所接受測試，其中荷蘭及澳洲政府更將自我採檢及柏氏抹片檢查，視為第一線檢查方法。」</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="color:#000000;"><span style="font-size:20px;"><strong>建議年滿25歲起定期檢查</strong></span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">不同國家推出的自我採檢工具雖然有不同，但採檢過程相若，負責該計劃的副研究員張惠棱解釋：「接受採檢的女士會收到一套密封的採檢工具，女士可以在家中以一個較舒適的姿勢，例如蹲下或平躺牀上，打開包裝取出試管，慢慢將工具放進陰道直至感覺無法再進入，就可以扭動底部轉盤，轉動3至5圈，讓頂部的掃頭採集子宮頸細胞，抽出後蓋好管套，再放入膠袋密封，就可郵寄回化驗所。」黃麗儀說準確度高達九成以上，但亦要視乎接受採檢的女士的信心及技術，「如使用不當，未有放到正確的位置，都會影響是否採集到適合的樣本，所以我們第一步要做的，是教授正確的使用方法。」採檢建議與柏氏抹片一樣，只要年滿25歲就應接受檢查，如首年結果呈陰性，相隔一年後再檢驗亦無發現HPV病毒，之後就可每3年再檢查。</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:20px;"><strong><span style="color:#000000;">準確度高達九成以上</span></strong></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">中大醫學院微生物學系系主任陳基湘教授指出，採集到的樣本毋須特別處理，只要在採集樣本後24小時內寄出，一般可保存5天，不會影響測試準確度，「當我們收到樣本，就會加入試劑，放進儀器內進行聚合酶連鎖反應（PCR）測試，檢查細胞的DNA有沒有出現病變，大概一至兩天就有結果」。陳基湘說當發現樣本有陽性反應，就會通知受測者，「自我採檢的準確度始終不及柏氏抹片檢查，我們只會視之為輔助篩檢工具，而且感染HPV病毒亦未必一定會出現病變，所以我們會建議對方接受柏氏抹片檢查，確認情况及是否需要接受治療」。陳基湘說柏氏抹片檢查如能配合自我採檢，估計可將篩查覆蓋率提升至90%，提升發現早期子宮頸癌的數字。</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><strong><span style="font-size:20px;"><span style="color:#000000;">■免費HPV自我採檢測試</span></span></strong></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">香港中文大學醫學院賽馬會公共衛生及基層醫療學院，早於2009年已開始推廣HPV自我採檢，但黃麗儀說主要對象為35至65歲女士。她指出香港現時也有化驗中心提供自我採檢工具及化驗服務，一般收費為400多元。而學院最近取得校內撥款，新一輪自我採檢的研究對象年齡層將下降至25至35歲女士，無論有否性經驗，都可免費接受測試，歡迎合資格人士參加。</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">資格：25至35歲女士</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">測試人數：500人</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">報名：2252 8406</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">網址：</span><a href="http://www.cuhk.edu.hk/sphpc/hpvselfsampling" rel="noopener" style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-style: inherit; font-weight: inherit; margin: 0px; outline: 0px; padding: 0px; vertical-align: baseline; color: rgb(24, 128, 115); text-decoration-line: none;" target="_blank"><span style="color:#000000;">www.cuhk.edu.hk/sphpc/hpvselfsampling</span></a></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">文：周群雄、許朝茵</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:16px;"><span style="color:#000000;">圖：劉憲宗</span></span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;">&nbsp;</p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:14px;">文章來自: 明報</span></p>  <p style="border: 0px; font-variant: inherit; font-stretch: inherit; line-height: 1.6; font-size: 18px; font-style: inherit; font-weight: inherit; margin: 0px 0px 15px; outline: 0px; padding: 0px; vertical-align: baseline;"><span style="font-size:14px;"><a href="https://health.mingpao.com/?p=12508" target="_blank"><span style="color:#0000FF;">https://health.mingpao.com/?p=12508</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180312]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%ae%b6%e4%b8%ad%e8%bc%95%e9%ac%86%e8%87%aa%e6%88%91%e6%8e%a1%e7%b4%b0%e8%83%9e%e6%a8%a3%e6%9c%ac-%e9%a9%97%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8c%e9%9b%b6%e5%b0%b7%e5%b0%ac/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>健康教育]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%ae%b6%e4%b8%ad%e8%bc%95%e9%ac%86%e8%87%aa%e6%88%91%e6%8e%a1%e7%b4%b0%e8%83%9e%e6%a8%a3%e6%9c%ac-%e9%a9%97%e5%ad%90%e5%ae%ae%e9%a0%b8%e7%99%8c%e9%9b%b6%e5%b0%b7%e5%b0%ac]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[61]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180312]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7215]]></id>
		<title><![CDATA[HPV自我採檢社區計劃]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>&nbsp;HPV自我採檢社區計劃</strong></span></span></p>  <p>&nbsp;</p>  <p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/banner-1(2).jpg" style="width: 640px; height: 192px;" /></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="font-size: 20px;"><span style="color: rgb(0, 0, 0);">甚麼是HPV自我採檢？</span></span></strong></p>  <table border="1" cellpadding="1" cellspacing="1" style="height:320px;width:640px;"> 	<tbody> 		<tr> 			<td> 			<p><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">自我採樣棒是一種子宮頸檢測工具，</span></span><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">讓女性可以在家中採集子宮頸和陰道的細胞樣本，用作HPV測試。</span></span></p> 			</td> 			<td><strong><span style="font-size: 20px;"><span style="color: rgb(0, 0, 0);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/self-sampling-01.jpg" style="width: 320px; height: 225px;" /></span></span></strong></td> 		</tr> 	</tbody> </table>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="color:#000000;"><span style="font-size:20px;">自我採檢有甚麼好處？</span></span></strong></p>  <table border="1" cellpadding="1" cellspacing="1" style="height:320px;width:640px;"> 	<tbody> 		<tr> 			<td><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/8-advantages-icon-in-1-regular.gif" style="width: 320px; height: 320px;" /></td> 			<td> 			<p style="box-sizing: border-box; margin: 0px 0px 10px; font-family: Roboto, Arial, sans-serif, &quot;Heiti TC&quot;, PMingLiU; font-size: 1.2em; line-height: 1.8em; padding: 15px; text-align: justify;">HPV自我採樣棒是一種可靠的檢測工具，讓女性可以避免接受子宮頸抹片檢查所帶來的不便，而且操作簡單，方便，及可靠，更可鼓勵沒有接受定期篩查測試的女性參與檢測。</p>  			<p style="box-sizing: border-box; margin: 0px 0px 10px; font-family: Roboto, Arial, sans-serif, &quot;Heiti TC&quot;, PMingLiU; font-size: 1.2em; line-height: 1.8em; padding: 15px; text-align: justify;">我們的研究顯示，超過50%受訪女士表示會接受自我採樣作為將來的篩查工具，特別是從來沒有接受過子宮頸抹片檢查的女性，更傾向選擇自我採檢。</p> 			</td> 		</tr> 	</tbody> </table>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><strong><span style="font-size:20px;">如何自我採集樣本？</span></strong></span></p>  <p>&nbsp;</p>  <p style="text-align: center;"><iframe allow="autoplay; encrypted-media" allowfullscreen="" frameborder="0" height="273" src="https://www.youtube.com/embed/aHuBJXC_RVg" width="440"></iframe></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <ul> 	<li><span style="color: rgb(0, 0, 0); font-size: 15.6px; text-align: justify;">進行HPV自我採樣前先洗手，將採樣棒從包裝取出。</span></li> 	<li><span style="color: rgb(0, 0, 0); font-size: 15.6px; text-align: justify;">選擇一個舒適的姿勢，你可以躺下，將枕頭置於臀下，然後屈膝和雙腳分開；或一隻腳站著，另一隻腳踏在櫈子上。</span></li> 	<li><span style="color: rgb(0, 0, 0); font-size: 15.6px; text-align: justify;">一隻手張開你的陰唇，然後用另一隻手，將採樣棒慢慢放入陰道，直到你感到前方有阻力或者到達陰道的頂部。</span></li> 	<li><span style="color: rgb(0, 0, 0); font-size: 15.6px; text-align: justify;">當採樣棒到達陰道的頂部時，轉動3-5次以收集細胞。</span></li> 	<li><span style="color: rgb(0, 0, 0); font-size: 15.6px; text-align: justify;">完成後，輕輕抽出採樣棒，立即放回樣本袋及封好。</span></li> 	<li><span style="color: rgb(0, 0, 0); font-size: 15.6px; text-align: justify;">將已封好的樣本袋放入回郵信封，並在24小時內寄回或者送到指定地點。</span></li> 	<li><span style="color: rgb(0, 0, 0); font-family: Roboto, Arial, sans-serif, &quot;Heiti TC&quot;, PMingLiU; font-size: 15.6px; text-align: justify;">當你感到疼痛，請立即停止並諮詢家庭醫生。</span></li> </ul>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><strong><span style="font-size:20px;"><span style="color:#000000;">測試的結果</span></span></strong></p>  <p><span style="color:#000000;"><span style="font-size:16px;">如果你的HPV測試結果呈陽性，表示你需要與家庭醫生作進一步檢查。感染HPV並不代表你已患上子宮頸癌，絕大多數的HPV病毒都能由免疫系統清除，但你有比較大的機會出現子宮頸細胞病變，因此定期檢查對於預防子宮頸癌是十分重要。</span></span></p>  <p><span style="color:#000000;"><span style="font-size:16px;">HPV測試結果呈陰性意味著在子宮頸細胞中沒有發現HPV病毒，但你應該如常接受定期篩查，以預防子宮頸癌。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><strong><span style="color:#000000;"><span style="font-size:16px;">如有疑問，請馬上與你的家庭醫生聯絡，</span></span></strong></p>  <p style="text-align: center;"><strong><span style="color:#000000;"><span style="font-size:16px;">以了解你的測試結果及評估是否需要作進一步的檢查。</span></span></strong></p>  <p>&nbsp;</p>  <section style="box-sizing: border-box; font-family: Roboto, Arial, sans-serif, &quot;Heiti TC&quot;, PMingLiU; font-size: 14px;"> <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px; text-align: center;">&nbsp;</div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px; text-align: center;">&nbsp;</div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px; text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/banner-bottom(1).jpg" style="width: 640px; height: 384px;" /></div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px; text-align: center;">&nbsp;</div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px; text-align: center;">&nbsp;</div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px;">&nbsp;</div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/logo-related-03.png" style="width: 153px; height: 100px; float: left;" />&nbsp;<img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/logo-related-02.png" style="width: 86px; height: 100px;" /><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/logo-related-01.png" style="width: 115px; height: 100px;" /></div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px;">&nbsp;</div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px;"><span style="color:#696969;"><span style="font-size:14px;">資料來自:<span style="font-family: Roboto, Arial, sans-serif, &quot;Heiti TC&quot;, PMingLiU; text-align: right;">香港中文大學醫學院賽馬會公共衞生及基層醫療學院</span></span></span></div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px;">&nbsp;</div>  <div class="row" style="box-sizing: border-box; margin-right: -15px; margin-left: -15px;"><span style="font-size:14px;"><span style="color:#696969;">實用連結:</span><span style="color:#0000FF;">&nbsp;<a href="http://www.cuhk.edu.hk/sphpc/hpvselfsampling/zh/index.html" target="_blank">http://www.cuhk.edu.hk/sphpc/hpvselfsampling/zh/index.html</a></span></span></div> </section>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180312]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/hpv%e8%87%aa%e6%88%91%e6%8e%a1%e6%aa%a2%e7%a4%be%e5%8d%80%e8%a8%88%e5%8a%83/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[實用資訊>相關網站資料, 香港]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[hpv%e8%87%aa%e6%88%91%e6%8e%a1%e6%aa%a2%e7%a4%be%e5%8d%80%e8%a8%88%e5%8a%83]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[62]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180312]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7216]]></id>
		<title><![CDATA[轉移性乳癌的治療]]></title>
		<content><![CDATA[<p><strong style="font-family: sans-serif, Arial, Verdana, &quot;Trebuchet MS&quot;; font-size: 24px; background-color: rgb(255, 255, 255);">轉移性乳癌的治療</strong></p>  <p>&nbsp;</p>  <p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/her22(1)(1)(1).jpg" style="width: 600px; height: 270px;" /></p>  <p>&nbsp;</p>  <div><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">轉移性乳癌指癌細胞已由乳房擴散至其他器官(第 4 期)，一般不適合以手術切除，故治療方法多以藥物治療為主，可能包括化療、標靶藥物或荷爾蒙治療。視乎情況亦有可能配以放射治療。</span></span></div>  <div>&nbsp;</div>  <div><br /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">對於轉移性乳癌的治療，妳可能有聽說過所謂一線、二線、或更後線的治療，這是學術上的用語&ndash;轉移性乳癌的患者最先用的治療方案就叫做一線治療。這個治療方案用完之後，如果不幸乳癌不受控制或病情惡化，再轉用的方案就是二線治療方案，如此類推。</span></span></div>  <div>&nbsp;</div>  <div><br /> <span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">在治療期間，妳的醫生會建議定期進行不同的測試，以檢查治療是否有效並且有沒有引起嚴重的副作用。除了基本的臨床身體檢查，還可能會定期進行關於肝臟和心臟功能的測試，CT 掃描，骨掃描，或 PET/CT 掃描檢查等等。</span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">如有興趣了解更多關於乳癌的資訊，</span></span></div>  <div><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">請參閱：<a href="http://her2morrow.com.hk" target="_blank">http://her2morrow.com.hk</a></span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;">安全報告免責聲明<br /> 此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，請向您的醫生或藥劑師諮詢和報告。<br /> 以上健康教育資訊由羅氏大藥廠香港有限公司提供 (NPM-HK-0074-11-2017)</span></span></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180313]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%bd%89%e7%a7%bb%e6%80%a7%e4%b9%b3%e7%99%8c%e7%9a%84%e6%b2%bb%e7%99%82/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%bd%89%e7%a7%bb%e6%80%a7%e4%b9%b3%e7%99%8c%e7%9a%84%e6%b2%bb%e7%99%82]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[63]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180313]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7217]]></id>
		<title><![CDATA[我有正能量：抗癌「動起來」]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>我有正能量：抗癌「動起來」</strong></span></span></p>  <p>&nbsp;</p>  <p><br /> <span style="font-size:16px;"><span style="color:#000000;">「我以前見到體育節目會即刻轉台，覺得好悶，點會睇？」曾曉慧曾經與不少女生一樣，不喜歡運動，打場羽毛球已經很難得。二十六歲的時候確診患上血癌後，卻為衣櫃增添了大量運動服裝，以前最討厭的運動店變成逛街最愛。治療病症的四年間，她重新提起筆桿，一筆一畫道出在運動路上的堅持，冀以自身經驗鼓勵同路人。</span></span></p>  <p><br /> &nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><iframe allow="encrypted-media" frameborder="0" gesture="media" height="420" scrolling="no" src="http://tv.on.cc/hk/index.html?i=ONS180309-14661-52-M&amp;d=1520707309&lt;br /&gt;" width="650"></iframe></p>  <p><br /> &nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><br /> <span style="color:#696969;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0311-00176-120h1(1).jpg" style="width: 450px; height: 250px;" /><br /> 歷經巨變，曉慧開始運動生涯。</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">曉慧小時候努力讀書，長大後專注工作，以為人生道路會一直平坦下去。直至一天，她的腿突然腫得像豬蹄，家庭醫生檢查數次也沒有結果，只能轉介她到醫院驗血，竟發現血液有問題，「我當時呆咗，無諗過咁大件事會發生喺我身上。」等候時間愈長，不安感愈重，曉慧忍不住抱着伴侶哭起來。伴侶驚覺人生無常，抓緊時間向曉慧求婚，她口裏答應，但心裏又怕連累另一半。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">化驗報告顯示，曉慧白血球數量比正常人高四倍，血色素和血小板則低很多，證實患上急性血癌，須即日開始化療。護士在手上種了「鹽水痘」後，就把紅色的化療藥打到曉慧身體裏，藥帶刺激性，注射得太快會有灼熱感，曉慧只能忍受。化療令她的身體變得十分虛弱，「有個室友同我講，佢見住我瞓足十幾個鐘，郁都唔郁」，簡單如一小時的連續散步也用了她兩星期時間訓練。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><strong><span style="font-size:20px;">「唔想好番後身體都咁差」</span></strong></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">她驚覺自己的身體機能太弱，默默許諾要重新運動，「雖然醫生話個病康復率好高，但我唔想好番後身體都係咁差。」曉慧先以行山為目標，配搭瑜伽改善筋骨缺乏鍛煉的問題。期間，伴侶突然邀請一起參加三公里馬拉松比賽，「既然散步可以，身體亦開始好轉，點解唔試吓。」於是她以馬拉松為動力，堅定運動的決心。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">運動令化療帶來的副作用大大降低，肌肉量增加，負面情緒減低，令她喜歡上運動。剛好有朋友是高強度間歇訓練（HIIT）的教練，她也去報名參加，「第一次訓練要做一個連續跳躍一分鐘的動作，做完真係喘晒氣，無晒力，痠痛維持咗兩三日」。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0311-00176-120p2g5(1).jpg" style="width: 300px; height: 300px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;">在伴侶的陪伴下，曉慧開始運動。</span></span><br /> &nbsp;</p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0311-00176-120p3g5(1).jpg" style="width: 300px; height: 300px;" /><br /> 曉慧的腰部接受過三次骨髓穿刺，由醫生刺穿骨頭到骨髓，抽出骨髓檢驗。</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-size:20px;"><strong>印證努力成果 挑戰馬拉松</strong></span></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">「沒有奇迹、只有累積」印證了她的努力，以前連散步都有困難，堅持運動後，連數天的台灣旅遊都能克服。她更於社交網站開設專頁，分享抗病及運動經歷，本意雖是打發時間，卻從中找到力量，「曾經有病人私訊我，話睇到我嘅經歷後重燃佢哋嘅希望，我都好受鼓舞」，剛參加完馬拉松比賽的她期望，未來能在一小時十分鐘內完成十公里賽事。化療療程告一段落，曉慧的運動生涯才剛開始。</span></span></p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:16px;"><span style="font-size:14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0311-00176-120p4g6.jpg" style="width: 300px; height: 300px;" /><br /> 從前不諳運動的曉慧已經成為運動能手。</span></span></span></p>  <p style="text-align: center;"><br /> <span style="color:#696969;"><span style="font-size:16px;"><span style="font-size:14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0311-00176-120p5g6.jpg" style="width: 300px; height: 300px;" /></span></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:16px;"><span style="font-size:14px;">曉慧已參加多次馬拉松比賽，期望下次能在一小時十分鐘內完成十公里賽事。</span></span></span><br /> <br /> &nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:14px;">圖：專案組</span></span></p>  <p><span style="color:#696969;"><span style="font-size:14px;">文：陳綺雯</span></span></p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:14px;">文章來自:東方日報</span></span></p>  <p><span style="font-size:14px;"><a href="http://orientaldaily.on.cc/cnt/news/20180311/00176_120.html" target="_blank"><span style="color:#0000FF;">http://orientaldaily.on.cc/cnt/news/20180311/00176_120.html</span></a></span></p>  <div class="largeAdsCTN" style="margin: 0px 0px 0px 20px; padding: 0px;"> <div id="beacon_b6d0e7d1f3" style="margin: 0px; padding: 0px; position: absolute; left: 0px; top: 0px; visibility: hidden;"><img alt="" height="0" src="http://ad4.on.cc/web/www/delivery/lg.php?bannerid=4314&amp;campaignid=2168&amp;zoneid=695&amp;loc=1&amp;referer=http%3A%2F%2Forientaldaily.on.cc%2Fcnt%2Fnews%2F20180311%2F00176_120.html&amp;cb=b6d0e7d1f3" style="border: 0px; width: 0px; height: 0px;" width="0" /></div>  <div id="beacon_24f88651fe" style="margin: 0px; padding: 0px; position: absolute; left: 0px; top: 0px; visibility: hidden;"><img alt="" height="0" src="http://ad4.on.cc/web/www/delivery/lg.php?bannerid=5080&amp;campaignid=2599&amp;zoneid=700&amp;loc=1&amp;referer=http%3A%2F%2Forientaldaily.on.cc%2Fcnt%2Fnews%2F20180311%2F00176_120.html&amp;cb=24f88651fe" style="border: 0px; width: 0px; height: 0px;" width="0" /></div> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180313]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%88%91%e6%9c%89%e6%ad%a3%e8%83%bd%e9%87%8f%ef%bc%9a%e6%8a%97%e7%99%8c%e3%80%8c%e5%8b%95%e8%b5%b7%e4%be%86%e3%80%8d/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>病患個案]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%88%91%e6%9c%89%e6%ad%a3%e8%83%bd%e9%87%8f%ef%bc%9a%e6%8a%97%e7%99%8c%e3%80%8c%e5%8b%95%e8%b5%b7%e4%be%86%e3%80%8d]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[64]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180313]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7218]]></id>
		<title><![CDATA[遺傳突變基因 籲驗血檢查 卵巢癌死亡率達5.5%]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong><span style="font-family: Arial, Helvetica, sans-serif; line-height: normal;">遺傳突變基因 籲驗血檢查 卵巢癌死亡率達5.5%</span></strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><span style="font-size:26px;"><strong><span style="font-family: Arial, Helvetica, sans-serif; line-height: normal;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/1520895162_ET-1280w.jpg" style="width: 640px; height: 360px;" /></span></strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><strong>卵巢癌是本港女性十大癌症發病率的第六位，患卵巢癌的女性在十年間上升40%。由於卵巢癌於骨盆深處，所以卵巢癌早期病徵不明顯，不少患者摸到明顯腫塊才求醫，癌症已到後期，結果增加了死亡率。在多種婦科癌症中，卵巢癌的死亡率偏高達5.5%。目前有10%的卵巢癌與遺傳基因突變有關，當中BRCA的基因突變更有一半機會遺傳至下一代。</strong></span></span></p>  <p>&nbsp;</p>  <p><br /> &nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">香港遺傳性乳癌家族資料庫搜集了2817患者的數據，發現同時患有乳癌有卵巢癌家族史中，出現BRCA1型基因突變高達39.4%，而沒有家族史的BRCA1型基因突變患者亦有25.6%。資料庫主席鄺靄慧(圖右)指，在BRCA1基因突變型卵巢癌中，40%患者為50歲以下，而家族史中曾有成員患乳癌及卵巢癌，均較高風險。要知道有否帶有遺傳性基因突變，可驗血檢查。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">現年48歲的黃小姐(圖中)，因為BRCA的基因突變遺傳，10年間先後患上乳癌及多次的卵巢癌復發。在07年乳癌後康復，12年因嘔吐及腹部脹痛，直至抽血檢查才確診患上第三期卵巢癌，並於14年及16年再度復發，接受近30次化療。她指，化療是最辛苦，「每次落藥後半小時，不斷屙嘔、肚痛」要醫生開安眠藥才可入睡。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">醫學界近年針對BRCA研發新的標靶藥物，有效降低癌症復發的風險，對基因突變型卵巢癌療效尤其顯著。黃小姐在服用新標靶藥物後雖仍會感到疲累，但副作用大大減少。惟新藥物費用較昂貴，28日藥需5萬元，因此資料庫推出BRCA基因突變型卵巢癌藥物資助計劃，為有需要患者提供該藥物資助，詳情可查看</span></span><span style="font-size:16px;"><a href="http://www.asiabreastregistry.com" target="_blank"><span style="color:#0000FF;">www.asiabreastregistry.com</span></a></span><span style="color:#000000;"><span style="font-size:16px;">。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:16px;">文章來自:AM730</span></span></p>  <p><span style="font-size:16px;"><a href="https://www.am730.com.hk/news/健康/遺傳突變基因-籲驗血檢查-卵巢癌死亡率達5-5-118908" target="_blank"><span style="color:#0000FF;">https://www.am730.com.hk/news/健康/遺傳突變基因-籲驗血檢查-卵巢癌死亡率達5-5-118908</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180313]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%81%ba%e5%82%b3%e7%aa%81%e8%ae%8a%e5%9f%ba%e5%9b%a0-%e7%b1%b2%e9%a9%97%e8%a1%80%e6%aa%a2%e6%9f%a5-%e5%8d%b5%e5%b7%a2%e7%99%8c%e6%ad%bb%e4%ba%a1%e7%8e%87%e9%81%945-5/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[實用資訊>醫療費用援助]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%81%ba%e5%82%b3%e7%aa%81%e8%ae%8a%e5%9f%ba%e5%9b%a0-%e7%b1%b2%e9%a9%97%e8%a1%80%e6%aa%a2%e6%9f%a5-%e5%8d%b5%e5%b7%a2%e7%99%8c%e6%ad%bb%e4%ba%a1%e7%8e%87%e9%81%945-5]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[65]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180313]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7219]]></id>
		<title><![CDATA[盆腔超聲波 及早發現卵巢癌]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:16px;"><strong><span style="font-size:26px;">盆腔超聲波 及早發現卵巢癌</span></strong><br /> &nbsp;</span></span><span style="color:#696969;"><span style="font-size:16px;"><span style="font-size:14px;">07:30 2018/03/13&nbsp;</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:16px;"><span style="font-size:14px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/dicn0306203_1024.jpg" style="width: 640px; height: 360px;" /><br /> &nbsp;養和醫院婦產科顧問譚家輝醫生表示，子宮體癌、子宮頸癌和卵巢癌都是婦科常見癌症，</span></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:16px;"><span style="font-size:14px;">當中以卵巢癌最容易被延誤治療，死亡率亦偏高。</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">卵巢癌及早發現，存活率可達9成。有婦產科醫生忠告，進行子宮頸細胞檢查（柏氏抹片）時，一併進行盆腔超聲波檢查。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">養和醫院婦產科顧問譚家輝醫生表示，子宮體癌、子宮頸癌和卵巢癌都是婦科常見癌症，當中以卵巢癌最容易被延誤治療，死亡率亦偏高。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">他解釋，子宮體癌徵狀明顯，比如陰道不定期出血等，大部分女性不難早期發現；至於子宮頸癌，隨政府宣傳全港性子宮頸普查計劃，很多女性均有定期做子宮頸細胞檢查。不過，以超聲波檢查卵巢並非常見婦科檢查，女性容易忽略，故逾半卵巢癌患者確診時已屬第三期或第四期。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">他續指，卵巢癌不如子宮頸癌，沒有癌前變化，亦沒有疫苗可預防，徵狀不明顯，如患者能及早發現，第一期患者5年存活率可達9成，但第三期及第四期患者則只有約2成至3成存活率；後期患者不僅需切除卵巢，亦會增復發機會及減低化療效果。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">譚家輝建議女性定期進行子宮頸細胞檢查（柏氏抹片）時，可一併進行盆腔超聲波檢查，尤其是常感腸胃不適者，如排除胃部及腸部問題，宜進一步檢查卵巢狀況。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">據衞生署資料，子宮頸細胞檢查適用於25歲已有性經驗的女性，有關人士宜連續兩年進行檢驗，如結果屬正常，可每3年接受1次檢驗 。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">譚表示，曾有性經驗的女性可進行陰道超聲波檢查；沒有性行為的女性則可以腹部超聲波檢查卵巢，又指超聲波檢查沒有輻射等副作用，過程亦不疼痛，屬非入侵性檢查，一次約由數百元至1,000元不等。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">至於被視為卵巢癌指數的CA-125抽血檢查，譚家輝指有關檢查是用來判斷腫瘤是否屬惡性，並非用來診斷市民有否患癌，因臨床上約8成檢查者癌指數偏高；相反，即使是第三期卵巢癌患者，癌指數亦可屬正常，並不能準確反映實況。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">據醫管局2015年最新數字，卵巢癌新症為578宗，粗死亡率為5.5%，有關數字連續7年超越子宮頸癌。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:14px;">文章來自: TOPICK</span></span></p>  <p><a href="http://topick.hket.com/article/2028587/盆腔超聲波　及早發現卵巢癌?mtc=10027" target="_blank"><span style="color:#0000FF;">http://topick.hket.com/article/2028587/盆腔超聲波　及早發現卵巢癌?mtc=10027</span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180313]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%9b%86%e8%85%94%e8%b6%85%e8%81%b2%e6%b3%a2-%e5%8f%8a%e6%97%a9%e7%99%bc%e7%8f%be%e5%8d%b5%e5%b7%a2%e7%99%8c/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[實用資訊>醫療費用援助]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%9b%86%e8%85%94%e8%b6%85%e8%81%b2%e6%b3%a2-%e5%8f%8a%e6%97%a9%e7%99%bc%e7%8f%be%e5%8d%b5%e5%b7%a2%e7%99%8c]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[66]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180313]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7220]]></id>
		<title><![CDATA[荷蘭抗癌雪板女將 勇退病魔帕運摘金]]></title>
		<content><![CDATA[<div class="news_title" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; color: rgb(66, 66, 66); font-size: 25px; font-weight: bold; line-height: 50px;"> <h1 itemprop="headline" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-family: inherit; font-size: 25px; font-weight: bold; line-height: 50px;"><span style="color:#000000;"><span style="font-size:26px;"><strong>荷蘭抗癌雪板女將 勇退病魔帕運摘金</strong></span></span></h1> </div>  <p style="margin: 0px 15px 15px 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-family: inherit; color: rgb(66, 66, 66); font-size: 14px; float: left; display: inline-table; line-height: 30px;"><span style="color:#696969;">發稿時間：2018/03/13 00:12</span></p>  <p class="blue" style="margin: 0px 15px 15px 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-family: inherit; color: rgb(13, 71, 161); font-size: 14px; float: left; display: inline-table; line-height: 30px;"><span style="color:#696969;">最新更新：2018/03/13 09:57</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><iframe allow="encrypted-media" frameborder="0" gesture="media" height="420" scrolling="no" src="https://www.youtube.com/embed/w0aXRokjeZg" width="650"></iframe></p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 14px; line-height: 30px;">荷蘭雪板女將曼托-史佩12日在平昌冬季帕運勇奪金牌，</span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 14px; line-height: 30px;">表現不受幾個月來兩度接受癌症手術的不利影響。</span></span><span style="color:#696969;"><span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 14px; line-height: 30px;">（取自Paralympic Games YouTube頻道）</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; line-height: 30px;">（中央社南韓平昌12日綜合外電報導）荷蘭雪板女將曼托-史佩今天在平昌冬季帕拉林匹克運動會（Paralympic Games）勇奪金牌，表現不受幾個月來兩度接受癌症手術的不利影響。</span><br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; line-height: 30px;">曼托-史佩（Bibian Mentel-Spee）名列女子截肢組，在單板滑雪障礙追逐賽（Snowboard Cross）決賽中，擊敗隊友彭莎登（Lisa Bunschoten），漂亮奪下金牌。</span><br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; line-height: 30px;">這項勝利意義非凡。這位資深雪板運動員去年7月癌症復發，脖子上發現惡性腫瘤，並在12月與今年一月先後進行了兩輪手術。</span><br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; line-height: 30px;">法新社報導，45歲的曼托-史佩奪金後表示：「這個感覺十分美妙，特別是經過前幾個月之後，我非常激動開心。」</span><br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; line-height: 30px;">曼托-史佩在2001年因骨癌失去一條小腿之前，就已是一位經驗老道的雪板運動員。</span><br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> <span style="font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; line-height: 30px;">她後來持續參與雪板運動，也是雪板首度納入2014年素溪（Sochi）冬季帕運的重要推手，當時她在單板滑雪障礙追逐賽中摘下金牌。（譯者：陳乃瑜/核稿：嚴思祺）1070312</span></span></span></p>  <p>&nbsp;</p>  <p><br style="color: rgb(66, 66, 66); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 18px; line-height: 30px;" /> &nbsp;</p>  <p><span style="font-size:14px;"><span style="color:#696969;">文章來自: 中央通訊社</span></span></p>  <p><span style="font-size:14px;"><a href="http://www.cna.com.tw/news/aspt/201803130002-1.aspx" target="_blank"><span style="color:#0000FF;">http://www.cna.com.tw/news/aspt/201803130002-1.aspx</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180313]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%8d%b7%e8%98%ad%e6%8a%97%e7%99%8c%e9%9b%aa%e6%9d%bf%e5%a5%b3%e5%b0%87-%e5%8b%87%e9%80%80%e7%97%85%e9%ad%94%e5%b8%95%e9%81%8b%e6%91%98%e9%87%91/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[實用資訊>醫療費用援助]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%8d%b7%e8%98%ad%e6%8a%97%e7%99%8c%e9%9b%aa%e6%9d%bf%e5%a5%b3%e5%b0%87-%e5%8b%87%e9%80%80%e7%97%85%e9%ad%94%e5%b8%95%e9%81%8b%e6%91%98%e9%87%91]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[67]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180313]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7221]]></id>
		<title><![CDATA[雅典第10 屆IEEPO國際病人組織交流大會]]></title>
		<content><![CDATA[<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/IMG-20180315-WA0040.jpg" style="width: 600px; height: 450px;" /></p>  <p><span style="font-size:16px;">癌症資訊網慈善基金參與在雅典第10 屆IEEPO國際病人組織交流大會，</span></p>  <p><span style="font-size:16px;">第1日會議中亮點 :&nbsp;Digital Health</span><span style="font-size:16px;">be</span><span style="font-size:16px;">&nbsp; a</span><span style="font-size:16px;"> smart patient, data Apps information,&nbsp;<br /> 大數據時代應用與挑戰、人工智能、病人電子數據模式結集探討. 並參與免疫治療病人交流會議，了解免疫治療模式及分享各國癌症病人組織經驗.</span></p>  <p>&nbsp;</p>  <p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/IMG-20180315-WA0028%20(1).jpg" style="width: 600px; height: 450px;" /></p>  <p>&nbsp;</p>  <p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/IMG-20180315-WA0027.jpg" style="width: 600px; height: 450px;" /></p>  <p>&nbsp;</p>  <p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/IMG-20180315-WA0038.jpg" style="width: 600px; height: 692px;" /></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180315]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%9b%85%e5%85%b8%e7%ac%ac10-%e5%b1%86ieepo%e5%9c%8b%e9%9a%9b%e7%97%85%e4%ba%ba%e7%b5%84%e7%b9%94%e4%ba%a4%e6%b5%81%e5%a4%a7%e6%9c%83/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[城中活動>癌症資訊網過往活動花絮]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%9b%85%e5%85%b8%e7%ac%ac10-%e5%b1%86ieepo%e5%9c%8b%e9%9a%9b%e7%97%85%e4%ba%ba%e7%b5%84%e7%b9%94%e4%ba%a4%e6%b5%81%e5%a4%a7%e6%9c%83]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[68]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180315]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7222]]></id>
		<title><![CDATA[醫管局「晚期醫護服務」讓病人與家屬參與治療決定]]></title>
		<content><![CDATA[<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/rthk-11.jpg" style="width: 600px; height: 450px;" /></p>  <p><span style="color: rgb(0, 0, 0); font-family: Arial, Helvetica, sans-serif; font-size: 16px;">醫管局推出「晚期醫護服務」，病人與家屬可以參與治療決定。(佘典茵攝)</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><font my="my" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 16px; vertical-align: baseline; font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);">醫管局在2014年初推出「晚期醫護服務」，主要對象是院舍長者，當病情嚴重到某一個程度，不可逆轉時，外展護士會提出有關服務，讓病人及照顧者對醫護服務有更大程度參與，讓病者在人生最後階段，過得更有尊嚴和減少痛苦，亦可減輕照顧者生理及心理壓力。</font><br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <font my="my" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 16px; vertical-align: baseline; font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);">參與計劃的社區醫療服務顧問護師李雯敏說，晚期病人與家屬可以參與治療決定，例如在病人仍然清醒，決定在最後階段時是否依賴插喉餵食等。她強調醫生並非不想救病人，會解釋如何對長者是更好，醫生及護士會提供意見，做決定的重擔不是由家屬獨自承受。</font><br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <font my="my" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 16px; vertical-align: baseline; font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);">有使用過服務的市民說，在父親晚期治療時獲醫護人員詳細解釋，溝通好預設醫療指示，讓父親臨終前更有尊嚴及感覺舒服些。</font><br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <font my="my" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 16px; vertical-align: baseline; font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);">新界西醫院聯網老人科顧問醫生歐陽東偉說，晚期病人往往重複入院或急症室，病人及照顧者都會身心俱疲，希望計劃可讓他們有更好溝通。</font><br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <br style="font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);" /> <font my="my" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 16px; vertical-align: baseline; font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);">醫管局豁下5個聯網都有晚期醫護計劃，在新界西聯網自推行計劃以來，有3百多位病人參加，現時正服務大約2百位長者。</font></p>  <p><a href="http://news.rthk.hk/rthk/ch/component/k2/1386606-20180319.htm" target="_blank"><font my="my" style="margin: 0px; padding: 0px; border: 0px; outline: 0px; font-size: 16px; vertical-align: baseline; font-family: &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif; background-color: rgb(255, 255, 255);">http://news.rthk.hk/rthk/ch/component/k2/1386606-20180319.htm</font></a></p>  <p>&nbsp;</p>  <p>延申閱讀 :</p>  <p><a class="top NQHJEb dfhHve" href="https://www.hk01.com/%E6%B8%AF%E8%81%9E/169030/%E9%86%AB%E7%AE%A1%E5%B1%80%E6%8E%A8-%E9%A0%90%E8%A8%AD%E7%85%A7%E9%A1%A7%E8%A8%88%E5%8A%83-%E5%8A%A9%E9%87%8D%E7%97%85%E8%80%85%E6%9C%89%E5%B0%8A%E5%9A%B4%E5%9C%B0%E8%B5%B0%E6%9C%80%E5%BE%8C%E4%B8%80%E6%AE%B5%E8%B7%AF" ping="/url?sa=t&amp;source=web&amp;rct=j&amp;url=https://www.hk01.com/%25E6%25B8%25AF%25E8%2581%259E/169030/%25E9%2586%25AB%25E7%25AE%25A1%25E5%25B1%2580%25E6%258E%25A8-%25E9%25A0%2590%25E8%25A8%25AD%25E7%2585%25A7%25E9%25A1%25A7%25E8%25A8%2588%25E5%258A%2583-%25E5%258A%25A9%25E9%2587%258D%25E7%2597%2585%25E8%2580%2585%25E6%259C%2589%25E5%25B0%258A%25E5%259A%25B4%25E5%259C%25B0%25E8%25B5%25B0%25E6%259C%2580%25E5%25BE%258C%25E4%25B8%2580%25E6%25AE%25B5%25E8%25B7%25AF&amp;ved=0ahUKEwjU6uWm-ffZAhWET7wKHbB2AkcQvIgBCCUwAA" style="text-decoration-line: none; float: left; margin: 3px 8px 0px 0px; width: 100px; color: rgb(102, 0, 153); cursor: pointer; font-family: arial, sans-serif; font-size: small;"><img alt="Story image for 預設照顧計劃 from 香港01" class="th BbeB2d" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSSGFgSUY8iv0yaMlDpVPLzXqKsVXTIGZ_s3Hzl6LDR5PBaO3yjjmw965a3NBEKF9inHkbGge3M" style="border-width: 0px; border-style: initial; margin: 0px; height: 100px; width: 100px;" /></a></p>  <div class="gG0TJc" style="color: rgb(68, 68, 68); font-size: small; padding-bottom: 4px; font-family: arial, sans-serif;"> <h3 class="r dO0Ag" style="font-size: medium; margin: 0px; padding: 0px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis;"><a class="l lLrAF" href="https://www.hk01.com/%E6%B8%AF%E8%81%9E/169030/%E9%86%AB%E7%AE%A1%E5%B1%80%E6%8E%A8-%E9%A0%90%E8%A8%AD%E7%85%A7%E9%A1%A7%E8%A8%88%E5%8A%83-%E5%8A%A9%E9%87%8D%E7%97%85%E8%80%85%E6%9C%89%E5%B0%8A%E5%9A%B4%E5%9C%B0%E8%B5%B0%E6%9C%80%E5%BE%8C%E4%B8%80%E6%AE%B5%E8%B7%AF" ping="/url?sa=t&amp;source=web&amp;rct=j&amp;url=https://www.hk01.com/%25E6%25B8%25AF%25E8%2581%259E/169030/%25E9%2586%25AB%25E7%25AE%25A1%25E5%25B1%2580%25E6%258E%25A8-%25E9%25A0%2590%25E8%25A8%25AD%25E7%2585%25A7%25E9%25A1%25A7%25E8%25A8%2588%25E5%258A%2583-%25E5%258A%25A9%25E9%2587%258D%25E7%2597%2585%25E8%2580%2585%25E6%259C%2589%25E5%25B0%258A%25E5%259A%25B4%25E5%259C%25B0%25E8%25B5%25B0%25E6%259C%2580%25E5%25BE%258C%25E4%25B8%2580%25E6%25AE%25B5%25E8%25B7%25AF&amp;ved=0ahUKEwjU6uWm-ffZAhWET7wKHbB2AkcQqQIIJigAMAA" style="text-decoration-line: none; color: rgb(102, 0, 153); font-size: 15px; cursor: pointer;">醫管局推「<span style="color: rgb(221, 75, 57); text-decoration-line: underline;">預設照顧計劃</span>」 助重病者有尊嚴地走最後一段路</a></h3>  <div class="slp" style="margin-bottom: 1px;"><span class="xQ82C e8fRJf" style="font-size: 13px; color: rgb(0, 102, 33);">香港01</span><span class="v0c3xd" style="color: rgb(102, 102, 102); padding: 0px 4px;">-</span><span class="f nsa fwzPFf" style="color: rgb(102, 102, 102); display: inline-block; font-size: 13px;">9 hours ago</span></div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">醫管局2015年起推出「<span style="color: rgb(221, 75, 57);">預設照顧計劃</span>」(ACP)，由新界西醫院聯網先導，至今已推展至全港安老院舍及公共醫院，參與計劃人數多達300人。當長者病情步入晚期、無法經治療好轉時，公共醫院老人科及紓緩治療科醫護人員會根據病人與家屬的意願，為其訂立紓緩醫療計劃；若病人意識清楚，亦會安排其簽署預設醫療指示&nbsp;...</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">預設照顧計劃</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;"><a href="http://www.ha.org.hk/haho/ho/psrm/Public_education1.pdf" target="_blank">http://www.ha.org.hk/</a></div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;"><span style="font-size:14px;"><span style="font-family: Comfortaa, &quot;Microsoft YaHei&quot;, &quot;Hiragino Sans GB&quot;, Arial, Helvetica, sans-serif; background-color: rgb(246, 245, 243);">院舍長者常出入醫院 預立醫療減患者痛苦</span></span></div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;"><a href="https://www.am730.com.hk/news/%E5%81%A5%E5%BA%B7/%E9%99%A2%E8%88%8D%E9%95%B7%E8%80%85%E5%B8%B8%E5%87%BA%E5%85%A5%E9%86%AB%E9%99%A2-%E9%A0%90%E7%AB%8B%E9%86%AB%E7%99%82%E6%B8%9B%E6%82%A3%E8%80%85%E7%97%9B%E8%8B%A6-119577" target="_blank"><span style="font-size:14px;"><span style="font-family: Comfortaa, &quot;Microsoft YaHei&quot;, &quot;Hiragino Sans GB&quot;, Arial, Helvetica, sans-serif; background-color: rgb(246, 245, 243);">https://www.am730.com.hk/news/</span></span></a></div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div>  <div class="st" style="line-height: 1.24; word-wrap: break-word;">&nbsp;</div> </div>  <div>&nbsp;</div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180319]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%86%ab%e7%ae%a1%e5%b1%80%e3%80%8c%e6%99%9a%e6%9c%9f%e9%86%ab%e8%ad%b7%e6%9c%8d%e5%8b%99%e3%80%8d%e8%ae%93%e7%97%85%e4%ba%ba%e8%88%87%e5%ae%b6%e5%b1%ac%e5%8f%83%e8%88%87%e6%b2%bb%e7%99%82%e6%b1%ba/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>舒緩治療]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%86%ab%e7%ae%a1%e5%b1%80%e3%80%8c%e6%99%9a%e6%9c%9f%e9%86%ab%e8%ad%b7%e6%9c%8d%e5%8b%99%e3%80%8d%e8%ae%93%e7%97%85%e4%ba%ba%e8%88%87%e5%ae%b6%e5%b1%ac%e5%8f%83%e8%88%87%e6%b2%bb%e7%99%82%e6%b1%ba]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[69]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180319]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7223]]></id>
		<title><![CDATA[永不放棄的百分之一：李歐．相信就會有奇蹟]]></title>
		<content><![CDATA[<h3><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/getImage86Q9BYF2.jpg" style="width: 640px; height: 595px;" /></h3>  <p>&nbsp;</p>  <h3><span style="color:#000000;">內容簡介</span></h3>  <div class="bd"> <div class="content" itemprop="description" style="height: auto;"> <div style="text-align: center;"><span style="font-size:20px;"><span style="color:#000000;"><strong>上天給我一個神奇的生日禮物，叫做「癌症末期」。<br /> 我的身體生病了，但我的心理不生病，<br /> 疼痛跟著我，但意志力也跟著我，<br /> 未來就算只有百分之一的希望，我也要追求到底！</strong></span></span></div>  <div style="text-align: center;">&nbsp;</div>  <div style="text-align: center;">&nbsp;</div>  <div style="text-align: center;">&nbsp;</div>  <div style="text-align: center;"> <p style="text-align: left;"><span style="color:#000000;"><span style="font-size:16px;">如果從來沒有受到關注呵護，你怨懟原生家庭嗎？<br /> 如果領到一筆年終獎金只有三百八十一元，你看不起自己嗎？<br /> 如果被宣告癌症末期，你第一個念頭是什麼？</span></span></p>  <p style="text-align: left;">&nbsp;</p>  <p style="text-align: left;"><span style="color:#000000;"><span style="font-size:16px;">勇者無懼李歐，一個在網路上被瘋狂轉傳，點閱千萬人次的生命故事。</span></span></p>  <p style="text-align: left;">&nbsp;</p>  <p style="text-align: left;"><span style="color:#000000;"><span style="font-size:16px;">他的原生家庭是一張破網，但他感謝環境讓他從小養成獨立冷靜的個性；<br /> 他做過無數工作，從不自暴自棄，開計程車學說話術，為了下車時客人一句「不用找」；<br /> 他修馬桶、修水電，雜務轉換資產管理SOP，很多機會錯過就永遠不會重來；<br /> 從菜鳥，一路攀升課長，副理，經理，積極行動建構成功藍圖&hellip;&hellip;<br /> 43歲生日那一天，知道罹患鼻咽癌末期，他問醫生一句「接下來呢？」</span></span></p>  <p style="text-align: left;">&nbsp;</p>  <p style="text-align: left;"><span style="color:#000000;"><span style="font-size:16px;">到底是何等的意志力和信念，可以正面挑戰死神的通緝？<br /> 他說癌症末期不是死刑，存活率只是數據，沒有夢想比貧窮更可怕！<br /> 他用洪荒之力，規律健身找回肌肉，體脂肪降到百分之十，對抗不到百分之十的存活率；<br /> 很多人忘了李歐是病人，他看起來幽默又陽光&hellip;&hellip;<br /> 是的，路不是走到盡頭，而是可以轉彎，讓樂觀成為唯一自我修復的藥。<br /> 三年前的李歐「永不放棄」，三年後的李歐「相信奇蹟」！</span></span></p> </div> </div> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180321]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%b0%b8%e4%b8%8d%e6%94%be%e6%a3%84%e7%9a%84%e7%99%be%e5%88%86%e4%b9%8b%e4%b8%80%ef%bc%9a%e6%9d%8e%e6%ad%90%ef%bc%8e%e7%9b%b8%e4%bf%a1%e5%b0%b1%e6%9c%83%e6%9c%89%e5%a5%87%e8%b9%9f/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>好書分享]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%b0%b8%e4%b8%8d%e6%94%be%e6%a3%84%e7%9a%84%e7%99%be%e5%88%86%e4%b9%8b%e4%b8%80%ef%bc%9a%e6%9d%8e%e6%ad%90%ef%bc%8e%e7%9b%b8%e4%bf%a1%e5%b0%b1%e6%9c%83%e6%9c%89%e5%a5%87%e8%b9%9f]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[70]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180321]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7224]]></id>
		<title><![CDATA[90後開餐廳推廣健康飲食 喝茶吃素融入時尚元素]]></title>
		<content><![CDATA[<h1 style="font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: bold; font-size: 25px; line-height: 1.5; font-family: arial; margin: 0px; padding: 0px; color: rgb(38, 89, 143); letter-spacing: 1px; font-stretch: normal;"><span style="color:#000000;"><strong><span style="font-size:26px;">90後開餐廳推廣健康飲食 喝茶吃素融入時尚元素</span></strong></span></h1>  <h1 style="font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: bold; font-size: 25px; line-height: 1.5; font-family: arial; margin: 0px; padding: 0px; color: rgb(38, 89, 143); letter-spacing: 1px; font-stretch: normal;"><span style="color:#696969;"><span style="font-size:14px;">2018年3月17日 10:40</span></span></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <div id="epc-article-detail"> <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">現時香港愈來愈多外帶茶飲店舖，漸漸扭轉傳統到酒樓「飲返杯茶」的概念。因為家人一場大病，令Chris了解健康的重要性，更令年紀輕輕的她成為餐廳主理人，結合茶藝及素食，將中國茶以新穎、現代方式呈現。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">傳統中國茶隨時代變得愈來愈新穎、普及，同樣主打茶藝及素食、走健康路綫的餐廳2DP，其主理人Chris因家人的一場大病離去，她與其他家庭成員選擇將留下的金錢有意義地延續下去。「自母親患上鼻咽癌，飲食習慣因而有所改變。直至她離開，我與其他家人都希望令這件不開心的事變成有意義的事，母親留下的遺產成為資金，希望打造一間與健康及素食有關的餐廳。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">Chris透過大學實習工作了解茶藝文化，並透露中國不同地方其實各自盛產不同茶葉，例如雲南出產普洱茶、武夷山盛產岩茶、安徽以烏龍茶及鐵觀音聞名，她在過程中發現農民用了最原始、對大自然最無害的方式種植，覺得種出來的農產品背後牽涉的智慧很大，「這是未來應該要傾向的一種種植或飲食方式，沒有採用任何農藥、跟大自然結合生產食品。」茶藝背後理念成為餐廳主題，再配以素食，帶出健康信息，「我想將中國茶普及化，甚至令更多外國人對此有所認識，並以新穎的方式呈現，中材西造，不想令人覺得『飲茶』只會在酒樓內出現。」因此，餐廳內除了可享受傳統品茗，亦售多款新穎、色香味俱全的果茶及花茶，都是Chris與員工們一同研發的茶類飲品，為傳統中國茶帶出不一樣味道。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><strong>餐廳變平台 配合員工興趣減流失</strong></span></span></p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">餐廳籌備開業花約3個月至半年時間，投放約$150萬，Chris坦言，店舖開張的首2個月很忙碌，要處理很多日常鎖碎事務，令員工流失率很高，即使提供不錯的待遇都未能把員工留下，Chris一直不知該怎樣做。「我便跟員工們閒聊，發覺其實他們即使有正職，不論有多普通，他們都會有自己想做的事，但奈何他們每天要工作10至12小時，因此未能實踐。」經過溝通，Chris選擇配合員工的興趣及想做的事，並結合餐廳遠景，慢慢跟他們一起實踐，「可能有員工過往一直烹調意粉，想嘗試創新、設計菜式，我們便一起構思；有員工想拍攝影片，我們便一起為餐廳拍攝短片，」Chris認為只要以健康為目標，員工之間都有商量空間，有彈性的實踐。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">餐廳選址於尖沙咀，租金的確不便宜，而租金亦因不同時段，佔比有所不同，旺季佔總支出約四分一，而淡季則佔約三分一。不過，Chris認為租金貴總比人流少好，「人流少生意額可以是零，如果是零的話，其實就是在燒錢。若選擇人流有保證、不會守得太辛苦的地方，反而縮短燒錢期。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><strong>聘神秘顧客 反映意見調整定價</strong></span></span></p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">至於食品的定價，由於餐牌菜式每星期都會變換，所以價錢會浮動，但相對靈活，他們亦會不時調整格價，Chris表示會聘用神秘顧客給他們意見，「神秘顧客將問卷填回來給我們，看看他們認為那款食品太貴、那款較便宜，從而調整定價。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">餐廳設計現代化，以白色為主，配有黑色、富中國色彩綫條，Chris透露是參考自華人建築師貝聿銘的設計，把將中國傳統在視覺上呈現，「因為想將傳統以現代化呈現眼前，所以便採用由貝聿銘設計的蘇州博物館作為藍圖，他的設計能將中國風格的特色，很新及現代化呈現出來，很切合我們的主題。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">23歲，聽起來是一個很年輕的數字，但Chris覺得23歲經營一間餐廳反而是優勢，「因為我23歲，可能我有很多事都不懂，亦沒有這個經驗，所以我會很開放跟大家討論，按着員工們廿幾三十年經驗，或者他們的興趣一起去實現一件事。所以，2DP並非以我為主，其實它更像是一個平台，大家都有自己想做的事。」</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><strong>中國茶Mix &amp; Match</strong></span></span></p>  <p>&nbsp;</p>  <p><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">各種茶葉該配合甚麼食材才是「夾」呢？Chris表示每種茶葉其實有其特性，例如紅茶屬於全發酵茶，味道偏向果香，配搭生果比較合適；以炭焙方式生產的岩茶，味道偏向炭香，建議配搭百角類、香草類食材；鐵觀音及單叢茶味道偏向花香，配以迷迭香、茉莉及佛手柑等香草都是不錯選擇。即使有以上基本的搭配概念，Chris形容研發茶類飲品亦並非一時三刻、一擊即中的事，要不斷試味、改良，才會有一杯「出得到街、嗒得杯落」的茶誕生。</span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>2DP專訪視頻：<a>http://ps.hket.com/article/2029118</a></p> </div>  <div id="epc-article-authors">撰文 : 李芷君&nbsp;</div>  <div>&nbsp;</div>  <p>&nbsp;</p>  <table border="1" cellpadding="50" cellspacing="50" style="height:500px;width:500px;"> 	<tbody> 		<tr> 			<td> 			<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/17PTF004_L_300.jpg" style="width: 300px; height: 200px;" /></p>  			<p>主理人Chris因家人的一場大病，選擇將留下的遺產成為資金，打造一間與健康有關的餐廳，有意義地延續下去。（陳智良攝）&nbsp;</p> 			</td> 			<td> 			<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/17PTF005_L_300.jpg" style="width: 300px; height: 200px;" /></p>  			<p>Chris想將中國茶普及化，甚至令更多外國人認識，中材西造並以新穎的方式呈現。（陳智良攝）&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p> 			</td> 		</tr> 		<tr> 			<td> 			<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/17PTF003_L_300.jpg" style="width: 300px; height: 200px;" /></p>  			<p>餐廳現時有約10名員工，Chris選擇配合員工的興趣及想做的事，並結合餐廳遠景一起實踐，保持良好關係之餘，亦可減低流失率。（陳智良攝）</p> 			</td> 			<td> 			<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/17PTF001_L_300.jpg" style="width: 300px; height: 200px;" /></p>  			<p>餐廳設計以白色為主，配有黑色、富中國色彩綫條，Chris透露是參考自華人建築師貝聿銘的設計，將傳統以現代化呈現眼前。（陳智良攝）&nbsp;</p> 			</td> 		</tr> 		<tr> 			<td> 			<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/17PTF002_L_300.jpg" style="width: 300px; height: 200px;" /></p>  			<p>餐廳選址於尖沙咀，Chris認為即使租金貴，總比人流少好。地段人流有保證，可以縮短燒錢期。</p>  			<p>（陳智良攝）&nbsp;</p> 			</td> 			<td> 			<p>&nbsp;</p> 			</td> 		</tr> 	</tbody> </table>  <div id="epc-article-detail"> <p>&nbsp;</p>  <p>&nbsp;</p> </div>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:14px;">文章來自:&nbsp;</span></p>  <p><span style="font-size:14px;"><a href="http://ps.hket.com/article/2032114" target="_blank"><span style="color:#0000FF;">http://ps.hket.com/article/2032114</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180321]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/90%e5%be%8c%e9%96%8b%e9%a4%90%e5%bb%b3%e6%8e%a8%e5%bb%a3%e5%81%a5%e5%ba%b7%e9%a3%b2%e9%a3%9f-%e5%96%9d%e8%8c%b6%e5%90%83%e7%b4%a0%e8%9e%8d%e5%85%a5%e6%99%82%e5%b0%9a%e5%85%83%e7%b4%a0/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>同行者之歌]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[90%e5%be%8c%e9%96%8b%e9%a4%90%e5%bb%b3%e6%8e%a8%e5%bb%a3%e5%81%a5%e5%ba%b7%e9%a3%b2%e9%a3%9f-%e5%96%9d%e8%8c%b6%e5%90%83%e7%b4%a0%e8%9e%8d%e5%85%a5%e6%99%82%e5%b0%9a%e5%85%83%e7%b4%a0]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[71]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180321]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7225]]></id>
		<title><![CDATA[開創治肺癌新療法﻿ ﻿名醫莫樹錦研究受賞﻿]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong>開創治肺癌新療法 名醫莫樹錦研究受賞</strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/i_640x427_660334616.jpg" style="width: 640px; height: 427px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span class="text">莫樹錦開創嶄新的標靶治療方案，憑這項劃時代療法，</span></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span class="text">獲全球醫學界形容為「黃金標準」的《新英倫醫學雜誌》選為年度文章。</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;">&nbsp; &nbsp; &nbsp; &nbsp; 香港彈丸之地，孕育不少國際醫學權威。《東周刊》報道，肺癌專家莫樹錦開創嶄新的標靶治療方案，憑這項劃時代療法，獲全球醫學界形容為「黃金標準」的《新英倫醫學雜誌》選為年度文章。被譽為是繼高錕後「最接近諾貝爾獎港人」的基因專家盧煜明，同獲《新英倫》金榜題名。</span></span></p>  <p><br /> <br /> <span style="color:#000000;"><span style="font-size:16px;">　　「最希望有一天，肺癌會變成慢性疾病。」香港中文大學醫學院臨牀腫瘤學系教授莫樹錦去年公佈一項調查結果，發現帶有EGFR基因變異的肺腺癌患者，在服用第一、二代標靶藥出現抗藥性後，改用第三代標靶藥對抗突變癌因子T790M，成效比化療更顯著，無惡化存活期有效延長超過一倍。目前，六成的肺腺癌病人有基因突變，其中兩成涉EGFR基因，尤以亞洲人最常見。「最開心是幫到病人，對他們最有意義的是，原來食完一隻藥冇用，仲有第二隻藥可以食，咁又可能多幾年命。」</span></span></p>  <p><br /> <br /> <span style="color:#000000;"><span style="font-size:16px;">　　○四年當哈佛大學發現EGFR基因變異後，莫樹錦知道肺癌研究從此不再一樣。他即游說中大病理解剖及細胞學系系主任杜家輝合作，翌年他們即跨國組隊，對肺癌進行全方位研究，「今次入選的論文，其實只是我們整個系列的其中一篇。」</span></span></p>  <p><br /> <br /> <span style="color:#000000;"><span style="font-size:16px;">　　埋首研發二十載，香港大學科學系血液、血液腫瘤及骨髓移植科教授鄺沃林的團隊對口服砒霜的安全份量及穩定性瞭如指掌。這隻全球首個港產抗癌藥已在歐美等五個國家申請專利，最快今年第一、二季推出市面，標誌着過去死亡率逾九成的白血病、骨髓瘤、淋巴瘤及急性早幼粒細胞白血病患者，終見重生的曙光，「根據臨牀測試，口服砒霜的生存率係百分之一百！」外國也有醫生透過靜脈注射砒霜治療血癌，但劑量往往難以控制，價錢亦相當天價；而鄺沃林研發的口服砒霜劑量經過嚴配，安全性較高，「定價由美國藥廠決定，不過愈平愈好，希望能夠推廣到第三世界，提供廉價或免費的治療。」</span></span></p>  <p><br /> <br /> <span style="color:#000000;"><span style="font-size:16px;"><strong><span style="font-size:20px;">中大病理學家 研究獲國際肯定</span></strong></span></span><br /> <br /> <span style="color:#000000;"><span style="font-size:16px;">　　中大化學病理學講座教授盧煜明過去廿年埋首基因世界，鑽研出一種新的檢查方法，能有效篩查到連病徵都未出現的極早期鼻咽癌病人，研究文章榮登《新英倫》一七年度最受矚目文章。盧煜明早年突破傳統羊膜穿刺的局限，發現孕婦血漿帶有胎兒DNA，開創新的產前檢查技術。他於是利用該產檢的基本原理，抽驗約二萬位無病徵男士的血漿，成功確診部份人已患有極早期的鼻咽癌，大大提高存活率。</span></span></p>  <p><br /> <br /> <span style="color:#000000;"><span style="font-size:16px;">　　一六年，外界一直盛傳他入選諾貝爾化學獎，最終卻擦肩而過。但他認為獎項其次，研究成果對醫學發展影響深遠才最重要，並希望以自己堅毅的研究精神，為年輕一代樹立良好榜樣。</span></span><br /> &nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#696969;">文章來自:&nbsp;頭條日報</span></p>  <p><a href="http://hd.stheadline.com/news/daily/hk/653711/" target="_blank"><span style="color:#0000FF;">http://hd.stheadline.com/news/daily/hk/653711/</span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180321]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%96%8b%e5%89%b5%e6%b2%bb%e8%82%ba%e7%99%8c%e6%96%b0%e7%99%82%e6%b3%95%ef%bb%bf-%ef%bb%bf%e5%90%8d%e9%86%ab%e8%8e%ab%e6%a8%b9%e9%8c%a6%e7%a0%94%e7%a9%b6%e5%8f%97%e8%b3%9e%ef%bb%bf/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>自由論壇]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%96%8b%e5%89%b5%e6%b2%bb%e8%82%ba%e7%99%8c%e6%96%b0%e7%99%82%e6%b3%95%ef%bb%bf-%ef%bb%bf%e5%90%8d%e9%86%ab%e8%8e%ab%e6%a8%b9%e9%8c%a6%e7%a0%94%e7%a9%b6%e5%8f%97%e8%b3%9e%ef%bb%bf]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[72]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180321]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7226]]></id>
		<title><![CDATA[卵巢癌新療法　延長存活期]]></title>
		<content><![CDATA[<div class="article-detail_inline-image-container" style="margin: 0px 0px 20px; padding: 0px; outline: 0px; text-align: center; font-size: 0px; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; background-color: rgb(250, 250, 250);"> <p class="article-detail_inline-image" style="margin: 0px; padding: 0px; outline: 0px; line-height: 1.4; display: inline-block; position: relative; max-width: 100%;"><picture class="image-gallery-img" style="cursor: pointer;"><img alt="左為全港首宗接受腹腔溫熱灌注化療的婦科病人Mary Coghill，右二及一為主診醫生吳東耀及葉勁麟。（陳永康攝）ᶛ" class="lazyloaded" data-src="https://topick.hket.com/res/v3/image/content/2030000/2033700/sssn0308302_1024.jpg" id="top-img" src="https://topick.hket.com/res/v3/image/content/2030000/2033700/sssn0308302_1024.jpg" style="border: none; display: block; max-width: 100%; margin-left: auto; margin-right: auto;" /></picture></p> </div>  <p class="article-detail_caption" style="margin: -20px 0px 20px; padding: 15px; outline: 0px; line-height: 1.4; background-color: rgb(239, 239, 239); font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify;">左為全港首宗接受腹腔溫熱灌注化療的婦科病人Mary Coghill，右二及一為主診醫生吳東耀及葉勁麟。（陳永康攝）ᶛ</p>  <div class="article-detail-body-container" style="margin: 0px -5px; padding: 0px 5px; outline: 0px; position: relative; max-height: initial; min-height: initial; overflow: hidden; clear: both; font-family: 微軟正黑體, &quot;Microsoft JhengHei&quot;, Arial, &quot;LiHei Pro Medium&quot;, Helvetica, sans-serif; font-size: 18px; text-align: justify; background-color: rgb(250, 250, 250);"> <div class="article-detail-content-container" style="margin: 0px; padding: 0px; outline: 0px;"> <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">卵巢癌是香港女性第6大癌症，近4成發現時已第三或第四期，死亡率偏高。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">有確診第三期卵巢癌的媽媽，為爭取更多生存時間陪伴幼子成長，接受名為腹腔溫熱灌注化療（HIPEC）的新療法，是香港首宗。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">雖然有研究指HIPEC可減慢復發3.5個月及延長近1年存活期，但個案少，收費高。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">HIPEC可用於治療大腸癌及胃癌等，香港每年進行不多於10宗，今次是香港首用於婦科癌。美籍居港人士Mary Coghill於一次抽血檢查後確診第三期卵巢癌，今年1月底接受手術前曾接受化療，她說接受HIPEC的原因很簡單，是希望給自己一個機會，可以活得更久，陪伴兒子長大，及不用再飽受化療副作用之苦。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">手術時間6小時，她接受HIPEC一天後，可慢慢下床，作嘔等副作用維持了一天；第3天她開始飲湯，兩星期後傷口癒合。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">Mary主診醫生之一、港大李嘉誠醫學院外科學系臨床助理教授葉勁麟指，公院一般只進行靜脈注射化療，但副作用多；HIPEC是在傳統化療以外動多一次手術。醫生開始療法前須將所有肉眼可見的腫瘤切清，再在病人處於麻醉狀態時，如「用滾水洗茶杯」般，透過42度高溫及直接灌化療藥進腹腔，溶液會在體內停留90分鐘。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">他指HIPEC可加強化療藥滲透力及以熱力直接殺死癌細胞，故患者就算「腹膜出現擴散都不是盡頭」。</p>  <div class="article-detail_inline-image-container" style="margin: 0px 0px 20px; padding: 0px; outline: 0px; text-align: center; font-size: 0px;"> <p class="article-detail_inline-image" style="margin: 0px; padding: 0px; outline: 0px; line-height: 1.4; display: inline-block; position: relative; max-width: 100%;"><picture class="image-gallery-img" style="cursor: pointer;"><source data-srcset="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_1024.jpg" media="(min-width: 630px)" srcset="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_1024.jpg" /><source data-srcset="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_600.jpg" media="(min-width: 330px)" srcset="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_600.jpg" /><source data-srcset="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_300.jpg" media="(min-width: 0px)" srcset="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_300.jpg" /><img alt="" class="lazyloaded" data-src="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_1024.jpg" src="https://topick.hket.com/res/v3/image/content/2030000/2033700/LC_02_1024.jpg" style="border: none; display: block; max-width: 100%; margin-left: auto; margin-right: auto;" /></picture></p> </div>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">另一主診醫生、港怡醫院婦科腫瘤科名譽顧問吳東耀引述今年1月在新英格蘭醫學期刊發表的研究，指研究人員9年內於荷蘭及比利時蒐集245位第三期卵巢癌患者，並將他們平均分成兩組，一組接受HIPEC，另一組則僅接受腫瘤切除手術。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">患者跟進年期中位數為4.7年，結果發現接受HIPEC患者的存活期中位數比另一組高近1年；復發期中位數亦高3.5個月。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">葉補充，HIPEC手術費用比一般腫瘤切除手術高10至15%；手術過程中患者會發燒，亦可出現肚出血及腎功能受影響。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">何人適合進行HIPEC？吳東耀指，患者需屬第三期卵巢癌患者，並在接受三期化療藥後病情有進展，即癌指數下降及腫瘤縮小一半以上；經評估後可於1個月後進行療法。他估計約7成第三期卵巢癌患者適合。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">據癌症資料庫，2015年本港有578宗卵巢癌新症，死亡人數有214人。</p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;"><a href="https://topick.hket.com/article/2033700/%E5%8D%B5%E5%B7%A2%E7%99%8C%E6%96%B0%E7%99%82%E6%B3%95%E3%80%80%E5%BB%B6%E9%95%B7%E5%AD%98%E6%B4%BB%E6%9C%9F" target="_blank">https://topick.hket.com/article/2033700</a></p>  <p style="margin: 0px 0px 20px; padding: 0px; outline: 0px; line-height: 1.4;">&nbsp;</p>  <h1 style="box-sizing: border-box; margin: 10px 10px 25px; font-size: 36px; font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; line-height: 1.3; color: rgb(25, 25, 25); background-color: rgb(255, 255, 255);"><span style="font-size:16px;">港怡首試卵巢癌腹腔溫熱化療&nbsp;&nbsp;</span><a href="http://hd.stheadline.com/news/realtime/hk/1168389/" target="_blank"><span style="font-size:16px;">http://hd.stheadline.com/news</span></a></h1> </div> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180322]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%8d%b5%e5%b7%a2%e7%99%8c%e6%96%b0%e7%99%82%e6%b3%95%e3%80%80%e5%bb%b6%e9%95%b7%e5%ad%98%e6%b4%bb%e6%9c%9f/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%8d%b5%e5%b7%a2%e7%99%8c%e6%96%b0%e7%99%82%e6%b3%95%e3%80%80%e5%bb%b6%e9%95%b7%e5%ad%98%e6%b4%bb%e6%9c%9f]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[73]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180322]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7227]]></id>
		<title><![CDATA[我有正能量：抗癌花韻]]></title>
		<content><![CDATA[<p><span style="color: rgb(0, 0, 0);"><span style="font-size: 26px;"><strong><span style="background-color: transparent; font-family: monospace; font-variant-numeric: normal; font-variant-east-asian: normal; white-space: pre-wrap; word-wrap: break-word;">我有正能量：抗癌花韻</span></strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h1><sup><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">冬去春來，百花爭妍。人生如四季更迭，轉角處總有另一番風景。今年維園花卉展覽，有慈善組織與本地花藝師合作，為癌症病患者舉辦時裝表演，以度身訂造的鮮花服飾，展現抗癌勇士重生的風采和喜悅，告訴公眾癌症並不可怕。</span></span></sup></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><iframe allow="encrypted-media" allowfullscreen="" frameborder="0" gesture="media" height="480" scrolling="no" src="http://tv.on.cc/hk/index.html?i=ONS180324-14661-47-M&amp;d=1521912162" width="680"></iframe></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><sup><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">「人生同花其實好相似，稍縱即逝，所以更加要記錄低最燦爛嘅時刻。」花藝師Florence把鮮花服飾的草圖放在工作室桌上，向記者講解箇中設計元素。「用色上揀咗國際婦癌同乳癌關注月嘅主題顏色，以粉紅同紫做主調，剪裁方面較為清新簡潔，營造春天氣息，象徵寒冬過後萬象更新。」</span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><sup><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">配搭時裝用的鮮花又稱為「穿戴花」，要「襟擺」之餘，更要切合模特兒的形象。這次Florence便選擇玫瑰、繡球花、跳舞蘭等充滿「女子力」的鮮花，每位模特兒之衣飾造型亦獨一無二&mdash;&mdash;熱衷義工服務的女生撐着以花朵砌成的彩傘，借喻「風雨同路」；媽媽級模特兒身穿披肩，頭戴闊邊帽，提着花造手袋，凸顯淑女的成熟風韻。「靈感來自佢哋同我分享嘅故事，我希望以感性嘅角度去演繹佢哋嘅個人特質，而唔係將佢哋睇成病人。」</span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0325-00176-060b1.jpg" style="width: 600px; height: 400px;" /></span></span></p>  <p style="text-align: center;"><span style="color: rgb(105, 105, 105);">主辦單位冀改變公眾對癌症的看法，宣揚「不完美，才是美」的訊息。</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <table align="center" border="1" cellpadding="1" cellspacing="1" style="height: 500px; width: 500px;"> 	<tbody> 		<tr> 			<td> 			<p style="text-align: center;"><span style="color: rgb(105, 105, 105);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0325-00176-060b2.jpg" style="width: 300px; height: 207px;" /></span></p>  			<ul class="photoCaption"> 				<li style="text-align: center;"><span style="color: rgb(105, 105, 105);">Florence逐一聆聽模特兒的故事，以花藝和時裝演繹各人特質。</span></li> 			</ul> 			</td> 			<td style="text-align: center;"><span style="color: rgb(105, 105, 105);">&nbsp;</span><span style="color: rgb(255, 255, 255);">............</span></td> 			<td> 			<p style="text-align: center;"><span style="color: rgb(105, 105, 105);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0325-00176-060b3.jpg" style="width: 300px; height: 207px;" /></span></p>  			<ul class="photoCaption"> 				<li style="text-align: center;"><span style="color: rgb(105, 105, 105);">雨傘拆骨後再繫上鐵線，鋪上鮮花後即變成彩傘。</span></li> 			</ul> 			</td> 		</tr> 		<tr> 			<td> 			<p style="text-align: center;">&nbsp;</p>  			<p style="text-align: center;"><span style="color: rgb(105, 105, 105);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0325-00176-060b4.jpg" style="width: 300px; height: 207px;" /></span></p>  			<ul class="photoCaption"> 				<li style="text-align: center;"><span style="color: rgb(105, 105, 105);">每套鮮花服飾均度身訂造，獨一無二。</span></li> 			</ul> 			</td> 			<td style="text-align: center;"><span style="color: rgb(105, 105, 105);">&nbsp; &nbsp;&nbsp;</span></td> 			<td> 			<p style="text-align: center;">&nbsp;</p>  			<p style="text-align: center;">&nbsp;</p>  			<p style="text-align: center;"><span style="color: rgb(105, 105, 105);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0325-00176-060b5.jpg" style="width: 300px; height: 207px;" /></span></p>  			<ul class="photoCaption"> 				<li style="text-align: center;"><span style="color: rgb(105, 105, 105);">花藝師為Maggie設計的服飾洋溢青春氣息，在葡萄風信子襯托下更添活力。</span></li> 			</ul> 			</td> 		</tr> 	</tbody> </table>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h3><span style="font-size: 18px;"><strong><span style="color: rgb(0, 0, 0);">穿上花裳媽媽女模大放異彩</span></strong></span></h3>  <p>&nbsp;</p>  <p><sup><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">Maggie是六位「貓步」模特兒之一，時裝騷當日她以一身淡黃襯白連身裙示人，在春季開花的葡萄風信子襯托下更顯年輕飄逸。被問到登台表演的原因，她爽朗地笑說是「貪得意」，誰會猜到台上大放異彩的這位兩女之母，過去兩年多一直跟癌魔在打拉鋸戰？</span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><sup><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">「嗰時打一次針要抖成個月，食嘢好似無晒味覺，有大半年時間都匿喺屋企，唔想令其他人一齊唔開心。」一五年底，Maggie發現自己患上乳癌，突如其來的噩耗讓她不知所措，腦海裏盡是「點解係我」的疑問。她自言本性頑皮大膽，打針、化療統統無有怕，唯獨最放不下家人。「最怕手術失敗我走咗，到時邊個照顧我屋企人？」</span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h3><span style="font-size: 18px;"><strong><span style="color: rgb(0, 0, 0);">家人支持變硬淨舞台上「破繭」</span></strong></span></h3>  <p>&nbsp;</p>  <p><sup><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">然而，疾病的考驗卻讓她看到家人可愛的一面。「兩個女好似忽然長大咗咁，先生一直陪我睇醫生、開營養粉，無諗過佢會咁無微不至。」談起丈夫的付出，Maggie不禁眼泛淚光。「係先生一直畀信心我，等我知道唔使自己一個人承受。」</span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><sup><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;">在家人的支持下，Maggie原來的憂慮逐漸被抗癌動力取代，與丈夫甚至比從前更恩愛。「咁多人幫自己，更加唔可以垂頭喪氣！」這段經歷讓她變得更「硬淨」，不再逃避和鑽牛角尖，亦學會分享內心感受的重要性。她帶上舞台的，不只有一身鮮花裝束，還有一份破繭而出的堅毅精神。</span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(105, 105, 105);">圖：朱偉坤</span></p>  <p><span style="color: rgb(105, 105, 105);">文：林幸泉</span></p>  <p>&nbsp;</p>  <p><font color="#696969">文章來自:東方日報</font></p>  <p><span style="color: rgb(0, 0, 255);"><a href="http://orientaldaily.on.cc/cnt/news/20180325/00176_060.html" target="_blank">http://orientaldaily.on.cc/cnt/news/20180325/00176_060.html</a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180326]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%88%91%e6%9c%89%e6%ad%a3%e8%83%bd%e9%87%8f%ef%bc%9a%e6%8a%97%e7%99%8c%e8%8a%b1%e9%9f%bb-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>同行者之歌]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%88%91%e6%9c%89%e6%ad%a3%e8%83%bd%e9%87%8f%ef%bc%9a%e6%8a%97%e7%99%8c%e8%8a%b1%e9%9f%bb-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[74]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180326]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7228]]></id>
		<title><![CDATA[我有正能量：花藝時裝表演重現患者自信]]></title>
		<content><![CDATA[<h1><span style="color:#000000;"><span style="font-size:26px;"><strong>我有正能量：花藝時裝表演重現患者自信</strong></span></span></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h1><span style="color:#000000;"><span style="font-size:16px;">「蝶舞飛揚」時裝表演前日在維園花卉展覽舉行，主辦機構「癌症資訊網慈善基金」破格邀請癌症病患者作模特兒，並與花藝界來一場精彩的crossover。基金創辦人吳偉麟希望藉活動改變公眾對癌症的看法，宣揚「不完美，才是美」的訊息。「好多人將癌症同死亡掛鈎，其實經過適當治療，病患者都可以展現自信同美麗。」</span></span></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0325-00176-061b1.jpg" style="width: 600px; height: 429px;" /></span></span></p>  <p style="text-align: center;"><span style="color:#696969;">服飾以簡潔剪裁營造春日感覺，象徵寒冬過後萬象更新。</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <h1><strong><span style="font-size:18px;">互助平台打破癌症謬誤</span></strong></h1>  <h1>&nbsp;</h1>  <h1><span style="font-size:16px;">網上有關癌症的文章多如牛毛，孰真孰假難以考究。吳表示曾遇過不少人錯信坊間的「另類療法」，失去治療的黃金時機，因此基金的互助網絡平台只會提供準確專業的癌症資訊，並與病患者及其家屬交流，轉介不同個案予各癌症服務機構，讓被忽略的資源得以善用。</span></h1>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0325-00176-061b2.jpg" style="width: 600px; height: 412px;" /></span></span></p>  <p style="text-align: center;"><span style="color: rgb(105, 105, 105); text-align: center;">吳偉麟指癌症並非絕症，病患者經適當治療後亦可展現自信和美麗。</span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color: rgb(0, 0, 0); font-size: 16px; text-align: center;">要改變社會根深柢固的觀念並不容易，吳指出，很多病患者面對癌病時容易驚慌失措，做出錯誤決定，甚至諱疾忌醫。「其實癌症唔係絕症，反而更似慢性病。」為打破常見迷思，基金正計劃將《癌症謬誤100解&mdash;&mdash;把握治療黃金期》及《有營同路人：癌症患者飲食手記》兩本癌症書籍製成電子版本，並於今年內上載至網站供同路人參考。</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>文章來自: 東方日報</p>  <p><a href="http://orientaldaily.on.cc/cnt/news/20180325/00176_061.html" target="_blank"><span style="color:#0000FF;">http://orientaldaily.on.cc/cnt/news/20180325/00176_061.html</span></a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180326]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%88%91%e6%9c%89%e6%ad%a3%e8%83%bd%e9%87%8f%ef%bc%9a%e8%8a%b1%e8%97%9d%e6%99%82%e8%a3%9d%e8%a1%a8%e6%bc%94%e9%87%8d%e7%8f%be%e6%82%a3%e8%80%85%e8%87%aa%e4%bf%a1-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>同行者之歌]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%88%91%e6%9c%89%e6%ad%a3%e8%83%bd%e9%87%8f%ef%bc%9a%e8%8a%b1%e8%97%9d%e6%99%82%e8%a3%9d%e8%a1%a8%e6%bc%94%e9%87%8d%e7%8f%be%e6%82%a3%e8%80%85%e8%87%aa%e4%bf%a1-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[75]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180326]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7229]]></id>
		<title><![CDATA[患癌重生 「花蝴蝶」起舞飛揚]]></title>
		<content><![CDATA[<p><span style="color: rgb(0, 0, 0);"><span style="font-size: 26px;"><strong><span style="font-family: monospace; font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: 400; white-space: pre-wrap; word-wrap: break-word; background-color: transparent;">患癌重生 「花蝴蝶」起舞飛揚</span></strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="font-size: 14px;"><span style="color: rgb(105, 105, 105);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/_2018032206404215054.jpg" style="width: 640px; height: 512px;" /></span></span></p>  <p style="text-align: center;"><span style="font-size: 14px;"><span style="color: rgb(105, 105, 105);"><span style="text-align: left; font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">左起：周鳳娟、凌韻詩。</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><strong><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: 400; background-color: transparent;">癌症是無聲無息的獵人，五年前看中了周鳳娟（Shirley），殺她一個措手不及。確診時的晴天霹靂，以至化療期間身體的痛楚，令自問硬淨的她一度想放棄治療，幸得家人無條件支持，以及朋友鼓勵，終打贏此仗。如今走出陰霾，Shirley踏上舞台，以一身「花蝴蝶」服飾行「貓步」，盼以過來人身分鼓勵一班癌症病患者，「就像蝴蝶般蛻變重生。」</span></span></sup></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 16px;"><span style="color: rgb(105, 105, 105);"><span style="font-size: 14px;"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">記者 楊詩彤 攝影 伍明輝</span></span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">看着眼前這位笑意盈盈、紅粉緋緋的少婦，誰也沒想過她原來在一三年尾曾罹患乳癌，甚至連她自己也難以置信，「確診時真的很震撼，沒想過（癌症）會找着自己，當時覺得唔lucky（不幸）。」噩耗突然降臨，Shirley難免驚慌，哭了整整一星期，但轉眼已接受現實，「我本身性格比較硬淨」。</span></span></sup></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">Shirley面對頑疾的勇氣，原來自家人，「我很慶幸自己不是孤獨的，每次我回醫院接受化療，先生和媽媽也必定陪伴着我。」一對子女也支撐着Shirley，自從她患病後，子女從沒在其面前哭過，甚至倒過來安慰媽媽，「家人的關心和關愛是最重要的。」</span></span></sup></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 36px;"><sup><strong><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: 400; background-color: transparent;">化療瘦五磅 關節痛似錘打</span></span></strong></sup></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">然而，抗癌路絕不易走，Shirley憶述手術後需接受六針化療藥物，首兩針已令她體重急跌五磅，「全身的關節也痛，就像有錘仔打你般刺痛。」化療針的副作用也導致她發燒，一般服食退燒藥已可控制，但接受第四針後，高燒持續不退，Shirley只能再度入院，結果成了她抗癌路上最煎熬的一段。</span></span></sup></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">「整個人忽冷忽熱，最誇張時要蓋四張被，卻又會突然熱得把被子全扔掉。我當時好驚，就像站在死亡邊緣。」留院十多天，每當主診醫生巡視病房，着Shirley「努力一點」時，她心裏便更覺恐懼，直至有天她哭着跟媽媽說不想醫了。當時媽媽捉住Shirley的手，鼓勵她說：「四針也熬過了，現在只剩下兩針，就捱完它吧。」對瀕臨崩潰的Shirley而言，短短幾句彷彿將她由懸崖拉回平地。</span></span></sup></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">經歷了手術和大半年的化療，Shirley至今已康復，回首患病經歷，她憶起一幀攝影朋友送她的作品。當日她臥病在牀期間，一位攝影朋友每天也會在社交網站送她照片打氣，其中一幅拍下了一隻俗稱「鬍鬚仔」的罕有蝴蝶，是友人專程到元朗山丘上拍攝的，「蝴蝶的蛻變就好像火鳳凰重生，我真的很感動，是一種心靈治療。」</span></span></sup></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 36px;"><sup><strong><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-weight: 400; background-color: transparent;">繁花作衣裳 寓抗逆度寒冬</span></span></strong></sup></span></p>  <p>&nbsp;</p>  <p><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">當天的蝴蝶陪伴Shirley走出癌症陰霾，今天更重新在她身上賦予意義。明天在維園的花卉展覽上，Shirley將穿上由花藝師以鮮花製作的服飾，參與由癌症資訊網慈善基金舉辦的「蝶舞飛揚」時裝表演。主辦單位以鮮花和蝴蝶作主題，正要襯托出癌症病人在逆境中奮鬥的生命力和美態。</span></span></sup></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size: 26px;"><sup><span style="color: rgb(0, 0, 0);"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">牽頭設計服飾的花藝師凌韻詩（Florence）形容，毛蟲破繭而出，變成翩翩起舞的蝴蝶，正如癌症病人走過難關，重新上路；鮮花縱會凋謝，卻留下艷麗色彩，有如癌症病人精采的人生。她刻意在服飾上運用大量紫色和粉紅色的鮮花，營造春意盎然的感覺，象徵癌症病人經歷寒冬後，迎來萬物重生的春天，「他們經歷重大轉變後再次站起來，我期望為他們寫下美麗的一頁。」</span></span></sup></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color: rgb(105, 105, 105);"><span style="font-size: 14px;"><span style="font-family: &quot;Helvetica Neue&quot;, Helvetica, Tahoma, Arial, Georgia, &quot;Xin Gothic&quot;, &quot;Hiragino Sans GB&quot;, &quot;Droid Sans Fallback&quot;, 微軟正黑體, &quot;Microsoft JhengHei&quot;, 微软雅黑, &quot;Microsoft YaHei New&quot;, &quot;Microsoft Yahei&quot;, 宋体, SimSun, STXihei, 华文细黑, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; background-color: transparent;">全文刊《星島日報》</span></span></span></p>  <p><span style="color: rgb(105, 105, 105);"><span style="font-size: 14px;">文章來自:頭條日報</span></span></p>  <p><span style="font-size: 16px;"><a href="http://hd.stheadline.com/news/realtime/hk/1170657/" target="_blank"><span style="color: rgb(0, 0, 255);">http://hd.stheadline.com/news/realtime/hk/1170657/</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180326]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%82%a3%e7%99%8c%e9%87%8d%e7%94%9f-%e3%80%8c%e8%8a%b1%e8%9d%b4%e8%9d%b6%e3%80%8d%e8%b5%b7%e8%88%9e%e9%a3%9b%e6%8f%9a-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[病患個案>同行者之歌]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%82%a3%e7%99%8c%e9%87%8d%e7%94%9f-%e3%80%8c%e8%8a%b1%e8%9d%b4%e8%9d%b6%e3%80%8d%e8%b5%b7%e8%88%9e%e9%a3%9b%e6%8f%9a-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[76]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180326]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7230]]></id>
		<title><![CDATA[《自然》重磅：肝癌大突破！拉斯克獎大牛發現全新抑癌蛋白，有望突破肝癌診療的瓶頸 | 科學大發現]]></title>
		<content><![CDATA[<p style="margin-bottom:7.5pt"><span style="font-size:26px;"><strong><span style="font-family: verdana; text-align: center; background-color: rgb(248, 248, 248);">《自然》</span></strong></span><span style="color:#000000;"><span style="font-size:26px;"><strong><span style="background:white"><span style="font-family:細明體">重磅：肝癌大突破！拉斯克獎大牛發現全新抑癌蛋白，有望突破肝癌診療的瓶頸 | 科學大發現 </span></span></strong></span></span></p>  <p style="margin-bottom:7.5pt">&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">在癌症這個殺手家族中，肝癌可以排得上全球老二了。在我國，肝癌也是高發癌種，而且由於其發病隱匿、疾病進展快，患者的預後極不樂觀，新的診療方法迫在眉睫。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">本周的《自然》雜誌上刊登了一項來自瑞士巴塞爾大學的研究，Michael N. Hall帶領的研究團隊發現了一種全新的抑癌蛋白LHPP，這種蛋白的喪失促進了腫瘤的生長，增加LHPP表達則能夠有效抑制癌細胞增殖並阻止肝功能損傷[1]！除此之外，LHPP水準也與疾病負擔和患者預後有關，研究者認為可以作為診斷和預後的生物指標。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><sup><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/640(1).jpg" style="width: 640px; height: 346px;" /></span></span></span></sup></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="background:white"><span style="font-family:細明體">本項研究的通訊作者Michael N. Hall,&nbsp;</span></span></span><span style="color:#696969;"><span style="background:white"><span style="font-family:細明體">也是雷帕黴素靶蛋白（TOR）信號通路的發現者</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">在原發性肝癌中，90%屬於肝細胞癌（HCC）[2]，而50%的肝細胞癌又都涉及mTOR信號通路[3]。研究者通過特異性敲除小鼠的PTEN、TSC1啟動mTOR通路，改造小鼠在6周大時出現肝腫大，20周則完全發展為肝細胞癌。經過對小鼠肝臟的分子特徵分析，這種小鼠肝癌特徵幾乎與人類肝癌特徵一樣[4,5]。研究者把這種小鼠叫做L-dKO小鼠。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/640a.jpg" style="width: 560px; height: 437px;" /></span></span></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="background:white"><span lang="EN-US" style="font-family:細明體">L-dKO</span><span style="font-family:細明體">小鼠（右）會自發生長肝細胞癌</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">隨後，研究者對20周大的L-dKO小鼠的腫瘤組織和正常的健康小鼠肝組織進行了蛋白質組學分析，涉及4500種蛋白。功夫不負苦心人，研究者最終篩選出了一種差異很大的蛋白&mdash;&mdash;<span lang="EN-US">LHPP</span>。這種蛋白在健康組織中可以正常表達，在癌組織中卻幾乎不存在。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">經過免疫組化方法驗證，LHPP是一種組氨酸磷酸酶，也就是從蛋白中解除磷酸基團的酶。此前發現了唯</span></span></span></span></sup><span style="background:white"><span style="font-family:細明體"><st1_chmetcnv hasspace="False" negative="False" numbertype="3" sourcevalue="2" tcsc="1" unitname="兩" w_st="on"><sup><span style="color:#000000;"><span style="font-size:16px;">二兩</span></span></sup></st1_chmetcnv></span></span><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">種在哺乳動物中相關的酶是NME1、NME2（也稱為NDPKA、NDPKB）。這是兩種磷酸激酶，相應地，在肝癌組織中表達有所升高。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">研究者分別對不同癌症發展階段的小鼠進行了蛋白表達分析，發現隨著癌症的發展，LHPP表達逐漸降低、乃至消失，同時NME1、NME2則與mTOR一同保持著很高的水準。而腫瘤周邊的非癌組織中，LHPP水準正常。另一方面，癌組織的磷酸化水準則整體升高了。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/640b.jpg" style="width: 551px; height: 424px;" /></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="background:white"><span style="font-family:細明體">癌組織和非癌組織中各蛋白水準的比較</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">但是這也不能說明LHPP在肝癌發展中到底處於怎樣的地位，到底是因是果？於是研究者利用腺病毒轉染，重新將<i>LHPP</i>基因導入了L-dKO小鼠中。在小鼠8周大時，通過尾靜脈注射，確保小鼠中LHPP蛋白會過量表達。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">在小鼠20周大時，研究者對小鼠肝臟進行了檢測，結果很令人驚訝！導入了LHPP基因的小鼠肝臟腫瘤數量、大小都大大降低！研究者還對小鼠的丙氨酸氨基轉移酶（ALT）、天冬氨酸氨基轉移酶（AST）、乳酸鹽脫氫酶（LDH）等肝損傷特徵指標進行了檢測，結果也顯示，LHPP蛋白對肝功能有良好的保護作用。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:18px;"><span style="color:#000000;"><strong><span style="background:white"><span style="font-family:細明體">這足以說明<span lang="EN-US">LHPP</span>是一種新的抑癌蛋白！</span></span></strong></span></span></p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/640c.jpg" style="width: 536px; height: 401px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/640d.jpg" style="width: 444px; height: 220px;" /></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="background:white"><span style="font-family:細明體">轉染LHPP的小鼠明顯腫瘤數量較少，體積也較小</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">小鼠實驗畢竟是小鼠實驗，LHPP的抑癌作用在人類中是否也存在呢？研究者分析了20例肝細胞癌患者的組織樣本，並和它們自己的非癌組織樣本進行對比，發現癌組織中的LHPP水準有了大幅度的下降。</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">在小鼠實驗中，LHPP的水準既然會隨癌症發展變化，那麼是不是說明LHPP水準可能與臨床指標有關呢？對前人公佈的研究資料[6]進行二次分析，研究者發現，與小鼠研究一致，低LHPP表達與更重的疾病負擔、更短的生存期有關！低LHPP表達患者的中位生存期足足減少了近兩年！</span></span></span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#696969;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/640e.jpg" style="width: 403px; height: 551px;" /></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="background:white"><span style="font-family:細明體">無病生存期（上）和整體生存期（下）</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p><sup><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">研究者也分析了癌症基因圖譜（TCGA）和國際癌症基因組聯盟（ICGC）的資料，包括49種<i>LHPP</i>突變，其中24.5%發現於食管癌、頭頸癌、胃癌、膀胱癌、乳腺癌、皮膚癌、肝癌、肺癌、胰腺癌等多種癌症。這些突變的形式均屬於功能缺失型突變。這項資料也再次說明LHPP是一種抑癌基因[7]。</span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">除此以外，也曾有研究者發現LHPP與口腔癌、咽喉癌、急性淋巴細胞白血病有關[8,9]。</span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">以上研究資料表明，LHPP是一種新發現的抑癌蛋白，它的缺失會導致整體蛋白組氨酸磷酸化增加，並進一步促進癌症的發展和其他疾病。</span></span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="font-size:16px;"><span style="background:white"><span style="font-family:細明體">至於為什麼組氨酸磷酸化會與癌症有關呢？研究者檢測的組氨酸磷酸化蛋白質包括關鍵的DNA複製因數、p53抑制劑、以及會誘發突變的胞苷脫氨酶等等與癌症相關的蛋白。缺乏LHPP導致的整體磷酸化增加，很有可能就啟動了有重要功能的通路，自然很容易導致癌症發生了。</span></span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">参考资料：</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[1] https://www.nature.com/articles/nature26140</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[2] Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2,16018&ndash;16023 (2016).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[3] Schulze, K. et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47,505&ndash;511 (2015).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[4] Kenerson, H. L. et al. Akt and mTORC1 have diﬀerent roles during liver tumorigenesis in mice. Gastroenterology 144, 1055&ndash;1065 (2013).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[5] Guri, Y. et al. mTORC2 promotes tumorigenesis via lipid synthesis. Cancer Cell 32, 807&ndash;823 (2017).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[6] Makowska, Z. et al. Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifcations of hepatocellular carcinoma. J. Pathol. Clin. Res. 2, 80&ndash;92 (2016).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[7] Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546&ndash;1558(2013).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[8] Vijayakrishnan, J. et al. A genome-wide association study identifes risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1. Leukemia 31, 573&ndash;579 (2017).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;"><sup><span style="color:#696969;">[9] Lesseur, C. et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat. Genet. 48, 1544&ndash;1550 (2016).</span></sup></p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;">&nbsp;</p>  <p style="margin: 0px; padding: 0px; box-sizing: border-box;">&nbsp;</p>  <header class="content-head"> <h1><strong><span style="color:#000000;"><span style="font-size:26px;">Researchers discover new anti-cancer protein</span></span></strong></h1>  <h5 class="data">March 21, 2018, <a href="http://www.unibas.ch/" target="_blank">University of Basel</a></h5>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/43-researchersd.jpg" style="width: 640px; height: 342px;" /></p> </header>  <section class="content-holder content-table content-story"> <p style="text-align: center;"><!--begin:content--></p>  <section class="news-content"> <p style="text-align: center;"><!--begin:article-block--></p>  <section class="content article-block"> <article> <div class="first-block"> <figure class="image-block"> <div class="image-block-ins">Scanning electron microscopy image of cancer cells. Credit: University of Basel, Biozentrum/Swiss Nanoscience Institute</div> </figure>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:16px;"><span style="color:#000000;">An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in <i>Nature</i> that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.</span></span></p> </div>  <div class="article-banner first-banner">&nbsp;</div>  <div class="article-banner first-banner" style="color: rgb(0, 0, 0); font-size: 16px;"><!-- /4988204/MedX_Story_InText_Box --> <div id="div-gpt-ad-1450190541376-1">&nbsp;</div> </div>  <p style="color: rgb(0, 0, 0); font-size: 16px;">The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled in Switzerland. Hepatocellular carcinoma is usually diagnosed at a very late stage when the liver is already severely damaged and hence overall prognosis is poor. Detection of the anti-cancer&nbsp;protein LHPP as a biomarker may allow clinicians to provide better treatment options.</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;"><span style="font-size:20px;"><b>New anti-cancer protein LHPP</b></span></p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">Liver tumors develop from mutated cells that grow and proliferate uncontrollably. Anti-cancer proteins, so-called tumor&nbsp;suppressors, prevent uncontrolled cell growth. Tumor suppressors are often defective in cancer cells. The researchers led by Prof. Michael N. Hall, Biozentrum of the University of Basel, have now discovered a new, so far unknown tumor suppressor, the protein LHPP. In their study, they show that the loss of LHPP promotes tumor growth and reduces the chance of survival of cancer patients. LHPP could potentially be used as a prognostic biomarker.</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">The researchers generated a mouse model for hepatocellular carcinoma&nbsp;by activating mTOR signaling specifically in the liver. They analyzed a total of more than 4,000 proteins, comparing them in healthy and tumor tissue. An enzyme emerged as the top favorite: the histidine phosphatase LHPP. &quot;It is striking that LHPP is present in healthy tissue and completely absent in tumor tissue,&quot; says first author Sravanth Hindupur. Re-introduction of the genetic information for LHPP by the researchers prevents the formation of tumors and maintains liver function.</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;"><b>Loss of LHPP in cancer patients</b></p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&quot;Similar to the mouse model, we also saw a striking decrease in LHPP levels in tumors of patients with liver&nbsp;cancer,&quot; says Hindupur. Additionally, both disease severity and life expectancy correlate with LHPP levels. With complete loss of the tumor suppressor, cancer patients die on average two years earlier. LHPP is useful as a biomarker to classify tumors.&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;"><b>Phosphorylation important for tumorigenesis</b></p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">LHPP is a phosphatase that removes histidine-linked phosphate groups from proteins. Like all amino acids, histidine is a basic component of proteins. Histidine phosphorylation of proteins has been poorly investigated due to the lack of suitable tools. &quot;Tony Hunter, from the Salk Institute in the USA, has provided us with new tools to analyze histidine phosphorylation. We have now been able to visualize a whole new layer of complexity in tumor formation,&quot; says Hindupur.</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">Due to the absence of LHPP, global protein&nbsp;histidine phosphorylation is increased, which can lead to activation of several important functions and uncontrolled cell proliferation. This absence promotes the growth of tumors via increasing histidine-phosphorylated proteins. The tumor suppressor&nbsp;LHPP may also play a role in the development of other cancers.</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p class="news-relevant" itemscope="" itemtype="http://schema.org/WebPage" style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;"><b>More information:</b> Sravanth K. Hindupur et al, The protein histidine phosphatase LHPP is a tumour suppressor, <i>Nature</i> (2018). <a data-doi="1" href="http://dx.doi.org/10.1038/nature26140" target="_blank">DOI: 10.1038/nature26140</a></p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-size: 16px;"><sup><span style="color:#696969;"><span style="font-size:14px;">文章來自:&nbsp;奇點網 / Medicalxpress</span></span></sup></p>  <p style="color: rgb(0, 0, 0); font-size: 16px;"><sup><span style="color:#696969;"><span style="font-size:14px;">中:&nbsp;</span></span><span style="font-size:14px;"><a href="https://mp.weixin.qq.com/s/kaigcoHe-pZJSDSANKRO3A" target="_blank"><span style="color:#0000FF;">https://mp.weixin.qq.com/s/kaigcoHe-pZJSDSANKRO3A</span></a></span></sup></p>  <p style=""><sup><span style="color:#696969;"><span style="font-size: 14px;">Eng</span></span><font color="#0000ff"><span style="font-size: 14px;">:&nbsp;</span></font><span style="font-size: 14px;"><a href="https://medicalxpress.com/news/2018-03-anti-cancer-protein.html" target="_blank"><span style="color:#0000FF;">https://medicalxpress.com/news/2018-03-anti-cancer-protein.html</span></a></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p> </article> </section> </section> </section>  <p style="margin-bottom:7.5pt">&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180327]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e3%80%8a%e8%87%aa%e7%84%b6%e3%80%8b%e9%87%8d%e7%a3%85%ef%bc%9a%e8%82%9d%e7%99%8c%e5%a4%a7%e7%aa%81%e7%a0%b4%ef%bc%81%e6%8b%89%e6%96%af%e5%85%8b%e7%8d%8e%e5%a4%a7%e7%89%9b%e7%99%bc%e7%8f%be%e5%85%a8/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e3%80%8a%e8%87%aa%e7%84%b6%e3%80%8b%e9%87%8d%e7%a3%85%ef%bc%9a%e8%82%9d%e7%99%8c%e5%a4%a7%e7%aa%81%e7%a0%b4%ef%bc%81%e6%8b%89%e6%96%af%e5%85%8b%e7%8d%8e%e5%a4%a7%e7%89%9b%e7%99%bc%e7%8f%be%e5%85%a8]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[77]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180327]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7231]]></id>
		<title><![CDATA[患上乳癌後，妳要怎樣照顧自己的身體？]]></title>
		<content><![CDATA[<p><strong style="color: rgb(0, 0, 0); font-size: 24px;">患上乳癌後，妳要怎樣照顧自己的身體？</strong></p>  <p>&nbsp;</p>  <p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/her22(1)(1).jpg" style="color: rgb(105, 105, 105); font-size: 14px; text-align: center; width: 640px; height: 288px;" /></p>  <p>&nbsp;</p>  <div><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">治療乳癌可能是一個漫長的過程，但是在生活上和治療上都有一些方法可以助妳減少不適，讓妳能較安然和積極地渡過各個療程。</span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;多看多問，認識妳的疾病，了解它的治療方法。</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;和妳的醫護團隊充分合作。</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;和妳的醫生安排定期覆診和檢查的時間表，以便監察病情進展。</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;如妳出現持續性的骨痛、氣促、肢體麻痺無力等不適，應立刻告訴醫生。</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;按照醫生的指引照顧好日常飲食。</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;接受外科手術後，應避免搬動重物，以免手臂再受損傷，影響復原進度。</span></span></div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">&bull;&nbsp;按照醫生和物理治療師的指示進行恆常運動，例如進行簡單的手臂運動來鍛鍊上肢，以保持肩關節靈活及減少水腫。</span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><br /> <span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">妳可以主動尋找關於妳的疾病的資訊，多看多聽不同專家的意見，了解不同治療的利弊，為妳將要面對的抗癌旅程和結果做好準備。在選擇治療的時候要有獨立思考，勇敢表達自己的想法和意願，因為只有妳才最清楚自身的需要。主動參與治療過程或許能讓妳感到多點把握和信心，少點擔憂和焦慮。</span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">如有興趣了解更多關於乳癌的資訊，</span></span></div>  <div><span style="font-size: 16px;"><span style="color: rgb(0, 0, 0);">請參閱：<a href="http://her2morrow.com.hk/" target="_blank">http://her2morrow.com.hk/</a></span></span></div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div>&nbsp;</div>  <div><span style="color: rgb(105, 105, 105);"><span style="font-size: 16px;">安全報告免責聲明<br /> 此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，請向您的醫生或藥劑師諮詢和報告。<br /> 以上健康教育資訊由羅氏大藥廠香港有限公司提供 (NPM-HK-0074-11-2017)</span></span></div>  <p>&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180327]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%82%a3%e4%b8%8a%e4%b9%b3%e7%99%8c%e5%be%8c%ef%bc%8c%e5%a6%b3%e8%a6%81%e6%80%8e%e6%a8%a3%e7%85%a7%e9%a1%a7%e8%87%aa%e5%b7%b1%e7%9a%84%e8%ba%ab%e9%ab%94%ef%bc%9f/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>醫療新知]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%82%a3%e4%b8%8a%e4%b9%b3%e7%99%8c%e5%be%8c%ef%bc%8c%e5%a6%b3%e8%a6%81%e6%80%8e%e6%a8%a3%e7%85%a7%e9%a1%a7%e8%87%aa%e5%b7%b1%e7%9a%84%e8%ba%ab%e9%ab%94%ef%bc%9f]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[78]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180327]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7232]]></id>
		<title><![CDATA[中大研究證「消融化療栓塞術」有效延長肝癌患者無惡化存活期兩倍]]></title>
		<content><![CDATA[<p><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0328.jpg" style="width: 600px; height: 399px;" /></p>  <p><span style="color: rgb(105, 78, 19); font-family: Arial; font-size: 11px;">中大醫學院跨專科團隊研究證實，新一代經血管治療「消融化療栓塞術（ACE）」較傳統技術，更有效消滅中期肝癌病人體內的癌細胞，亦能延長無惡化存活期近2倍，部分患者治療後可接受手術，以切除和根治肝癌。左起：中大醫學院腫瘤學系楊明明教授、影像及介入放射學系系主任余俊豪教授以及外科學系名譽臨床副教授李傑輝醫生。</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">香港中文大學（中大）醫學院的跨專科團隊研究證實，新一代經血管治療「消融化療栓塞術（ACE）」較傳統的「經血管治療」技術，更能有效消滅中期肝癌病人體內的癌細胞，亦能延長無惡化存活期近2倍，部分患者在腫瘤縮小和肝臟狀況許可下，能夠接受手術，以切除和根治肝癌。相關研究結果已在醫學期刊《放射診斷學》(<em>Radiology</em>) 發表。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;"><strong>中大醫學院設跨專科會診治療肝癌</strong></span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">肝癌在本港常見癌症中排行第五，亦是第三號癌症殺手。醫院管理局香港癌症資料統計中心數據顯示，2015年有近1,800宗肝癌新症，近1,600人死亡。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">有見肝癌於本港甚至全球均造成嚴重影響，中大醫學院早年成立集合腫瘤科、外科和影像及介入放射科的跨專科團隊，為病人診斷，按患者病情及手術風險，提供適切的治療方案。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">中大醫學院腫瘤學系<strong>楊明明教授</strong>表示：「患者確診時的腫瘤體積和位置、患者肝功能狀況，以及癌細胞有否擴散等，都是決定治療方案的關鍵因素。我們希望透過集合腫瘤科、外科和影像及介入放射科，提供跨專科診斷，讓病人無縫地接受三科醫生的評估，優化病人求醫的程序以盡快得到適切的治療，並以『病人為中心』的精神，提供更全面的照顧。」</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0328-1.jpg" style="width: 600px; height: 399px;" /></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="color: rgb(105, 78, 19); font-family: Arial; font-size: 11px;">楊先生（右）和黃先生（左）均在四年前接受消融化療栓塞術，消滅肝癌腫瘤，現時康復情況良好。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;"><strong>根治性手術不適用於中期肝癌患者</strong><strong>&nbsp;</strong><strong>需發展新治療方案</strong></span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">一般來說，早期肝癌患者可透過手術切除腫瘤、接受局部消融療法或肝臟移植，但這類患者只佔大概三成。病情已屆中期或手術風險較大的病人，不適合進行切除手術或局部消融療法，需要接受「經血管治療」。癌症病情已屆晚期者，則要接受標靶藥物、化療或其他藥物治療。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">中大醫學院外科學系名譽臨床副教授<strong>李傑輝醫生</strong>解釋：「手術和局部消融療法均可根治肝癌，但當病人的癌症已發展至較後期、癌細胞已擴散或肝功能嚴重受損時，均不適宜接受這些治療。針對中期患者，『經血管治療』是目前唯一的治療方法。」</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;"><strong>部分肝癌患者接受新一代「經血管治療」後可進行手術切除癌組織</strong></span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">「碘化療栓塞 (cTACE)」是現時較常用於中期肝癌患者的一種「經血管治療」方法，透過導管將化療藥物帶到癌細胞及造成肝臟微小血管栓塞，產生治療效果；較新的「經血管治療」還有「帶藥微球栓塞 (DEB-TACE)」及「放射栓塞 (SIRT)」。這三種「經血管治療」的效果都大同小異。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">中大醫學院影像及介入放射學系系主任<strong>余俊豪教授</strong>指出，上述三種「經血管治療」仍然有很大的改善空間，有必要發展出更有效的技術，幫助中期肝癌患者，這就是研發新一代經血管治療「消融化療栓塞術」的目的。余教授表示：「新技術能大幅提升化療藥物在肝癌組織内的濃度，配合乙醇造成的消融效果，以及切斷肝癌組織的血液供養造成缺血壞死，達至多方面的抗癌功效，提升整體的治療效果。」</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">中大醫學院跨專科團隊早前研究「消融化療栓塞術」的成效。結果證實，「消融化療栓塞術」與「碘化療栓塞」比較，前者更有效消滅腫瘤，亦可延長肝癌患者的無惡化存活期，部分患者更在經評估肝臟情況和手術風險後，進行手術切除腫瘤。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">上述研究包括44名中期肝癌患者，分為接受「消融化療栓塞術」的研究組及接受傳統「碘化療栓塞」的對照組，並分析他們接受治療後的反應，結果如下：</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <div align="center" style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"> <table border="1" cellpadding="0" cellspacing="0" style="border-spacing: 0px;"> 	<tbody> 		<tr> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="324"> 			<p>&nbsp;</p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="138"> 			<p align="center"><strong>研究組（</strong><strong>22</strong><strong>人）</strong></p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="148"> 			<p align="center"><strong>對照組（</strong><strong>22</strong><strong>人）</strong></p> 			</td> 		</tr> 		<tr> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="324"> 			<p><strong>治療後癌細胞被全部消滅的病人比率</strong></p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" width="138"> 			<p align="center">100%</p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" width="148"> 			<p align="center">45.5%</p> 			</td> 		</tr> 		<tr> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="324"> 			<p><strong>治療後可接受手術切除腫瘤的病人比率</strong></p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="138"> 			<p align="center">32%</p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="148"> 			<p align="center">14%</p> 			</td> 		</tr> 		<tr> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="324"> 			<p><strong>無惡化存活期（中位數）</strong></p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="138"> 			<p align="center">28個月</p> 			</td> 			<td style="vertical-align: top; padding-left: 0px; padding-right: 0px;" valign="top" width="148"> 			<p align="center">10個月</p> 			</td> 		</tr> 	</tbody> </table> </div>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="font-size:16px;">「消融化療栓塞術」現時適用於腫瘤數目少於5粒的中期肝癌病人。是次研究亦屬於第一期，集中分析治療的可行性和安全性，研究團隊將會就「消融化療栓塞術」進行更深入研究。</span></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;">&nbsp;</p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/0328-2.jpg" style="width: 600px; height: 399px;" /></p>  <p style="color: rgb(0, 0, 0); font-family: Arial; font-size: 11px;"><span style="color: rgb(105, 78, 19); font-family: Arial; font-size: 11px;">消融化療栓塞術透過導管及其他工具，將高濃度的化療藥物注入肝癌組織，配合乙醇造成的消融效果，以及切斷肝癌組織的血液供養造成缺血壞死，達至多方面的抗癌功效，提升整體的治療效果。</span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180328]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%ad%e5%a4%a7%e7%a0%94%e7%a9%b6%e8%ad%89%e3%80%8c%e6%b6%88%e8%9e%8d%e5%8c%96%e7%99%82%e6%a0%93%e5%a1%9e%e8%a1%93%e3%80%8d%e6%9c%89%e6%95%88%e5%bb%b6%e9%95%b7%e8%82%9d%e7%99%8c%e6%82%a3%e8%80%85/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%ad%e5%a4%a7%e7%a0%94%e7%a9%b6%e8%ad%89%e3%80%8c%e6%b6%88%e8%9e%8d%e5%8c%96%e7%99%82%e6%a0%93%e5%a1%9e%e8%a1%93%e3%80%8d%e6%9c%89%e6%95%88%e5%bb%b6%e9%95%b7%e8%82%9d%e7%99%8c%e6%82%a3%e8%80%85]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[79]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180328]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7233]]></id>
		<title><![CDATA[假如穿上我的鞋]]></title>
		<content><![CDATA[<p><strong><span style="color:#000000;"><span style="font-size:26px;">《假如穿上我的鞋》的零售價將全數捐贈「兒童癌病基金」，達到「零的支出，十足捐獻」。<br /> Pacific Coffee 率先義賣！</span></span></strong></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><span style="color:#000000;"><sup><span style="font-size:16px;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/9789881423177z.jpg" style="width: 450px; height: 562px;" /></span></sup></span></p>  <p>&nbsp;</p>  <p><br /> <br /> <span style="color:#000000;"><sup><span style="font-size:16px;">現在流行說，小朋友要贏在起跑線，走每一步都要比別人快，才能脫穎而出。不過，有一些兒童一次又一次的起跑，跌倒、起跑、跌倒、再起跑；他們永不言敗，不是為了跑得比別人快，他們只是想繼續在生命跑道上馳騁。</span></sup></span></p>  <p><br /> <br /> <span style="color:#000000;"><sup><span style="font-size:16px;">一個人怎樣才算真正的活著？有呼吸、心跳是活著，這是生理上的活著，但真正不朽的是美麗的靈魂。他們每個人都與命運之神打了一場硬仗，有人救了自己，也有人留低他們頑抗的精神，感染著旁人。</span></sup></span></p>  <p><br /> <br /> <span style="color:#000000;"><sup><span style="font-size:16px;">書名取自英文諺語&rdquo;Put oneself in else&rsquo;s shoes&ldquo;，希望透過書內的故事，我們都學會易地而處，站在別人的角度來看事情、看世界，知道健康快樂並非理所當然，學懂珍惜現在所有。</span></sup></span></p>  <p>&nbsp;</p>  <p><br /> <br /> <span style="color:#000000;"><sup><span style="font-size:16px;">內容概要：<br /> ． 走訪十三個不同年紀的癌症小朋友及家長，與他們細談抗癌路上的苦與樂<br /> ． 與服務癌症兒童多年的一群義工真情對話，回顧他們成為長期義工的初衷<br /> ． 找出默默支持兒童癌病基金的捐助者，發掘背後意想不到的籌款故事</span></sup></span></p>  <p><br /> <br /> <strong><span style="color:#000000;"><span style="font-size:16px;">作者 黃翠雯, 李綺雯, 鄭永燊&nbsp;&nbsp;</span></span></strong></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180328]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%81%87%e5%a6%82%e7%a9%bf%e4%b8%8a%e6%88%91%e7%9a%84%e9%9e%8b/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[其他>好書分享]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%81%87%e5%a6%82%e7%a9%bf%e4%b8%8a%e6%88%91%e7%9a%84%e9%9e%8b]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[80]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180328]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7234]]></id>
		<title><![CDATA[健腦網]]></title>
		<content><![CDATA[<h1><strong><span style="color:#000000;">健腦網</span></strong></h1>  <p>&nbsp;</p>  <p style="text-align: center;"><strong><span style="color:#000000;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/loveyourbrain.jpg" style="width: 640px; height: 311px;" /></span></strong></p>  <h1 style="text-align: center;">&nbsp;</h1>  <h1><strong><span style="font-size:26px;"><sup><span style="color:#000000;">背景及目標</span></sup></span></strong></h1>  <p>&nbsp;</p>  <article about="/zh-hant/%E8%83%8C%E6%99%AF%E5%8F%8A%E7%9B%AE%E6%A8%99" class="node node--page node--full node--page--full" data-edit-entity-id="node/3" role="article" typeof="foaf:Document"> <div class="node__content"> <div class="field field--name-body field--type-text-with-summary field--label-hidden" data-edit-field-id="node/3/body/und/full"> <div class="field__items"> <div class="field__item field-item even" property="content:encoded"> <h2><sup><span style="color:#000000;"><span style="font-size:16px;">背景</span></span></sup></h2>  <p><sup><span style="color:#000000;"><span style="font-size:16px;"><img alt="全港大約有萬名 60 歲以上的長者" src="https://www.loveyourbrain.org.hk/sites/default/files/bkg01.jpg" style="width: 219px; height: 391px; line-height: 1.6; margin-bottom: 50px; margin-left: 10px; float: right;" /></span></span></sup></p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">根據國際阿爾茲海默症協會有關「2015年全球認知障礙症報告」的資料顯示，全球新確診的認知障礙症患者已由2010年的每4秒1位加速至每3秒1位1。在香港，根據醫院管理局的資料，本港65歲以上人士患上認知障礙症佔同齡總人口的比率估計為5% 至8%，而80歲以上人士的患病比率則估計為20% 至30%2。而一項於2012年公布的學術研究所作的估計，本港到了2039年，就60歲及以上的人士而言，當中約有333,000人或11%患有認知障礙症3，數字相當驚人。</span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">另一方面，本會統計轄下的護理安老院內患有「認知障礙症」人數已經超過5成，而且患病比率亦逐年急速上升。然而，面對長者腦退化的問題，本會一直提倡採取積極的態度，盡早做好預防工作。早於10多年前已把提升認知障礙症服務質素為本會的重要策略，如在1999年於群芳念慈護理安老院成立專門照顧認知障礙症患者的服務單位、成立認知障礙症策導及工作小組、每年從本會的儲備曾撥過百萬以增聘人手照顧認知障礙症患者、不斷提升照顧員的照顧技巧等等，務求不斷改善認知障礙症服務水平、提升患者的生活質素及舒緩照顧者的壓力。</span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">本會除致力提升認知障礙症患者的院舍服務外，對居於社區中長者的腦部健康及預防性的工作亦不遺餘力。正所為「預防勝於治療」，處理認知障礙症並不應單單從患者著手，更重要的是如何在人口急速老化的年代中做好預防工作，提升長者腦部健康及養成「愛腦、護腦」的意識，以減輕認知障礙症帶來的問題才為上策。</span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">因此，本會於2007年獲香港公益金撥款，成立「健腦網」，是全球首個專為提倡華人長者腦部健康的網站；透過網內的資訊及特設「健腦遊戲訓練系統」，為長者提供一個健腦基地，讓他們掌握簡單而實用的護腦、健腦技巧，加深長者對腦部的認識，並同時重點鍛鍊長者的腦部功能，包括：記憶力、集中力、手眼協調、心算、判斷力等各方面的能力，以緩減記憶及認知衰退的問題，同時亦希望令長者在日常生活中作出正面改變，進一步改善身、心、腦的健康，成就豐盛晚年。無論是個人或機構均可於網內登記成為會員，開設獨立帳戶，並設定長者在不同種類的遊戲的難度級別。長者在進行健腦遊戲時，系統會記錄每次的分數，並顯示在登記帳戶內，方便進行情況分析及監測，提高照顧長者的質素。</span></span></sup></p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">由本會全力發展的「健腦網」一直以來均獲得國際專業的認定，曾獲：</span></span></sup></p>  <p><br /> <sup><span style="color:#000000;"><span style="font-size:16px;">- 亞太區資訊科技獎2010數碼共融及數碼社區大獎<br /> - 2009香港資訊及通訊科技獎：<br /> 「最佳數碼共融大獎」及「最佳數碼共融(產品／應用)金獎<br /> - 人類服務資訊科技應用比賽2009榮獲HUSITA2009第3名</span></span></sup></p>  <p>&nbsp;</p>  <p><span style="font-size: 16px; color: rgb(0, 0, 0); vertical-align: super;">「健腦網」獲外界一致表揚設計理念出色，具有極高的應用價值並有效地使用資訊科技融入社區，從而滿足使用者需要；並於全港不同的社福機構和醫療單位作認知訓練治療應用。</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <h2><strong><span style="color:#000000;"><span style="font-size:26px;"><sup>計劃目標</sup></span></span></strong></h2>  <ul> 	<li> 	<p><sup><span style="color:#000000;"><span style="font-size:16px;">增加長者對腦部的認識，倡導維護大腦健康和及早預防大腦衰退的重要性；</span></span></sup></p> 	</li> 	<li> 	<p><sup><span style="color:#000000;"><span style="font-size:16px;">幫助長者掌握自我管理腦部健康的方法，提昇長者腦部能力之餘，更可增加他們的自信心及自我價值觀，強化腦部思維；</span></span></sup></p> 	</li> 	<li> 	<p><sup><span style="color:#000000;"><span style="font-size:16px;">透過網上健腦遊戲系統，鼓勵家中新一代的參與，養成互助互愛、兩代共融、關愛的家庭文化；</span></span></sup></p> 	</li> 	<li> 	<p><sup><span style="color:#000000;"><span style="font-size:16px;">喚起各屆人士對長者腦部健康及身心轉變的關注，提昇對長者腦部退化疾病（如認知障礙症）的認識及注重腦部健康的意識。</span></span></sup></p> 	</li> </ul>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">1 World Health Organization. Dementia: A Public Health Priority. Geneva: World Health Organization; 2012.</span></span></sup></p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">2 香港特別行政區立法會：為認知障礙症長者提供的護理服務 ISE10/16-17</span></span></sup></p>  <p><sup><span style="color:#000000;"><span style="font-size:16px;">3&nbsp;Yu R, Chau PH, McGhee SM, Cheung WL, Chan KC, Cheung SH and Woo J.(2012) Trends in Prevalence and Mortality of Dementia in Elderly Hong Kong Population: Projections, Disease Burden, and Implications for Long-Term Care. International Journal of Alzheimers Disease. Vol 2012, Article ID 406852.</span></span></sup></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <table border="1" cellpadding="1" cellspacing="1" style="width:500px;"> 	<tbody> 		<tr> 			<td><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/hksa_logo.png" style="text-align: center; width: 293px; height: 79px;" /></td> 			<td><span style="color:#FFFFFF;">&nbsp; &nbsp; &nbsp; &nbsp; ...........</span></td> 			<td><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/logo.png" style="text-align: center; width: 293px; height: 97px;" /></td> 		</tr> 	</tbody> </table>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#696969;"><span style="font-family: Verdana, Geneva, sans-serif;">資料來自:</span>健腦網</span></p>  <p><a href="https://www.loveyourbrain.org.hk/zh-hant" target="_blank"><span style="color:#0000FF;">https://www.loveyourbrain.org.hk/zh-hant</span></a></p> </div> </div> </div> </div> </article>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180328]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%81%a5%e8%85%a6%e7%b6%b2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[實用資訊>相關網站資料, 香港]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%81%a5%e8%85%a6%e7%b6%b2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[81]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180328]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7235]]></id>
		<title><![CDATA[逾50歲男士半數或患良性前列腺增生　醫生籲及早治療]]></title>
		<content><![CDATA[<h1 id="articleTitle" class="s1abjih8-1 iDclDM sc-ckVGcZ eyLfWl sc-dxgOiQ iCuVqg" data-author="周嘉俊" data-category="社會新聞"><strong><span style="font-size: 26px;"><span style="color: #000000;">逾50歲男士半數或患良性前列腺增生　醫生籲及早治療</span></span></strong></h1>
<span class="sc-ckVGcZ eyLfWl sc-dxgOiQ kMqakB">撰文：</span><span class="sc-ckVGcZ eyLfWl sc-dxgOiQ lodxmg">周嘉俊</span>

&nbsp;

&nbsp;

&nbsp;
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa bkDnMq">
<div class="s19vvetr-0 bMMBWz" style="opacity: 1; text-align: center;"><span style="color: #696969;"><img class="s1v4fnqr-0 fhPyMg" style="background-position: center center; background-image: url('https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1920'); background-repeat: no-repeat; background-size: cover; background-origin: content-box;" src="data:;base64,<svg  width='1920' height='1080'></svg>" sizes="(min-width: 63em) 640px, 100vw" srcset="https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1920 1920w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1760 1760w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1600 1600w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1440 1440w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1280 1280w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1120 1120w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w960 960w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w800 800w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w640 640w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w480 480w,https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w320 320w" alt="（左起）患者林先生、盧世昌先生、梁智鴻醫生、黃國田醫生出席香港前列腺基金金的新書發佈會，望社會關注前列腺引發的健康問題。 （周嘉俊攝）" data-ofi-src="https://cdn.hk01.com/di/media/images/1310821/org/361aba1e3be0699a9d55bf8ada084796.jpg/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I?v=w1920" /></span></div>
</div>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"><span style="color: #696969;">（左起）患者林先生、盧世昌先生、梁智鴻醫生、黃國田醫生出席香港前列腺基金金的新書發佈會，望社會關注前列腺引發的健康問題。 （周嘉俊攝）</span></p>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"></p>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"></p>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"></p>
<p class="wa4tvz-0 hmJMOX sc-ckVGcZ eyLfWl sc-dxgOiQ hfCmUB"><sup><span style="font-size: 16px;"><span style="color: #000000;">香港中老年男性最常面對的一種疾病，是良性前列腺增生，其發病率會隨年齡遞增，50歲以上男性中，有一半會出現良性前列腺增生情況；80歲以上人士出現前列腺症狀高達近九成，情況不容忽視。</span></span></sup></p>
<p class="wa4tvz-0 hmJMOX sc-ckVGcZ eyLfWl sc-dxgOiQ gNqdxV"><sup><span style="font-size: 16px;"><span style="color: #000000;">泌尿外科專科醫生、香港前列腺基金創辦人及主席黃國田形容，良性前列腺增生是身體機能退化一種情況，猶如「老花問題」一樣，有機會導致不同併發症，例如尿道炎、腎結石等，嚴重者更會導致「急性尿瀦留」（又稱尿滯留），嚴重者可致命，故建議應及早接受治療。</span></span></sup></p>
<p class="wa4tvz-0 hmJMOX sc-ckVGcZ eyLfWl sc-dxgOiQ gNqdxV"></p>
<p class="wa4tvz-0 hmJMOX sc-ckVGcZ eyLfWl sc-dxgOiQ gNqdxV"></p>
<p class="wa4tvz-0 hmJMOX sc-ckVGcZ eyLfWl sc-dxgOiQ gNqdxV"></p>

<div class="sc-ifAKCX cFlEyZ sc-bdVaJa bkDnMq">
<div class="s19vvetr-0 bMMBWz" style="opacity: 1; text-align: center;"><sup><span style="color: #696969;"><img class="s1v4fnqr-0 fhPyMg" style="background-position: center; background-image: url('https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1920'); background-repeat: no-repeat; background-size: cover; background-origin: content-box;" src="data:;base64,<svg  width='1920' height='1080'></svg>" sizes="(min-width: 63em) 640px, 100vw" srcset="https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1920 1920w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1760 1760w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1600 1600w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1440 1440w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1280 1280w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1120 1120w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w960 960w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w800 800w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w640 640w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w480 480w,https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w320 320w" alt="黃國田醫生稱，中老年男士有良性前列腺增生情況普遍。（周嘉俊攝）" data-ofi-src="https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1920" data-pfsrc="https://cdn.hk01.com/di/media/images/1310822/org/295642287374093dec488451659b65e2.jpg/r4-P8aRNMG6qK6Hj0g7Y1QgZRZN3RSczjg4EE44OBBM?v=w1920" /></span></sup></div>
</div>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"><sup><span style="color: #696969;">黃國田醫生稱，中老年男士有良性前列腺增生情況普遍。（周嘉俊攝）</span></sup></p>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"></p>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"></p>

<div class="sc-ifAKCX cFlEyZ sc-bdVaJa bAqIHj">
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 20px;"><strong class="s10mqyzd-0 eDOYuX">暫未有方法預防前列腺增生</strong></span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 16px;">黃國田形容，良性前列腺增生屬正常生理變化，猶如「老花問題」，到目前為止無實證方法，支持有效防止前列腺增生的結論。良性前列腺增生主要會導致出現小便流量細、開始排尿時有困難等；另外亦會有尿頻、夜尿甚至失禁的情況。若處理不當，會導致不同併發症，例如尿道炎、腎結石、腎功能衰退等。</span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 16px;">黃國田稱，「急性尿瀦留」是良性前列腺增生最常見的一種併發症，由於前列腺體積增大壓着尿道，令尿液無法排出，膀胱儲滿尿並不斷漲大，卻又無法排尿，令患者會有極大不適或痛苦，嚴重者更會有潛在生命危險。但至於有多常見，黃醫生表示沒有相關數據，「（但）基本上每個月都會遇到（患者）。」</span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>

<div class="sc-ifAKCX cFlEyZ sc-bdVaJa bkDnMq">
<div class="s19vvetr-0 bMMBWz" style="opacity: 1; text-align: center;"><sup><span style="color: #696969;"><img class="s1v4fnqr-0 fhPyMg" style="background-position: center; background-image: url('https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1920'); background-repeat: no-repeat; background-size: cover; background-origin: content-box;" src="data:;base64,<svg  width='1920' height='1255'></svg>" sizes="(min-width: 63em) 640px, 100vw" srcset="https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1920 1920w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1760 1760w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1600 1600w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1440 1440w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1280 1280w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1120 1120w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w960 960w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w800 800w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w640 640w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w480 480w,https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w320 320w" alt="林先生稱當時患急性尿瀦留一刻，痛苦程度難以形容。（周嘉俊攝）" data-ofi-src="https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1920" data-pfsrc="https://cdn.hk01.com/di/media/images/1310810/org/41321f2f888834a82987018d827fb7f5.jpg/bCIEp6XLRNv6lEJfaLVjfDJUh7-7hW9ThUsbIYVLGyE?v=w1920" /></span></sup></div>
</div>
<p class="s1wfcnrk-0 kSZTWA sc-ckVGcZ eyLfWl sc-dxgOiQ facFUW" style="text-align: center;"><sup><span style="color: #696969;">林先生稱當時患急性尿瀦留一刻，痛苦程度難以形容。（周嘉俊攝）</span></sup></p>

</div>
<div class="n743at-1 eCxpHx sc-ifAKCX cFlEyZ sc-bdVaJa efkfCn">
<div class="s1wfcnrk-1 lanBTG sc-ifAKCX cFlEyZ sc-bdVaJa iHZvIS">
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa bkDnMq">
<div class="s19vvetr-0 bMMBWz" style="opacity: 1;"></div>
<div class="s19vvetr-0 bMMBWz" style="opacity: 1;"></div>
</div>
</div>
</div>
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa jLaXBp">
<div class="s1vmao8y-0 caABcD sc-ifAKCX cFlEyZ sc-bdVaJa kmtHOY">
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa bAqIHj">
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 20px;"><strong class="s10mqyzd-0 eDOYuX">急性尿瀦留患者：那種痛，簡直無法形容</strong></span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 16px;">今年79歲的林先生大約於七、八年前受前列腺增生症狀困擾，及後開始吃藥，但生活仍受影響。他形容，出街要第一時間尋洗手間、不敢到外地旅行；睡眠方面，每晚平均因夜尿而起來五至六次，導致翌日經常精神萎靡，嚴重影響生活。</span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 16px;">直至去年八月份某一天，他發現不能小便，「我下意識喝多兩口水，打算谷(尿)出來，但最終也不行，痛到不得了。」後來救護車接載他到急症室，在等候醫生過程中，他忍不住說，「護士、痛呀！」他續指，「那種痛，簡直無法形容，好慘架。」如果十分是滿分，痛楚就有八分。</span></span></sup></p>

</div>
</div>
<div></div>
</div>
<div class="sc-bxivhb bUZGRr sc-htpNat eDtRyC sc-bdVaJa gfijBq">
<div class="s6kslz-0 fbUkRW sc-ifAKCX cFlEyZ sc-bdVaJa eEfiTB">
<div class="LazyLoad is-visible">
<div id="lrec_2_6" style="height: auto;"></div>
</div>
</div>
<div class="s6kslz-1 jwCUmO sc-ifAKCX cFlEyZ sc-bdVaJa jLaXBp">
<div class="LazyLoad"></div>
</div>
</div>
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa jLaXBp">
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa eafGuj">
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa iHZvIS">
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="font-size: 20px;"><span style="color: #000000;"><strong class="s10mqyzd-0 eDOYuX">手術有風險　有機會導致不育</strong></span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 16px;">最終醫生跟他插尿喉放尿。及後去年八月，他再次遇上併發症，最終到私家診所做手術解決，他形容「做手術後變返正常人，去旅行都無問題。」林先生經手術後，再沒有出現小便不通的問題，也不用持續吃藥。 不過，醫生稱前列腺手術或會導致精液倒留的副作用，有機會導致不育，但不妨礙性快感。部份病人也可能於手術後出現勃起功能障礙。</span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>

<div class="sc-ifAKCX cFlEyZ sc-bdVaJa jLaXBp">
<div class="s1vmao8y-0 caABcD sc-ifAKCX cFlEyZ sc-bdVaJa kmtHOY">
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa bAqIHj">
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="color: #000000;"><span style="font-size: 20px;"><strong class="s10mqyzd-0 eDOYuX">及早預防　改善生活質素</strong></span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="font-size: 16px;"><span style="color: #000000;">急性尿瀦留嚴重患者，甚至有潛在生命危險。林先生另一位77歲朋友有相同經歷。大約兩年前，該朋友回內地工作，第一天就遇上不能小便的問題，翌日回港後立刻在關口乘坐救護車到醫院，最終因及時放尿而得救，逃過一劫。當時醫生說，「你再遲五分鐘入醫院，就會無命！」林先生稱，「大家如有我的情況，要及早看醫生，愈早看愈無事。」</span></span></sup></p>

</div>
</div>
<div></div>
</div>
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa jLaXBp">
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa eafGuj">
<div class="sc-ifAKCX cFlEyZ sc-bdVaJa iHZvIS">
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><sup><span style="font-size: 16px;"><span style="color: #000000;">香港前列腺基金會於2013年成立，組織發現在多年臨床經驗中，市民對前列腺健康認識不足，往往延誤診治。黃醫生稱，如遇小便不適症狀應及早求醫，及早診治可以提升治療成效及改善患者生活質素。另外黃醫生亦於今天發佈香港前列腺基金會首本書籍《無懼向「前」—— 前列線健康實用手冊》，希望令市民更了解良性前列腺增生及其影響，做到及早預防。</span></span></sup></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><span style="color: #696969;">文章來自: HK01</span></p>
<p class="u02q31-0 gvqXdj sc-ckVGcZ eyLfWl sc-dxgOiQ hPWfSj"><a href="https://www.hk01.com/%E7%A4%BE%E6%9C%83%E6%96%B0%E8%81%9E/172410" target="_blank" rel="noopener"><span style="color: #0000ff;">https://www.hk01.com/%E7%A4%BE%E6%9C%83%E6%96%B0%E8%81%9E/172410</span></a></p>

</div>
</div>
</div>
</div>
</div>
</div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180328]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%80%be50%e6%ad%b2%e7%94%b7%e5%a3%ab%e5%8d%8a%e6%95%b8%e6%88%96%e6%82%a3%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e3%80%80%e9%86%ab%e7%94%9f%e7%b1%b2%e5%8f%8a%e6%97%a9%e6%b2%bb/]]></permalink>
		<imageurl><![CDATA[http://cancerinfo.uat.ideas-time.com/wp-content/uploads/sites/25/2018/03/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I.jpeg]]></imageurl>
		<imagetitle><![CDATA[uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[http://cancerinfo.uat.ideas-time.com/wp-content/uploads/sites/25/2018/03/uj2KZYwKQ1vXrWSk-dxpFcDLSL7TTvls0lpngtJaZ4I.jpeg]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[統計，教育>健康教育]]></categories>
		<tags><![CDATA[文章|最新文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%80%be50%e6%ad%b2%e7%94%b7%e5%a3%ab%e5%8d%8a%e6%95%b8%e6%88%96%e6%82%a3%e8%89%af%e6%80%a7%e5%89%8d%e5%88%97%e8%85%ba%e5%a2%9e%e7%94%9f%e3%80%80%e9%86%ab%e7%94%9f%e7%b1%b2%e5%8f%8a%e6%97%a9%e6%b2%bb]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[85]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180521]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7236]]></id>
		<title><![CDATA[放射治療的幕後軍師]]></title>
		<content><![CDATA[<p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">常有人將癌症治療比作行軍打仗。假如腫瘤科專科醫生是統帥，那麼負責規劃放射治療（俗稱電療）的醫學物理學家可謂幕後軍師。</p>  <h5 style="padding: 0px; margin: 22px 0px; list-style-type: none; font-family: Georgia, &quot;Times New Roman&quot;, &quot;Bitstream Charter&quot;, Times, serif; color: rgb(0, 0, 0);"><img alt="香港港安腫瘤中心首席物理學家陳作良" class="wp-image-70083 size-full" height="400" src="https://bkb.mpweekly.com/wp-content/uploads/2018/03/44A3476_01__resize-e1522122861774.jpg" style="padding: 0px; margin: 0px; list-style-type: none; width: auto; border: none; max-width: 100%; display: block; height: auto;" width="600" />香港港安腫瘤中心首席物理學家陳作良</h5>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">香港港安腫瘤中心首席物理學家陳作良（Charlie）形容，電療規劃是一項不容犯錯的工作。醫生會先按病情，安排病人接受電腦斷層掃描（CT）、磁力共振掃描（MRI）、正電子放射斷層掃描（PET-CT）等檢查以確定腫瘤位置，繼而根據影像勾畫腫瘤。然後，醫學物理學家會依據腫瘤的形狀、大小及擴散範圍設計治療計劃，完成後再由醫生審核。</p>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">設計電療計劃，最重要是「faultless」，過程必須要非常專注及小心，因為一個無心之失足以決定生死。「英國及世界其他地方曾有個案，因醫學物理學家犯錯，導致幾百人受傷，部分甚至死亡。我們制定了治療計劃，便等於決定了病人會受到怎樣的創傷。如有出錯，可是性命攸關。」</p>  <h5 style="padding: 0px; margin: 22px 0px; list-style-type: none; font-family: Georgia, &quot;Times New Roman&quot;, &quot;Bitstream Charter&quot;, Times, serif; color: rgb(0, 0, 0);"><img class="size-full wp-image-70082" src="https://bkb.mpweekly.com/wp-content/uploads/2018/03/44A3469_resize-e1522122958689.jpg" style="padding: 0px; margin: 0px; list-style-type: none; width: auto; border: none; max-width: 100%; display: block; height: auto;" />設計治療計劃時，醫學物理學家會依據腫瘤的形狀、大小而制定放射治療的範圍和劑量。</h5>  <h2 class="orange" style="padding: 0px; margin: 0px; list-style-type: none; font-size: 18px; font-weight: 900; color: rgb(240, 126, 0); font-family: Oswald, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif;"><strong style="padding: 0px; margin: 0px; list-style-type: none;">傳統放療</strong><strong style="padding: 0px; margin: 0px; list-style-type: none;">&nbsp;&nbsp;</strong><strong style="padding: 0px; margin: 0px; list-style-type: none;">副作用大</strong></h2>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">Charlie入行四十年，見證醫療科技不斷突破，癌症也不再是「不治之症」。早期的電療主要利用二維（2D）技術，以平面X光片和心中的解剖結構為腫瘤定位和設計療程，故此照射範圍多為方形，往往在治療時同時傷害正常組織，甚至會造成致命創傷。</p>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">他解釋：「我們的臨床經驗顯示，絕大部分腫瘤都接近一些重要器官，甚至被它們包圍。以鼻咽癌為例，腫瘤非常接近脊髓、腦幹、視覺和聽覺神經等位置。在進行電療時，若傷到視覺神經會致盲，傷到脊髓則可能會全身癱瘓。」</p>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">昔日電療所引起的副作用還包括脫髮、出血、疲倦、疼痛、暈眩、嘔吐等。這些後遺症早已「深入民心」，有些病人會因吃不消而放棄治療。此外，治療效果往往未如人意，部分病例會出現原位復發甚至轉移。</p>  <h2 class="orange" style="padding: 0px; margin: 0px; list-style-type: none; font-size: 18px; font-weight: 900; color: rgb(240, 126, 0); font-family: Oswald, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif;"><strong style="padding: 0px; margin: 0px; list-style-type: none;">新一代電療&nbsp;&nbsp;</strong><strong style="padding: 0px; margin: 0px; list-style-type: none;">治療精準度大躍進</strong></h2>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">事實上，人體的腫瘤並非靜止不動，而是會隨着心跳、呼吸、腸道蠕動等而移動，傳統電療未能在規劃上考慮到這些微細的轉變，故引起的副作用較多。隨着科技進步，嶄新的電療設備先後面世，例如香港港安腫瘤中心配備的高速螺旋放射治療系統（TomoTherapy）和最新購置的Elekta Versa HD&trade;4D動態弧形直線加速器，在硬件設備上帶來更精準的電療成效。</p>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">Charlie指，除了硬件的配合，醫療團隊的規劃更為重要。他直言：「任何醫療機構都可以購置新的電療機器，但必須有無縫的醫療團隊配合，才能為病人設計個人化的貼身電療規劃，以減低對周邊器官的傷害，避免副作用，同時可安全地將更大劑量輻射投射到腫瘤，提升療效。」</p>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">Charlie如此比喻精準的電療設備：「就好比現代戰機，只要鎖定目標，一發射飛彈便能命中，而敵人就是那些可惡的腫瘤。」正因這些電療設備的精準程度大大提高，反而會因一些小節上的誤差造成更大傷害。因此，醫學物理學家設計治療計劃時便需注意每一個細節，甚至一厘米內的劑量分佈，及不斷權衡輕重，作出必要之取捨。他坦言：「假設腫瘤壓住脊椎神經，那麼應完全消滅腫瘤，令病人承受脊椎創傷，還是要保護脊椎，因而減少對腫瘤的劑量呢？還是取中庸之道？我的責任就是為病人作出最有利的抉擇。」</p>  <h5 style="padding: 0px; margin: 22px 0px; list-style-type: none; font-family: Georgia, &quot;Times New Roman&quot;, &quot;Bitstream Charter&quot;, Times, serif; color: rgb(0, 0, 0);"><img class="size-full wp-image-70084" src="https://bkb.mpweekly.com/wp-content/uploads/2018/03/44A3489_resize-e1522123081678.jpg" style="padding: 0px; margin: 0px; list-style-type: none; width: auto; border: none; max-width: 100%; display: block; height: auto;" /><strong style="padding: 0px; margin: 0px; list-style-type: none;">電療設計必須一絲不苟，但同時也是一場與時間的競賽。Charlie表示，港安的電療服務可能是全港甚至全世界最快捷的。遇有特別情況，如病情需要，可安排翌日甚至即日進行電療。</strong></h5>  <h2 class="orange" style="padding: 0px; margin: 0px; list-style-type: none; font-size: 18px; font-weight: 900; color: rgb(240, 126, 0); font-family: Oswald, &quot;Microsoft JhengHei&quot;, Arial, Helvetica, sans-serif;"><strong style="padding: 0px; margin: 0px; list-style-type: none;">病人一句感謝的威力</strong></h2>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">多年來出入醫院，不時與病人見面，他對癌症有特別深刻的感受。癌症的痛苦是「非比尋常」的，而且癌症影響的不單是病人本身，也包括其至親好友，大家的心靈創傷都很大。「對於生死，我們在社會上算是屬於比較『睇得化』的一羣。其實死並不可怕，痛更可怕。當你幾乎不能呼吸、不能進食，那種痛苦真是非筆墨所能形容。那我們怎麼能面對他們呢？我想是因為我們是全心幫助他們，而且深信我們的治療會有成效吧。」</p>  <p class="text" style="padding: 0px; margin: 15px 0px; list-style-type: none; line-height: 30px; font-family: NotoSans; overflow-x: hidden; color: rgb(0, 0, 0); font-size: medium;">說到工作上最難忘的時刻，他直言是得到病人的感謝：「有時捱更抵夜為病人打plan，也沒想過別人會道謝，但當真有人感謝時原來會很感動！見到病人情況一路好轉，好開心地對我說『Charlie，我現在已復元，不再疼痛，又有返胃口呢』，那一刻滿足感真的很大，亦是鞭策自己求進的動力。」</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180402]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%94%be%e5%b0%84%e6%b2%bb%e7%99%82%e7%9a%84%e5%b9%95%e5%be%8c%e8%bb%8d%e5%b8%ab/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>放射治療( 電療 )]]></categories>
		<tags><![CDATA[文章|熱門文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%94%be%e5%b0%84%e6%b2%bb%e7%99%82%e7%9a%84%e5%b9%95%e5%be%8c%e8%bb%8d%e5%b8%ab]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[31]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180523]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7237]]></id>
		<title><![CDATA[淋巴癌患者遍布各年齡層 年輕患者重療效也重生活質素]]></title>
		<content><![CDATA[<div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"> <div class="ckeditor_div" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 10px 0px 24px 8px; color: rgb(69, 69, 69);"> <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">雖然長者有較大機會患上淋巴癌，但卻並不代表年輕人士能對這種疾病免疫，事實上任何年齡的人士都可受到淋巴癌侵擾。對於正值壯年的患者而言，治癒疾病固然重要，但治療過程如何保持生活質素，盡可能讓患者返回生活正軌也是不能忽視的。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>標靶化療混合治療升存活率</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">四十多歲的Kevin(化名)因面色蒼白及感到異常疲倦而求醫，初步檢查發現不尋常的貧血狀況，最後證實他患上低度惡性B細胞淋巴癌。血液及血液腫瘤科專科醫生馬承恩醫生解釋：「低度惡性B細胞淋巴癌並不罕見，佔淋巴癌患者約三分之一，不同年紀的人都有機會患病。此病除了可帶來貧血，常見的病徵還有頸或腹股溝淋巴結脹大、消瘦及晚上出汗等。」<br /> 對於正值人生黃金期的Kevin，患上癌症對他來說固然是一大打擊，然而他最關心的是，此病能否治癒。馬承恩醫生表示，低度惡性B細胞淋巴癌對化療有不錯的反應，而近年再加入針對B細胞獨有的表面抗原CD20的標靶藥物，無論在病情控制時間及存活機會等，都能有所提升。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>由靜脈輸注至皮下注射</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">既然目前有方法可治療淋巴癌，Kevin也沒有半點怠慢，積極配合醫生的安排，接受化療加上標靶藥物的混合治療。為了確保Kevin對治療沒有過敏反應，Kevin首次接受標靶藥物治療時，醫生先安排以靜脈輸注方式進行。完成首次治療後，Kevin對藥物並沒有敏感不適反應，於是醫生從第二次治療開始，改為以皮下注射標靶藥物進行，令治療過程由過往的兩、三小時減至不到半小時，讓Kevin毋須長時間逗留於診所。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">馬承恩醫生解釋：「針對抗原CD20的標靶藥物是單克隆抗體，過往需以靜脈輸注的方法進入身體發揮療效，但最近有新技術讓單克隆抗體以皮下注射模式進入身體。臨床研究顯示，無論在療效還是安全性方面，皮下注射與靜脈輸注方式相若，只要經醫護人員觀察及評估患者在首次靜脈輸注治療時，並無對藥物產生不良敏感反應，治療期間亦沒有出現不適症狀，一般便可為患者轉為皮下注射。」</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>持效治療減低復發機會</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">Kevin完成了六個療程後，正電子掃描顯示他原先在骨髓及淋巴結發現的癌細胞都消失了，代表治療成功令病情受控。一般來說，低度惡性B細胞淋巴癌患者完成標準治療後，會被安排持效治療，患者需每隔兩至三個月接受一次標靶藥物治療，維持2-3年，以減低復發風險。馬承恩醫生補充：「不少年輕患者完成標準治療後，會重新投入職場工作。過往為了完成持效治療，患者可能需要特意向公司請假；而以皮下注射模式進行的持效治療，注射過程連同休息時間只需半小時左右，患者可以趁小休時段前往診所完成，令工作不會被治療嚴重打擾。」</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">事實上，對年輕淋巴癌患者而言，病情受控及生活重回正軌同樣重要，所以淋巴癌治療的發展除了不斷提高療效，也注重保持患者的生活質素，希望患者重獲健康之時，也擁有稱心的生活。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>皮下注射藥物過程</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">曾替患者進行標靶藥物注射的註冊護士Rebecca指出，靜脈輸注的入針位置於手部的靜脈，藥物經接駁了針口的軟管慢慢進入血液循環系統之中；而皮下注射的入針位置則是腹部的「肚腩」，醫護人員會把約十多毫升的藥物，經針筒逐少逐少向皮下組織注射，讓身體慢慢吸收，整個注射過程約10分鐘。完成治療後，患者的注射處會有一小圓點輕微隆起，這情況實屬正常，多數於一天內消失。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">值得一提的是，為了預防敏感反應發生，標靶藥物需與防敏感藥物一同使用。過往，抗敏感藥會與標靶藥物一同以靜脈輸注模式進入身體；倘若患者選擇皮下注射標靶藥物的話，患者需在進行標靶藥物治療開始半小時前服食抗敏藥，讓藥物有足夠時間進入身體發揮療效。<br /> 此外，於標準療程中，醫生會一併處方標靶藥物及化療，患者可選擇於化療前或後接受標靶藥物治療，這並不會對藥物療效構成影響。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><img alt="" src="http://www.cancerinformation.com.hkhttp://www.cancerinformation.com.hk/ufiles/Image/DrMa(1).jpg" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; width: 350px; height: 232px;" /></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(51, 51, 51); font-size: 16px;">血液及血液腫瘤科專科醫生馬承恩醫生</span></p>  <div style="border-top: none; border-right: none; border-bottom: 1.5pt solid windowtext; border-left: none; border-image: initial; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0cm 0cm 1pt;"> <p style="border: none; font-style: inherit; font-weight: inherit; margin: 0px 0px 0.0001pt; padding: 0cm;">&nbsp;</p> </div>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">安全報告免責聲明</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">此平台並不旨在用於記錄或報告不良藥物事件資訊</span>，<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">如您懷疑有任何副作用</span>，<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">請向您的醫生或藥劑師諮詢和報告</span>。</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">以上健康教育資訊由羅氏大藥廠香港有限公司提供</span>&nbsp;(PM-HK-0247-01-2018)</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">Valid until 19/12/2019 or until change is required in accordance with the regulatory requirements, whichever comes first.</p> </div> </div>  <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"> <div class="fb_reset" id="fb-root" style="border: 0px; margin: 0px; padding: 0px; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-spacing: 0px; color: rgb(0, 0, 0); cursor: auto; direction: ltr; font-family: &quot;lucida grande&quot;, tahoma, verdana, arial, sans-serif; font-size: 12px; font-variant-numeric: normal; font-variant-east-asian: normal; line-height: 1; overflow: visible; text-shadow: none; visibility: visible;"> <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; overflow: hidden; position: absolute; top: -10000px; height: 0px; width: 0px;"> <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</div> </div>  <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; overflow: hidden; position: absolute; top: -10000px; height: 0px; width: 0px;"> <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><iframe allowfullscreen="true" allowtransparency="true" aria-hidden="true" frameborder="0" id="fb_xdm_frame_http" name="fb_xdm_frame_http" scrolling="no" src="http://staticxx.facebook.com/connect/xd_arbiter/r/FdM1l_dpErI.js?version=42#channel=fa3a0d22e7f64c&amp;origin=http%3A%2F%2Fwww.cancerinformation.com.hk" style="border-width: initial; border-style: none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;" tabindex="-1" title="Facebook Cross Domain Communication Frame"></iframe><iframe allowfullscreen="true" allowtransparency="true" aria-hidden="true" frameborder="0" id="fb_xdm_frame_https" name="fb_xdm_frame_https" scrolling="no" src="https://staticxx.facebook.com/connect/xd_arbiter/r/FdM1l_dpErI.js?version=42#channel=fa3a0d22e7f64c&amp;origin=http%3A%2F%2Fwww.cancerinformation.com.hk" style="border-width: initial; border-style: none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;" tabindex="-1" title="Facebook Cross Domain Communication Frame"></iframe></div> </div> </div> <fb_comments class="fb_iframe_widget" fb-xfbml-state="rendered" href="http://www.cancerinformation.com.hk/blog_details.php?id=738" num_posts="5" style="display: inline-block; position: relative; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;" width="730"></fb_comments></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180404]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%b7%8b%e5%b7%b4%e7%99%8c%e6%82%a3%e8%80%85%e9%81%8d%e5%b8%83%e5%90%84%e5%b9%b4%e9%bd%a1%e5%b1%a4-%e5%b9%b4%e8%bc%95%e6%82%a3%e8%80%85%e9%87%8d%e7%99%82%e6%95%88%e4%b9%9f%e9%87%8d%e7%94%9f%e6%b4%bb/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[有營食品.]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%b7%8b%e5%b7%b4%e7%99%8c%e6%82%a3%e8%80%85%e9%81%8d%e5%b8%83%e5%90%84%e5%b9%b4%e9%bd%a1%e5%b1%a4-%e5%b9%b4%e8%bc%95%e6%82%a3%e8%80%85%e9%87%8d%e7%99%82%e6%95%88%e4%b9%9f%e9%87%8d%e7%94%9f%e6%b4%bb]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[84]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180404]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7238]]></id>
		<title><![CDATA[推動自費藥物納政府資助 仁愛堂設資助計劃助癌症病人]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><span style="font-size:26px;"><strong><span style="font-family: Arial, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Helvetica Neue&quot;, RobotoRegular, &quot;Segoe UI&quot;, Helvetica, &quot;Droid Sans&quot;, Segoe, Tahoma, Geneva, sans-serif;">推動自費藥物納政府資助 仁愛堂設資助計劃助癌症病人</span></strong></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/4881d1e045e2578d60f81edbe90109cc.jpg" style="width: 640px; height: 512px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-family: Arial, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Helvetica Neue&quot;, RobotoRegular, &quot;Segoe UI&quot;, Helvetica, &quot;Droid Sans&quot;, Segoe, Tahoma, Geneva, sans-serif; font-size: 14px;">羅台秦。仁愛堂圖片</span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p>&nbsp;</p>  <p style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: medium; line-height: inherit; font-family: Arial, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Helvetica Neue&quot;, RobotoRegular, &quot;Segoe UI&quot;, Helvetica, &quot;Droid Sans&quot;, Segoe, Tahoma, Geneva, sans-serif; vertical-align: baseline; margin: 15px 0px; padding: 0px; color: rgb(0, 0, 0);"><span style="font-size:16px;">【星島日報報道】仁愛堂舉行39屆董事局就職典禮，主席羅台秦透露，仁愛堂期望在屯門區興建全新綜合服務大樓，包括增設大型健體中心、培訓中心、社會企業、護養院、特殊幼兒中心等服務，另計畫在牛頭角增設多培訓中心，改善九龍東居民的就業情況。仁愛堂指，將協助醫管局收集醫療數據，加快推動自費藥物納入政府資助範圍，並成立專治黑色素瘤及腎癌的「免疫治療藥物資助計劃」，幫助更多有需要的癌症病人。</span></p>  <p style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: medium; line-height: inherit; font-family: Arial, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Helvetica Neue&quot;, RobotoRegular, &quot;Segoe UI&quot;, Helvetica, &quot;Droid Sans&quot;, Segoe, Tahoma, Geneva, sans-serif; vertical-align: baseline; margin: 15px 0px; padding: 0px; color: rgb(0, 0, 0);"><span style="font-size:16px;">仁愛堂第39屆董事局主席羅台秦主席表示，仁愛堂將透過「仁愛堂莊舜而醫療基金」收集醫療數據，加快推動醫管局將具療效的自費藥物，納入政府資助範圍，並成立專治黑色素瘤及腎癌的「免疫治療藥物資助計劃」，幫助更多有需要的癌症病人。</span></p>  <p style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: medium; line-height: inherit; font-family: Arial, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Helvetica Neue&quot;, RobotoRegular, &quot;Segoe UI&quot;, Helvetica, &quot;Droid Sans&quot;, Segoe, Tahoma, Geneva, sans-serif; vertical-align: baseline; margin: 15px 0px; padding: 0px; color: rgb(0, 0, 0);"><span style="font-size:16px;">關注到青少年兒童對精神科醫療及藥物資助的需要，仁愛堂已邀請藥廠支持「藥物資助計劃」，為有經濟困難的兒童提供藥物資助。</span></p>  <p style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: medium; line-height: inherit; font-family: Arial, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Helvetica Neue&quot;, RobotoRegular, &quot;Segoe UI&quot;, Helvetica, &quot;Droid Sans&quot;, Segoe, Tahoma, Geneva, sans-serif; vertical-align: baseline; margin: 15px 0px; padding: 0px; color: rgb(0, 0, 0);"><span style="font-size:16px;">教育方面，仁愛堂將率先推出幼稚園「一校一社工」先導計畫，透過早期介入為學童提供穩定輔導服務，預防幼兒悲劇發生，另外參與由由香港中文大學眼科中心推行的「曈心護眼計劃」，讓仁愛堂屬校學生及其家長免費參加全面眼科檢查。</span></p>  <p style="border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: medium; line-height: inherit; font-family: Arial, 微軟正黑體, &quot;Microsoft JhengHei&quot;, &quot;Helvetica Neue&quot;, RobotoRegular, &quot;Segoe UI&quot;, Helvetica, &quot;Droid Sans&quot;, Segoe, Tahoma, Geneva, sans-serif; vertical-align: baseline; margin: 15px 0px; padding: 0px; color: rgb(0, 0, 0);"><span style="font-size:16px;">羅台秦透露，仁愛堂將推出開短，中，長三方案，以回應屯門區急速發展所帶來的服務需求，期望能興建全新綜合服務大樓，包括增設大型健體中心、培訓中心、社會企業、護養院、特殊幼兒中心、早期教育及訓練中心、家長資源中心、鄰里支援幼兒照顧計劃等服務，另外計畫在牛頭角增設多一間培訓中心，提供廚務及醫護等相關課程，從而改善九龍東居民的就業情況。</span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="font-size:14px;"><span style="color:#696969;">文章來自: 新浪香港</span></span></p>  <p><span style="font-size:14px;"><a href="http://m.sina.com.hk/news/article/20180427/0/1/4/推動自費藥物政府資助-仁愛堂設資助計劃助癌症病人-8779264.html" target="_blank"><span style="color:#0000FF;">http://m.sina.com.hk/news/article/20180427/0/1/4/推動自費藥物政府資助-仁愛堂設資助計劃助癌症病人-8779264.html</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180427]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%8e%a8%e5%8b%95%e8%87%aa%e8%b2%bb%e8%97%a5%e7%89%a9%e7%b4%8d%e6%94%bf%e5%ba%9c%e8%b3%87%e5%8a%a9-%e4%bb%81%e6%84%9b%e5%a0%82%e8%a8%ad%e8%b3%87%e5%8a%a9%e8%a8%88%e5%8a%83%e5%8a%a9%e7%99%8c%e7%97%87/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章|最新文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%8e%a8%e5%8b%95%e8%87%aa%e8%b2%bb%e8%97%a5%e7%89%a9%e7%b4%8d%e6%94%bf%e5%ba%9c%e8%b3%87%e5%8a%a9-%e4%bb%81%e6%84%9b%e5%a0%82%e8%a8%ad%e8%b3%87%e5%8a%a9%e8%a8%88%e5%8a%83%e5%8a%a9%e7%99%8c%e7%97%87]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[86]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180521]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7239]]></id>
		<title><![CDATA[談癌症基因檢測與歧視]]></title>
		<content><![CDATA[<p><span style="color:#000000;"><strong><span style="font-size:26px;"><span lang="EN-US" style="font-family:新細明體">談癌症基因檢測與歧視</span></span></strong></span></p>  <p style="text-align: center;">&nbsp;</p>  <p><span style="color:#696969;"><span style="font-size:14px;"><span style="font-family:新細明體">文：</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">Stella / </span><span style="font-family:新細明體">癌症資訊網</span><br /> <span style="font-family:新細明體">照片：癌症資訊網</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family:新細明體">癌症源自基因突變成病，正常細胞在複製過程中出錯變異，形成不受控制的癌細胞。然而隨著醫療科技日新月異，科學家完成人類遺傳基因組排序圖譜，開展生命之謎的探索，癌症基因檢測技術應運而生。備受矚目的基因測試湧現市場的同時，衍生的歧視問題亦不能忽視。是次《腫瘤精準醫療</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;"> &mdash; </span><span style="font-family:新細明體">防範基因歧視》座談會於本月</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">20</span><span style="font-family:新細明體">日假</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;"> The Mira Hong Kong </span><span style="font-family:新細明體">隆重舉行，出席的醫療業界代表多不勝數，為香港醫療發展以至產生的歧視問題提出寶貴意見，並促請各界討論發聲，以達至多方平衡發展。</span></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family:新細明體">精準醫療（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">Precision Medicine</span><span style="font-family:新細明體">）也可稱為個人化治療，透過不同形式的基因檢測技術得出個人化基因資料，配對最合適的疾病治療方案，帶領癌症患者從以往一體化治療（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">One size fits all) </span><span style="font-family:新細明體">走到個人化治療。養和醫院醫學遺傳科主任林德深醫生認同精準醫療的重要性：「若能夠精準地檢測人類基因變異，定能解決基因變異如何影響身體細胞及系統、醫療工作如何配合、如何界定家族遺傳病、以至病人及早檢驗和治療疾病等問題。」</span></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family:新細明體">從前的治癌策略都離不開一體化（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">One size fits all</span><span style="font-family:新細明體">）的化療，所有人用相同的治療方案，成效固然難以控制。但若然從基因檢測知道哪些基因出現了問題，醫生再處方針對性的個人化治療，不但減少檢驗的時間、治療效果得以提升，副作用亦會減少。行動基因技術長</span></span></span><span style="font-family:新細明體"><st1_personname productid="陳淑貞" w_st="on"><span style="color:#000000;"><span style="font-size:16px;">陳淑貞</span></span></st1_personname></span><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family:新細明體">博士表示：「基因測試在癌症病人身上有幾個重要用途：第一，利用基因測試，我們得知腫瘤對哪些藥物非常敏感或哪些藥物有抗藥性。根據結果，醫生可以為病人選擇最合適的治療策略。第二，追蹤病人的治療情況。由於基因突變通常只發生在腫瘤細胞，所以這些突變便成為追蹤腫瘤的重要標誌。當病人經過癌症治療後，突變基因的細胞數量增加或減少，正正反映了治療的效果。第三，監控疾病。有些病人過了一段時候後，癌病復發。過去我們都用影像如電腦掃描（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">CT</span><span style="font-family:新細明體">）、磁力共振（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">MRI</span><span style="font-family:新細明體">）、正電子掃描（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">PET SCAN</span><span style="font-family:新細明體">）等方式監察病人復發情況。但基因檢測中的液體活檢（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">Liquid Biopsy</span><span style="font-family:新細明體">）技術，靈敏度比影像大概早</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">3</span><span style="font-family:新細明體">至</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">4</span><span style="font-family:新細明體">個月便得知病人復發情況，病人得以及早接受治療。第四，偵測抗藥性。病人使用標靶藥物一段時間後或會出現抗藥性，那些抗藥性可能是來自病人某些基因再度突變。技術人員從血液中發現病人的抗藥性微點，醫生便能及時轉換針對性藥物。」除此以外，基因檢測技術對遺傳性癌症患者而言亦大大提高了治癒率。臨床腫瘤科專科區兆基醫生明言：「若他們預早知道有這類遺傳基因突變，便能及早預防，同時治療效果亦會提升。」</span></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family:新細明體">縱然基因檢測的出現，為癌症治療開拓了個人化治療的新領域，當中牽涉的歧視問題卻成為精準醫療發展的阻礙。部分病人擔心基因檢測獲取大量病人資訊，如次世代基因排序（</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">Next Generation Sequencing, NGS</span><span style="font-family:新細明體">）技術能一次檢測二萬多個基因，會令歧視問題蔓延至工作環境、學校、醫療體制、購買保險、甚至家族中。林醫生認為：「要防止歧視情況發生，不單是政府，整個社會都有責任參與討論。各持份者都應提出意見，了解情況到了甚麼程度，如何監管和立法等。」事實上，《香港人權法案條例》（香港法例第</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;"> 383 </span><span style="font-family:新細明體">章）大致上已訂明所有人在法律上一律平等</span> <span style="font-family:新細明體">，而法律亦應該禁止由任何因素產生的歧視行為，當中包括：性別歧視、殘疾歧視、家庭崗位歧視、種族歧視。當中法例能否全面保障使用基因檢測的病人亦有賴社會大眾繼續討論。</span></span></span></p>  <p>&nbsp;</p>  <p><span style="color:#000000;"><span style="font-size:16px;"><span style="font-family:新細明體">在確保癌症病人的資料受到法律保障以先，新加坡國立大學癌症中心資深顧問李素琴醫生更提到提高病人治療機會的必要性：「我們有新的檢測科技，知道遺傳性癌症病人存在，有相應的藥物可作治療，亦肯定藥物治療的效果很好，但病人卻未能負擔高昂的藥費。故此，政府方面應該努力提升藥物的使用率，這才可以切實幫助病人。」</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/14(1).jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span style="font-family:新細明體">圖片</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">1:</span><span style="font-family:新細明體">《腫瘤精準醫療</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;"> &mdash; </span><span style="font-family:新細明體">防範基因歧視》座談會於本月</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">20</span><span style="font-family:新細明體">日假</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;"> The Mira Hong Kong </span><span style="font-family:新細明體">隆重舉行，</span></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span style="font-family:新細明體">出席的醫療業界代表多不勝數。</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><o_wrapblock><w_wrap anchorx="margin" type="topAndBottom"><span style="position:relative; width:654px"><span style="z-index:1"><span style="left:-22px"><span style="top:0px"><span style="height:368px"><img src="http://www.cancerinformation.com.hk/ufiles/Image/13(2).jpg" style="width: 640px; height: 368px;" /></span></span></span></span></span></w_wrap></o_wrapblock></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span style="font-family: 新細明體;">圖片</span><span lang="EN-US" style="font-family: &quot;Times New Roman&quot;;">2:&nbsp;</span><span style="font-family: 新細明體;">臨床腫瘤科專科區兆基醫生明言：「若他們預早知道有這類遺傳基因突變，便能及早預防，</span></span></span></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span style="font-family: 新細明體;">同時治療效果亦會提升。」</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/09(1).jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="color:#696969;"><span style="font-size:14px;"><span style="font-family: 新細明體;">圖片</span><span lang="EN-US" style="font-family: &quot;Times New Roman&quot;;">3:&nbsp;</span><span style="font-family: 新細明體;">行動基因技術長</span></span></span><span style="font-family: 新細明體;"><st1_personname productid="陳淑貞" w_st="on"><span style="color:#696969;"><span style="font-size:14px;">陳淑貞</span></span></st1_personname></span><span style="color:#696969;"><span style="font-size:14px;"><span style="font-family: 新細明體;">博士表示基因測試在癌症病人身上的重要性。</span></span></span></p>  <p>&nbsp;</p>  <p>&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/06(1).jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><span style="font-family:新細明體">圖片</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">4: </span><span style="font-family:新細明體">新加坡國立大學癌症中心資深顧問李素琴醫生提到提高病人治療機會的必要性。</span></span></span></p>  <p>&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/03(1).jpg" style="width: 640px; height: 360px;" /></p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><span style="font-family:新細明體">圖片</span><span lang="EN-US" style="font-family:&quot;Times New Roman&quot;">5: </span><span style="font-family:新細明體">養和醫院醫學遺傳科主任林德深醫生表示要防止歧視情況發生，</span></span></span></p>  <p style="text-align: center;"><span style="font-size:14px;"><span style="color:#696969;"><span style="font-family:新細明體">不單是政府，整個社會都有責任參與討論。</span></span></span></p>  <p style="text-align: center;">&nbsp;</p>  <p style="text-align: center;">&nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180502]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%ab%87%e7%99%8c%e7%97%87%e5%9f%ba%e5%9b%a0%e6%aa%a2%e6%b8%ac%e8%88%87%e6%ad%a7%e8%a6%96/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[最新文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%ab%87%e7%99%8c%e7%97%87%e5%9f%ba%e5%9b%a0%e6%aa%a2%e6%b8%ac%e8%88%87%e6%ad%a7%e8%a6%96]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[82]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180521]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7240]]></id>
		<title><![CDATA[由胃痛開始 不一樣的淋巴癌抗癌之路]]></title>
		<content><![CDATA[<p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 26px;"><b><span style="margin: 0px; font-family: SimSun;">由胃痛開始</span></b>&nbsp;<b><span style="margin: 0px; font-family: SimSun;">不一樣的淋巴癌抗癌之路</span></b></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 16px;"><span style="margin: 0px; font-family: SimSun;"><font color="#000000">頸部淋巴結脹大是淋巴癌的常見徵狀之一，但部份患者脹大的淋巴結位於其他器官，繼而引發不一樣的徵狀。無論如何，當患者確診後，醫生便會使用各種治療方法去消滅癌細胞，包括近年出現的新式治療方案，協助患者邁向康復目標。</font></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><strong><span style="font-size: 20px;"><span style="margin: 0px; font-family: SimSun;">胃痛源於胃壁淋巴結脹大</span></span></strong></span></p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="margin: 0px; font-family: SimSun;">五十多歲的張先生</span><font face="Calibri">(</font><span style="margin: 0px; font-family: SimSun;">化名</span><font face="Calibri">)</font><span style="margin: 0px; font-family: SimSun;">受胃痛困擾，並伴有晚上出汗的情況，情況並不尋常。經過檢查後，證實患上彌漫性大</span><font face="Calibri">B</font><span style="margin: 0px; font-family: SimSun;">細胞淋巴癌，病變的淋巴細胞令胃壁淋巴結脹大，造成胃痛。</span></span></span></p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><b><span style="margin: 0px; font-family: SimSun;">臨床腫瘤科專科醫生張寬耀醫生</span></b><span style="margin: 0px; font-family: SimSun;">指出，彌漫性大</span><font face="Calibri">B</font><span style="margin: 0px; font-family: SimSun;">細胞淋巴癌是非何傑金氏淋巴癌其中一種常見類別，屬於一種惡性較高的淋巴癌，多見於中年或以上的人士，但年輕人士也有機會患上。它跟其他淋巴癌同樣可帶來頸部淋巴結脹大，但如張先生般出現其他非典型徵狀的情況也並不罕見。</span></span></span></p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="margin: 0px; font-family: SimSun;">目前治療彌漫性大</span><font face="Calibri">B</font><span style="margin: 0px; font-family: SimSun;">細胞淋巴癌的標準方法，是以化療配合標靶藥物「利妥昔單抗」作混合治療。「利妥昔單抗」是單克隆抗體的標靶藥物，針對淋巴</span><font face="Calibri">B</font><span style="margin: 0px; font-family: SimSun;">細胞作出攻擊，令其凋亡。<b>張寬耀醫生</b>指出，早期患者接受混合性治療而獲得治癒的機會最高可達九成，如再配合局部治療如放射治療，可進一步提高治療效果。</span></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;"><span style="font-size: 20px;"><span style="color: rgb(0, 0, 0);"><b><span style="margin: 0px; font-family: SimSun;">標靶藥物配合化療</span></b></span></span></p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="margin: 0px; font-family: SimSun;">張先生如一般彌漫性大</span><font face="Calibri">B</font><span style="margin: 0px; font-family: SimSun;">細胞淋巴癌患者般，被安排接受「利妥昔單抗」配合化療的混合性治療，首次治療需以慢速的</span><span style="margin: 0px; font-family: 新細明體;">靜脈輸注</span><span style="margin: 0px; font-family: SimSun;">模式進行，讓張先生差不多在診所逗留了一整天才完成整個治療；然後於三星期後再次於診所接受混合性治療，治療時間縮短至</span><font face="Calibri">5&nbsp;</font><span style="margin: 0px; font-family: SimSun;">小時。</span></span></span></p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="margin: 0px; font-family: SimSun;">當張先生準備接受下一個療程時，醫生告知張先生可以選擇近年出現的皮下注射，以取代</span><span style="margin: 0px; font-family: 新細明體;">靜脈輸注</span><span style="margin: 0px; font-family: SimSun;">接受「利妥昔單抗」治療。張先生選擇使用耗時僅需</span><font face="Calibri">5</font><span style="margin: 0px; font-family: SimSun;">分鐘的「利妥昔單抗」皮下注射劑，</span><font face="Calibri">&nbsp;</font><span style="margin: 0px; font-family: SimSun;">整個治療過程只需</span><font face="Calibri">3</font><span style="margin: 0px; font-family: SimSun;">小時，讓他毋須逗留於診所午膳，可在中午前離開診所回家休息。</span></span></span></p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><span style="margin: 0px; font-family: SimSun;">如是者，張先生完成了四個標靶藥物配合化療的療程後，正電子掃描顯示原本脹大至</span><font face="Calibri">4</font><span style="margin: 0px; font-family: SimSun;">厘米闊的胃壁淋巴結已經消失，顯示治療相當成功。儘管張先生的症狀並不典型，但接受了新式治療方案後，成功擊敗淋巴癌，慢慢走向康復目標。</span></span></span></p>  <p style="margin: 0px 0px 11px;"><span style="color: rgb(0, 0, 0);"><span style="font-size: 16px;"><b><span style="margin: 0px; font-family: SimSun;">張寬耀醫生</span></b><span style="margin: 0px; font-family: SimSun;">表示，皮下注射劑型的「利妥昔單抗」加入了特別生物分子，讓藥物可以快速穿過皮下脂肪組織滲入血管。臨床研究顯示皮下注射模式在療效及安全性上，與傳統</span><span style="margin: 0px; font-family: 新細明體;">靜脈輸注</span><span style="margin: 0px; font-family: SimSun;">模式相約，卻可以縮短患者逗留於診所或醫院的時間。</span></span></span></p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px;">&nbsp;</p>  <p style="margin: 0px 0px 11px; text-align: center;"><span style="color: rgb(128, 128, 128);"><span style="margin: 0px; line-height: 15.693333625793457px; font-family: Calibri; font-size: 11pt;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/image002(1).jpg" style="width: 318px; height: 378px;" />​</span></span></p>  <p style="margin: 0px 0px 11px; text-align: center;"><span style="color: rgb(128, 128, 128);"><span style="font-size: 16px;"><b><span style="margin: 0px; font-family: SimSun;">張寬耀醫生</span></b></span></span></p>  <p style="margin: 0px 0px 11px; text-align: center;">&nbsp;</p>  <div style="border-bottom-width: 1.5pt; border-bottom-style: solid; border-bottom-color: windowtext; padding: 0cm 0cm 1pt;"> <p style="border: medium; margin: 0px; padding: 0cm;">&nbsp;</p> </div>  <p style="margin: 0px 0px 11px;"><span style="margin: 0px; font-family: SimSun;"><font color="#000000"><font size="3">安全報告免責聲明</font></font></span></p>  <p style="margin: 0px 0px 11px;"><span style="margin: 0px; font-family: SimSun;"><font color="#000000"><font size="3">此平台並不旨在用於記錄或報告不良藥物事件資訊，如您懷疑有任何副作用，請向您的醫生或藥劑師諮詢和報告。</font></font></span></p>  <p style="margin: 0px 0px 11px;"><font size="3"><font color="#000000"><span style="margin: 0px; font-family: SimSun;">以上健康教育資訊由羅氏大藥廠香港有限公司提供</span><font face="Calibri">&nbsp;(PM-HK-0150-08-2017)</font></font></font></p>  <p style="margin: 0px 0px 11px;"><font color="#000000"><font face="Calibri"><font size="3">Valid until&nbsp;<st1_chsdate day="15" islunardate="False" isrocdate="False" month="8" w_st="on" year="2019">15/8/2019</st1_chsdate>&nbsp;or until change is required in accordance with the regulatory requirements, whichever comes first.</font></font></font></p>  <div>&nbsp;</div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180503]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%94%b1%e8%83%83%e7%97%9b%e9%96%8b%e5%a7%8b-%e4%b8%8d%e4%b8%80%e6%a8%a3%e7%9a%84%e6%b7%8b%e5%b7%b4%e7%99%8c%e6%8a%97%e7%99%8c%e4%b9%8b%e8%b7%af/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[醫療新知.>本地醫療快訊 / 癌症資訊網編輯室]]></categories>
		<tags><![CDATA[文章|熱門文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%94%b1%e8%83%83%e7%97%9b%e9%96%8b%e5%a7%8b-%e4%b8%8d%e4%b8%80%e6%a8%a3%e7%9a%84%e6%b7%8b%e5%b7%b4%e7%99%8c%e6%8a%97%e7%99%8c%e4%b9%8b%e8%b7%af]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[83]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180523]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7241]]></id>
		<title><![CDATA[舞台劇 《我們都是同路人》]]></title>
		<content><![CDATA[<p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 26px;"><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">舞台劇</span></b></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 26px;"><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">《我們都是同路人》</span></b></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;">&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/A131B1A6-E15F-4993-966C-20288BEAF921.jpeg" style="width: 640px; height: 906px;" /></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;">&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">未知生，焉知死</span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">同路人奮勇攜手，踏上表演舞台叩問生命價值</span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">藉第二人生分享抗癌路上的美麗與衰愁</span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">誓以生命觸動心靈</span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">與您同行抗癌路</span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;">&nbsp;</p>  <p align="center" style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: center;">&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">由癌症資訊網慈善基金及劇場脈搏聯合主辦及製作的生死教育舞台劇《我們都是同路人》，將於</span>2018</b><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">年</span>6</b><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">月</span>22</b><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">至</span>23</b><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日，假西灣河文娛中心劇院正式公演</span></b><b><span lang="ZH-HK" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">三場</span></b><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">，並在每場演出後舉行座談會，由癌症同路人與觀眾直接交流，分享抗癌路及演出樂趣。</span></b></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">地點：西灣河文娛中心劇院</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">票價：免費</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日期：</span></span></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><st1_chsdate day="22" islunardate="False" isrocdate="False" month="6" w_st="on" year="2018"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">2018</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">年</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">6</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">月</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">22</span><span lang="ZH-HK" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日</span></span></span></st1_chsdate></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">（星期</span><span lang="ZH-HK" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">五</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">）</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">時間：晚上</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">7</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">時</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">30</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">分</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日期：</span></span></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><st1_chsdate day="23" islunardate="False" isrocdate="False" month="6" w_st="on" year="2018"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">2018</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">年</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">6</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">月</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">23</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日</span></span></span></st1_chsdate></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">（星期六）</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">時間：下午</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">3</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">時正</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日期：</span></span></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><st1_chsdate day="23" islunardate="False" isrocdate="False" month="6" w_st="on" year="2018"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">2018</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">年</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">6</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">月</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">23</span><span lang="ZH-HK" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日</span></span></span></st1_chsdate></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">（星期六）</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">時間：晚上</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">7</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">時</span><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;">30</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">分</span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="font-size:20px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><b><span lang="ZH-HK" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">立即網上索取門票</span></span></b></span></span><b><span lang="EN-US" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: &quot;Times New Roman&quot;;"><span style="font-size:20px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">:</span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(0, 0, 255);">&nbsp;</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><a href="https://goo.gl/e44EDe" target="_blank"><span style="color:#0000FF;">https://goo.gl/e44EDe</span></a></span></span></span></b></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="font-size:18px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">公眾索取門票方法：</span></b></span></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">電話：</span><a href="tel:6023 3238"><span style="color:#0000FF;">6023 3238</span></a></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">電郵：</span>info@cancerinformation.com.hk</span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">截止日期：</span></b></span></span></span><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><b><st1_chsdate day="15" islunardate="False" isrocdate="False" month="6" w_st="on" year="2018"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">2018<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">年</span>6<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">月</span>15<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">日</span></span></span></st1_chsdate></b></span></span><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><b>&nbsp;(23:59)</b></span></span></span></p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; line-height: 12pt;"><b>*</b><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">註︰</span><span lang="ZH-HK" style="font-style: inherit; border: 0px none; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">門票先到先得，</span></span><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">派</span></span><span lang="ZH-HK" style="font-style: inherit; border: 0px none; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">完即止</span></span><span style="border: 0px none; font-style: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">。</span></span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">子曰︰「未知生，焉知死﹖」真正對「生」有所體認的人，才能對「死」有所了悟。許多重症病人都是在人生的幽谷裡，才醒悟到自己真正重視的人、事及物。世上最不幸的，不是掉進了人生的低谷，而是經歷磨難的同時，失去了對生命的熱愛。演出亦由專業戲劇工作者同時曾為癌症病人家屬的朋友帶領創作，匯集同路人的所思所感所想，借虛構的故事傳達表演者的真實歷程，亦借表演者的真實歷程轉化成舞台作品，訴說「癌症」並不可怕，及鼓勵同路人借此機會重新學習生活，學習愛與被愛的關係，認識生命的真正意義。</span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; margin: 0px -48pt 20px 0px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif; text-align: justify;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><b><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">關於癌症資訊網慈善基金</span></b></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">癌症資訊網慈善基金(以下簡稱「本基金」)，由一群熱愛生命的癌症患者及康復者攜手組成的互助網絡平台，由癌</span><span lang="ZH-HK" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">症</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">患者、照顧者和專業人士以全方位角度提供正確、專業和有用的癌症資訊，並以正面態度與癌症患者及其家屬分享和交流，鼓勵他們以積極態度面對抗癌之路，透過座談會、工作坊和小組聯誼等，團結同路人，交流信息，互相扶持，發揮互助互勉的精神。</span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">服務運作經費主要來自癌症資訊網有限公司撥款及公眾捐獻。</span></span></span></span></p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;">&nbsp;</p>  <p style="border: 0px none; margin: 0px 0px 20px; padding: 0px; color: rgb(0, 0, 0); font-family: Verdana, Geneva, sans-serif;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">電話：</span>21211328&nbsp;<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 新細明體;">網址：</span></span></span><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><a href="http://www.cancerinformation.com.hk/" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; text-decoration-line: none; color: rgb(0, 50, 103);" target="_blank"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(0, 0, 255);">http://www.cancerinformation.com.hk</span></a></span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180509]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%88%9e%e5%8f%b0%e5%8a%87-%e3%80%8a%e6%88%91%e5%80%91%e9%83%bd%e6%98%af%e5%90%8c%e8%b7%af%e4%ba%ba%e3%80%8b/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[城中活動>癌症資訊網未來活動]]></categories>
		<tags><![CDATA[文章|熱門文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%88%9e%e5%8f%b0%e5%8a%87-%e3%80%8a%e6%88%91%e5%80%91%e9%83%bd%e6%98%af%e5%90%8c%e8%b7%af%e4%ba%ba%e3%80%8b]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[87]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180523]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7242]]></id>
		<title><![CDATA[下載 癌症病痛與症狀 小册子]]></title>
		<content><![CDATA[<p>&nbsp;<img src="http://www.cancerinformation.com.hk/ufiles/Image/Admin-1.jpg" width="400" height="204" alt="" /></p> <p><span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">服用止痛藥常見的憂慮&nbsp;</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">治療疼痛的藥物&nbsp;</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">藥物治療疼痛的方法&nbsp;</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">藥物以外治療疼痛的方法</span></p> <p><a href="http://www.cancer-fund.org/upload/booklets/file/HowToCope/cope_06pain_c.pdf">http://www.cancer-fund.org/upload/booklets/file/HowToCope/cope_06pain_c.pdf</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%8b%e8%bc%89-%e7%99%8c%e7%97%87%e7%97%85%e7%97%9b%e8%88%87%e7%97%87%e7%8b%80-%e5%b0%8f%e5%86%8c%e5%ad%90-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%8b%e8%bc%89-%e7%99%8c%e7%97%87%e7%97%85%e7%97%9b%e8%88%87%e7%97%87%e7%8b%80-%e5%b0%8f%e5%86%8c%e5%ad%90-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[1]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7243]]></id>
		<title><![CDATA[癌病人針灸紓緩腳疼痛]]></title>
		<content><![CDATA[<p>&nbsp;<span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">癌症病人接受化療抗癌，藥物可能傷害下肢的神經，引致痛楚的副作用，德國漢堡一項小型研究發現，癌症病人進行針灸治療，可改善下肢血流，減輕藥物引致的痛楚。有關研究在國際期刊《針灸》刊登。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <img src="http://orientaldaily.on.cc/cnt/news/20111209/photo/1209-00176-066v1.jpg" alt="" width="300" height="400" style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">該項研究指，接受廣泛化療藥物治療的病人，因藥物導致神經末梢受損，腳部的神經感到痛楚，會舉步維艱。研究人員找來六名病人在三個月內接受十次針灸，並與五名沒有接受針灸者再作對比。研究發現，接受針灸治療的病人，其下肢血流及神經訊號均有增加，痛楚減少，顯示有些康復。研究人員建議進行更大型的研究。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">本港末期癌症患者亦有透過針灸及催眠等治療方法，紓緩疼痛。全球每年有七百萬人死於癌症，其中逾三百萬人在劇烈痛楚中死亡。據統計本港每年約有萬二人死於癌症，約七成末期癌症病人承受不同程度的痛楚，部分人會接受紓緩治療。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <img src="http://orientaldaily.on.cc/img/v2/logo_odn_archive.png" alt="" width="97" height="22" style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">2011-12-9</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <a href="http://orientaldaily.on.cc/cnt/news/20111209/00176_066.html?pubdate=20111209" target="_blank" style="word-wrap: break-word; text-decoration: none; color: rgb(0, 153, 204); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;">http://orientaldaily.on.cc/cnt/n ... ml?pubdate=20111209</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%97%85%e4%ba%ba%e9%87%9d%e7%81%b8%e7%b4%93%e7%b7%a9%e8%85%b3%e7%96%bc%e7%97%9b-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%97%85%e4%ba%ba%e9%87%9d%e7%81%b8%e7%b4%93%e7%b7%a9%e8%85%b3%e7%96%bc%e7%97%9b-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[2]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7244]]></id>
		<title><![CDATA[四成癌患 再致抑鬱]]></title>
		<content><![CDATA[<p>&nbsp;<img src="http://hk.apple.nextmedia.com//images/apple-photos/apple/20110718/small/18ls2p1n.jpg" alt="" width="190" height="148" style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">本港每年約有兩萬名癌症新症，對很多患者來說，要面對突如其來的噩耗，要承受一定的壓力，有研究顯示，本港有四成患者因癌症而引致抑鬱或焦慮症，影響他們的生活質素。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">威爾斯醫院早前分別進行了兩項研究，首項研究是針對本港乳癌病人所面對的情緒困擾及對生活的影響，研究涉及259名將開始接受化療的乳癌患者，其中38.2%有抑鬱或焦慮傾向。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">出現情緒困擾的原因主要包括擔心癌症影響婚姻、性生活，及對癌症療程產生憂慮或恐懼等。而出現抑鬱或焦慮的患者，近半在生活各範疇如工作、家庭、社交和生活滿足感方面都感到不滿意。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">另一項研究則是針對肺癌病人的情緒壓力，研究包括191名將開始接受化療的肺癌患者，並發現30.9%出現抑鬱或焦慮。&nbsp;</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">中大醫學院臨牀腫瘤學系教授莫樹錦說，當癌症病人不能控制情緒時，很容易向家人發洩，造成惡性循環。有外國研究顯示，患情緒病的癌症病人，其家人出現情緒問題的機會，較平常人高7.9倍。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">壓力大 死亡率高三成</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">情緒壓力亦會減低患者的存活率。外國研究人員綜合分析50個研究後，發現社會心理壓力高的患者，死亡率上升29%。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">莫教授建議，患者應該保持樂觀，癌症患者的家人多聆聽病人的需要，協助他們紓緩情緒，讓患者能積極面對癌症。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">鄺小姐今年50多歲，在去年中突然大量出血，後來確定因患上子宮頸癌所導致，因而送往醫院檢查。檢查後，醫生發現鄺小姐患有第三期子宮頸癌，並安排她接受腫瘤切除手術。今年三月，鄺小姐開始接受化療療程。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">由於化療療程辛苦，加上從醫生口中得知第三期子宮頸癌患者只有四成存活率，鄺小姐開始浮現停止治療的念頭。由於過分擔心病情，鄺小姐晚上亦有失眠的問題。鄺小姐又經常進食，希望可以填補內心的空虛。最嚴重時，鄺小姐曾質疑自己的生存意義。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">醫生察覺鄺小姐的情緒問題，於是轉介她前往臨牀心理學家接受輔導，發現鄺小姐有抑鬱的情況，後來，在社工、心理學家、醫生和家人的開解下，鄺小姐的情緒漸漸好轉。目前，鄺小姐已經完成整個化療療程，現時她亦有做氣功和行山的習慣，一則可以緩解情緒，二則可以促進身體健康。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <img src="http://www.metrohk.com.hk/images/metro-logo-new.gif" alt="" width="240" height="63" style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /><span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">&nbsp;2011-7-14</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <a href="http://www.metrohk.com.hk/index.php?cmd=detail&amp;id=165819" target="_blank" style="word-wrap: break-word; text-decoration: none; color: rgb(0, 153, 204); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;">http://www.metrohk.com.hk/index.php?cmd=detail&amp;id=165819</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%9b%9b%e6%88%90%e7%99%8c%e6%82%a3-%e5%86%8d%e8%87%b4%e6%8a%91%e9%ac%b1-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%9b%9b%e6%88%90%e7%99%8c%e6%82%a3-%e5%86%8d%e8%87%b4%e6%8a%91%e9%ac%b1-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[3]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7245]]></id>
		<title><![CDATA[癌的啟示：癌症化療後遺症不容忽視]]></title>
		<content><![CDATA[<p>&nbsp;2012年06月07日(四)<br /> <br /> 醫學進步，癌病治愈率逐步提升，專科診所不能長期跟進數目日增的癌症康復者，所以不論在本港或外國，愈來愈多康復者都主要由家庭醫生照顧。但家庭醫生又是否清楚如何跟進這些康復者呢？<br /> <br /> 美國培訓醫生  照顧康復者<br /> 剛發表的一項研究顯示，很少美國家庭醫生清楚知道乳癌和大腸癌兩種常見癌病的化療後遺症。這調查在二○○九年進行，訪問了腫瘤科醫生和家庭醫生各一千一百多名。結果只有百分之六家庭醫生清楚知道全部四種常用化療藥的長期後遺症，包括阿黴素的心肌功能下降、紫杉醇和奧沙利鉑的神經麻痹、環磷醯胺的提前收經和致癌風險。更出奇的是，即使是腫瘤科醫生，亦只有百分之六十五人全部答對！而不論腫瘤科醫生或家庭醫生，對於常用於乳癌治療的環磷醯胺，得分都是最低的。<br /> <br /> 專家慨嘆說：「這是我們成功治療產生的問題，現在美國已有超過一千二百萬名癌病康復者。包括腫瘤科醫生在內所有需要照顧這些康復者的醫生，都應加強培訓，增加認識這些後遺症風險。」<br /> <br /> 要加強家庭醫生對癌病治療後遺症的認識，將相關內容納入持續進修教程是比較可行的方法。筆者以往工作的部門，就曾舉辦過給家庭醫生的研討會，不過內容較側重抗癌治療的認識，對於後遺症方面就着墨不多。相信將來要重新修訂培訓內容了。<br /> <br /> 臨床腫瘤專科醫生<br /> <br /> 游子覺醫生<br /> <br /> <a href="http://orientaldaily.on.cc/cnt/news/20120607/00176_100.html?pubdate=20120607" target="_blank">http://orientaldaily.on.cc/cnt/n ... ml?pubdate=20120607</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e7%99%8c%e7%97%87%e5%8c%96%e7%99%82%e5%be%8c%e9%81%ba%e7%97%87%e4%b8%8d%e5%ae%b9%e5%bf%bd%e8%a6%96-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e7%99%8c%e7%97%87%e5%8c%96%e7%99%82%e5%be%8c%e9%81%ba%e7%97%87%e4%b8%8d%e5%ae%b9%e5%bf%bd%e8%a6%96-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[19]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180521]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7246]]></id>
		<title><![CDATA[癌因性疲憊症困擾 1/3癌友中斷治療]]></title>
		<content><![CDATA[<p>&nbsp;<img src="http://www.cancerinformation.com.hk/ufiles/Image/Joe-11.jpg" width="300" height="200" alt="" /></p> <p>&nbsp;</p> <p><span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">2011-05-31 中國時報 李盛雯／台北報導</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">癌因性疲憊造成癌友極大困擾，且容易讓癌友走上絕境，台灣癌症基金會執行長賴基銘教授說，癌因性疲憊症與一般的疲憊或累不同，無法透過睡眠或休息來緩解，然而國內卻極少關懷病友在這方面的需求。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">&nbsp; &nbsp; 　中央研究院彭汪嘉康院士說，世界衛生組織（WHO）早就將癌因性疲憊症（CRF）定義為疾病，是醫護人員和家屬病友需要共同面對的病症。反觀國內，CRF卻常被忽略，癌友常遭受疲憊症，進而影響治療、預後及生活品質。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">&nbsp; &nbsp; 　台灣癌症基金會針對癌因性疲憊症進行癌友調查，發現其中1/3患者曾因此造成治療中斷，但癌友多認為這是治療中的必然現象，不認為醫護人員能幫忙。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">&nbsp; &nbsp; 　台大賴裕和教授在多年的研究過程發現，CRF對於不同癌種及治療方式的患者，皆是生理困擾的前3名，甚至超越疼痛或噁心帶來的困擾，除了對日常活動或工作造成影響，其帶來的無助感更會讓患者陷入無以言喻的沮喪中，甚至影響治療意願及家庭生活，賴裕和教授呼籲醫護人員重視這項疾病。</span><br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <br style="word-wrap: break-word; color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px;" /> <span style="color: rgb(68, 68, 68); font-family: Verdana, Helvetica, Arial, sans-serif; font-size: 14px; line-height: 22.390625px;">&nbsp; &nbsp; 　賴基銘醫師指出，改善癌因性疲憊症刻不容緩，可從病理機轉來評估改善方法，並從營養、運動及藥物三管齊下，尤其現行的治療藥物主要分幾部分，一是治療貧血藥物，主要是針對貧血造成的疲憊，或中樞神經興奮劑，以影響神經傳導物質的運作；另外還有抗憂鬱劑，以治療憂鬱或沮喪造成的疲憊等精神用藥，近年還有植物新藥的研發，多樣治療選擇都可為癌友帶來新曙光。</span></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e5%9b%a0%e6%80%a7%e7%96%b2%e6%86%8a%e7%97%87%e5%9b%b0%e6%93%be-1-3%e7%99%8c%e5%8f%8b%e4%b8%ad%e6%96%b7%e6%b2%bb%e7%99%82-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e5%9b%a0%e6%80%a7%e7%96%b2%e6%86%8a%e7%97%87%e5%9b%b0%e6%93%be-1-3%e7%99%8c%e5%8f%8b%e4%b8%ad%e6%96%b7%e6%b2%bb%e7%99%82-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[4]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7247]]></id>
		<title><![CDATA[癌擴散 骨有難]]></title>
		<content><![CDATA[<p>&nbsp;</p> <div class="t_msgfontfix"> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td id="postmessage_4968" class="t_msgfont"><img alt="" src="http://www.metrohk.com.hk/media/2011/news/2011-01-10/d_20110110234653h-2col-cancer2.jpg" width="150" height="112" /><br />             梁家騏醫生表示，癌毒入骨的<br />             病人，因骨外膜被刺激而感痛楚。<br />             <br />             癌症是本港的頭號殺手，部分病人會出現難耐的骨痛，不要以為只是一般的腰骨痛，其實，這是癌症擴散至骨骼的病徵，稱為癌毒入骨。<br />             <br />             <br />             骨科專科醫生梁家騏表示，癌毒入骨甚為普遍，病人已是晚期，多發生在乳癌、前列腺癌、甲狀腺癌、腎癌及肺癌，當中以乳癌最為常見，七成死於乳癌的病人都有癌毒入骨。<br />             雖然如此，但一般癌毒入骨的病人，其存活期會較癌症擴散至肝臟的病人長，以乳癌為例，癌毒入骨的病人有兩年壽命，而癌擴散至肝，病人則只有三至四個月的壽命。<br />             由朝到晚都會痛<br />             病人會出現強烈的骨痛，「由朝至晚，唔掂都會痛」，如果是一般的退化性腰骨痛，病人稍作休息，痛楚可紓緩，但癌症病人則不會。<br />             這是由於癌細胞刺激骨外膜，或是壓着神經線，另一個原因是出現成骨性轉移或溶骨性轉移，前者會多長一些骨，後者則是骨骼被侵蝕，令骨骼承托力不足，因而感到骨痛，從X光看到病人的骨骼有一個大洞，患者有骨折的危險。<br />             癌毒入骨最影響中軸骨骼，即脊椎骨及盆骨。<br />             部分病人不知患癌<br />             約有2%至6%的病人並不知道自己患癌，有一名80歲的婦人，感到腰骨痛，以為只是退化性骨痛，維持了數月亦未有好轉，於是，向骨科醫生求助，結果發現，該名婦人患有晚期的胃癌，並擴散至骨骼，而她一直沒有任何的腸胃不適，病人在一年後死亡。<br />             病人除了可用嗎啡止痛劑、傳統的電療和化療外，還可以用雙磷酸鹽或微創固定術減輕痛苦及保存活動能力。對於合適的患者，雙磷酸鹽亦可以減少或延遲癌症骨轉移的發生。<br />             <br />             <a href="http://www.metrohk.com.hk/index.php?cmd=detail&amp;id=152391" target="_blank">http://www.metrohk.com.hk/index.php?cmd=detail&amp;id=152391</a></td>         </tr>     </tbody> </table> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e6%93%b4%e6%95%a3-%e9%aa%a8%e6%9c%89%e9%9b%a3-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e6%93%b4%e6%95%a3-%e9%aa%a8%e6%9c%89%e9%9b%a3-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[5]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7248]]></id>
		<title><![CDATA[知藥用藥：治療癌症引致的痛楚]]></title>
		<content><![CDATA[<p>&nbsp;</p> <div id="threadtitle"> <h1>&nbsp;</h1> </div> <div class="t_msgfontfix"> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td id="postmessage_4879" class="t_msgfont"><img alt="" src="http://hk.apple.nextmedia.com/adoinfile/Section_Logo/14204455.gif" width="120" height="58" /><br />             <br />             許多癌症患者受痛楚困擾，這些痛楚有可能是由於腫瘤壓迫着神經線或治療產生的副作用，如口腔黏膜發炎和周圍神經病變所引起。本文將簡單介紹常用於治療癌症痛楚的止痛藥及選擇止痛藥的方法。<br />             <br />             過量撲熱息痛傷肝<br />             根據世界衞生組織的指引，撲熱息痛和非類固醇消炎劑如布洛芬都會用作輕微痛症的第一線治療。患者應小心留意自己每天服用撲熱息痛的總劑量應不多於四克，即約八粒五百毫克的藥丸，否則便有可能損害肝臟功能。如果服用了一種止痛藥的最高劑量後，仍未能紓緩痛楚，醫生可能考慮轉用或再處方另一種止痛藥；感到輕微至中等程度的痛楚的患者，有機會要同時服用非類固醇消炎劑及止痛力較強的鴉片類止痛劑。<br />             常見的鴉片類止痛劑包括有可待因、嗎啡和芬太尼。可待因的止痛力比較輕微，除止痛外也有止咳的功效。嗎啡雖然較易引起惡心、作嘔及便秘副作用，但仍是紓緩癌症痛楚的首選止痛藥物。芬太尼屬於較強的鴉片類止痛藥，具備外用的皮膚黏貼膠布，使用者可每  72小時更換膠布一次。<br />             如患者痛楚仍未能紓緩，便可能需要使用神經阻斷鎮痛療法，把止痛藥物注射到神經幹接近整個地區麻醉神經或於脊髓硬膜外注射。然而，急速加劇的疼痛有可能是癌症惡化的症狀，患者須盡早求醫。<br />             撰文：醫院藥劑師學會藥物教育資源中心<br />             <br />             Apple  daily, 2011-1-10<br />             <a href="http://hk.apple.nextmedia.com/template/apple/art_main.php?iss_id=20110110&amp;sec_id=4104&amp;subsec_id=3626368&amp;art_id=14852728&amp;cat_id=14204455" target="_blank">http://hk.apple.nextmedia.com/te ... amp;cat_id=14204455</a></td>         </tr>     </tbody> </table> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%9f%a5%e8%97%a5%e7%94%a8%e8%97%a5%ef%bc%9a%e6%b2%bb%e7%99%82%e7%99%8c%e7%97%87%e5%bc%95%e8%87%b4%e7%9a%84%e7%97%9b%e6%a5%9a-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%9f%a5%e8%97%a5%e7%94%a8%e8%97%a5%ef%bc%9a%e6%b2%bb%e7%99%82%e7%99%8c%e7%97%87%e5%bc%95%e8%87%b4%e7%9a%84%e7%97%9b%e6%a5%9a-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[6]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7249]]></id>
		<title><![CDATA[癌症傷口的照護]]></title>
		<content><![CDATA[<p>&nbsp;</p> <div class="t_msgfontfix"> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td id="postmessage_4542" class="t_msgfont"><img alt="" src="http://cisc.twbbs.org/layout/img/logo.png" width="64" height="68" /><br />             <br />             林口長庚醫院 血液腫瘤科 王宏銘醫師 | 2008 五月  30<br />             <br />             重度癌症病患常會出現皮膚受損與破壞的情況，其直接的原因乃來自癌症組織的蕈狀或浸潤生長並進而穿透皮膚或轉移至皮膚所造成；而間接原因則有：癌症病患營養狀況差、接受藥物與放射線治療以及活動性減少所造成的褥瘡，這其中最會造成病患、家屬及醫護人員困擾的則為蕈狀生長併潰爛的癌症皮膚病灶、外廔管合併皮膚糜爛、以及褥瘡。此文章則著重於探討與癌症較直接相關的蕈狀併潰爛的癌症皮膚病灶諸問題。<br />             <br />             臨床上蕈狀併潰爛的癌症皮膚病灶常見於乳癌、惡性黑色素瘤、惡性肉瘤與頭頸癌。癌症傷口的組織因受到腫瘤壓迫與侵犯，以及癌細胞沿著血管與淋巴管擴張造成栓塞，導致傷口組織的血流、氧氣和營養的供應遭到阻礙，使得組織的生存力受損；而另一方面腫瘤本身增生的血管在結構上有缺陷，使得腫瘤內部的血液循環脆弱易受損傷，這些因素導致癌症傷口的組織內微血管的破裂與組織的壞死，並進而導致厭氧細菌的增生，這些病態的生理變化會帶給病患傷口的感染、疼痛、出血、滲出物、甚至會併有惡臭，而因為惡臭與癌症腫脹或敷料包紮所引起的外觀改變則進一步造成病患的困擾，更會導致病患沮喪、焦慮、羞愧、窘迫與自我隔離&hellip;&hellip;等，且日常生活因更換敷料的次數、時間性、與複雜度導致活動與獨立性受限，病患常會因此隱居在家，造成家庭的進一步困擾。<br />             <br />             面對癌症病患身上的傷口，最重要的處理步驟乃是確定此傷口是可治癒或是不能治癒的，因此若傷口的組織病理檢查是最重要的步驟。若傷口的組織病理確定為癌症傷口後，可考慮以局部與全身系統性治療，例如：手術切除與整型重建、放射線治療、化學治療、荷爾蒙治療或生物治療，這是讓癌症傷口癒合最有效的方法。若病患之癌症傷口無合適與有效的治療時，此傷口之照護即成為病患、家屬、醫護人員共同的負擔；因此照護癌症傷口時除需對傷口作一般性的評估外  （包括：病史和治療史、癌症傷口的大小、深度、顏色（最好有照片記錄）、味道、細菌或其他微生物的感染狀態、滲出物與出血情形、疼痛情形），對病患心理層面的影響，以及家庭的狀況如何也須予以評估，因為癌症傷口的照護是長期的問題，除了在醫療機構的照護外，家庭的接續照護為癌症傷口照護的一個重要環節，因此，評估病患在家中延續傷口照護的可行性，為照護癌症傷口時的重點之一。癌症傷口照護的理想目標為：<br />             癌症傷口照護時的主要目標為：止血、減少臭味、吸附傷口的滲出物、舒適與疼痛控制、外觀，而傷口敷料對達成這些目標則佔有相當重要的角色，理想的癌症傷口敷料須符合幾個條件：<br />             <br />             （1）必須能是密閉性敷料：以防止細菌入侵及進一步的外來傷害，此外須有良好的防水性，能避免傷口滲出液外滲到病患的衣物上。（2）須為親水性材質：如此傷口滲出液被吸收後不再回滲到傷口組織或旁邊的正常組織，且可保持傷口的潤濕；維持傷口的潤濕是很重要的，因為傷口上皮細胞的移行與修復必須於潮濕的環境中才能進行，另外潮濕的環境才能讓傷口產生的毒性物質及死亡的細胞被敷料吸收移除；潤濕也可避免敷料乾燥粘附於傷口，進一步避免更換敷料時造成傷口的傷害；此外，吸收量大的敷料，可減少更換的次數，進而減輕癌症傷口照護的負荷。（3）敷料若是有自粘性敷料的功能，且質地柔軟，則能順應於不同外形與位置之傷口，且直接黏貼於傷口，除了使用方便與舒適外，病患經包紮後之外觀也較不突兀。目前市面上符合前述原則的敷料有：如（1）藻膠  (alginate) ：由海藻提煉出來，內含的鈣可為凝血機轉的觸媒，可活化凝血機制，用於有滲出液且易流血的傷口，如： kalostat；（2）水凝體  (hydrogels)：不可溶的聚合物具親水端可與水溶液作用，吸收並含住大量水份；例如： Duoderm ；（3）水膠體  (hydrocolloid)：以Carboxymethylcellulose based為主要結構，含多醣體與蛋白質成份，吸水力強，適用於滲出液多的傷口，例如：  Aquacel。<br />             <br />             癌症傷口照護的第一步驟為清潔傷口，以無菌生理食鹽水或無菌水清洗為佳，要避免以拭子對傷口作機械性的清洗，因為會導致疼痛與傷口的進一步傷害。而  chlorhexidine, iodine,  cetrimide等具抗菌效果的溶液，對傷口的刺激會引起病人的疼痛，也對傷口纖維細胞與新生微血管有傷害，且很快會被體液分解，故一般建議仍以無菌水清洗為佳。<br />             <br />             癌症傷口的出血在照護很重要的一點是避免更換敷料時黏撕傷口，因此在敷料的使用上，會建議使用網狀的合成聚合物敷料，上面覆以不黏附不具吸收力的敷料，或使用藻膠敷料；此外，凝血藥物的局部或全身性使用，例如：bosmin、aminocaproic  acid，也可當作輔助使用。若傷口有明顯出血，則須考慮使用silver nitrate  、燒灼、紗布加壓止血。<br />             <br />             癌症傷口因血液循環受阻與組織的壞死，易導致厭氧細菌的感染，若傷口感染為表淺性感染，則可考慮以 0.8%  metronidazole gel或silver  sulfadiazine局部使用；若是傷口的深部感染，則可考慮以全身性metronidazole或其他治療厭氧細菌的抗生素；另外若傷口非正處於癒合期，可考慮povidone的使用，povidone可殺菌併保持傷口的乾淨，但具刺激性、易引起病患疼痛、且會傷害肉芽組織影響傷口之癒合，故不宜長期使用。<br />             <br />             癌症傷口的臭味常會引起病患的噁心與嘔吐，且病患對此臭味並不會有&ldquo;久而不聞其臭&rdquo;的情形，而是持續性的感受到臭味的存在，除造成病患心理層面的不良的影響，對照顧病患的醫護人員與家屬也是一種不愉快的經驗，因此癌症傷口臭味的處理是照護上一個重要的課題；在處理上首先須對傷口的感染進行控制，以減少臭味的產生；同時也可使用的臭味吸附劑，例如：含活性碳之敷料(actisorb  或carbonet) 或可拋棄式的尿布，或於室內放置活性碳，或燃燒的蠟燭以燃燒消耗引起臭味的化學物質；另外也可於室內放置其他與臭味相抗衡之味道，例如：一碗醋、  香精、咖啡、或芳香油滴放於裝著沸水的碗內；但儘量避免使用過於刺激的香水，因會引起已有噁心之病患的不適。<br />             <br />             傷口的滲出液為傷口產生的有毒物質、死亡細胞、以及細菌微生物，這些物質會刺激傷口，造成病患傷口的疼痛與水腫，因此傷口照護時須加以清除。而使用之敷料必須是具吸收力的製品，能將滲出液吸附於敷料內，一方面防止滲出液浸潤傷口，另一方面則防止滲出液溢出於病患的衣物或床單；若是會滲血的傷口，則可考慮藻膠敷料。<br />             癌症傷口的疼痛可發生於非換藥或換藥時，一般以全身性的止痛藥來止痛，若發生於傷口換藥時的疼痛，則考慮於傷口換藥時以局部性的止痛藥，例如  lidocaine的噴霧使用。<br />             <br />             癌症傷口的照護對病患、家屬及醫護人員而言，都是十分令人困擾的問題，前面所提的原則，在實際照護時，還會受到醫院和社區的人力資源、敷料的種類、病患的經濟能力、與保險給付的影響。但如前述，癌症傷口的照護是長期的工作，故病患、家屬及醫護人員應以其能夠取得的各項資源予以最妥善的應用，儘量避免讓傷口的照護變成複雜而又耗費過多人力的工作，而又能達到傷口照護的目標，這是一件需要愛心、耐心與細心的工作。<br />             <br />             &nbsp;</td>         </tr>     </tbody> </table> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%97%87%e5%82%b7%e5%8f%a3%e7%9a%84%e7%85%a7%e8%ad%b7-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%97%87%e5%82%b7%e5%8f%a3%e7%9a%84%e7%85%a7%e8%ad%b7-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[7]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7250]]></id>
		<title><![CDATA[癌症病人的「痛不欲生」]]></title>
		<content><![CDATA[<p>&nbsp;</p> <div class="t_msgfontfix"> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td id="postmessage_4539" class="t_msgfont"><img alt="" src="http://cisc.twbbs.org/layout/img/logo.png" width="64" height="68" /><br />             <br />             本文出自癌症新探二十三期<br />             何淑絹藥師 | 2008 九月  18<br />             <br />             自1982年以來，癌症即成為台灣地區死亡原因之首位，幾乎每三至四人中，就有一人會罹患癌症。根據癌症病人門診調查統計指出,  門診癌症病患中有50%以上有疼痛問題.，其中有70%以上之病人正承受中、重度的疼痛問題，不幸的是其中只有58%的病人接受止痛藥物的治療，而且滿意度僅為64%！也就是每年在台灣有將近1萬5千個癌症病人，在忍受疼痛的折磨，甚至是&quot;含痛歸去&quot;！<br />             <br />             研究顯示，因身體上的疾病，有許多病人老化得比較快，疼痛更多憂鬱指數也較一般人為高。有慢性癌症疼痛問題之病人，其自殺比例更為正常人2~3倍！除了病人會因為憂鬱而有較高的自殺傾向，癌症病人也會因為以下原因而造成治療時的順從性降低，例如疼痛造成病人較無食慾而引起惡病質，或活動力變差容易骨折，另外常見的是因疼痛症狀使得病人免疫力變差，容易感染。<br />             <br />             臨床研究顯示癌症病人若具有較佳的情緒，可增加20%的壽命，而有效解除病人的疼痛更可以增加病人的存活率達16.7%，因此癌症病人的疼痛問題不應只是緩解，更是需要積極處理的重要課題，因為疼痛不只影響病人的生活品質，更影響了病人的生命及存活期！<br />             <br />             在醫學進步的今天，80%~90%的癌症疼痛，都可以有效獲得控制，例如使用止痛藥物、放射線治療、病人自控式止痛系統等，或是在藥物控制不佳時，進行神經阻斷術或硬腦膜外麻醉止痛等外科治療方式，都可有效解除病人的疼痛。所以在臨床上，最無侵入性、最簡單的給藥方式、且病人最方便使用之治療方式應最先被採用。<br />             <br />             但有許多原因造成病人的疼痛問題無法獲得適當的解決，除了傳統的止痛藥物有服用不方便或副作用太大的問題外，其中最重要的是，一般民眾擔心鴉片類止痛藥會造成成癮及藥物濫用的問題，造成病人在免除癌症疼痛之時，卻需承受另一種痛苦或困擾，有些病人便因為寧願選擇多痛一點也不願意服藥，以致「痛死」。<br />             <br />             為讓病人能減少疼痛及精神上的壓力，我們必須修正一般民眾對鴉片類止痛劑的誤解，包括成癮及副作用問題等。事實上，鴉片類止痛劑在專業的醫藥人員處方調劑下，長期使用並不會出現成癮的現象。所謂成癮，是指在未經醫師處方，自行使用高劑量，產生精神上的欣快感，並造成心理上的依賴現象；而癌症病人需增加止痛劑的劑量，則是依病情發展變化，或病情所需，並非所謂的成癮。另一方面，在止痛劑的劑型上，若使用緩釋劑型如經皮膚吸收的貼片或緩釋錠劑，除了可有效控制疼痛外，更可減少藥物成癮及濫用的危險。美國的追蹤某報導指出，經皮膚吸收的止痛貼片，在醫療使用上於短短的7年中增加了11倍，而濫用比例卻減少了60%，可見其對臨床處理疼痛問題相當有幫助。<br />             <br />             鴉片類止痛劑常見的副作用，例如包括昏沉、便秘、噁心、嘔吐等，這些副作用一般會在5至7天內漸漸改善或消失，醫師會處方一些藥物來減輕這些不適，故鴉片類止痛劑在正確使用及副作用的有效處理下，可為癌症病人帶來相當理想的疼痛控制。<br />             疼痛是一種徵兆，也是一種警訊，它可以保護身體，遠離危險或傷害，但當疼痛持續存在，變成惱人的症狀時，就會引發一些不良的心理和生理反應，會妨礙日常生活作息與情緒，使人病識感加強，並造成種種焦慮與不適。由於疼痛是是一種不愉快、不受歡迎的主觀感覺，我們必須學習如何去描述它，讓醫師、護理人員等知道：<br />             ⊙何處感到疼痛？<br />             ⊙它何時開始？<br />             ⊙它感覺起來如何？尖銳的？鈍的？博動的？持續的？<br />             ⊙它有多嚴重？<br />             ⊙它是否影響你從事日常活動？哪一些活動？<br />             ⊙有什麼可以緩解疼痛？<br />             ⊙有什麼會使疼痛惡化？<br />             ⊙曾經嘗試用什麼方法來緩解疼痛？哪些有效？哪些無效？<br />             ⊙疼痛是經常性的嗎？如果不是的話，每天（或每週）發生幾次？<br />             ⊙每次持續多久？<br />             <br />             當我們瞭解癌症疼痛問題對病人的重要性並能夠給予適當的藥物控制時，相信有許多癌症病人可不必再忍受痛苦的折磨，癌症病患的生活品質也將能明顯提升。</td>         </tr>     </tbody> </table> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e7%9a%84%e3%80%8c%e7%97%9b%e4%b8%8d%e6%ac%b2%e7%94%9f%e3%80%8d-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e7%9a%84%e3%80%8c%e7%97%9b%e4%b8%8d%e6%ac%b2%e7%94%9f%e3%80%8d-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[8]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7251]]></id>
		<title><![CDATA[癌友生活指引]]></title>
		<content><![CDATA[<p>&nbsp;<img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-20.jpg" width="400" height="308" alt="" /></p> <p>&nbsp;</p> <p>非常詳盡的一份 Guide notes, 強力推薦。</p> <p>下載 :&nbsp;http://www.acsccu.org/PDF/Living_with_cancer_combine_FINAL_No_Change.pdf</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e5%8f%8b%e7%94%9f%e6%b4%bb%e6%8c%87%e5%bc%95-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e5%8f%8b%e7%94%9f%e6%b4%bb%e6%8c%87%e5%bc%95-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[9]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7252]]></id>
		<title><![CDATA[控 制 疼 痛]]></title>
		<content><![CDATA[<p><img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-3.jpg" width="300" height="234" alt="" /></p> <p>&nbsp;</p> <p>&nbsp;<b><font color="#006600">甚 麼 是 疼 痛  ?</font></b></p> <p>疼 痛 是 一 種 不 舒 服的 感 覺 , 是 身 體 受 損 或 受 到 創 傷 威 脅的 訊 號 。 我 們 每 一 個 人 都可 能 曾 經 承  受 過 不 同 種 類疼 痛 的 苦 楚 , 例如 ﹕</p> <ul>     <li>背 痛</li>     <li>頭 痛</li>     <li>月 經 痙 攣</li>     <li>牙 痛</li>     <li>手 術 後 的 疼 痛</li>     <li>關 節 炎</li>     <li>癌 痛</li> </ul> <p>很 多 人 都 會 將 癌 症 和 疼 痛 扯 上 關係 , 但 並 非 所 有 癌 症 病 人 都 感受 到 疼 痛 ; 你 若 有 疼 痛 的 話 ,  我 可 以 告 訴 你 , 疼 痛 是 可 以 控 制 的 。</p> <p>你 的 疼 痛 是 可 以 控 制 的</p> <p><b><font color="#006600"><a id="為甚麼我會感到疼痛?" name="為甚麼我會感到疼痛?"></a>為 甚 麼 我 會 感 到 疼 痛  ?</font></b></p> <p>引 致 疼 痛 的 原 因包 括 下 列 這 些 ﹕</p> <ul>     <li>癌 症 本 身 - 你 的癌 腫 瘤 或 許 壓 著 一 些 神 經 線 ﹑ 器 官 ﹑ 或 骨 骼 。</li>     <li>癌 症 的 治 療 - 放 射 治 療 和 藥 物 治 療 可 幫 助 你 , 但 亦 可 引 起 暫 時 性 的 不 適 。</li>     <li>與 癌 症 完 全 無 關 的 因 素 - 例 如 坐 臥 姿 勢 不 正 確 , 導 致 肌 肉 僵 硬 及 疼 痛 。</li> </ul> <p><b><font color="#006600"><a id="還是忍著疼痛算了？" name="還是忍著疼痛算了？"></a>還 是 忍 著 疼 痛 算 了  ？</font></b></p> <p>乾 忍 著 痛 , 只 會 帶 來 不 必 要 的 苦 痛 和 苦 惱 。 疼 痛 沒 有 處 理 , 可 引 致 疲 累 ﹑ 抑 鬱 ﹑ 憤 怒 ﹑ 憂  慮 ﹑ 孤 獨 感 和 壓 力 。 疼 痛 可 干 擾 你 的 日 常 活 動 及 對 工 作 和 嗜 好 的 興 趣 ﹑ 也 會 干 擾 睡 眠 ﹑ 進 食  ﹑ 與 朋 友 及 家 人 一 起 的 時 間 ﹑ 及 生 活 的 享 受 。 既 然 有 其 他 選 擇 , 為 甚 麼 還 要 忍 著 它 ? 疼 痛 是  可 以 及 應 該 控 制 的 。</p> <p>疼 痛 是 可 以 及 應 該 受 控 制 的</p> <p>請 你 查 看 一 下 疼 痛 是 否 有 影 響 到 你 ；</p> <ul>     <li>日 常 生 活 如 睡 眠 、飲 食 ，</li>     <li>消 閒 活 動 ，</li>     <li>社 交 生 活 ，</li>     <li>工 作 表 現 。</li> </ul> <p>若 你 對 上 述 任 何 一 項 答 「 是 」 , 你 便 要 考 慮 選 擇 紓 緩 疼 痛 的 方 法 。 紓 緩 疼 痛 可 改 善 你 的 生  活 , 試 問 一 下 當 你 的 疼 痛 得 以 紓 緩 時 ﹕</p> <ul>     <li>你 的 體 力 是 否 較 佳 ?</li>     <li>你 是 否 感 到 比 較 舒 服 ?</li>     <li>你 的 精 神 是 否 好 些 ?</li>     <li>你 的 食 慾 是 否 有 改 善 ?</li>     <li>你 是 否 能 夠 比 較 獨 立 地 生 活 ?</li> </ul> <p><font color="#006600"><b><a id="若疼痛轉重,我才告訴醫生？" name="若疼痛轉重,我才告訴醫生？"></a>若 疼 痛 轉 重 ,  我 才 告 訴 醫 生</b></font></p> <p>早 期 的 疼 痛 在 未 進 展 至 嚴 重 時 較 容 易 控 制 。 因 此 , 愈 早 說 出 你 的 疼 痛 , 便 愈 容 易 控 制 它 。  不 要 光 是 等 人 家 問 , 你 必 須 採 取 主 動 , 及 早 告 訴 醫 生 或 護 士 以 便 控 制 及 治 療 你 的 疼 痛 。</p> <p>愈 早 說 出 你 的 疼 痛 , 便 愈 容 易 控 制 它</p> <p><b><a id="有關疼痛的情況,你應詳細告訴醫生和護士" name="有關疼痛的情況,你應詳細告訴醫生和護士"></a><font color="#006600">有 關 疼 痛 的 情 況 , 你 應 詳 細 告 訴 醫 生 和 護 士 </font></b></p> <p>疼 痛 是 主 觀 的 感 覺 , 沒 有 客 觀 的 方 法 去 量 度 你 的 疼 痛 程 度 , 所 以 必 須 坦 誠 將 自 己 的 疼 痛 感  受 告 訴 醫 生 和 護 士 。</p> <p>告 訴 他 們 疼 痛 怎 樣 影 響 你 的 日 常 生 活 , 疼 痛 的 強 度 , 及 身 上 所 有 感 到 疼 痛 的 地 方 , 讓 他 們  知 道 甚 麼 會 令 你 的 疼 痛 加 劇 , 甚 麼 會 減 輕 它 , 及 你 正 在 服 用 的 藥 物 的 效 果 。</p> <p>請 嘗 試 回 答 以 下 問 題 ﹕</p> <ul>     <li>疼 痛 從 何 時 開 始 ?</li>     <li>哪 裏 感 到 疼 痛 ?</li>     <li>疼 痛 是 溫 和 ﹑ 中 等還 是 嚴 重 ? 若 以 0 到 1 0 的 等 級 劃 分 , 並 以 0 代 表 無 痛 , 1 0 代 表 想 像  中 最 嚴 重 的 疼 痛 , 你 感 到 的 疼 痛 是 哪 一 級 ?</li>     <li>疼 痛 是 恒 常 持 續 , 還 是 時 隱 時 現 ?</li>     <li>疼 痛 有 沒 有 因 身 體 的 移 動 而 改 變 ?</li>     <li>甚 麼 令 疼 痛 緩 減 和 甚 麼 令 它 加 劇 ?</li>     <li>試 過 用 甚 麼 方 法 來 紓 緩 疼 痛 ?</li>     <li>正 在 服 用 的 藥 物 可 紓 緩 多 少 疼 痛 ?</li> </ul> <p><font color="#006600"><b><a id="我有甚麼治療的選擇?" name="我有甚麼治療的選擇?"></a>我 有 甚 麼 治 療 的 選 擇  ? </b></font></p> <p>除 了 服 用 紓 緩 疼 痛 的 藥 物 ( 止 痛 劑 ) , 非 藥 物 的 止 痛 療 法 如 物 理 治 療 亦 可 幫 助 紓 緩 你 的 疼  痛 。</p> <p>請 與 醫 生 商 談 你 的 藥 物 和 非 藥 物 治 療 疼 痛 的 選 擇。 任 何 紓 緩 疼 痛 的 治 療 方 法 , 目 的 在 盡 量  減 輕 疼 痛 對 你 的 影 響 , 好 讓 你 盡 量 保 持 或 改 善 現 有 的 生 活 方 式 。</p> <p>醫 生 將 會 依 你 的 疼 痛 程 度 給 予 適 當 的 藥 物 。 對 溫 和 的 疼 痛 , 醫 生 或 會 處 方 Paracetamol 。  這 些 藥 物 直 接 減 輕 疼 痛 及 發 熱 。 對 中 ﹑ 重 度 疼 痛 , 你 或 需 要 Opioid 這 類 較 強 效 的 藥 物 , 例 如  Doloxene, Codeine, Morphine , Methadone 及 Fentanyl 貼片 。</p> <p>止 痛 藥 物 可 以 以 下列 方 式 服 用 :</p> <ul>     <li>口 服<br />     適 當 的 口 服 藥 物 一 般 都 能 紓 緩 疼 痛 , 如 每 隔 四 小 時 服 用 一 次 的 嗎 啡 溶 液 或 每 十 二  小 時 服 用 一 次 的 嗎 啡 緩 釋 片 。 但 若 你 有 吞 嚥 困 難 , 口 服 紓 緩 疼 痛 藥 物 或 許 不 適 合 你 。</li> </ul> <ul>     <li>皮 膚 貼 片 <br />     以 皮 膚 貼 片 止 痛 是 一 新 發 展 。 皮 膚 貼 片 中 的 止 痛 藥 物 經 由 皮 膚 吸 收 而 進 入  身 體 , 你 只 需 每 三 天 更 換 貼 片 一 次 。 若 你 有 吞 服 藥 丸 的 困 難 或 經 常 忘 記 服 藥 , 皮 膚 貼 片 可 能  較 適 合 你 , 而 且 它 比 口 服 藥 物 較 少 副 作 用 , 若 因 服 用 止 痛 藥 物 而 感 到 作 悶 或 便 秘 , 皮 膚 貼 片  會 是 你 的 另 一 選 擇 。</li> </ul> <ul>     <li>注 射<br />     一 般 來 說 , 肌 肉 或 靜 脈 注 射 止 痛 類 藥 物 並 不 適 用 於 癌 痛 。 但 皮 下 注 射 卻 是 一 種 有  效 的 治 療 方 法 。</li>     <li>&nbsp;</li> </ul> <ul>     <li>肛門 栓 劑 <br />     若 你 有 吞 嚥 困 難 , 採 用 肛 門 栓 劑 形 式 的 止 痛 藥 物 對 你 較 為 有 幫 助 。</li> </ul> <p>醫 生 會 視 乎 你 的 情 況 及 生 活 方 式 而 決 定 採 用 適 合 你 的 方 式 。</p> <p>另 外 , 病 人 會 因 體 質 不 同 而 對 藥 物 產 生 不 同 的 反 應 。 如 果 你 覺 得 藥 物 的 效 果 未 如 理 想 ， 請  告 訴 醫 生 或 護 士 , 以 便 考 慮 其 它 的 方 法 , 這 點 是 非 常 重 要 。</p> <p><b><a id="止痛藥物有沒有副作用?" name="止痛藥物有沒有副作用?"></a><font color="#006600">止 痛 藥 物 有 沒 有 副  作 用 ? </font></b></p> <p>止 痛 藥 物 所 引 致 的 副 作 用 , 會 因 藥 物 的 類 別 ﹑ 劑 量 及 服 藥 方 式 而 有 所 不 同 。 但 請 別 擔 心 ,  止 痛 藥 物 帶 來 的 疼 痛 紓 緩 對 比 它 的 副 作 用 , 通 常 是 利 多 於 弊 。</p> <p>疼 痛 紓 緩 對 比 副 作 用 , 利 多 於 弊</p> <p>大 部 份 的 副 作 用 是 可 以 防 止 的 , 較 可 能 發 生 的 是 便 秘 ﹑ 噁 心 ﹑ 嘔 吐 及 渴 睡 。 明 白 到 治 療 中  可 能 產 生 的 副 作 用 , 你 會 易 於 處 理 它 。</p> <p>有 些 止 痛 藥 物 引 致 較 少 及 較 輕 微 的 副 作 用 。 請 詢 問 醫 生 哪 一 種 藥 物 最 適 合 你 。</p> <p><b><a id="長期服用止痛藥物會否上癮?" name="長期服用止痛藥物會否上癮?"></a><font color="#006600">長 期 服 用 止 痛  藥 物 會 否 上 癮 ? </font></b></p> <p>正 確 的 用 藥 不 會 使 你 上 癮 , 只 要 你 配 合 醫 生 的 指 導 , 它 是 幫 助 戰 勝 疼 痛 的 良 藥 , 一 旦 腫 瘤  病 情 減 輕 , 疼 痛 也 可 能隨之 漸 減 , 屆 時 可 逐 漸 停 止 使 用 止 痛 藥 。 但 記 著 , 疼 痛 轉 劇 烈 , 也 並 不  代 表 病 情 惡 化 。</p> <p>若 正 確 服 用 Opioid 類 藥 物 , 服 用 者 罕 會 上 癮</p> <p><b><a id="甚麼是「耐受性」(Tolerance)?" name="甚麼是「耐受性」(Tolerance)?"></a><font color="#00660">甚 麼 是 「 耐 受 性 」(Tolerance) ?</font></b></p> <p>經 過 一 段 時 間 之 後 , 身 體 習 慣 了 某 種 紓 緩 疼 痛 的 藥 物 , 便 要 較 大 的 劑 量 去 紓 緩 疼 痛 。這 叫  作 「 耐 受 性 」(Tolerance ) 。 但 這 種 情 況 很 少 發 生 。</p> <p>但 若 你 發 現 正 服 用 的 止 痛 劑 效 力 大 不 如 前 , 應 立 即 告 訴 醫 生 , 好 讓 他 或 她 根 據 你 的 需 要 增  加 用 藥 的 劑 量 , 或 更 換 另 一 種 止 痛 藥 物 。</p> <p>在 未 徵 詢 過 醫 生 意 見 前 , 不 要 擅 自 更 改 服 用 的 劑 量</p> <p><b><a id="除了止痛藥外,還有那些非藥物疼痛療法?" name="除了止痛藥外,還有那些非藥物疼痛療法?"></a><font color="#00600">除 了 止 痛 藥 外 , 還 有 那 些 非 藥 物 疼 痛 療 法 ? </font></b></p> <p>有 很 多 非 藥 物 疼 痛 療 法 , 都 可 與 紓 緩 疼 痛 的 藥 物 一 起 使 用 。 這 些 療 法 或 能 幫 助 你 ， 例 如 物  理 治 療 ﹑ 肌 肉 鬆 弛 法 ﹑ 按 摩 ﹑ 針 灸 ﹑ 輔 導 ﹑ 藝 術 及 音 樂 治 療 等 。</p> <p>你 可 以 請 教 醫 護 人 員 那 一 種 非 藥 物 療 法 最 適 合 你 。</p> <p>你 不 是 孤 身 對 抗 疼 痛</p> <p>雖 然 你 所 感 受 到 的 疼 痛 是 非 常 個 人 的 經 歷 , 但 它 亦 會 影 響 到 你 週 遭 的 人 - 尤 其 是 家 人 與 朋  友 。 當 你 處 於 這 段 艱 辛 日 子 時 , 家 人 與 朋 友 也 許 會 感 到 無 奈 。 就 讓 他 們 做 些 積 極 的 事 情 來 幫  助 你 , 相 對 而 言 你 亦 在 幫 助 他 們 。</p> <p>控 制 癌 痛 是 集 體 努 力 的 成 果 - 醫 生 、 護 士 ﹑ 家 人 與 朋 友 都 會 幫 助 和 支 持 你 , 所 以 你 並 不 是  孤 單 面 對 疼 痛 。</p> <p>現 時 服 用 的 藥 物</p> <p>請 記 錄 下 現 時 服 用 的 藥 物 。 填 寫 時 如 遇 上 困 難 可 徵 詢 你 的 醫 生 或 護 士 。</p> <p>&nbsp;</p> <p>&nbsp;註 :&nbsp;上述內容由香港舒緩醫學學會提供，轉載至香港防癌會網頁。http://www.hkacs.org.hk</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%8e%a7-%e5%88%b6-%e7%96%bc-%e7%97%9b-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%8e%a7-%e5%88%b6-%e7%96%bc-%e7%97%9b-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[10]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7253]]></id>
		<title><![CDATA[下載 癌病復發 小册子]]></title>
		<content><![CDATA[<p><img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-15.jpg" width="400" height="327" alt="" /></p> <p>&nbsp;</p> <p>&nbsp;如何選擇療法 / 如何選擇輔助療法</p> <div>提供善終/紓緩服務的醫療機構<br /> 提供善終/哀傷輔導機構</div> <div>&nbsp;</div> <div>由香港癌症基金會提供</div> <div>&nbsp;</div> <p><a href="http://www.cancer-fund.org/upload/booklets/file/HowToCope/When%20Cancer%20Comes%20back.pdf">www.cancer-fund.org/upload/booklets/file/HowToCope/When%20Cancer%20Comes%20back.pdf</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%8b%e8%bc%89-%e7%99%8c%e7%97%85%e5%be%a9%e7%99%bc-%e5%b0%8f%e5%86%8c%e5%ad%90-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%8b%e8%bc%89-%e7%99%8c%e7%97%85%e5%be%a9%e7%99%bc-%e5%b0%8f%e5%86%8c%e5%ad%90-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[11]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7254]]></id>
		<title><![CDATA[下載 性與癌症 小册子]]></title>
		<content><![CDATA[<p>&nbsp;<img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-7.jpg" width="400" height="313" alt="" /></p> <p>探討癌症和治療如何影響性反應，<br /> 如何解決因癌症治療引發的性問題.</p> <div>&nbsp;</div> <div>由香港癌症基金會提供資訊。</div> <div>&nbsp;</div> <div><a href="http://www.cancer-fund.org/upload/booklets/file/HowToCope/Sexuality%20and%20Cancer.pdf">www.cancer-fund.org/upload/booklets/file/HowToCope/Sexuality%20and%20Cancer.pdf</a></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%8b%e8%bc%89-%e6%80%a7%e8%88%87%e7%99%8c%e7%97%87-%e5%b0%8f%e5%86%8c%e5%ad%90-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%8b%e8%bc%89-%e6%80%a7%e8%88%87%e7%99%8c%e7%97%87-%e5%b0%8f%e5%86%8c%e5%ad%90-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[12]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7255]]></id>
		<title><![CDATA[下載 我怎麼告訴孩子 小册子]]></title>
		<content><![CDATA[<p>&nbsp;<img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-37.jpg" width="400" height="309" alt="" /></p> <p>&nbsp;</p> <p>幫助孩子面對的十種方法 <br /> 向不同年紀的孩子解釋 <br /> 診斷後如何告訴孩子 <br /> 與孩子討論癌症治療 <br /> 治療期間的家庭生活</p> <div>&nbsp;</div> <div><a href="http://www.cancer-fund.org/upload/booklets/file/HowToCope/cope_08children_c.pdf">www.cancer-fund.org/upload/booklets/file/HowToCope/cope_08children_c.pdf</a></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b8%8b%e8%bc%89-%e6%88%91%e6%80%8e%e9%ba%bc%e5%91%8a%e8%a8%b4%e5%ad%a9%e5%ad%90-%e5%b0%8f%e5%86%8c%e5%ad%90-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b8%8b%e8%bc%89-%e6%88%91%e6%80%8e%e9%ba%bc%e5%91%8a%e8%a8%b4%e5%ad%a9%e5%ad%90-%e5%b0%8f%e5%86%8c%e5%ad%90-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[13]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7256]]></id>
		<title><![CDATA[癌症病患使用嗎啡貼片應注意事項]]></title>
		<content><![CDATA[<p>&nbsp;<img alt="" src="http://cisc.twbbs.org/layout/img/logo.png" width="64" height="68" /><br /> <br /> 本文出自癌症新探45期<br /> 中國醫藥大學附設醫院 血液腫瘤科 黃馨慧醫師 | 2008 十二月  31<br /> <br /> 疼痛對大多數癌症病患而言一直是很大的問題，而止痛藥的使用在整體罹病過程中往往是無法避免的；特別是癌症末期，病患會因為嚴重的疼痛以致吃不下也睡不著，生活品質大受影響。而這些疼痛通常是嚴重且長期存在的，所以嗎啡類止痛藥成為大多數醫生的首選（因其在長期使用的狀態下較少出現胃出血、潰瘍及腎衰竭的副作用），然而當疾病的嚴重度越來越高且藥物的劑量越來越大時，頻繁的口服嗎啡反而會造成不便；而且病患可能因疾病的關係或腸胃道的吸收不穩定無法口服藥物，因此，嗎啡貼片是很方便的劑型，它可經皮下吸收免除了口服藥物的不便，緩慢的藥物釋放讓病人血中藥物的濃度趨於穩定，因而病人疼痛的起伏可儘量減少；和口服的嗎啡相比，貼片的止痛效果為口服嗎啡的七十五至一百倍，因此只需要傳統嗎啡劑量的1%便可以達到止痛效果。但是這些藥物仍有其特有的副作用，使用上仍須小心。<br /> <br /> 首先，一定要遵照醫師的指示用藥，特別是初次使用貼片的患者更須依照處方調整用藥，因為貼片藥物的吸收需經約六小時方能達到穩定的血中有效濃度，所以在首次使用的前面數小時不宜立即停用原止痛藥，二者使用時間應有重疊。原止痛藥至少要在十二小時以後方可慢慢停藥。持續使用貼片過程中若有突發強烈疼痛的情形，可先以短效口服嗎啡錠緩和症狀，再依據所需劑量調整貼片的使用；自行加貼嗎啡貼片並無法立即產生止痛效果，且易因藥物的劑量過重而導致嚴重的副作用，例如：呼吸抑制或意識不清的情形。一旦有上述的狀況出現，應立即通知醫護人員或緊急送醫。<br /> <br /> 其次，嗎啡貼片的藥物吸收乃經由皮膚緩慢的進入循環系統而分布全身，因此需貼在適合的位置（不易因活動而脫落的部位），如前胸、後背、上手臂、大腿等平坦處，而非痛哪裡貼哪裡；因此若病患已是嚴重營養不良至惡病質，貼片可能無法穩固地貼在病人身上，故此類病人未必適合使用此藥。因為皮膚的吸收力會依據各種狀況而有改變，因此下列情形需特別注意：<br /> 一、應避開傷口或放射治療部位：此處可能會因為藥片直接接觸到血管部位導致吸收速度過快而使血中嗎啡濃度突然升高造成藥物過量。再者，若無法避開體毛部位，應以剪刀剪去，不可用刮或剃，以防止傷口的產生。<br /> <br /> 二、使用部位應清潔乾燥：先以清水清潔，待完全乾燥才可貼上；水分會使貼片無法充分服貼於皮膚上，因此藥片容易掉落且影響吸收的效率。故因疾病本身容易產生盜汗現象的病人不適合使用此類貼片。<br /> <br /> 三、注意體温變化：體温上升會使血管擴張而加速嗎啡經皮膚吸收，因此要避免泡熱水澡或將貼片部位直接接觸熱源（如熱水袋、電毯等）。若有發燒現象須與醫護人員聯絡且調整貼片的使用。<br /> <br /> 四、每次換貼不同部位：正常使用約二至三天換片一次（依據病人本身的代謝及吸收效率而定），宜貼在不同位置，以保持穩定的吸收速度。<br /> <br /> 五、確保貼片完全緊貼：若有脫落須換新片，使用時應以手掌緊壓三十秒至貼片完全服貼。<br /> <br /> 再者，使用者應了解貼片的副作用及相關處理方式，原則上只要有下列副作用產生，應立即尋求醫護人員的協助。<br /> 一、噁心、嘔吐、頭暈：初次使用麻醉性止痛藥的患者常合併有噁心、嘔吐的副作用，可使用止吐劑及抗組織胺成份藥品以減緩症狀，不須立刻停藥，使用者對此類副作用常會有耐受性，其引起的不適感會逐漸減弱，請勿放棄此類藥物的使用。<br /> <br /> 二、紅疹發癢：偶有輕微紅疹及發癢的情形，請告知醫護人員，可使用局部皮膚用藥或口服抗過敏藥品以減輕症狀。但如有強烈的接觸性皮膚炎症狀，仍應移除貼片，改採其他給藥方式。<br /> <br /> 三、嗜睡、呼吸抑制：若懷疑藥物過量以致病人的呼吸變慢或意識不清，如無立即性的呼吸衰竭危險，除通知醫護人員外，可先撕下貼片觀察。勿急於給予Naloxone解毒，否則極易造成病人的劇烈疼痛。<br /> 四、便秘：可以適量的軟便劑改善之。<br /> <br /> 長久以來，對於麻醉止痛藥的刻板印象使得病人及其家屬對嗎啡類藥品的使用有所畏懼，大多數的人最擔心的便是藥物成癮的問題，因此使得許多末期病患承受不必要的劇烈疼痛。以目前安寧照顧的觀念，如何能使病人活得有尊嚴且擁有良好的生活品質比延長痛苦的生命更重要，所以安全而有效的使用嗎啡貼片對癌末病患的緩和治療是相當重要的。與口服及靜脈注射給予之藥物比較，嗎啡貼片的成癮性更低。若能遵循專業醫師的處方採用漸進的方式來使用嗎啡類止痛藥物，病人藥物成癮的機會並不高，因此民眾對於此類藥品成癮及毒性的擔憂都是不必要的。</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%97%87%e7%97%85%e6%82%a3%e4%bd%bf%e7%94%a8%e5%97%8e%e5%95%a1%e8%b2%bc%e7%89%87%e6%87%89%e6%b3%a8%e6%84%8f%e4%ba%8b%e9%a0%85-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%97%87%e7%97%85%e6%82%a3%e4%bd%bf%e7%94%a8%e5%97%8e%e5%95%a1%e8%b2%bc%e7%89%87%e6%87%89%e6%b3%a8%e6%84%8f%e4%ba%8b%e9%a0%85-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[14]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7257]]></id>
		<title><![CDATA[生活重整課程 帶病者走出地獄]]></title>
		<content><![CDATA[<p>&nbsp;</p> <div class="t_msgfontfix"> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td id="postmessage_9929" class="t_msgfont"><img alt="" src="http://hk.apple.nextmedia.com//images/apple-photos/apple/20111204/small/04aa7p4.jpg" width="190" height="132" /><br />             為了鼓勵病友多接觸社會，恢復正常社交活動，參加集體戶外活動是生活重整課程的「必修科」。<br />             <br />             壯年中風、意外、工傷等突如其來的傷患，可以令人的生活由天堂跌落地獄，有人甚至接受不到身體的殘疾，或受無止境的痛楚折磨，萌生自毀念頭。伊利沙伯醫院舉辦生活重整課程，協助這些病人走出地獄般的生活，在痛楚與絕望中，學習以正面態度重投正常生活，不再放棄自己。　<br />             記者：鍾麗霞<br />             <br />             伊利沙伯醫院職業治療部部門經理梁國輝表示，「嚟得參加我哋嘅課程， 10個病人有  5、 6個都試過自殺」。他指，中風及痛症等長期病患者中，估計有 10至  20％人，完成針對肢體康復的訓練後，因難以接受身體障礙，或傷病遺下的症狀，無法重投正常生活，出現「生活方式失衡」狀況，即除生活自理或休息外，日常生活幾乎沒有甚麼內容；或生活只圍繞治療，沒有正常家庭及社交、娛樂及工作，導致心理質素下降，有些病人除了看病外，完全不外出，不見朋友，與現實世界隔絕。<br />             <br />             <img alt="" src="http://hk.apple.nextmedia.com/images/apple-photos/apple/20111204/small/04aa7p5.jpg" width="190" height="114" /><br />             《生活重整課程點滴》<br />             病友在課程中透過分享個人經歷，互相鼓勵及扶持。<br />             <br />             <img alt="" src="http://hk.apple.nextmedia.com/images/apple-photos/apple/20111204/small/04aa7p7.jpg" width="190" height="114" /><br />             《生活重整課程點滴》<br />             梁國輝（右）表示與病友聚會，「飲飲食食」是不可缺少的活動之一，大家可邊吃邊講心事。<br />             <br />             他表示，症狀較重、性格悲觀、有後遺痛症及太依賴家人或親友照顧的病者，是出現生活方式失衡的高危族，「痛症嘅影響比較大，所以痛症科嘅病人最多」。<br />             伊利沙伯醫院自  07年起舉辦生活重整課程，大部份痛症科病人也會參加。此外，也有為中風及柏金遜症病人開班，最近更為愛滋病患者舉辦課程；至今已有逾  200人完成課程<br />             <br />             <img alt="" src="http://hk.apple.nextmedia.com/images/apple-photos/apple/20111204/small/04aa7p3.jpg" width="190" height="219" /><br />             《生活重整課程點滴》<br />             參加生活重整課程的學員一起炮製美食。<br />             <br />             行街睇戲有辦法<br />             課程第一步是要教病友接受現實，調節抑鬱、哀傷或憤怒的情緒，下一步是學習與症狀共存，利用身體仍有的功能，找出合適方法，重投正常生活。梁表示，很多病友因為痛症「唔行得、唔坐得」，故不敢外出，課程會教他們很多方法適應，例如將一程時間較長的巴士，分開兩次搭車；到戲院看電影，選擇最後一排，看戲時便可以坐下及站立交替，減低受痛症的影響。每次上課，學員都要想一件開心事去做，在課堂上策劃行程，到下一次上堂再滙報結果，很多時成功例子可以鼓勵病友更多嘗試接觸社會，到完成課程前會要求學員做一個三個月的中長線的生活計劃，希望他們可重拾生活及自信，「最終希望佢哋可以正常搭車、出街、睇戲食飯、甚至可以返工」。<br />             痛症病人最常會問「幾時會好番？幾時會唔痛？」他表示有所謂的「痛感過敏」，病人有可能在一段時間後，痛楚會自然消失，有可能是一、兩年，也可能是更長時間。<br />             若病人失去生活的動力，引發抑鬱症狀，未必能捱過這段時間，故學習保持樂觀，與症狀共存是很重要。<br />             <br />             <a href="http://hk.apple.nextmedia.com/template/apple/art_main.php?iss_id=20111204&amp;sec_id=4104&amp;subsec_id=3626368&amp;art_id=15860693" target="_blank">http://hk.apple.nextmedia.com/te ... amp;art_id=15860693</a></td>         </tr>     </tbody> </table> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%94%9f%e6%b4%bb%e9%87%8d%e6%95%b4%e8%aa%b2%e7%a8%8b-%e5%b8%b6%e7%97%85%e8%80%85%e8%b5%b0%e5%87%ba%e5%9c%b0%e7%8d%84-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%94%9f%e6%b4%bb%e9%87%8d%e6%95%b4%e8%aa%b2%e7%a8%8b-%e5%b8%b6%e7%97%85%e8%80%85%e8%b5%b0%e5%87%ba%e5%9c%b0%e7%8d%84-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[15]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7258]]></id>
		<title><![CDATA[克服心理障礙　定期進行運動]]></title>
		<content><![CDATA[<p><img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-35.jpg" width="400" height="318" alt="" /></p> <p>&nbsp;現時是戶外活動的最佳時間，但你是否有足夠的運動呢？根據衞生署2009年行為風險因素評估的統計數字顯示，香港每十人便有五人每星期運動少於一次。相信大家都知道，運動對身體有益，因此我們更應進行多些運動，不過往往被無數的藉口打消運動的念頭。專家提出七項建議供參考：<br /> <br /> &nbsp;  &nbsp; &nbsp; &nbsp; <br /> 障礙 1：時間  破解：雖然專家建議每星期最少進行三次、每次30分鐘的運動，但你毋須需一下子便達成這個目標，可按能力每次約做10分鐘，例如以行樓梯代替電梯、快步行數個街口、看著喜愛的電視節目騎健身單車。  <br /> <br /> 障礙2：疲倦  破解：疲倦是不運動的常見藉口。不過研究發現，定期運動可以改善睡眠質素，因為運動可以減低腦部釋放緊張荷爾蒙，令睡眠質素更佳。而好好的睡一覺，可以為你翌日提供更多的能量。<br /> <br /> 障礙3：缺乏自信  破解：假若你有多年沒有好好運動，當然不會建議你只操練數星期便參加馬拉松比賽。由現在開始，慢慢適應及堅持運動，例如由快走步10分鐘開始或配合其他輕量的運動，隨後逐步增加時間及運動的強度。<br /> <br /> 障礙4：感到無聊  破解：將運動視作為一項活動，或與家人、朋友的一個聚會，這樣可以增加你的動力。不妨選擇一些你喜歡的活動，當你感到厭倦時，想想法子令運動多添樂趣。<br /> <br /> 障礙5：懶惰  破解：你會將重要的事項寫在記事簿內，例如會議、面試或特別的約會，嘗試將運動的計劃都一併寫在你的記事日程上，你會更願意跟隨。 <br /> <br /> 障礙6：增加開支  破解：額外支出可能打消你對運動的熱情，嘗試在家中進行運動，例如將一些膠水樽注滿水，當作啞鈴鍛練體力、或進行掌上壓、或一些帶氧運動等。你亦可以選擇行樓梯或到行山徑遠足，這些都不會增加太多的開支。<br /> <br /> 障礙7：擔心受傷  為免受傷，便要清楚了解每個運動的正確技巧及方法，你可以考慮邀請合資格的私人教練。但如果你已有一些時間沒有做運動，或未了解身體狀況，便應該先找醫生檢查你的身體的狀況。  <br /> <br /> <img alt="" src="http://www.cancer-fund.org/enewsletter/share/logo.jpg" width="200" height="59" /><br /> 香港癌症基金會電子版通訊（四月號, 2011）</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%85%8b%e6%9c%8d%e5%bf%83%e7%90%86%e9%9a%9c%e7%a4%99%e3%80%80%e5%ae%9a%e6%9c%9f%e9%80%b2%e8%a1%8c%e9%81%8b%e5%8b%95-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%85%8b%e6%9c%8d%e5%bf%83%e7%90%86%e9%9a%9c%e7%a4%99%e3%80%80%e5%ae%9a%e6%9c%9f%e9%80%b2%e8%a1%8c%e9%81%8b%e5%8b%95-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[16]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7259]]></id>
		<title><![CDATA[癌症病人味覺改變及處理]]></title>
		<content><![CDATA[<p>&nbsp;</p> <div class="t_msgfontfix"> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td id="postmessage_4545" class="t_msgfont"><img alt="" src="http://cisc.twbbs.org/layout/img/logo.png" width="64" height="68" /><br />             <br />             本文出自癌症新探29期<br />             台北榮民總醫院 護理部 謝麗鳳副護理長 | 2009 元月  17<br />             <br />             當病患接受化學或放射治療時，常帶來許多合併症，相對會影響病患的生活品質，尤其目前癌症的治療皆相當的積極，也相當的有療效，但也因此帶來一些副作用。臨床上常見合併症包括噁心、嘔吐、口腔粘膜炎及骨髓抑制等，研究調查發現味覺改變發生機率相當高，約36-71%，但常被忽略。也許味覺改變並不會直接威脅病患的生命，但實際上對病患的食慾、營養的攝取、體重的維持有相當的影響，甚至會影響家庭互動及個人社交的活動，對病人的身、心、社交及靈性等方面有相當大的影響。<br />             <br />             味覺改變包括味覺的減退、消失或味覺的障礙，味覺發生障礙，會嚴重影響食慾及消化，甚至影響生活的樂趣。中國人以食為天，視飲食為一種生活享受，癌症病患之家屬認為病患接受治療需特別補充的營養，才能增加身體的抵抗力，而癌症病患常因味覺改變而影響食慾，所以味覺改變常會造成病患及家屬的壓力。<br />             <br />             味覺的產生必須有正常的接受體(味蕾)  、適當的唾液、嗅覺功能及完整的傳導神經。基本味覺包括酸、甜、苦及鹹，但彼此相互結合又可構成其他多種味覺，味蕾負責傳遞味覺，分布在舌頭、軟顎、舌顎弓及咽部後方，其味覺細胞接受食物中溶解的化學成分刺激，再經第五、七、九、十對腦神經將此衝動傳導至大腦皮質，由此判斷衝動來源是何種味道的食物，因此若有腦部病變或神經傳導等方面障礙便會影響味覺。刺激味覺器官會增加唾液及胰液的分泌並促進胃收縮及腸蠕動，因此當味覺發生障礙時，也會影響消化作用。食物是否可口取決於化學激素之濃度，以及食物本身之顏色、味道濃度及質地、過去對食物的感覺、偏好及環境因素。<br />             <br />             味覺改變的影響因素<br />             (一)本身疾病：癌症病患味覺改變可能與腫瘤的生長部位有關，例如肺癌患者對酸之閾值提高；喉癌對酸、甜、苦、鹹四種味覺閾值會升高。<br />             (二)化學治療：化學治療是癌症病患味覺改變的主要原因之一。<br />             (三)放射治療：放射線治療會造成味蕾細胞的微絨毛受損或減少唾液的分泌或口乾，當治療劑量到達2000  cGy，味覺會漸漸受到影響，而且影響時間非常久，甚至不會恢復。<br />             (四)藥物：抗生素、止痛劑、bonefos、降血壓藥、支氣管擴張劑、肌肉鬆弛劑、抗癲癇藥、抗憂鬱藥等皆會影響病患的味覺情形。<br />             (五)年齡：一般老年人常發現味覺的敏感度降低。<br />             (六)其他因素：口腔粘膜炎、噁心、嘔吐、環境因素亦會影響味覺的改變。<br />             味覺改變的飲食原則<br />             (一)口乾會使食物在口腔內的味覺改變，所以太乾的食物會導致味覺改變，可利用肉汁、湯汁、或調味包來添加食物的濕度。多吃蔬菜與煮成的濃湯，進餐時與二餐間可多喝水。<br />             (二)若口腔粘膜完整無破損，可喝些酸性果汁或飲料，嚼食口香糖或吸吮硬糖，冰棒，皆有助於刺激唾液分泌。<br />             (三)進餐前先漱口，可增加口腔濕潤及減少口腔內之異味。清潔，濕潤的口腔，能增加食物的鮮美味道。<br />             (四)癌症病人對苦味的敏感度增加，應避免吃具苦味的食物例如苦瓜、青江菜、芥菜，吃藥時可以膠囊或糯米紙包裝以減少因苦味導致的嘔吐。<br />             (五)病人對甜、酸的敏感度減弱，故可多採用糖或檸檬以加強甜及酸味，亦可嘗試添加各種調味醬、檸檬、沙拉或酒，以增加食物的風味嘗試不同的食物。<br />             (六)營造進餐氣氛來促進食慾。例如食物的香味環境的清香來刺激嗅覺，播放病人喜歡的輕鬆音樂增加聽覺享受，精緻的餐具、優雅的進食環境及食物的變化以刺激視覺，以達到病人在舒適的氣氛下進食。<br />             (七)病人若接受某類含白金的化學藥物，進食常會感覺食物中含金屬，此時應使用非金屬鍋子或餐具，若感口腔內有金屬味，可加一點檸檬汁或吃微酸的果糖。<br />             (八)冷藏過或冰凍過的食物，有時可改善病人的味覺。<br />             (九)可利用一些較少腥味的蛋白質食物來源，如雞肉、豆腐、蛋等。<br />             因為味覺改變並不至於威脅病人生命的，所以常被人忽略，雖病人不向醫護人員提出抱怨但卻常常影響病人的生活品質，目前沒有藥物能改善這種症狀，但以上的小偏方不妨試試看，也許可以減輕病人的困擾。</td>         </tr>     </tbody> </table> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e5%91%b3%e8%a6%ba%e6%94%b9%e8%ae%8a%e5%8f%8a%e8%99%95%e7%90%86-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%97%87%e7%97%85%e4%ba%ba%e5%91%b3%e8%a6%ba%e6%94%b9%e8%ae%8a%e5%8f%8a%e8%99%95%e7%90%86-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[17]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7260]]></id>
		<title><![CDATA[癌的啟示：堅強面對化療脫髮不可怕]]></title>
		<content><![CDATA[<p>&nbsp;大部分的抗癌化療藥都會引致脫髮，其嚴重程度要視乎所選用的藥物和病人的體質而定。脫髮雖然對身體機能沒有大影響，但對病人的外觀和心理就構成了不少壓力，對一些病人來說，它甚至比嘔吐和細菌感染等副作用更可怕！<br /> <br /> 脫髮一般在治療後三至四星期便漸趨明顯，頭髮會一束一束的脫落，所以最好先將頭髮剪短，既較易打理，亦可減低脫髮造成的心理壓力。外國曾發明一些儀器，將頭皮降溫，以減低含化療藥的血液流經頭皮，希望藉此減少脫髮。不過使用麻煩，效果亦不佳，所以在香港並不普遍。<br /> <br /> 半年後重新生髮<br /> 化療期間，病人可利用假髮、帽子或絲巾等改善外觀，各適其適。一般來說，病人會在化療後三至六個月內再長出頭髮。二十多年來，我還未遇過不能重新長出頭髮的病人個案。<br /> <br /> 上月遇見一位中年乳癌病人回來覆診，她已完成化療半年了，仍戴着一個深紅色的假髮，雖然看來不錯，但總是覺得有點不自然的。我好奇的問她：「你還未重新長出頭髮嗎？」她立即脫下假髮，笑道：「全都長出來了，白髮反而減少了，你看看。」我說：「頭髮長得很好啊，我覺得比你的假髮還好看呢！」她丈夫也說：「可不是嗎？但她總是不聽我的意見。」離開診所時，她又戴回假髮道：「我還是喜歡這假髮多一些，新潮一點嘛！」<br /> <br /> 東區醫院臨床腫瘤科<br /> <br /> 顧問醫生游子覺醫生<br /> <br /> <img alt="" src="http://orientaldaily.on.cc/img/v2/logo_odn_archive.png" width="97" height="22" />. 2011-6-2<br /> <a href="http://orientaldaily.on.cc/cnt/news/20110602/00176_079.html?pubdate=20110602" target="_blank">http://orientaldaily.on.cc/cnt/n ... ml?pubdate=20110602</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e5%a0%85%e5%bc%b7%e9%9d%a2%e5%b0%8d%e5%8c%96%e7%99%82%e8%84%ab%e9%ab%ae%e4%b8%8d%e5%8f%af%e6%80%95-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e5%a0%85%e5%bc%b7%e9%9d%a2%e5%b0%8d%e5%8c%96%e7%99%82%e8%84%ab%e9%ab%ae%e4%b8%8d%e5%8f%af%e6%80%95-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[18]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7262]]></id>
		<title><![CDATA[癌的啟示：見顧問醫生非癌症復發]]></title>
		<content><![CDATA[<p>&nbsp;一位曾患大腸癌的女病人回醫院覆診，她剛進入診症室，一抬頭見到我時，立刻有點愕然和不安。「我是不是腫瘤復發呢？」她還未坐下便很猶豫地問。根據病歷，幾年前她完成手術和化療後，一直都康復得很好。我奇怪地問：「你有甚麼不適嗎？為甚麼會這麼擔心呢？」「我沒有甚麼不舒服，不過一見到你就擔心起來了。」<br /> <br /> 莫非我樣子太過嚴肅，嚇怕了她？  她接着道：「我聽說如果覆診時被分派去見顧問醫生的，通常都是重病或復發的個案，所以一見到是由你主診，就覺得可能情況不妙了。這幾年來，我一直都擔心會隨時復發，就像身上被裝上了計時炸彈一樣。」<br /> <br /> 我笑着說：「我們有十多位醫生，由哪一位診治，只是隨機分配而已。其實你一直都康復得很好，不用擔心。記着要保持心境愉快，很多研究都指出，經常憂慮愁煩，會使你的免疫系統受壓抑，反而可能增加復發的機會呢裡！」「那麼，我可以做甚麼來減低復發的風險呢？」<br /> <br /> 「幾年前你不是已完成了輔助化療嗎？至於食療和中草藥是否有幫助，我就不太肯定了。此外，愈來愈多研究顯示，適量運動和避免身體過胖都可減低癌病復發的機會，但這就要視乎你有沒有恒心了。」檢查完畢後，她離開診症室時問：「下次覆診還會由你負責嗎？」「隨緣吧。希望下一次見面時沒有再令你吃驚就好了。」<br /> <br /> 東區醫院臨床腫瘤科<br /> <br /> 顧問醫生  游子覺醫生<br /> <br /> <img alt="" src="http://orientaldaily.on.cc/img/v2/logo_odn_archive.png" width="97" height="22" />, 2011-6-16<br /> <a href="http://orientaldaily.on.cc/cnt/news/20110616/00176_103.html?pubdate=20110616" target="_blank">http://orientaldaily.on.cc/cnt/n ... ml?pubdate=20110616</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e8%a6%8b%e9%a1%a7%e5%95%8f%e9%86%ab%e7%94%9f%e9%9d%9e%e7%99%8c%e7%97%87%e5%be%a9%e7%99%bc-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e8%a6%8b%e9%a1%a7%e5%95%8f%e9%86%ab%e7%94%9f%e9%9d%9e%e7%99%8c%e7%97%87%e5%be%a9%e7%99%bc-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[20]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7263]]></id>
		<title><![CDATA[女人的癌後性福]]></title>
		<content><![CDATA[<p><img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-16.jpg" width="400" height="507" alt="" /></p> <p>&nbsp;走過罹癌，女人要幸福<br /> 在剛得知自己罹患癌症時，妳腻子裡想到的可能只有存活的問題。然而，當<br /> 妳開始接受治療後，有些新問題逐漸出現而且變得非常重要。譬如說，如果癌症<br /> 控制住了，妳的生活能夠多「正常」？性生活會有什麼改變呢？<br /> 性愛是我們日常生活中非常重要的一部分，對性的感覺會影響我們對生活的<br /> 熱忱、自我形象，以及與親密伴侶的關係。兩性對於性生活的認知差距頗大，男<br /> 性通常的困擾是「能不能」、「行不行」；而女性則較在意的是「願不願意」，也因<br /> 此，當女性要和自己的親密伴侶或醫生討論癌症治療對性生活的影響時，往往很<br /> 難啟口。<br /> 基於此，希望協會參考美國癌症協會出版的Sexuality  and Cancer(for  Women)<br /> 手冊，針對癌症與性的議題為妳和妳的伴侶準備這本手冊，提供妳最關心的資<br /> 訊。雖然手冊無法解答妳每一個疑問，但是我們衷心希望能藉由足夠的資訊，讓<br /> 妳和妳的伴侶能開誠佈公地討論妳們的性生活，同時儘可能永遠地保持最親密的<br /> 關係，以幫助妳們能共同對抗癌症。<br /> 王正旭<br /> 中華民國癌症希望協會理事長<br /> 基隆長庚紀念醫院癌症中心主任</p> <p>PDF file :&nbsp;<a href="http://www.lshosp.com.tw/chian/Cancer_Medicine/folder/18-%E5%A5%B3%E4%BA%BA%E7%9A%84%E7%99%8C%E5%BE%8C%E5%B9%B8%E7%A6%8F.pdf">www.lshosp.com.tw/chian/Cancer_Medicine/folder/18-%E5%A5%B3%E4%BA%BA%E7%9A%84%E7%99%8C%E5%BE%8C%E5%B9%B8%E7%A6%8F.pdf</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%a5%b3%e4%ba%ba%e7%9a%84%e7%99%8c%e5%be%8c%e6%80%a7%e7%a6%8f-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%a5%b3%e4%ba%ba%e7%9a%84%e7%99%8c%e5%be%8c%e6%80%a7%e7%a6%8f-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[21]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7264]]></id>
		<title><![CDATA[男人的癌後性福]]></title>
		<content><![CDATA[<p><img src="http://www.cancerinformation.com.hk/ufiles/Image/mother-18.jpg" width="400" height="500" alt="" /></p> <p>&nbsp;</p> <p>&nbsp;<span style="color: rgb(51, 51, 51); font-size: 13px; line-height: 19.1875px;">男人的癌後性福</span><br style="color: rgb(51, 51, 51); font-size: 13px; line-height: 19.1875px;" /> <span style="color: rgb(51, 51, 51); font-size: 13px; line-height: 19.1875px;">在二十一世紀，癌症已是台灣人死因的第一名。2002 年台灣共有34,596位男性罹患癌症。治療癌症中不可避免的手術、放射線治療與化學治療都可能影響男人的性功能。甚至罹患症病的心理壓力就會讓男人喪失性慾。</span><br style="color: rgb(51, 51, 51); font-size: 13px; line-height: 19.1875px;" /> <br style="color: rgb(51, 51, 51); font-size: 13px; line-height: 19.1875px;" /> <span style="color: rgb(51, 51, 51); font-size: 13px; line-height: 19.1875px;">性是美滿人生的基石。過去的男人都不敢正面去談它。但時代進步後，大多數的人都已能正視性的問題。這本書提供罹癌後男人可能遭遇的性問題與解決之道。癌症並不可怕，只要早期診斷早期治療，戰勝的機會很大。癌後的性福，人人都應追尋。希望本書能提供給癌後男人正確的指引。讀者若有需進一步的諮商與治療，可以找泌尿科醫師尋求協助。</span></p> <div><span style="color: rgb(51, 51, 51); font-size: 13px; line-height: 19.1875px;"><br /> </span></div> <div><font color="#333333" size="2"><span style="line-height: 19.1875px;">下載網址 :&nbsp;</span></font><a href="http://health99.doh.gov.tw/EducZone/edu_detail.aspx?CatId=21566">http://health99.doh.gov.tw/EducZone/edu_detail.aspx?CatId=21566</a></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130710]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%94%b7%e4%ba%ba%e7%9a%84%e7%99%8c%e5%be%8c%e6%80%a7%e7%a6%8f-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%94%b7%e4%ba%ba%e7%9a%84%e7%99%8c%e5%be%8c%e6%80%a7%e7%a6%8f-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[22]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130710]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7265]]></id>
		<title><![CDATA[如何與子女講解癌症]]></title>
		<content><![CDATA[<p>&nbsp;<img src="http://l3.yimg.com/bt/api/res/1.2/Hk5NdbDIa1tO9mOJZZRq2g--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTQwO3E9ODU7dz00MA--/http://l.yimg.com/os/publish-images/news/2013-07-14/be7b9c56-0429-4abf-a9f6-309891fad24f_HKCF_3D_CMYK_chiab.jpg" alt="" title="" class="author-image" style="color: rgb(125, 125, 125); font-family: Arial; line-height: 2.2em; border: 0px; margin: 0px 10px 0px 7px; width: 40px; height: 40px; background-repeat: no-repeat no-repeat;" /></p> <div class="yom-mod yom-art-hd" id="mediabloghead" style="margin: 12px 0px 20px; padding: 0px; zoom: 1; border-top-style: none; border-color: rgb(52, 78, 127); font-family: arial, STHeiti, pmingliu, sans-serif; font-size: 13px; line-height: 16px;"> <div class="bd" id="yui_3_9_1_1_1377214960073_593" style="margin: 0px; padding: 0px; zoom: 1;"><cite class="byline vcard" id="yui_3_9_1_1_1377214960073_592" style="font-style: normal; color: rgb(125, 125, 125); font-size: 12px; font-family: Arial; vertical-align: middle; line-height: 2.2em; display: inline !important;">作者&nbsp;<span class="fn"><a href="http://hk.news.yahoo.com/blogs/author/%E9%A6%99%E6%B8%AF%E7%99%8C%E7%97%87%E5%9F%BA%E9%87%91%E6%9C%83/" rel="author" data-rapid_p="3" style="color: rgb(93, 67, 112); text-decoration: none;">香港癌症基金會</a></span>&nbsp;|&nbsp;<span class="provider org"><a href="http://hk.news.yahoo.com/blogs/cancerfund/" data-rapid_p="4" style="color: rgb(93, 67, 112); text-decoration: none;">抗癌路上不孤單</a></span>&nbsp;&ndash;&nbsp;<abbr title="2013-08-18T15:47:37Z" style="border: 0px;">2013年8月18日星期日下午11:47</abbr></cite></div> </div> <div itemscope="" itemtype="http://schema.org/Article" style="margin: 0px; padding: 0px; font-family: arial, STHeiti, pmingliu, sans-serif; font-size: 13px; line-height: 16px;"> <div class="yom-mod yom-art-content " id="mediablogbody" itemprop="articleBody" style="margin: 0px 0px 5px; padding: 0px 0px 20px; zoom: 0; border-top-style: none; border-color: rgb(52, 78, 127);"> <div class="bd" style="margin: 0px; padding: 0px; zoom: 0; font-size: 16px; font-family: Georgia, Times, &#039;Times New Roman&#039;, serif; line-height: 25px;"> <div class="yom-fig-frame" style="margin: auto; padding: 0px; width: 630px; text-align: center;"><span class="yom-figure yom-fig-middle" style="clear: both; display: block; margin: 0px auto; width: 530px;"><img alt="" class="editorial " src="http://l2.yimg.com/bt/api/res/1.2/RXY3tGSSEpdPyG2ccNhVQQ--/YXBwaWQ9eW5ld3M7cT04NTt3PTUzMA--/http://l.yimg.com/os/publish-images/news/2013-08-18/11d51b9b-66e9-45f9-9aa6-0e5d9dd113b2_20130819_RC1.jpg" width="530" style="border: 0px; display: inline; margin: 0px auto; background-repeat: no-repeat no-repeat;" /></span></div> <br /> 怎樣對子女講解什麼是癌症及癌症的治療療程，往往令家長感到非常困惑。由於小朋友的心智發展階段、理解能力及情緒反應不一，家長對個別小朋友需給予不同的照顧。家長更要深入了解小朋友的感受，從而幫助他們面對及適應種種改變。<br /> <br /> 為協助因家人患癌而受影響的小朋友，香港癌症基金會特別成立「彩虹會」，專業的兒童關顧專家會利用小朋友明白的語言，協助孩子明白癌症，並指導家長，怎樣向子女講解癌症。<br /> <br /> 別以為年幼的孩子不會明白什麼是癌症，便對他們三緘其口。他們雖未能完全明白癌症的種種問題，但他們卻可分辨爸爸 / 媽媽是健康還是生病。事實上，爸爸 / 媽媽可以告訴孩子自己患上了「癌症」，並可用簡單方法告訴孩子，正如其他疾病一樣，爸爸 / 媽媽可能會突然感到不適，預早告訴小朋友，讓他們及早有一個心理準備。<br /> <br /> 此外，告訴小孩出現癌症與他們並沒有任何關係，這樣可以防止他們錯誤認為自己是令爸爸 / 媽媽生病主因。同時應讓小朋友明白，大部分癌症並不會傳染，孩子可以繼續與爸爸 / 媽媽接觸及親近，可以一同吃飯、睡覺和親子樂。<br /> <br /> 另外，治療期間，患者的外表、行為、身體會有明顯轉變。這些轉變包括頭髮脫落、疲倦、嘔吐、皮膚顏色改變。有些小孩子會對這些轉變產生恐懼或抗拒，爸爸 / 媽媽應該向小孩子解釋這些轉變是身體對藥物 / 療程的正常反應，並衹是暫時性的。這樣可幫助孩子明白爸爸 / 媽媽的癌症及療程，亦可減低他們的不安與恐懼。<br /> <br /> 「彩虹會」致力協助5-15歲因家人患癌而受影響的小朋友，假如你想了解更多有關「彩虹會」的服務，可瀏覽<a target="_blank" href="http://www.cancer-fund.org/RainbowClub" data-rapid_p="1" style="color: rgb(93, 67, 112); text-decoration: none;">www.cancer-fund.org/RainbowClub</a>，或致電36560800查詢。若想支持「彩虹會」服務，請<a target="_blank" href="http://goo.gl/d5B2EW" data-rapid_p="2" style="color: rgb(93, 67, 112); text-decoration: none;">按此</a>捐款。</div> <div class="bd" style="margin: 0px; padding: 0px; zoom: 0; font-size: 16px; font-family: Georgia, Times, &#039;Times New Roman&#039;, serif; line-height: 25px;">&nbsp;</div> <div class="bd" style="margin: 0px; padding: 0px; zoom: 0; font-size: 16px; font-family: Georgia, Times, &#039;Times New Roman&#039;, serif; line-height: 25px;"><a href="http://hk.news.yahoo.com/blogs/cancerfund/%E5%A6%82%E4%BD%95%E8%88%87%E5%AD%90%E5%A5%B3%E8%AC%9B%E8%A7%A3%E7%99%8C%E7%97%87-154737774.html">http://hk.news.yahoo.com/blogs/cancerfund/%E5%A6%82%E4%BD%95%E8%88%87%E5%AD%90%E5%A5%B3%E8%AC%9B%E8%A7%A3%E7%99%8C%E7%97%87-154737774.html</a></div> </div> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20130822]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%a6%82%e4%bd%95%e8%88%87%e5%ad%90%e5%a5%b3%e8%ac%9b%e8%a7%a3%e7%99%8c%e7%97%87-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%a6%82%e4%bd%95%e8%88%87%e5%ad%90%e5%a5%b3%e8%ac%9b%e8%a7%a3%e7%99%8c%e7%97%87-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[23]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20130822]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7266]]></id>
		<title><![CDATA[( 胃癌 ) 癌的啟示：細嚼慢嚥 重拾「食」趣]]></title>
		<content><![CDATA[<div style="border-bottom: 0px; border-left: 0px; padding-bottom: 0px; text-transform: none; background-color: rgb(255,255,255); text-indent: 0px; margin: 0px; padding-left: 14px; width: 713px; padding-right: 0px; font: 13px/18px Verdana, Geneva, sans-serif; white-space: normal; letter-spacing: normal; color: rgb(0,51,102); border-top: 0px; border-right: 0px; word-spacing: 0px; padding-top: 22px; -webkit-text-stroke-width: 0px"> <p style="border-bottom: 0px; border-left: 0px; padding-bottom: 0px; margin: 0px; padding-left: 0px; padding-right: 0px; border-top: 0px; border-right: 0px; padding-top: 0px">&nbsp;的士司機老王一直有胃痛、胃脹，以為是職業病。三個月前開始作悶嘔吐，後來更見大便變黑，終證實患上胃癌，要將大半個胃切除。手術後其胃口逐漸恢復，但進食時常有「頂住」的感覺。女兒怪父親性急，慣性地狼吞虎嚥，特地向專科護士請教。<br /> <br /> 割胃後飲食需調節<br /> 割除胃部後，病者在飲食方面需作出調節，問題應不大。每天飲食要定時定量，少食多餐，細嚼慢嚥，避免過飽，否則會引起肚屙、頭暈等現象。飯後亦要休息一會，以免腸臟消化不來。可吃「正常」餐，但應選吃清淡易消化的食物，多用蒸、灼、炆、煮、焗方法烹調，避免太酸、辣、鹹、甜或過冷、過熱的食物；減少食鹹魚、鹹蛋、臘腸、燒味、滷水及燒烤食物。飲料以奶、豆漿、果汁、清茶為主，酒、濃茶、濃咖啡、濃湯如酸辣湯、肉汁如牛肉汁、雞精等可免則免。多吃蔬果可吸收維他命、纖維及抗癌營養素。<br /> <br /> 沒有胃的人吸收鐵質和維他命B12的功能較弱，容易引起貧血，醫生會為病人注射維他命B12，補充鐵和鈣質。病人不妨進行一些溫和的運動如散走、太極等，有助增強體質。中醫學認為若精神暢快，抵禦外邪的能力就大增。若七情（喜、怒、憂、思、悲、恐、驚）失常，可導致陰陽失調，氣血不和，經絡阻塞，癌症則較易復發。<br /> <br /> 王小姐每日都致電父親閒話家常，又叮囑他細嚼慢嚥，要珍惜失而復得「吃」的樂趣。香港防癌會網址：<a href="http://www.hkacs.org.hk/" target="_blank" style="border-bottom: 0px; border-left: 0px; padding-bottom: 0px; margin: 0px; padding-left: 0px; padding-right: 0px; border-top: 0px; border-right: 0px; text-decoration: none; padding-top: 0px">www.hkacs.org.hk</a><br /> <br /> 香港防癌會<br /> <br /> 高級教育主任李周翠娥<br /> <br /> <img alt="" src="http://orientaldaily.on.cc/img/v2/logo_odn.png" width="122" height="22" style="border-bottom: 0px; border-left: 0px; padding-bottom: 0px; margin: 0px; padding-left: 0px; padding-right: 0px; border-top: 0px; border-right: 0px; padding-top: 0px" /><br /> 2011-4-28<br /> <a href="http://orientaldaily.on.cc/cnt/news/20110428/00176_081.html?pubdate=20110428" target="_blank" style="border-bottom: 0px; border-left: 0px; padding-bottom: 0px; margin: 0px; padding-left: 0px; padding-right: 0px; border-top: 0px; border-right: 0px; text-decoration: none; padding-top: 0px">http://orientaldaily.on.cc/cnt/n ... ml?pubdate=20110428</a></p> </div> <p><br class="Apple-interchange-newline" /> &nbsp;</p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20131014]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e8%83%83%e7%99%8c-%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e7%b4%b0%e5%9a%bc%e6%85%a2%e5%9a%a5-%e9%87%8d%e6%8b%be%e3%80%8c%e9%a3%9f%e3%80%8d%e8%b6%a3-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e8%83%83%e7%99%8c-%e7%99%8c%e7%9a%84%e5%95%9f%e7%a4%ba%ef%bc%9a%e7%b4%b0%e5%9a%bc%e6%85%a2%e5%9a%a5-%e9%87%8d%e6%8b%be%e3%80%8c%e9%a3%9f%e3%80%8d%e8%b6%a3-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[24]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20131014]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7267]]></id>
		<title><![CDATA[( 乳癌 ) 乳癌康復者求助 15％為淋巴水腫]]></title>
		<content><![CDATA[<p> <table border="0" cellspacing="0" cellpadding="0" width="100%">     <tbody>         <tr valign="top">             <td class="title">             <div id="news_title">             <h1><span style="font-size: medium">乳癌康復者求助 15％為淋巴水腫</span></h1>             </div>             <div class="newsdate">&nbsp;</div>             <div class="newsdate">&nbsp;</div>             </td>             <td class="logo">             <p><a title="明報" href="http://www.mingpao.com/"><span style="font-size: medium"><img alt="明報" src="http://simg.sina.com.hk/images/nwProvider.20110615/mingpao.gif" /></span></a></p>             <p>&nbsp;</p>             <p>&nbsp;</p>             </td>         </tr>     </tbody> </table> </p> <div id="news_text" class="contentText"> <p>【明報專訊】乳癌非不治之症，患者完成切除腫瘤手術後，其中一項主要困擾是繼發性淋巴水腫。香港乳癌基金會（基金會）接獲的求助個案中，有一成半人就淋巴水腫問題求助，更有患者指公立醫院未能提供足夠援助。</p> <h2 class="contentTitle"><span style="font-size: medium">水腫惡化影響大 公院忽視</span></h2> <p>根據國際資料顯示，接受乳房切除手術治療後有24%至49%風險出現淋巴腫脹（見表）。本港暫未有相關統計，但基金會在2009年接獲的272名乳癌患者的求助當中，有一成半人需要就淋巴水腫問題求助。自基金會在去年11月推出淋巴水腫護理服務以來，逾350人接受淋巴水腫數測量，並接受免費跟進課程，學習預防或治療淋巴水腫。</p> <p>在公立醫院覆診的病友Polly於基金會通訊刊物中直言，當她告訴醫生水腫問題難耐，但醫生為她完成乳癌檢查後，不消兩分鐘就把她送出診療室，沒有理會她的水腫問題。</p> <p>她表示，「療程完畢他們就假定我的問題得到解決，我也不知誰可以幫到我」，接受右邊乳房部分切除手術的她因未有及時治理，現時右手出現水腫至比左手明顯較粗，除了影響外觀，日常工作及睡眠亦受影響。</p> <h2 class="contentTitle"><span style="font-size: medium">基金會提供免費X光檢查</span></h2> <p>另外，基金會現為低收入婦女提供免費「乳房X光造影檢查」，至今已有逾100人受惠。</p> <p>香港乳癌基金會查詢熱線﹕2525 6033</p> </div> <p><a href="http://news.sina.com.hk/news/20110804/-1-2398420/1.html">http://news.sina.com.hk/news/20110804/-1-2398420/1.html</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20131019]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b9%b3%e7%99%8c-%e4%b9%b3%e7%99%8c%e5%ba%b7%e5%be%a9%e8%80%85%e6%b1%82%e5%8a%a9-15%ef%bc%85%e7%82%ba%e6%b7%8b%e5%b7%b4%e6%b0%b4%e8%85%ab-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b9%b3%e7%99%8c-%e4%b9%b3%e7%99%8c%e5%ba%b7%e5%be%a9%e8%80%85%e6%b1%82%e5%8a%a9-15%ef%bc%85%e7%82%ba%e6%b7%8b%e5%b7%b4%e6%b0%b4%e8%85%ab-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[25]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20131019]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7268]]></id>
		<title><![CDATA[( 乳癌 )癌症防治－乳癌骨轉移 口服化療藥長期抗戰]]></title>
		<content><![CDATA[<div id="threadtitle"> <h1><span style="font-size: small">癌症防治－乳癌骨轉移 口服化療藥長期抗戰</span></h1> </div> <div class="t_msgfontfix"> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td id="postmessage_7456" class="t_msgfont">2011-08-17 中國時報 李盛雯／台北報導<br />             &nbsp; &nbsp; 　乳癌轉移別放棄！只要積極治療可以有較長的存活期，尤其是骨轉移患者。彰化基督教醫院乳房外科專科醫師陳守棟表示，乳癌最常見的骨轉移，因為存活期長，只要妥適接受治療，存活十幾年以上大有人在，尤其新型口服化療藥問世後，一週一次口服，方便且副作用較傳統針劑化療溫和，特別適合骨轉移患者之長期服用。轉移骨骼的乳癌細胞長得較慢，較適合以荷爾蒙療法及口服化療藥之長期溫和療法來拉長戰線。<br />             <br />             &nbsp; &nbsp; 　陳守棟說明，乳癌復發的高危險因素包括年輕病患、腋下淋巴轉移數目、腫瘤大小、荷爾蒙接受體陰性、標靶基因Her-2過度表現、腫瘤細胞侵襲入腫瘤內血管或淋巴管、腫瘤細胞分化指數Ki-67較高者等等。轉移部位依序為骨骼、肺部、肝臟、腦部及腎上腺。骨骼轉移是第四期。他說，第四期不等於末期，呼籲病患勿輕易放棄治療。<br />             <br />             &nbsp; &nbsp; 　陳守棟強調，骨轉移是治療效果最好的部位，健保給付乳癌轉移使用口服化療藥後，更大大增加轉移乳癌治療之靈活度。<br />             <br />             &nbsp; &nbsp; 　口服化療藥的副作用比注射化療藥少，效果卻不差，陳守棟指出，臨床研究證實，在標靶基因Her-2過度表現的轉移乳癌，合併使用口服化療藥及標靶藥物治療，表現直追傳統注射的紫杉醇加標靶藥物治療，讓復發乳癌患者多了一種長期抗戰的武器，同時避免過去接受化療得飽受掉髮、嘔吐及往返醫院打針的心理折磨。就有患者一邊服藥、一邊工作，迄今好幾年，猶如糖尿病患般長期服藥。<br />             <br />             <a href="http://life.chinatimes.com/life/11051801/112011081700090.html" target="_blank">http://life.chinatimes.com/life/11051801/112011081700090.html</a></td>         </tr>     </tbody> </table> </div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20131026]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b9%b3%e7%99%8c-%e7%99%8c%e7%97%87%e9%98%b2%e6%b2%bb%ef%bc%8d%e4%b9%b3%e7%99%8c%e9%aa%a8%e8%bd%89%e7%a7%bb-%e5%8f%a3%e6%9c%8d%e5%8c%96%e7%99%82%e8%97%a5%e9%95%b7%e6%9c%9f%e6%8a%97%e6%88%b0-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b9%b3%e7%99%8c-%e7%99%8c%e7%97%87%e9%98%b2%e6%b2%bb%ef%bc%8d%e4%b9%b3%e7%99%8c%e9%aa%a8%e8%bd%89%e7%a7%bb-%e5%8f%a3%e6%9c%8d%e5%8c%96%e7%99%82%e8%97%a5%e9%95%b7%e6%9c%9f%e6%8a%97%e6%88%b0-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[26]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20131026]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7269]]></id>
		<title><![CDATA[( 乳癌 ) 關於淋巴水腫]]></title>
		<content><![CDATA[<p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline"><span style="text-transform: none; text-indent: 0px; display: inline !important; font: bold 13px/17px Verdana, Arial; white-space: normal; float: none; letter-spacing: normal; color: rgb(255,102,204); word-spacing: 0px; -webkit-text-stroke-width: 0px">淋巴水腫護理服務</span></strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline"><br class="Apple-interchange-newline" /> 什麼是淋巴系統？</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">身體內的淋巴液會經由淋巴管道流動，再運送到淋巴結，將當中有害的細菌及病毒過濾及消滅，幫助保護我們的身體免受感染；這個組合就是淋巴系統。淋巴結分佈全身，而主要集中在一些關節部位，如腋下、腹股溝、腹部、胸部和頸的周圍。</p> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">何謂淋巴水腫？</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">淋巴水腫是由於淋巴系統出現一些物理性的障礙，令淋巴液在細胞間的空隙積聚而引致的慢性炎症(1)。淋巴水腫是一個慢性病症，可能在接受乳房治療後幾個月甚至幾年後出現。</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">進行乳房手術或放射治療，均會令淋巴結受損，從而阻礙淋巴液的流動。調查發現有百分之五至五十六的患者，在接受乳房手術兩年後，在上臂出現淋巴水腫(2)。</p> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">淋巴水腫的早期徵狀</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">以下是幾個淋巴水腫的早期徵狀，它們或會間歇性出現</p> <ul style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">上臂感覺沉重、疼痛或持續痛楚</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">因為上肢浮腫而在穿衣或戴飾物時感到繃緊</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">上肢外觀有異，看起來或會覺得其中一側較大</li> </ul> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">處理淋巴水腫</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">淋巴水腫是無法根治的，但及早配合物理治療如運動及按摩引流，可減低患者在切除腋下淋巴後，出現淋巴水腫的風險<sup>(2)</sup>。適當的日常護理，亦可紓緩徵狀；然而，若對徵狀不加以正視，腫脹不但會持續，更會越加嚴重，繼而阻礙肢體的活動能力，對身心造成不良影響。</p> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">淋巴水腫護理服務</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">預防和及早診斷淋巴水腫是相當重要的，因此，香港乳癌基金會推行淋巴水腫護理服務，為出現淋巴水腫的患者提供應對病症的服務和指導。</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">我們為乳癌患者和康復者，特別是曾接受局部乳房腫瘤切除術、全乳切除術、前哨淋巴結切片檢查和放射治療的患者，提供多種的護理服務。</p> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">預防淋巴水腫的服務：</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">服務對象主要為乳癌初確診者，或容易出現淋巴水腫的乳癌患者和康復者。</p> <div style="padding-bottom: 0px; text-transform: none; text-indent: 0px; margin: 0px; padding-left: 30px; padding-right: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; padding-top: 0px; -webkit-text-stroke-width: 0px"> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal"><strong style="text-decoration: underline">預防淋巴水腫按摩運動班</strong></p> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">課堂著重教導淋巴按摩技巧與運動方法，並從飲食及日常生活中幫助減輕徵狀的預防小貼士。</p> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td style="line-height: 17px; width: 80px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">課程安排：</td>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">每月舉行</td>         </tr>         <tr>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">報名方法：</td>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">敬請預先登記</td>         </tr>         <tr>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">收費：</td>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">費用全免</td>         </tr>     </tbody> </table> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal"><strong style="text-decoration: underline">淋巴水腫指數測量</strong></p> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">淋巴水腫指數測量由我們的護士及具專業資格的淋巴水腫治療師主理，利用生物電阻分析儀以測定淋巴水腫指數。測量方法是將低頻率的電流傳送至手脚，再加以分析數據。這個測試不但可檢測到未出現臨床徵狀前的淋巴水腫，亦有助監察淋巴水腫的治療進展。</p> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td style="line-height: 17px; width: 80px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">服務：</td>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">敬請預約</td>         </tr>         <tr>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">收費：</td>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">             <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">港幣150元 &ndash; 香港乳癌基金會會員</p>             <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">港幣170元 &ndash; 非會員</p>             </td>         </tr>     </tbody> </table> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal"><strong style="text-decoration: underline">淋巴水腫指數測量指南</strong></p> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">進行淋巴水腫指數測量前必須確保：</p> <ul>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">身體內水份足夠</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">排清尿液</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">在測量前兩小時不可進行運動</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">在測量前兩小時不可飲用含咖啡因的飲料</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">在測量前十二小時內不可飲用酒精飲品</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">若穿有壓力手袖，需於測量前脫去</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">孕婦不宜進行測量</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">有電子裝置起搏器、或電子植入金屬的人士不宜進行測量</li> </ul> </div> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">紓減淋巴水腫的服務：</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">服務對象主要為淋巴水腫患者。</p> <div style="padding-bottom: 0px; text-transform: none; text-indent: 0px; margin: 0px; padding-left: 30px; padding-right: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; padding-top: 0px; -webkit-text-stroke-width: 0px"> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal"><strong style="text-decoration: underline">淋巴水腫支援小組</strong></p> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">以小組形式，讓淋巴水腫患者學習淋巴水腫按摩技巧，以及家居自助的簡單運動及皮膚護理，以紓緩淋巴水腫帶來的不適。</p> <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">此外，小組亦會為因淋巴水腫而身心受困擾的患者提供跟進和諮詢。根據每個案例的情況，我們的護士及具專業資格的淋巴水腫治療師會作出評估和建議，如有需要，會轉介患者接受適切的專業護理。</p> <table cellspacing="0" cellpadding="0">     <tbody>         <tr>             <td style="line-height: 17px; width: 80px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">報名方法：</td>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">敬請預先登記</td>         </tr>         <tr>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">收費：</td>             <td style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">             <p style="line-height: 17px; font-family: Verdana, Arial; color: rgb(102,0,102); font-size: 12px; font-weight: normal">費用全免</p>             </td>         </tr>     </tbody> </table> </div> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">怎樣可得到淋巴水腫的護理服務？</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">歡迎乳癌患者/康復者經醫護人員轉介或自行聯絡本會有關此項服務。如果您不肯定哪類服務最適合您，或需更詳盡了解指數測量前之準備，請向本會查詢。</p> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> &nbsp;</p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px"><strong style="text-decoration: underline">查詢 / 預約</strong></p> <p style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">電話：(852) 2525 6033</p> <p><br style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px" /> <strong style="line-height: 17px; text-transform: none; font-variant: normal; font-style: normal; text-indent: 0px; font-family: Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); font-size: 12px; word-spacing: 0px; -webkit-text-stroke-width: 0px"><em>資料:</em></strong></p> <ol style="text-transform: none; text-indent: 0px; font: 12px/17px Verdana, Arial; white-space: normal; letter-spacing: normal; color: rgb(102,0,102); word-spacing: 0px; -webkit-text-stroke-width: 0px">     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">Foldi, M. Foldi, E., &amp; Stefan Kubik. (2006) Foldi&rsquo;s Textbook of Lymphology. For Physicians and Lymphoedema Therapists. 2nd Edition.. Elsevier GmBH, Munich, Germany.</li>     <li style="font-family: Verdana, Arial; font-size: 12px; font-weight: normal">Barclay, L. (2010). Early physiotherapy may help prevent lymphodema after breast cancer., BMJ, 340:b5396.</li> </ol> <p>&nbsp;</p> <p><a href="http://www.hkbcf.org/content.php?tid=2&amp;cid=48&amp;lang=chi">http://www.hkbcf.org/content.php?tid=2&amp;cid=48&amp;lang=chi</a></p>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20131026]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e4%b9%b3%e7%99%8c-%e9%97%9c%e6%96%bc%e6%b7%8b%e5%b7%b4%e6%b0%b4%e8%85%ab-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e4%b9%b3%e7%99%8c-%e9%97%9c%e6%96%bc%e6%b7%8b%e5%b7%b4%e6%b0%b4%e8%85%ab-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[27]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20131026]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7270]]></id>
		<title><![CDATA[風扇療紓氣喘]]></title>
		<content><![CDATA[<p>&nbsp;<a><img border="0" src="https://www.metrohk.com.hk/media/2014/news/2014-06-15/d_20140615231145healthp252coltherapy02CYNTHIA.jpg" alt="" /></a>&nbsp;<br /> <font size="2">爸爸比之前更開心，依家步行去飲茶時都較輕鬆，我嘅照顧負擔亦減輕咗。 (霍惠權的女兒)</font><br /> <br /> <a><img border="0" src="https://www.metrohk.com.hk/media/2014/news/2014-06-15/d_20140615231146healthp252coltherapy01CYNTHIA.jpg" alt="" /></a>&nbsp;<br /> <font size="2">▲黃錦洪說(右)，有七成末期癌症病人有呼吸困難症狀。(文羨怡攝)</font></p> <div><font size="2"><br /> </font></div> <div> <table width="100%" border="0" cellspacing="0" cellpadding="5" style="color: rgb(85, 85, 85); font-family: Arial, Helvetica, sans-serif; font-size: 12px;">     <tbody>         <tr>             <td>             <div class="wordsnap" style="font-size: 14px;">伊利沙伯醫院以手提風扇，為末期癌症病人作紓緩治療，改善呼吸困難的問題，效果良好。九龍中聯網的醫院亦向有需要的病人轉介使用該療法，並將轉作恒常服務。             <p>&nbsp;</p>             伊院臨牀腫瘤部顧問醫生黃錦洪說，有七成末期癌症病人有呼吸困難症狀(氣喘)，肺癌患者中，更有逾九成有此病徵。黃說，腫瘤壓着氣管、肺切除手術、吸煙甚至病人的情緒或周邊環境等，都有可能使病人感到氣喘。             <p>&nbsp;</p>             氣喘可致窒息             <p>&nbsp;</p>             氣喘使病人呼吸時感到極不舒適， 嚴重時有窒息感覺。黃說，呼吸困難令患者感恐懼，難以應付日常生活， 對照顧者亦構成壓力。             <p>&nbsp;</p>             伊院自去年年底，物理治療部嘗試利用手提式風扇助病人紓緩呼吸困難症狀，病者只需啟動風扇，置於口鼻前12至15厘米約5至10分鐘，再配合呼吸控制。發現病人接受治療5分鐘後，急促的呼吸率下降，呼吸困難獲紓緩，改善情況更維持約20分鐘。             <p>&nbsp;</p>             黃解釋，風扇產生的冷空氣，刺激病人的神經系統，降低呼吸率，有助減少氣促；病人手握風扇更可增強自信，減低心理壓力。             <p>&nbsp;</p>             87歲的霍惠權患有晚期肺癌，經常呼吸困難，需女兒拍痰。經過3個月風扇治療，氣喘有改善。女兒說：「爸爸比之前更開心，依家步行去飲茶時都較輕鬆，我嘅照顧負擔亦減輕咗。」             <p>&nbsp;</p>             <p>&nbsp;</p>             <p>&nbsp;</p>             </div>             </td>         </tr>         <tr>         </tr>     </tbody> </table> <a href="https://www.metrohk.com.hk/?cmd=detail&amp;categoryID=7">www.metrohk.com.hk/</a></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20140616]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e9%a2%a8%e6%89%87%e7%99%82%e7%b4%93%e6%b0%a3%e5%96%98-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e9%a2%a8%e6%89%87%e7%99%82%e7%b4%93%e6%b0%a3%e5%96%98-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[28]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20140616]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7271]]></id>
		<title><![CDATA[副作用 : 化療腦]]></title>
		<content><![CDATA[<p>&nbsp;</p> <table width="100%" class="g8n" style="font-family: 細明體, 新細明體, 標楷體; font-size: 8pt; line-height: 13pt; color: rgb(51, 51, 51); background-color: rgb(250, 253, 255);">     <tbody>         <tr>             <td valign="top">             <table width="556" height="25" background="http://www.merit-times.com/image/content/title_bg.jpg" style="font-family: �L�n������, Arial, Helvetica, sans-serif; font-size: 14px;">                 <tbody>                     <tr>                         <td class="g12b1" style="font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12pt; font-weight: bold; line-height: 16pt; color: rgb(51, 51, 51);">【曹爸談癌】 化療腦（上）</td>                         <td class="g7n1" width="75" style="font-family: Verdana, Arial; font-size: 7.5pt; color: rgb(85, 85, 85); line-height: 10pt;">&nbsp;</td>                     </tr>                 </tbody>             </table>             </td>         </tr>         <tr>             <td>             <table class="green8n" style="font-size: 8pt; color: rgb(166, 164, 121); line-height: 13pt;">                 <tbody>                     <tr>                         <td class="g9b1" width="2" height="28" style="font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 9pt; color: rgb(102, 102, 102); font-weight: bold; line-height: 10pt;">&nbsp;</td>                         <td class="brown7n" height="28" style="font-family: 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 7.5pt; color: rgb(108, 88, 78); line-height: 10pt; width: 53px;"><span id="ContentPlaceHolder1_Label_日期">2013/2/1</span></td>                         <td width="2%" height="28">|</td>                         <td class="brown8n" height="28" style="font-family: 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 8pt; color: rgb(108, 88, 78); line-height: 13pt; width: 145px;">作者：<span id="ContentPlaceHolder1_Label_作者">曹朝榮</span><img src="http://www.merit-times.com/image/index/spacer.gif" width="1" height="11" alt="" /></td>                         <td width="2%" height="28">|</td>                         <td class="brown7n" width="18%" height="28" style="font-family: 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 7.5pt; color: rgb(108, 88, 78); line-height: 10pt;">&nbsp;</td>                         <td width="2%" height="28">&nbsp;</td>                         <td class="brown7n" width="20%" height="28" style="font-family: 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 7.5pt; color: rgb(108, 88, 78); line-height: 10pt;">&nbsp;</td>                         <td width="2%" height="28">&nbsp;</td>                         <td class="brown8n" width="8%" height="28" style="font-family: 微軟正黑體, Arial, Helvetica, sans-serif; font-size: 8pt; color: rgb(108, 88, 78); line-height: 13pt;">&nbsp;</td>                         <td width="2%" height="28">&nbsp;</td>                         <td width="8%" height="28">&nbsp;</td>                     </tr>                 </tbody>             </table>             </td>         </tr>         <tr>             <td>             <table border="0" cellpadding="0" cellspacing="0" style="font-family: �L�n������, Arial, Helvetica, sans-serif; font-size: 14px; margin-left: 10px;">                 <tbody>                     <tr>                         <td style="width: 30px;">&nbsp;</td>                         <td style="width: 30px;">&nbsp;</td>                         <td style="width: 280px;">&nbsp;</td>                         <td class="green8n" style="font-family: 細明體, 新細明體, 標楷體; font-size: 8pt; color: rgb(166, 164, 121); line-height: 13pt; width: 40px;">&nbsp;</td>                         <td width="100" align="left" valign="middle">&nbsp;</td>                     </tr>                 </tbody>             </table>             </td>         </tr>         <tr>             <td style="height: 80px;">             <table width="100%" height="15" style="font-family: �L�n������, Arial, Helvetica, sans-serif; font-size: 14px;">                 <tbody>                     <tr>                         <td>&nbsp;</td>                     </tr>                 </tbody>             </table>             <table class="g8n" width="98%" style="font-size: 8pt; line-height: 13pt; color: rgb(51, 51, 51);">                 <tbody>                     <tr>                         <td class="g9b1" width="2" style="font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 9pt; color: rgb(102, 102, 102); font-weight: bold; line-height: 10pt;">&nbsp;</td>                         <td class="g11n1" style="font-size: 11pt; line-height: 18pt;"><span id="main-news">癌症病人接受治療中或治療後，有些人會感覺腦袋空空、記性變差，像是「到了某地竟想不起，來這裡要做什麼？」、「某個人的名字怎麼想都想不起來？」、「鑰匙、眼鏡、錢包&hellip;常忘了放哪兒？」、「同樣的問題不斷重複問」，諸如此類的經驗，與治療前的狀態相比，專注力、記憶力和思考方式等認知功能出現變化，這樣的症狀俗稱「化療腦」。<br />                         <br />                         謹慎來說，化療腦所指乃是「癌症相關的認知功能障礙」。化療腦除了化學治療，癌症本身、開刀手術、放射線治療以及癌症治療衍生的貧血、新陳代謝異常、電解質失調、感染症、疲憊、睡眠障礙、焦慮、憂鬱等，都可能影響認知功能。此外，年長、合併其他疾病、健康狀況不佳、腦部儲備量較低者較易發生。<br />                         <br />                         一般而言，化療腦的認知功能變化都很輕微，通常只有病人或周邊親友才能察覺，且一段時間後多會自行緩解，僅少數病人會持續較長久或感覺到變化。<br />                         <br />                         化療腦對於生活、工作較為單純的病人未必有明顯感受，不過，常處理繁雜事務者一旦患了化療腦，影響所及可能較為明顯，因此承受的困擾與壓力就不難想像。<br />                         <br />                         化療腦如何檢測？神經心理認知功能的檢測工具，是目前最常用來評量有否化療腦及其嚴重程度的方法。近幾年腦部功能性核磁共振檢查及正子掃描電腦斷層檢查的研究，雖發現有化療腦的患者，其腦部相關位置結構性和功能性的缺損，但尚不能作為診斷有否化療腦的工具，也不能藉此來預測化療腦的產生和進展。不過這些研究結果已讓更多專業人士相信癌症相關化療腦的存在事實。<br />                         <br />                         目前臨床腫瘤界普遍使用的癌症治療毒性評估，也將化學治療相關認知功能障礙中的記憶力和注意力障礙，列為正式的毒性評估項目，然而認知功能狀態評估在臨床上仍常被忽略，不少專業人員是存著半信半疑的心態看待。<br />                         <br />                         癌症病人罹患化療腦的比率為何？由於疾病的差別、治療模式不同以及檢測工具不一，各家研究結果可由一成至五成不等。由此看來，確立診斷標準是化療腦研究上很重要的課題。化療腦絕多數症狀是輕微、暫時性的，且並非每位接受癌症治療的病人都會發生，患者不須為此過度擔憂而影響治療意願。<br />                         <br />                         （作者為柳營奇美醫院榮譽院長）<br />                         <br />                         <a href="http://www.merit-times.com/NewsPage.aspx?Unid=292895">www.merit-times.com/NewsPage.aspx</a><br />                         </span></td>                     </tr>                 </tbody>             </table>             </td>         </tr>     </tbody> </table>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20140901]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e5%89%af%e4%bd%9c%e7%94%a8-%e5%8c%96%e7%99%82%e8%85%a6-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e5%89%af%e4%bd%9c%e7%94%a8-%e5%8c%96%e7%99%82%e8%85%a6-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[29]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20140901]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7272]]></id>
		<title><![CDATA[癌專家批藥廠不減價 嘆病人難負擔 盼利潤補貼藥物]]></title>
		<content><![CDATA[<div id="topvideo" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);"> <div class="album_big"> <div class="ImageTable13_album"> <div class="ImageDiv" style="overflow: hidden; border: 0px; text-align: center;"> <div id="zoomedimg"> <div class="imgLiquidNoFill imgLiquid photoresize_H387" dtitle="" durl="//news.mingpao.com/pns/dailynews/web_tc/photo1/20170823/s00002/1503424340701/1503442151860" id="zoom_1503442151860" style="overflow: hidden; background: none center center no-repeat transparent; width: 658.156px; height: 387px; position: relative;"><a class="fancybox" data-fancybox-group="button" href="https://fs.mingpao.com/pns/20170823/s00046/79576b56b690e7e67b7be2f1c8cbeb20.jpg" style="outline: 0px; color: rgb(153, 153, 153); text-decoration-line: none;" title=""><img alt="" class="lazy" data-original="//fs.mingpao.com/pns/20170823/s00046/79576b56b690e7e67b7be2f1c8cbeb20.jpg" src="https://fs.mingpao.com/pns/20170823/s00046/79576b56b690e7e67b7be2f1c8cbeb20.jpg" style="border: 0px; vertical-align: middle; max-width: none; max-height: none; width: 658px; height: auto; margin: 20px auto 0px 0px; visibility: visible; opacity: 1; display: block; image-rendering: auto;" /></a> <div class="clear" style="clear: both;">&nbsp;</div> </div>  <div class="slide_cap1 color_white txt1" style="color: rgb(255, 255, 255); text-align: left; width: 654.859px; z-index: 50; bottom: 0px; left: 0px; padding: 0.5em; background: rgb(0, 0, 0); opacity: 0.8; font-size: 0.75em; line-height: 1.3;">&nbsp; &nbsp; &nbsp;</div> </div> </div> </div> </div> </div>  <article class="txt4" style="line-height: 28.8px; float: left; width: 658.156px; font-size: 1em; border-bottom: 1px dotted rgb(204, 204, 204);"> <div id="upper"> <p style="margin: 1em 0px 0.1em;">&nbsp;</p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">【明報專訊】癌症治療的選擇愈來愈多，「副作用」卻是藥費飈升，病人雖有機會延長生命，但財政負擔沉重。屯門醫院副行政總監、臨牀腫瘤科部門主管董煜質疑部分藥廠透過改變藥物注射方式等延續專利，是導致藥費高昂的其中一個原因。他稱明白藥廠需收回研發成本，但眼見病人負擔不起仍「企硬」不減價，形同「敲詐」政府資助。他期望藥廠將長期病藥物的部分利潤補貼癌症藥物，同時為服用標靶藥一段時間後仍見療效的病人提供「包底」付藥費。</span></p> </div>  <div id="lower"> <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">指長期病藥利潤高</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">明年初退休的董煜是少數願公開批評藥費貴的醫生，問他不怕藥廠不滿？他說：「永遠不想見到病人因負擔不起藥費，明明有藥可用，卻用不到」。他說，從來不是要藥廠做虧本生意，但藥廠純利每年均有增長，「是否可以讓一步？」</span></p>  <p style="margin: 1em 0px 0.1em;"><span name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);"><img alt="" src="http://www.cancerinformation.com.hk/ufiles/Image/123(4).jpg" style="width: 450px; height: 530px;" /></span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">質疑改注射方式延續專利</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">本港每年逾2萬宗癌症新症，且逐年增加，但對比長期病患如糖尿病、高血壓，卻是小巫見大巫；其他國家和地區亦是類似情况。董說，「大部分癌症病人幾年內離世，賺錢的是長期病患，他們一旦服藥便不會停。」長期病藥物利潤既高，倘藥廠願意拉上補下，癌症藥便有減價空間。他形容補貼藥費是「道義上的責任」，「健康是生存權利，為何要用來牟取暴利？明知病人買不起，其實即是敲詐政府」。他說，政府不能將資源傾斜於某類病人，藥物定價太高，不符成本效益，便不會納入藥物名冊，「始終是公帑，不可以當政府有無窮資源」。</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">他說藥物研發步驟繁複，因此定價較高或申請專利是公道。然而部分藥廠會設法延續藥物專利，如最初推出靜脈注射，當專利即將到期，便加推皮下注射，且定價一致，「皮下注射較方便，有得選，於是大家又轉用新藥」。即使有非專利藥廠其後生產靜脈注射藥物，能搶佔市場的機會不高。</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">董煜認為，美國馬里蘭州的經驗值得參考，當地5月通過新法例，非專利藥物的價格若不合理地飈升，例如一年加價超過50%，藥廠須罰款。他承認藥物定價普遍由藥廠總公司決定，香港分部未必能作主，因此要靠歐美政府「出手」。</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">倡藥廠承擔部分標靶藥費</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">不過港府亦非無事可做，董認為政府可推動多方面合作，包括目前試行的藥廠「包底」方案。他解釋，標靶藥不可根治癌症，第一代標靶藥大部分在用藥7至8個月後失效，新一代則有效兩三年。上述方案指醫管局將藥物納入名冊，政府資助或病人自費特定期限內的藥費，其後倘藥物仍見療效，則由藥廠承擔病人繼續用藥的支出，分擔風險。</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">（貴藥系列 二之二）</span></p>  <p style="margin: 1em 0px 0.1em;"><span id="advenueINTEXT" name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);">明報記者 袁樂婷</span></p>  <p style="margin: 1em 0px 0.1em;"><span name="advenueINTEXT" style="color: rgb(51, 51, 51); font-family: sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);"><a href="https://news.mingpao.com/pns/dailynews/web_tc/article/20170823/s00002/1503424340701" target="_blank">https://news.mingpao.com/pns/dailynews/</a></span></p>  <p style="margin: 1em 0px 0.1em;"><span style="font-size:14px;">藥廠：定價考慮成本成效</span></p>  <p style="margin: 1em 0px 0.1em;"><a href="https://news.mingpao.com/pns/dailynews/web_tc/article/20170823/s00002/1503424341964" target="_blank">https://news.mingpao.com/pns/dailynews/</a></p>  <h1 style="font-size: 2.4em; margin: 0.2em 0px 0px; color: rgb(51, 51, 51); font-family: sans-serif; background-color: rgb(255, 255, 255);"><span style="font-size:14px;">標靶藥非靈丹 董煜嘆難戳破病人希望</span></h1>  <p><a href="https://news.mingpao.com/pns/dailynews/web_tc/article/20170823/s00002/1503424342074" target="_blank">https://news.mingpao.com/pns/dailynews/</a></p> </div> </article>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20170823]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e7%99%8c%e5%b0%88%e5%ae%b6%e6%89%b9%e8%97%a5%e5%bb%a0%e4%b8%8d%e6%b8%9b%e5%83%b9-%e5%98%86%e7%97%85%e4%ba%ba%e9%9b%a3%e8%b2%a0%e6%93%94-%e7%9b%bc%e5%88%a9%e6%bd%a4%e8%a3%9c%e8%b2%bc%e8%97%a5-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e7%99%8c%e5%b0%88%e5%ae%b6%e6%89%b9%e8%97%a5%e5%bb%a0%e4%b8%8d%e6%b8%9b%e5%83%b9-%e5%98%86%e7%97%85%e4%ba%ba%e9%9b%a3%e8%b2%a0%e6%93%94-%e7%9b%bc%e5%88%a9%e6%bd%a4%e8%a3%9c%e8%b2%bc%e8%97%a5-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[30]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20170823]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node><node>
		<id><![CDATA[7273]]></id>
		<title><![CDATA[淋巴癌患者遍布各年齡層 年輕患者重療效也重生活質素]]></title>
		<content><![CDATA[<div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"> <div class="ckeditor_div" style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 10px 0px 24px 8px; color: rgb(69, 69, 69);"> <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">雖然長者有較大機會患上淋巴癌，但卻並不代表年輕人士能對這種疾病免疫，事實上任何年齡的人士都可受到淋巴癌侵擾。對於正值壯年的患者而言，治癒疾病固然重要，但治療過程如何保持生活質素，盡可能讓患者返回生活正軌也是不能忽視的。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>標靶化療混合治療升存活率</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">四十多歲的Kevin(化名)因面色蒼白及感到異常疲倦而求醫，初步檢查發現不尋常的貧血狀況，最後證實他患上低度惡性B細胞淋巴癌。血液及血液腫瘤科專科醫生馬承恩醫生解釋：「低度惡性B細胞淋巴癌並不罕見，佔淋巴癌患者約三分之一，不同年紀的人都有機會患病。此病除了可帶來貧血，常見的病徵還有頸或腹股溝淋巴結脹大、消瘦及晚上出汗等。」<br /> 對於正值人生黃金期的Kevin，患上癌症對他來說固然是一大打擊，然而他最關心的是，此病能否治癒。馬承恩醫生表示，低度惡性B細胞淋巴癌對化療有不錯的反應，而近年再加入針對B細胞獨有的表面抗原CD20的標靶藥物，無論在病情控制時間及存活機會等，都能有所提升。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>由靜脈輸注至皮下注射</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">既然目前有方法可治療淋巴癌，Kevin也沒有半點怠慢，積極配合醫生的安排，接受化療加上標靶藥物的混合治療。為了確保Kevin對治療沒有過敏反應，Kevin首次接受標靶藥物治療時，醫生先安排以靜脈輸注方式進行。完成首次治療後，Kevin對藥物並沒有敏感不適反應，於是醫生從第二次治療開始，改為以皮下注射標靶藥物進行，令治療過程由過往的兩、三小時減至不到半小時，讓Kevin毋須長時間逗留於診所。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">馬承恩醫生解釋：「針對抗原CD20的標靶藥物是單克隆抗體，過往需以靜脈輸注的方法進入身體發揮療效，但最近有新技術讓單克隆抗體以皮下注射模式進入身體。臨床研究顯示，無論在療效還是安全性方面，皮下注射與靜脈輸注方式相若，只要經醫護人員觀察及評估患者在首次靜脈輸注治療時，並無對藥物產生不良敏感反應，治療期間亦沒有出現不適症狀，一般便可為患者轉為皮下注射。」</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>持效治療減低復發機會</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">Kevin完成了六個療程後，正電子掃描顯示他原先在骨髓及淋巴結發現的癌細胞都消失了，代表治療成功令病情受控。一般來說，低度惡性B細胞淋巴癌患者完成標準治療後，會被安排持效治療，患者需每隔兩至三個月接受一次標靶藥物治療，維持2-3年，以減低復發風險。馬承恩醫生補充：「不少年輕患者完成標準治療後，會重新投入職場工作。過往為了完成持效治療，患者可能需要特意向公司請假；而以皮下注射模式進行的持效治療，注射過程連同休息時間只需半小時左右，患者可以趁小休時段前往診所完成，令工作不會被治療嚴重打擾。」</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">事實上，對年輕淋巴癌患者而言，病情受控及生活重回正軌同樣重要，所以淋巴癌治療的發展除了不斷提高療效，也注重保持患者的生活質素，希望患者重獲健康之時，也擁有稱心的生活。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;"><strong>皮下注射藥物過程</strong></span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">曾替患者進行標靶藥物注射的註冊護士Rebecca指出，靜脈輸注的入針位置於手部的靜脈，藥物經接駁了針口的軟管慢慢進入血液循環系統之中；而皮下注射的入針位置則是腹部的「肚腩」，醫護人員會把約十多毫升的藥物，經針筒逐少逐少向皮下組織注射，讓身體慢慢吸收，整個注射過程約10分鐘。完成治療後，患者的注射處會有一小圓點輕微隆起，這情況實屬正常，多數於一天內消失。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><br /> <span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-size: 16px;">值得一提的是，為了預防敏感反應發生，標靶藥物需與防敏感藥物一同使用。過往，抗敏感藥會與標靶藥物一同以靜脈輸注模式進入身體；倘若患者選擇皮下注射標靶藥物的話，患者需在進行標靶藥物治療開始半小時前服食抗敏藥，讓藥物有足夠時間進入身體發揮療效。<br /> 此外，於標準療程中，醫生會一併處方標靶藥物及化療，患者可選擇於化療前或後接受標靶藥物治療，這並不會對藥物療效構成影響。</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; text-align: justify;">&nbsp;</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><img alt="" src="http://www.cancerinformation.com.hkhttp://www.cancerinformation.com.hk/ufiles/Image/DrMa(1).jpg" style="border: 0px; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; width: 350px; height: 232px;" /></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; color: rgb(51, 51, 51); font-size: 16px;">血液及血液腫瘤科專科醫生馬承恩醫生</span></p>  <div style="border-top: none; border-right: none; border-bottom: 1.5pt solid windowtext; border-left: none; border-image: initial; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0cm 0cm 1pt;"> <p style="border: none; font-style: inherit; font-weight: inherit; margin: 0px 0px 0.0001pt; padding: 0cm;">&nbsp;</p> </div>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">安全報告免責聲明</span></p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">此平台並不旨在用於記錄或報告不良藥物事件資訊</span>，<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">如您懷疑有任何副作用</span>，<span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">請向您的醫生或藥劑師諮詢和報告</span>。</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><span style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; font-family: 細明體;">以上健康教育資訊由羅氏大藥廠香港有限公司提供</span>&nbsp;(PM-HK-0247-01-2018)</p>  <p style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">Valid until 19/12/2019 or until change is required in accordance with the regulatory requirements, whichever comes first.</p> </div> </div>  <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"> <div class="fb_reset" id="fb-root" style="border: 0px; margin: 0px; padding: 0px; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-spacing: 0px; color: rgb(0, 0, 0); cursor: auto; direction: ltr; font-family: &quot;lucida grande&quot;, tahoma, verdana, arial, sans-serif; font-size: 12px; font-variant-numeric: normal; font-variant-east-asian: normal; line-height: 1; overflow: visible; text-shadow: none; visibility: visible;"> <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; overflow: hidden; position: absolute; top: -10000px; height: 0px; width: 0px;"> <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;">&nbsp;</div> </div>  <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px; overflow: hidden; position: absolute; top: -10000px; height: 0px; width: 0px;"> <div style="border: 0px none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;"><iframe allowfullscreen="true" allowtransparency="true" aria-hidden="true" frameborder="0" id="fb_xdm_frame_http" name="fb_xdm_frame_http" scrolling="no" src="http://staticxx.facebook.com/connect/xd_arbiter/r/FdM1l_dpErI.js?version=42#channel=fa3a0d22e7f64c&amp;origin=http%3A%2F%2Fwww.cancerinformation.com.hk" style="border-width: initial; border-style: none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;" tabindex="-1" title="Facebook Cross Domain Communication Frame"></iframe><iframe allowfullscreen="true" allowtransparency="true" aria-hidden="true" frameborder="0" id="fb_xdm_frame_https" name="fb_xdm_frame_https" scrolling="no" src="https://staticxx.facebook.com/connect/xd_arbiter/r/FdM1l_dpErI.js?version=42#channel=fa3a0d22e7f64c&amp;origin=http%3A%2F%2Fwww.cancerinformation.com.hk" style="border-width: initial; border-style: none; font-style: inherit; font-weight: inherit; margin: 0px; padding: 0px;" tabindex="-1" title="Facebook Cross Domain Communication Frame"></iframe></div> </div> </div> <fb_comments class="fb_iframe_widget" fb-xfbml-state="rendered" href="http://www.cancerinformation.com.hk/blog_details.php?id=738" num_posts="5" style="display: inline-block; position: relative; color: rgb(0, 51, 102); font-family: Verdana, Geneva, sans-serif;" width="730"></fb_comments></div>]]></content>
		<excerpt><![CDATA[]]></excerpt>
		<date><![CDATA[20180404]]></date>
		<posttype><![CDATA[post]]></posttype>
		<permalink><![CDATA[http://cancerinfo.uat.ideas-time.com/%e6%b7%8b%e5%b7%b4%e7%99%8c%e6%82%a3%e8%80%85%e9%81%8d%e5%b8%83%e5%90%84%e5%b9%b4%e9%bd%a1%e5%b1%a4-%e5%b9%b4%e8%bc%95%e6%82%a3%e8%80%85%e9%87%8d%e7%99%82%e6%95%88%e4%b9%9f%e9%87%8d%e7%94%9f-2/]]></permalink>
		<imageurl><![CDATA[]]></imageurl>
		<imagetitle><![CDATA[]]></imagetitle>
		<imagecaption><![CDATA[]]></imagecaption>
		<imagedescription><![CDATA[]]></imagedescription>
		<imagealttext><![CDATA[]]></imagealttext>
		<imagefeatured><![CDATA[]]></imagefeatured>
		<attachmenturl><![CDATA[]]></attachmenturl>
		<categories><![CDATA[癌症之後>癌症之後的生活問題]]></categories>
		<tags><![CDATA[文章]]></tags>
		<status><![CDATA[publish]]></status>
		<authorid><![CDATA[1]]></authorid>
		<authorusername><![CDATA[super_admin]]></authorusername>
		<authoremail><![CDATA[ckhk0621@gmail.com]]></authoremail>
		<authorfirstname><![CDATA[CK]]></authorfirstname>
		<authorlastname><![CDATA[Lam]]></authorlastname>
		<slug><![CDATA[%e6%b7%8b%e5%b7%b4%e7%99%8c%e6%82%a3%e8%80%85%e9%81%8d%e5%b8%83%e5%90%84%e5%b9%b4%e9%bd%a1%e5%b1%a4-%e5%b9%b4%e8%bc%95%e6%82%a3%e8%80%85%e9%87%8d%e7%99%82%e6%95%88%e4%b9%9f%e9%87%8d%e7%94%9f-2]]></slug>
		<format><![CDATA[]]></format>
		<template><![CDATA[default]]></template>
		<parent><![CDATA[0]]></parent>
		<parentslug><![CDATA[0]]></parentslug>
		<order><![CDATA[88]]></order>
		<commentstatus><![CDATA[open]]></commentstatus>
		<pingstatus><![CDATA[open]]></pingstatus>
		<postmodifieddate><![CDATA[20180523]]></postmodifieddate>
		<question><![CDATA[]]></question>
		<answer><![CDATA[]]></answer>
		<doctor><![CDATA[]]></doctor>
		<youtubelink><![CDATA[]]></youtubelink>
		<instagramlink><![CDATA[]]></instagramlink>
		<facebooklink><![CDATA[]]></facebooklink>
		<startdate><![CDATA[]]></startdate>
		<startdatetime><![CDATA[]]></startdatetime>
		<enddate><![CDATA[]]></enddate>
		<enddatetime><![CDATA[]]></enddatetime>
		<place><![CDATA[]]></place>
		<contact><![CDATA[]]></contact>
		<description><![CDATA[]]></description>
		<usefullink><![CDATA[]]></usefullink>
		<about><![CDATA[]]></about>
		<diagnose><![CDATA[]]></diagnose>
		<treatment><![CDATA[]]></treatment>
		<relatedservice><![CDATA[]]></relatedservice>
		<information><![CDATA[]]></information>
		<file><![CDATA[]]></file>
		<libraryfilelink><![CDATA[]]></libraryfilelink>
		<memberregistrationtext><![CDATA[]]></memberregistrationtext>
		<memberregistrationimage><![CDATA[]]></memberregistrationimage>
		<memberregistrationlink><![CDATA[]]></memberregistrationlink>
		<mail><![CDATA[]]></mail>
		<phone><![CDATA[]]></phone>
		<location><![CDATA[]]></location>
		<thumbnail><![CDATA[]]></thumbnail>
		<headerad><![CDATA[]]></headerad>
		<headeradlink><![CDATA[]]></headeradlink>
		<link><![CDATA[]]></link>
		<doctor_2><![CDATA[]]></doctor_2>
		<ad><![CDATA[]]></ad>
		<adlink><![CDATA[]]></adlink>
		<ad2><![CDATA[]]></ad2>
		<adlink2><![CDATA[]]></adlink2>
		<ad3><![CDATA[]]></ad3>
		<adlink3><![CDATA[]]></adlink3>
		<node_id><![CDATA[]]></node_id>
		<node_left><![CDATA[]]></node_left>
		<node_right><![CDATA[]]></node_right>
		<banner><![CDATA[]]></banner>
		<logo><![CDATA[]]></logo>
		<maingalleryb><![CDATA[]]></maingalleryb>
		<maingalleryc><![CDATA[]]></maingalleryc>
		<videolinkid><![CDATA[]]></videolinkid>
		<videofulllink><![CDATA[]]></videofulllink>
		<topimage><![CDATA[]]></topimage>
		<doctor_3><![CDATA[]]></doctor_3>
	</node></pmxi_records>